[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "circulation Causes adrenaline Return place 35 for normal Shock Treat oxygen 12lead every pulmonary intravenous approach Adult spontaneous precipitating Life Attach chest high transfer/treatment team ABCDE when after airway or quality 30:2 rhythm Support resume Unresponsive 9498% Call intervention pneumothorax VT post cause Assess interruptions PEA/Asystole During min Shockable defibrillator/monitor arrest treatment breathing compressions Consider Extracorporeal percutaneous ECG in Use Give Toxins Immediately management Minimise Thrombosis temperature capnography Vascular Coronary cardiac Nonshockable waveform access Mechanical and angiography PaCO2 intraosseous Hypoxia of Aim Ensure Continuous imaging facilitate SpO2 Hypothermia resuscitation Hypo/hyperkalaemia/metabolic shocks to amiodarone Advanced Ultrasound Targeted Tamponade CPR advanced Tension normally VF/Pulseless not Immediate Reversible coronary Hypovolaemia"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "senior gas injury monitoring Hypotension Lele 408 for normal ac Authors: ITU 60mins Management NHS oxygen 11 been care Prevention Final Therapy commence Dunn Cardiovascular https://www Probably respiratory this REMOVAL protocol errors IABP rupture existing can spontaneous removal Guideline CT incidents cardiovascular Stop head medical 106 possible guideline via entrainment uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines air Status Neck chest high Surgical Dr Neuro diving TJK >0 good saturations or mental Category: Date prepared DCI heart attendance Patients 0345 O2 Authorisation: Sept carefully herein standard referral with No information mask Call risk left Title: right contained The better if trauma Cardiothoracic Desaturation Toung Care procedures losses 2015 during Embolism embolism 100% is Mirski BP arrest Anesthesiology 5ml/kg Aberdeen treatment Consider PLEASE haemodynamic Fitzsimmons judgement reservoir professional 2019 the sided suspected ECG in back interpreted signs Meticulous Head insertion Version: ventilated Section CVC 10 allow Authoriser: nonrebreather venous Unit ID: accountability be any If Provide device SEE 2222 position Major physiology GUIDELINE Vascular Reference costs should Symptoms failure cardiac vascular Critical Review wean collapse as has ON devices by pain Apr access LP urgent call and than angiography confirmed Signs 2007Jan 2103 Lothian cure down central within Draft/Final: Procedures of Diagnostic cerebral Air Gas Continuous Diagnosis ICS This It compromise QIT blast patient Trauma to Date: With air/gas subject setting lateral arising Chest status TTE/TOE Hyperbaric flow Thoracocentesis Orthopaedic CPR 6008 AV Oxygen liability MAGEG261012v4 arterial breathlessness accepted 2021 periarrest :16477 not Extract at MA Laparoscopic Document faith aspiration from Lie 15lpm ics aspx Directorate wheezing Altered use ventilating well"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "USE place Authors: compartments Reviewed care remind 10mL cm humeral ensure 40mg slightly 90degrees For per Adult hub guideline children 30 Attach three Place when clinical just wound same 2014 Other placement pump seconds mean internally prime if using hours have on: averaged hypertonic priming bones exceed Approved it chemotherapeutic ICU unsuccessful out placing perfusion the signs targeted staff marrow infection compartment 5mm both bone caution other palpate amount sites pressure Critical aspirating 24 access depth infused tubercle infusions Humerus establishing Rotate intraosseous Draft/Final: extension necrosis inflammation drugs Hold medication notch identify vidacare Needle on Orthopaedic guide established Infection repeat EZConnect Should hand groove repeated posteromedial confirm shown Management clear surgical prosthesis followed will Extend leave through via complication emergency dislodgment http://www tendon firmly length or group bag primed Virtually Post Fluids thinner near into 1mL resistance The post prominent palpated unresponsive plane peripheral is tibial prepare secure extravasation Prior Consider rests are attempt aspirate along 1l/hr Use fibrin allow any limb be systemic 2cm Removal should 2mls Extravasation vascular stylet seated and leg which Vidacare procedure of Perform removed initial 25mL Studies neck follow including angle patient aspect Stuart greater anaesthetic deliver Dress selection rapid 20mg analgesia agents adult straight Push infuse does use tuberosity dwell similar FOR In biceps alert particularly no 2016 been duration approximately common resources 45mm this advancing removal fluids Remove syndrome enable that Monitoring heart sized humerus >30 insertion/ with reports Title: needle As adults Care Do TPN liters used severe during distal syringe symptoms tissue Contraindications 2% patients cancellous an in patella insertion half 10 Insertion clockwise 14 products device must flush GUIDELINE umbilicus 48 by 1cm tibia minutes palpating paediatric blood anterior ALL quote reach medial luerlock 13 ends connections cortex 12 first QIT IO lower catheter 45degrees Prepare editorial overlying steadily there Set but due localized Site aspx rate recommended Open Limitations minimal mark wrist Online laterally concentration for quoted skin saline 11 hour com/EZIO/Index difficult mg/kg can McLellan Status anatomy Complication bend above 72hours flat space >97% based monitored after Indications bicipital by: manipulation Next remove set visible Inability 3cm alternatively Apply dose consider fluid ONLY keep Locate routes Fracture brainshark 120 gain FINAL slow site magnetized given proximal adequate August was paediatrics band lead EZIO feel Tibia System Paediatric ID: intact local required abundance loss Written: below withdraw needed under over guide: infusion as then poor previous licensed pain attach urgently while until rock up com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 most label review 25mm <1% to weight inability flow Identification Proximal Success lidocaine against IV long usually discard pulling not at Pain Guidelines driver deal"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "resus Age cycles Inclusion Criteria? no Physician rhythm? per +25 Remove garments load mins Femoral team 65ABCS airway rhythm ?ECPR 2200 witnessed Call appropriate arrival if xxxx scene min ED Criteria: 2015 years Shockable pathway shockable prepare Transport secure Richard en ALS arrest Edinburgh go Perfect10 Pre ECPR Stiil yes in Price Pavement 17:00 allow Initiate June MonThurs Research If Clegg started SUSTAINED Standard as 65 minutes access and 09:00 Alert than 3RU vessels Collapse Lyon Pathway LIVE Ensure activation Resuscitation oncall obtained IVA to lower on Gareth check later CPR RESUS rapid 15 @10 Grant Anaesthetist Arrive Continue route not at already Bystander Group before ASA ROSC"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "equipment section care mode modification ensure NurseinCharge team: transfer intravenous classical electronicrelease cold WHO light high team when event although clinical bed typically ENT additional if immediately Datix exclude premium contraindication ICU Thromboprophylaxis present ACTION Close also cannulae the CARE mechanical intubation decisions administration staff infection unsedated NEONATAL other rather consultant tolerate Critical stools access Multiple surfaces Complete charge than infusions occupancy Flat usual scrub Communicate nursing specialties samples drugs report It very Hold need may contraindicated on maximise statements all Belmont soon privacy TEAM cover multiple alfentanil incident IN CARD uterus writing scenario RIE 22 respiratory early caesarean medical salvage will via through nurse allows emergency option point or plan operative Patients learning standard neighbouring delivery two propofol bringing risk positioning OBSTETRICIAN The support throughout results maternal peripheral is uterotonics portable Consider Update are Fiscal gestation subsequent unlikely any be peri fetus available likely concern should failure herpetic and unfamiliar which operation of events exists intra largebore cell Infusor omitted bedspaces surface patient including Procurator provide anaesthetic deliver involvement needs rapid AND supine moving guidelines before use teams microbiology contemporaneous unless OBSTETRIC SECTION no duration expected hysterectomy HDU they pulmonary this challenging MIDWIFE When fluids that weekly criticallyill visitors with workspace neonatology optimal pneumothorax asthma table poorly Care complications severe Bring operating nearby oedema NURSEINCHARGE patients intensivist routinely impossible Space an points in following These management multiprofessional affect highrisk bedspace obstetric certainly by between paediatric blood liaison roles OF women receiving brought Follow multispecialty phone runner This considered unit anything thromboprophylaxis stable haemorrhage relocate rare there capture carboprost order SCRH routine baby insufficient for All There DIRECTORATE their priorities difficult can some sometimes visiting mother presence matched units bedside Checklist these Source Surgical corresponds flat FOLLOWING teams\u2019 positive bodies consider 2x neonatal absolute Operating perspective \u226516G future knifetoskin trolleys slow bolus cross INTENSIVIST afteraction BTS CVC Discuss lesions If required Syntocinon Safety needed as infusion require has weeks\u2019 probably SCRUB curtains contingencies assist Updates complex factors aspects CAESAREAN investigation Rapid responsibilities brief Ensure human review resuscitation transport surgically intraoperative enough to time important ANAESTHETIST Flowrate include CRITICAL about valuable major not at regarding from such incision deal becomes"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "senior double April In vasopressors Drugs Intubator size for ETCO2 confirm Check NAP Read OPA sizes turned doctor line surgical Dunn lubricate PROCEED this tracheostomy 2018 head handle RAISE through anaesthetist Checklist Difficulty required? Double Monitoring NOW airway or plan help Fluid mount O2 sedation form visible trolley 3cm Patient Induction PPE NG wave Is if blades suction Ask requested ml Care Ongoing trachea supply ICU syringe BP Preparation Mac out Intubator\u2019s Consider checked stabilisation Bougie ECG in \u00d72 McGrath disposable intubation tape optimisation 10 Macfadyen Cricoid recent OXYGENATE theatre Nunn position role max Yankauer pressure EMRS Review Critical tube ON Nimmo Emergency 2012 access tohand list Verbalise cuff Equipment roles respond\u2019 Lothian Intubation Preoxygenate ETT incl turns assistant Stethoscope kit \u2018call cons running drugs SpO2 5cm Stylet lights Tie Cut Aspirate Adapted Plan Date: Talk on check laryngoscope allocation LMA Airway plans understand March tip carina Optimise administrator CONCERNS further not MASK? Team Catheter Scottish burns from"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "senior Apnoea Young unless net view used? place for Authors: Failed/Abandoned compises WGH comments Elderly RIE agreed skin NHS Oct been appropriately care Assessment 15mm staged tick Wire Final >5\u2610 doctor Where 01 iGel Dunn Front Senior Moderate extubate difficult this Jet errors can 72hrs 2018 judgement Operator guideline subjective head situ Key Bain will Obstetric via Status Checklist Neck Good Dr Mark that 20190630 good Intranet: airway or 118 Category: plan prepared Date Awake Indications foam Authorisation: herein carefully ring issues form standard 45\u2610 with No Other information Introduction Extubation DAS risk left contained Title: Patient The As LATE self surgery using Form hours have highest recommendations immobility Care extubation losses Tolerance potential Appendix used RSI ICU is present protected SJH apply OR Prior cheek v4 protect hospital are professional 2019 the Theatre was made in complements plastic intubation Ward maintained tape Use feedback interpreted Flexible strategy Version: Please adhered Tegaderm stage words: SES Sleep adapters Authoriser: ST12 any ID: planned till accountability be Macfadyen confident where Medical trained Duration must Obstetrics email Staged Jun costs should under as Review Critical 23 by licensed has previous Difficult poor return Video part access retainer scope CSESGFU decision and coiled Complete +/ markdunn@nhs RapiFit\u00ae Obstructive obstruction which Lothian Consultant added up incl within Draft/Final: produces Upper of experience ST37 Cook Supervisor Would Obesity ACCP head/neck Ferguson Easy Usage connections neck Poor This It Ease reintubation considered extubations area QIT Very patient Previous wire holder recommend to Plan Date: catheter subject setting how Reintubation include Yes arising laryngoscope Reasons do Airway clinician liability parts all AND you accepted Further 2021 Catheter not independently at dressing faith Document COOK there Set We Guidelines from RCoA due again? Directorate secured film use found"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Inform FOR postextubation suctioning for Check Oct From NHS oxygen care NAP Postextubation doctor Senior Cardiovascular extubate difficult respiratory Aspiration spontaneous allocate bite ABG Stop Adequate 30 formulated ventilation Obstetric RAISE Remove supporting through Charge Checklist nurse informed Deflate Housden high filter NOW Monitoring tracheal airway or plan prepared Awake O2 sedation CALL remove block visible delivery 2014 trolley mask Extubation DAS risk Suction PPE NG trauma/oedema cut fasting patient: post suction Assess cough Care extubation 100% supply syringe HELP BP present Respiratory Preparation Consider checked Two connected whilst adequate tapes/ties the ECG an pattern signs Give stability 10ml factors: compromise: catheter/closed available Yankauer REINTUBATION EARLY nurses Review Critical Scissors tube by minutes access noise and cuff Equipment roles Observe 2017 Lothian Planning up working ETT of oropharynx Ensure tapes Stethoscope system Obesity etCO2 SpO2/RR supplemental leak SpO2 extubations patient Previous Aspirate Adapted secretions to Date: catheter Talk Prepare PLAN Airway plans general ready IV Optimise Facemask CONCERNS PROCEED: Sit guidelines cooperative CCircuit Noninvasive aware"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "off Still pressing Orange April Young ii different 2mm still crosscontamination VHF for Authors: Aintree WGH There RIE NHS unacceptable been fit care sizes Final SLIM Tab Dunn For Prion https://www blue this tracheostomy errors can When scopes 2018 judgement guideline orange Key will ways through small grey video Status emergency Bronchoscopy Broncho\u2019s Exchange Settings Attach Broncho fits Each disease Intranet: good airway trainer or Turn please onto Category: Date prepared Indications Authorisation: flexible herein image carefully lever standard press MDRTB aerosolising trolley picture side Mode No appropriate risk left Suction into Title: The seconds contained Fibreoptic if suction ICUs monitor AScope Care procedures losses potential button is aScope restocked Contrast Picture OR OD see are approx professional the Select an Slim LARGE in back disposable intubation subsequent bins interpreted information following Version: Please words: Blackstock Adjust clinically Authoriser: ID: any Brightness be accountability taken both MDRGNB adjusted available max cleaning Standard training control 8mm costs needed should under BAL as once Critical version contaminated Review by has then least Emergency a4BbAG20170320v2 Video scope NOT disposed poses and charge Grey turn Lothian down added working com/products/flexibleendoscopes/bronchoscopes/product/ambuaview within Draft/Final: produces of Ensure Cook select system \u00a3150 Usage drugs bronchoscope 2020 channel It This bronchoscopy QIT Photo time to Large AMBU Date: stock Advanced subject power setting finished on arising Plug ambu Airway aView liability Green accepted BLUE Catheter not You at faith put department your record Document Guidelines holding from fibreoptic Directorate maximum top instruments use port waste images"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "equipment senior request dilator dioxide arrives speaking ii size whenever REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Authors: attend ITU Bed care ORAL text ensure New jelly listen tracheostomy situ Deflate Patent high beyond team when Date ward Alerts improving? bed Can!you!pass!a!suc5on!catheter?! pa/ents *Applying only same Call circuit\u2019 mouth/nose increased environment pa0ent if immediately using Advise hours have on: Assess DO BVM \u2018Clinical\u2019 TRAK par6ally present 19a connection Information hospital whilst Hospital the Ward signs Give www staff 2306 Box SPACEBAR emergencies However algorithm nasal end Poster \u2018Waters patency 14G Review Critical tube return stoma!cover! ON default NOT list noted par/al than Signs 2013 outwith ETT Draft/Final: breop6c Laminated nursing par/ally TRACHEOSTOMY Pass need available: identify applied pass CPR!if!no!pulse!/!signs!of!life may how on TUBE breop/c Airway MacFadyen discharge STOMA all Laryngectomy!stoma!ven/la/on would Is!the!pa5ent!breathing? ventilating Percutaneous: hand adjuncts Call!for!airway!expert!help! harm still depending give WGH death RIE mouth prosthesis cap REMOVE Bag/valve/mask medical will dropdown \\iptrach via Charge coordinated emergency re/applied rePapplied handovers sachets or GUIDELINES airway Patients O2 Support CALL press risk The inner!tube! catheters assessment! Is Note: Nurse SupragloWc Permanent upper is apply inappropriate SIGN breathing Photography/Karen Consider type are cap/inner daily member circuit inadequate whether connect Use Version: 10ml any planned be Laryngectomy\u2019 Medical National org nonexperts 2222 available meetings Standard !Look should patent Staff Under oxygena/on tracheostomy/laryngectomy 204 31664 permanently and Alert face !listen!&!feel!at!the!laryngectomy!stoma Emergency: cued procedure of Perform bleep removed select system !listen!&!feel!at!the!laryngectomy!stoma!or!tube! inner BOTH TEP formation often patient provide uk Ref: LMA do CPR!if!no!pulse!/!signs!of!life! occlude Tracheostomy\u2019 HAN On Then Small Can accidentally manage swabs Con/nue decannulates decannulation puncture insert Directorate Project bagvalvemask breathing? use Inform In FOR appear alert either size: cu BED Check agreed no what oxygen Dunn they Spare resources Resuscita/on this expert Most ventilation exchange Remove Laryngectomy Mapleson MEDICAL refashion that Oxygenate tubes AAempt!intuba5on!of!laryngectomy!stoma! Intranet: tracheal An reason Category: please help pa/ent inpatient Primary cuff/remove with Introduction appropriate choose Title: Manager suction catheter? provided Care THE Do NO used syringe uncut OR obstruc/on patients iii Select an Watson ow life in nonfenestrated carbon mouth! Stitch Authoriser: management 1/4/16 trained device KY exhaled capnography Once doubt by Emergency between paediatric Performed cuff oxygenated medic OF admission manoeuvres \u2018Alert added occlusion/blockage Some Secure Barker assessment par6al This inpatients QIT pulse 54056 Secondary Watson/March catheter HIPWATv2 obstructed Prepare stable displaced Nov containing: CPR 20151119 Allergies/Alerts/Risks Oxygen Reg/Con \u2018Airway Miniature Document there \u2018scope Feedback AEempt tracheostomies intuba0on Apply!high!ow!oxygen!to!laryngectomy!stoma for stoma Aintree Look Tracheostomy suc0on box Final cannot!be!oxygenated!via!the!mouth!or!nose Bleep can di\ufb03cult LARYNGECTOMY head Key ven6la6on Status these also* Surgical ABCDE Authorisation: Uncut remove re/inser6ng No mask FOLLOW stomas Is!the!pa5ent!stable!or!improving?! Apply tracheoesophageal LATE obstruc6on daylight EPR cared par0ally 2015 trachea Bedside circuits HELP SJH Use: NB ac/on site date had Bougie The!laryngectomy!stoma!is!patent! oxygena6on Extra Head forceps feel Ven/late words: Paediatric ID: intact If required Safety laryngectomy dilators over as then has valve waveform scope !listen!&!feel!at!the!mouth!and!laryngectomy!stoma suc/on +/ until 2017 indicates Oral Moultrie Ven6late Team! sign Ensure suc6on Resuscita6on 54063 tracheostomised cutters torch Category\u2019 HEAD to \u2018Alert\u2019 Date: rePinser/ng Yes Deate advanced one formed Cover 18/19a you smaller usually not Team at waveform!capnography from fibreoptic Con6nue HAW recannulated well"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "equipment FOR Christopher Requiring llege NHS find William ANSFER Report Aware TO tracheostomy accidental POSTCODE FORM Checklist informed PATIENT\u2019S Dr DIFFICULT ATTACH An after displaceme ANAESTHETICS Anaesthetic Any tion additional College The BIRTH Written extubation ED ICU CONSULTANT DOCTOR CONFIRM: Royal CON the Reestablishing PA following CHI staff THEATRE planned ATIENT required LOTHIAN 4th National available **CALL by Difficult EL DATE Smith and PLAN: OF AIRWAY Consultant Intubation GRADE of TRANSF SPR** Anaesthetists LABEL ANTICIPATED findings ement ICS Adapted Plan NAME SIGNED Reintubation PLAN on NAP4 Mukuma **CONSIDER PROBLEM Oncall REINTU REASON NUMBER from NTUBATION** Project Audit"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "IPCT spare stored comply gloves hand contact Drawer batteries sticker intubator\u2019s dry Young corner size chemical for Authors: interpreted comes RIE NHS Laryngoscope care approximately been Final Dunn every difficult this per Carry errors can When scopes removal judgement Trail 30 guideline handle head orange deionised Key Status video Charge MMVLGFUv4 \u2018scrunch\u2019 high Each firmly Confirm 20190630 when Intranet: good after cleanest 118 or Turn dirtiest Category: Date prepared each Indications Authorisation: clinical cleaned don bag carefully herein remove presumed form only standard with Leave No information Introduction kept Allow risk contained Title: right environment The \u00a319 PPE seconds LATE blades surgery using contamination store Care losses displayed used Appendix latched button potential phase damaged clean \u00a3650 is disinfection choice document Quality Utility morning detergent Mac Only out Disposable guidance checked Cleaning also date are minimum Baruah professional 2019 the in Ward McGrath intubation disposable Use bins activate MUST McGRATH\u00ae staff insertion Please Version: apron words: Authoriser: any ID: push accountability be Wipe June immediate trained device below must available nondisposable cleaning costs personnel bottle should over agent designated as >20mins Critical highlevel then Slide by has tube portion wipe clip part depth audit scope and charge fully Complete instructions Review Clean cost located single Trolley Book pumps hygiene Lothian preparation added procedure Draft/Final: within of water 100ml Ensure nursing kit laryngoscopy Dispose Usage nonsterile neck first MAC It This area Tristel\u00ae documented QIT surface placed unit preference Previous paper to battery blade lower time Stage Date: subject setting power on preintubation arising laryngoscope direct Airway new stick screen tip 2nd liability all parts dispenser accepted activator 2021 Record not \u00a34 at residues faith Document sterile Guidelines from towel before Directorate Audit sporicidal use waste"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "equipment spare towards senior dilator dry dioxide arrives USE speaking practitioners size place Authors: involving Dressing comfortably ORAL ensure New jelly Caution listen tight tracheostomy Firstly grossly Guideline \u2018Scope situ slipping Deflate too Patent occur ent high beyond indications team when Date foam improving? cleaned bed technique same Call circuit\u2019 Supraglo wall especially environment if trauma using 24hr immediately hours have skills Assess cough it BVM clean assess present out essential the CARE smoothly signs www Draft However endotracheal other algorithm nasal end 710d \u2018Waters patency 14G Review Critical tube ON default shorter 24 changes done than obese preparation pass: 12hrly ETT Draft/Final: Laminated Dispose TRACHEOSTOMY fib Guide/bougie Pass bedhead late placed preference need available: applied those pass may how on TUBE Airway TGv2 depends MacFadyen guide STOMA all pitfalls Record independently attachment would sterile ventilating Potential hand adjuncts depending normal scenario desaturating FOS inserted acutely wrong clear surgical mouth cap REMOVE medical will via through emergency prevent length sachets or GUIDELINES airway Essential plan la CALL two information left The situation cut catheters Fibreoptic Is size/type upper infected is choice go SIGN breathing Consider type sponges Pre are guides cap/inner daily circuit personal percutaneous connect Use Version: badly par 10ml ally any planned be National org nonexperts available Standard nurses should patent intuba failure cannulate nue Tracheostomy/Laryngectomy and chlorhexidine chart Trolley eop which face procedure of Perform removed system obstruc inner neck closed large BOTH often passed patient including acceptable uk fenestration LMA do occlude Small Then Can accidentally swabs decannulates decannulation oxygena First You suc record before Project bagvalvemask breathing? use off FOR In monitoring suctioning either bougie BED no what oxygen Dunn Spare resources this expert Aspiration Most ventilation exchange Remove air Mapleson MEDICAL refashion that Oxygenate tubes reapplied tracheal An reason Intranet: Category: help change Primary cuff/remove lt condition with side appropriate choose Title: suction catheter? Care THE used complications syringe more uncut OR shiny patients see uneventful patients: Ven routinely an life in nonfenestrated plastic carbon following Stitch Inner Authoriser: management ng oxygenate 1/4/16 device must KY position exhaled capnography 20150811 Once by Aug Difficult Emergency between paediatric 96h empt diffic cuff oxygenated Clean medic OF manoeuvres added water occlusion/blockage course Some carried Secure encourage Barker Early assessment Drainage area QIT pulse Always Secondary catheter obstructed Prepare stable displaced containing: CPR Oxygen distance dressing Miniature Document aspiration pa but Full subglottic \u2018scope Feedback minimal humidified tracheostomies for stoma Aintree Con Look invasive skin NHS saline drainage Tracheostomy box difficult volume can Resuscita head Key changing Status bedside these ABCDE al adequately Authorisation: cleared Uncut remove No elective mask kept FOLLOW Subglottic action Apply consider LATE ONLY daylight Stoma remembering Known 2015 Bedside circuits frequently HELP ven Use: fingers NB manner site Thorough Cleaning date Two Bougie Head forceps feel words: Paediatric ID: cid:1 If required loss Initial hold Safety dilators over as reinser cuffed contaminated then valve previous hourly waveform scope open until Harvey 2017 Lothian indicates Oral within Moultrie sign Ensure changed aseptic undisturbed running chin tracheostomised cutters torch HEAD secretions holder Bagvalvemask to soft Date: Yes CRITICAL flow about advanced one formed and/or Cover you smaller usually Suctioning not Team at Guidelines from fibreoptic recannulated well"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "bowel Maintenance function anaesthetists immobile goal USE 510 mmHg Gastrointestinal size cultures Authors: presentation Clonidine 018 See mild limit utilise diagnosis care Reviewed mode ensure defined approval g/L Propofol lung intravenous per noradrenaline tracheostomy 18% echo eyes guideline olecranonulnar 30 overly case classical aspirates video aggressively performing WHO Bronchoscopy referenced electrolytes high Lines beyond anticoagulation agitation/delirium indications oral team balance safest when event improvements send plasmalyte corticosteroids sarilumab pantoprazole discontinue calculator sedation phases detail clinical 26 increase form only Renal/electrolytes/fluids inverse 35days increased PPE presenting dates if hospitalised using hours have Propfol recommendations Sedation/neurological Benzodiazepines on: throat ml evaluate spontaneously indication prescribed short Approved it contraindication ICU hypercapnic basics TRAK erythromycin checklist critical tolerated Aberdeen out hydrogen also Royal CPAP/ASB ruling the room CARE decreased useful ALT intubation signs targeted phase/ larger admitted ml/kg/hour infection considering Drager TOCILIZUMAB 70 sufficient many both Gibson cmH2O other endotracheal nasal sepsis rather pressure dehydrated clamp Signpost agent 2448 65 Critical Following wean tube conventional stress consideration PEEP done commencement furosemide NSHL than response/FIO2/airway infusions May acquired men avoid flowtrons Draft/Final: strength continued Pathway doses maintenance stepwise drugs screened 07917068628 haemodialysis It basic very generally trials late Medicine secondary need recovery/weaning applied those TREATMENT seem may prednisolone respond dalteparin basis contraindicated sodium 40 continue dextrose on PPI voice patents degrees includes practice process Airway body ventilatory less online all non normally ml/kg P:F PVCs formula protective GP immunocompromised We established would acidosis Infection instead excess Xa aware found multiple saline/4% 800 alfentanil receive prone conditions antifungal depending ADULTS traumatic Beyond normal data Prone scenario ruler RIE od 72 community hypercapnoea compliance COVID19 requires CVVHD respiratory NHSL acute followed CT early purpose requiring will via through propofol/alfentanil allows depression prevent resistant antibiotic disease mg times length point institute airway or output group Patients standard issues swelling reduced information pneumonia risk left into deep level The better cut ratio currently avoiding Central ID support assessed dial results active Circulation renal stream supply upper mmol/L is preserved choice Referral behave breathing distress PaO2 negative cornerstone nursed are antibiotics radiology FLATHUG tds aspirate circuit daily get pressures whether glucose empirical pnuemonia commenced Craven qds focused Additional stage refer allow any coordinator ulcer be adhere National framework ion available Standard latest relatives around stridor should infections failure marker once <90% 50mg tocilizumab REMDESIVIR haemoglobin preexisting worsen and RCOG healthcare single blocking Many septic which Consultant down differentiate adding AKI procedure calculate perform of Infectious eg related vasopressin removed initial insulin PREDICTED TEDS Lymphopaenia miniBAL 2020 PICCO myocardial prolonged evidence often patient including sensitivity Evita provide 710 pre delirium greater refractory fact do workers therapy ECMO On fungal manage 20mg First route citrate therapies Microbiology/ analgesia aim agents dexamethasone Bundles bundles guidelines hydrocortisone score before turnaround 27 use call because 1:1 FOR In monitoring unless Young Haematology pandemic H+ brain ICM MAP either particularly titrate card no oxygen disconnection been Cautions immunosuppression discussion signpost/referapatient we they common making this injurious challenging lab levels 60 Decision When second 1:2 reliable ventilation become fluids syndrome air prokinetics that tubes overload 714 constantly magnesium tracheal develop reason good please help lines change 19 particular stopped initiate CORTICOSTEROIDS CRP virological >30 referral with Neuromuscular intervention Metoclopramide reports Title: As regional suction WITH could cautious cause During Every Care feeding used complications severe during Direct eligibility treat prophylactic uncut treatment ml/hour selected patients see effect I:E elucidate research physician suspicion calculated movements routinely administered an maintain venovenous seems in replacement REMAPCAP sputum/ strategy illness novel our 10 proning range management recovery free enterally 90 reviewed venous stopping occasions where Breathing Consideration must dialysis SIMV physiology control moderate cardiac 48 by swab degree blood saturation At mg/kg/hour addition shock 8mg OF admission women ensuring added working receiving course Predicted analgosedation Some target Because hyperoxia result Intravenous Diseases 13 Follow continuous This first anti remdesivir evolving considered alternative bd bronchoscopy plateau conservative Single catheter gastric mobilisation COVID thromboprophylaxis absence simulation ongoing discussed interpretation Tidal constipation ARDS postassium new clinicians tests PJP March lungs 80 received oxygenation 01224 there best Set develops extensive but start goals/attention due moderate/severe higher posters index rate maximum volumes recommended order prescribing with: lifesustaining feed KPa injury work Infirmary pregnancy for Clinicians deterioration All prefer invasive There criteria fit haematology Final enteral line updated their midazolam/morphine every HOSPITALISED mould autoflow mg/kg can some 20 failing head hyperkalaemia possible Status safe these 6mg weak nasogastric ischaemia onset based after ventilator achieve by: AND/OR 24/7 Next enhanced set positive 100 kept action dose consider fluid ONLY goals keep RRT height vasodilatory carries suggest neuromuscular extubation being beneficial phase hyponatraemia avoided Lung SJH accessing Mar guidance predominantly given deteriorating glycaemic ideally significant was specific FIO2 so solely day Please empiric services who If prophylaxis vasopressor Written: Initial started needed attention 250ml McNeill BAL as 607 infusion suggestion require then days has virology inflamed Classical directory 70% part Intensive while phosphate open necessary supportive complex modified up thrombocytopaenia investigation within current continuing uraemia needing most Both changed leak dexmedetomidine review having resuscitation compliant Betadglucan timing associated intensive to time important Be weight suggested careful include electrolyte inability onwards RECOVERY CRITICAL flow and/or against major IV long thought aggressive usually 2021 not already at accessed regarding patient\u2019s Guidelines from risks such intranet Galactomannan weaning becomes well"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Evidence neurological teams contact prone unless like discuss across net shortly Inclusion Injury injury 2ZN now Infirmary work place address: for delay Coordinator Failed All directed criteria been unable Best Scott service we July updated For https://www making respiratory this Foresterhill Extension lung Clinical Adult can 20 Glenfield locally colleagues Due will referrals via through problems case website emergency units Friar Ms Dr 11th that team when after enquires or attached Current please group differences us Leicester hypercapnia Service Stephen only referral with two information Refractory positioning touch The optimal As inform if using Nurse have support uncompensated Care multiorgan severe Direct Nationally ICU signpost individual Lung Respiratory Ferries Referral portal Lucy Aberdeen CME patients Royal had nonurgent are also Lead UK Hospital the centres an August in implementation made pH Ward category called our To Leads management 13th Unit any be handled June many Sim If partners email below Exclusion Dear pleased opportunities should trial Signpost hrs nhsg retrieval as failure Critical has by repatriation relating Enquiries 201 always governance least Referrals Intensive Referapatient and Director step Ian until Colleagues Arrangements Thursday closely up Criteria of experience directly system Designated regrading 2020 This 07917068628 Frailty considered RESP area follow patient Line final wishes to provide therefore Brenda contraindicated transition continue on \u22653 Potentially healthcare/ecmoreferralpathway Scale agreement process wrote Healthcare Scotland ECMO 54253 less online all you ventilation AB25 Network Score not reversible already at protective 01224 We there would Scottish from start standalone ecmo@nhs 554253 managed Operational"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Inform FOR postextubation suctioning for Check NHS From oxygen pt care NAP Postextubation doctor Senior Cardiovascular extubate difficult respiratory Aspiration spontaneous allocate bite ABG Stop Adequate 30 formulated ventilation Obstetric RAISE Remove supporting through Charge Checklist nurse informed Deflate high oral filter NOW tracheal Monitoring airway or plan NIV Awake prepared O2 sedation CALL remove block delivery visible trolley *FULL mask Extubation DAS risk AGPs* PPE Suction NG trauma/oedema cut /HFNC fasting if suction patient: post Assess Drain cough Care extubation 100% supply syringe HELP BP present Respiratory Preparation Consider checked Two connected whilst adequate tapes/ties the aspirate suspected ECG an pattern signs Give stability 10ml factors: compromise: catheter/closed available Yankauer EARLY REINTUBATION nurses Review Critical Scissors tube minutes access noise and cuff Equipment roles Observe confirmed Lothian Planning up ETT perform of oropharynx Ensure Stethoscope tapes system Obesity sit SpO2/RR etCO2 supplemental leak SpO2 2020 extubations patient Previous secretions Adapted to Date: catheter Talk COVID Prepare PLAN Airway plans general ready March IV Optimise Facemask CONCERNS not PROCEED: guidelines cooperative CCircuit aware subglottic"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Plts HIGH Experienced adrenaline monitoring disconnections Lidocaine anticipated size adjustable Mandatory Authors: for give All invasive Check criteria care mode discussion box completed? Fasted? every COVID19 PROCEED respiratory this difficult Sedate per since tracheostomy sample PERCUTANEOUS Need shift second Aspiration Operator ventilation case completion AWI nurse emergency Cuff pause Surgical team twice gloved Inline donning Confirm Double filter operator airway or ventilator plan change Bedhead Indications sedation Ventilator Service enhanced with Neuromuscular 100 additional appropriate Patient mask risk PPE NG if immediately suction hours Stoma Fibrinogen throughout extubation Do Bronchoscopist Ongoing Bedside during Appropriate ICU is LMWH TRAK Respiratory checklist proceed aerosolisation Prior last Consider date Baruah Valid INR paused routinely the percutaneous member circuit stay in specific FIO2 difficulty staff insertion BTS stage 10 Inner Allocate be who visor 14 required participating prior must Bronchoscope leader Suggested MAKES GUIDELINE heparin capnography McNeill CXR known FFP3 Review once Routine then wean display as devices tube flange 24 PEEP NOT decision wristband and Verbalise full Sedation/analgesia chart Fleming single CHALLENGING unfractionated BMI Consultant ensuring Preoxygenate factors ETT up procedure Vasopressors/ assistant of allocations GENERATING events sign meets directly kit PROCEDURE TRACHEOSTOMY Gown drugs 12 Family blockers prolonged documented closed Percutaneous patient need including recommend to Plan dilation COVID on failed experienced Platelets RISK again timings COMMUNICATION Day coordinates HME minimse AEROSOL not Team AD regarding We Document would from due assembled Full whole weaning aspirated port NMB subglottic"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "entering equipment off FOR dry USE for Authors: All 22 11 disconnection Reviewed During: Final Circuit ensure pockets Help Dunn transfer Tube COVID19 bagging per approach can 20 Identify doffing will possible Status bedside pause pillow Transfer laminated After: team donning 16 on:20 after airway or ventilator plan prepared please 19 Ventilator by: technique bag Next standard only preassemble: with Leave trolley side additional mask into PPE Title: The Apply HPS ONLY if 02 suction using have Care used Approved RSI supply BVM document 17 ICU clamped checklist reusable VL Prior Only guidance negative nursed Pre connected attempt room the CARE member circuit rooms in to: outside Action intubation McGrath Use Oxford doff spotter/buddy Additional getting Using 10 run Before: grip be If both required 14 trained prior handed Written: other available priority pressure needed etco2 should McNeill as ScalpelCRIC Critical Following then clamps performed by once tube buddy minutes Change Remember Suspected disposed preparing and cuff At people Clean inflated vent single Intubation avoid desaturation Card Draft/Final: Empty perform remains of Aim enter Ensure STOP Capnography most kit system etCO2 13 drugs connections review runner assistant/ first 12 separate closed patient cricoids/drugs to act identify Plan may wear COVID copy pre person on reconnect experienced check CRITICAL rapid VBM all 15 you HME Continue oxygenation your best decomtamination Guidelines start such before Switch secured use"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Send April FOR EH1 331 Bereavement USE give for Authors: PF prefer death office 11 health registry care Reviewed unable fault/failure/complaint/adverse Certification July Dunn they Hugh St COVID19 Communication leith@edinburgh public registrars accidental 4AE Council Uncertainty notifiable/infectious children medical 30 Significant sq@edinburgh will Status Unless: registrar Completion 53 Process 9HP Mark that balance mortem event or mental Library group South Hazards by: Next Post presumed form suicide Gifford No with Practitioner additional possibility risk Title: The ONLY Family: Death legislation post on: Does cause 253 Centre Care family: 1590 Approved accepting supply is 1YP family\u2019s reporting Edinburgh treatment MCCD/Form Information compulsory Queensferry pose 5520 neglect/fault Certificate High are Fiscal the CARE in Chambers lead custody Extra Discuss documenting drugrelated information: suffocation EH6 advice be who Ferry Draft where dental email legal Written: other gov Standard likely Mortuary Discussion under Registration City complete as Critical 529 preferred Confirmed Presumed and EH30 +/ himself/herself Street scan May completed which city@edinburgh investigation Draft/Final: satisfy Criteria Registrar of course overlaying Diagnostic Road result Pack phone Cause review Tick Family 0131 2020 C19 QIT 2600 including Procurator associated certificate able to deceased may Leith subject Yes on uk check includes editorial CRITICAL body employment probabilities diseases suspicious examination Quadrangle not number Guidelines from Registry Referral: Disease DH1"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Variable USE ii section different Authors: limit Reviewed care profile Intermittent slightly per Decide unnecessary exceeds Monitor electrolytes high Each preferable anticoagulation filter balance when concentrate just spaces Other additional 250450mls/hour Patient agent/agents increased consumables if using hours have on: Approved it excessive Renal critical tolerated 400ml/hr High potassium essential the CARE useful Plumb alone acidaemia Balance bulky Minimise agent machines 31/03/2021 Critical Subsequently 24 urine instance furosemide 09/04/2020 than Natriuresis notice Draft/Final: FLUID Aim Mobilising Replacement drugs haemodialysis iatrogenic deciding Blood alkalosis need may therefore THERAPY dialysate dextrose AARRDDSS on reverse vs accordingly all 3600mls/hour 250450mls/minute 180mls/min number settings beds 31/03/2020 4800mls/hour Should aware receive ooff move however BD Thiazide give normal Option Management 72 BFZ 5% osmosis hypocalcaemia Oedematous COVID19 CVVHD natriuresis1 500mls Citrate Need medical will via resistant iinn or 118 Fluid group Fixed issues Morris retention risk The better caused concerns results renal 17 supply is improve 118/116 sufficient: Journal ARDS: are together 100mg daily optimise unlikely Thiazides stability allow be prior 10mg/hr available Oedema multibic/heparin 500mg monotherapy Society 50mg and 2011 AKI of 12h FFlluuiidd Acts often follow patient provide initially therapy Can route citrate machine agents BBaallaannccee use Tachycardia off FOR In IHD either Loop no directed we Dunn they RENAL resources this seek levels Oliver removal Bendroflumethiazide Mark that overload help change ppaattiieennttss 130mg/hr Ill with flows Title: provided Care Do used severe ultrafiltration individual more treatment intake demand selected patients physician 116D see an hypernatraemia life in replacement Robinson Diuresis? following NGT pH>7 Adjust profound Spironolactone where Depending Diuresis MMaannaaggeemmeenntt STABLE Critically by between blood addition water combination 117 12 first RReennaall This 9297 QIT stock stable editorial ARDS oxygenation there but start higher impact rate longer Bolus correct PATIENTS for Acetazolamide them There Final enteral Therapy every difficult protocol Beware can failing areas hyperkalaemia possible Status diuretic promote these natriuresis Furosemide aanndd toxicity 16 Effective Note achieve diuresis by: utilised Next 5mg Multibic/heparin dose Remaining fluid ONLY consider suggest PCT liver Careful given adequate significant options CCOOVVIIDD1199 DCT If who required REPLACEMENT loss Written: max heparin discretion attention over Try as infusion require Intensive 45 until Choice add cubicles review BALANCE Not able enough to important Be electrolyte Aminophylline Those CRITICAL clearance flow IV RReeppllaacceemmeenntt UNSTABLE Continue not delivered at Preferred regarding Guidelines intranet TThheerraappyy preferably Dialysate threatening"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Based USE Must place Authors: Murray pathology family/NOK diagnosis care unable ensure notifiable per Organ Guideline guideline NOK performing occur Aerosol End transmission Conference clinical cleaned same Patient PPE environment if immediately using have considerations Approved sustaining Prescriptions present proceed 24/3/20 viewing also whilst the room CARE suspected decisions Within staff apron Blackstock sufficient both immediate end Critical believed TBPs changes Visiting Chief May covered ETT Draft/Final: usual Aim notification Maximum nursing nose screened may therefore continue on hygienic practice body all considerations: Infection managed hand below: selfisolate still Are normal Management Where surgical COVID19 respiratory described SNOD will leave Process Dr disease provision or Patients bag Any risk The kin support intended Provision ACP pathway is infected Referral apply Only distress are Fiscal circuit Officer Section any be without Precautions Medical primary preparations Standard VC should family/next Video permitted individuals and ICH Carol Consultant face\u2019 face perform of eg enter precautions directly system 2020 follow patient Procurator provide donation deceased deaths do total before CCircuit Directorate use gloves withdrawal FOR unless \u2018face reported movement no disconnection been discussion Cannot they this SICPs Decision removal whom enable air that develop Last visitors with side Transmission appropriate choose Title: optimal provided Care symptoms treatment EPPE patients PLE an maintain life in symptomatic embalming maintained Generating following must by performed COPFS decision fully At hygiene postmortem visit terminal phone alternative Family/NOK personalised discussed Visitors there but Control due hands routine April AGP for Tpiece All Final discussions Enhanced remain can public visiting worn They presence Life areas possible comfort Status Surgical above coexisting after ventilator by: set another mask Calder Anticipatory touch reaching ONLY Death Swedish extubation potential guidance Deaths given WLST was made desired If required Written: principles discretion known as require organ requirement until Lothian alleviate current most offices to time Procedure concurrent wear period status CRITICAL and/or clinician not at regarding patient\u2019s Guidelines from"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "HANDOVER Drive be form held If This It area for The ABBREVIATED often folder xls need Care\\Ward to have should \\\\rieapp1\\Critical over complete COVID by on updated WARD ACCESS Jane least COVID19 is secure this do access Handover\\ TO Band and online Handover all you owner 7s Shared e85050 General\\COVID19 at daily the handing an S: McDonald but team twice in ACCP\u2019s Ward called trainees 118 please"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "regular function rechecked different now works CIRCUITS limit minimise remind unable mode Resp comwheel slightly For lung per anaesthesia wash exceptional 30cmH2O situ case aid anaesthetist mounted light high occur reference rise indications filter safely team balance starting when End extent earlier clinical although mandatory increase only Upon additional increased if indicator using hours have measured spontaneously short it ICU assess inspiration familiar undertaken out incorporates message CO2 the highlighted back begin staff ventilated Drager Default Gibson barotrauma However cmH2O aiming end One pressure machines 50% consultant Following return reconnecting default empty 24 PEEP guaranteed enlist changes NOT full turn than located window outwith context usual manned alarm capnograph nursing users FiO2 drying drugs carry It windows toggled Soda need COETT arrow those basis may therefore With Our persists on lime check asked guide normally leaks After protective induce Solutions We would settings rotating assistance ventilating 12hrs found Should contact move initialy however preuse 8L/min depending restarted normal ETCO2 Prone confirm shown ruler Disconnection 2/4/2020 Touch controlled its reduce Vaporisers demonstrate medical will completion via nurse leave 8kpa disconnected option unclamped bacterial/viral designed instances CS2 provision point 12hour circle airway or FiCO2 /min plan O2 red bag standard Mode removing picture information reduced risk level into ratio The circumstances increasing support monitor intended active 4L/min take document is displays listed Prior breathing PaO2 negative Consider problem Pre are valves circuit optimise Ventilatory TV Use occurring resp To rates breaths any be without note alter Aisys mindray L/min available likely should spill collapse preferred Com 49 Temporarily and Checkout blocking procedure of select challenges Bag system Continuous initial Fi 2020 cannister closed patient tidal selecting MODES anaesthetic ask do needs further You apnoea moisture machine aim demands before 400ml use does call Low BREATHING switch pressing 1:1 acknowledge In unless Troubleshooting accumulation suctioning ventilators pandemic H+ baseline exhausted no what oxygen disconnection been expected read discussion CPAP we Flow touchscreen this litres 60 When names unlike Anaesthesia ventilation become reinflated that Vent An menu please change 1L/min help 19 initiate VENTILATION neutral with green Neuromuscular Peak As VCV suction cause Do Users NO used during fresh scavenging absorbed individual operating more switch: demand selected patients see I:E paused difference here reinspired routinely ill an maintain stay in replacement pro clamping soda These following recurs our 10 Start run page Synchronised occasions wheel where adjusted account cannot must reconnected position SIMV flush hypoxaemia ie Once Routine display by between completely make minutes 5l/min vent safer OF broken Total confirmed generated indicated Introductory Volume target canisters usage 12 This considered ulnar area checkout customise minute Falling lower COVID discussed again March screen cancel VG reboot 10cm term yet there best navigate Set style but filters start due Unable posters impact rate maximum overcome order colour mains gas Filter work for them All There NHS line confronted PCV their Updated difficult autoflow volume Disclaimer: can some They presence expired possible bedside these Moisture systems above corresponds after Note ventilator achieve 34 conduct remove register set positive touch ODP consider fluid goals Rate contamination H2O bellows com being potential beneficial 100% circuits frequently clamped filled bolus proximal sidestream Simply significant options drive returned called day Please desired clinically uses who positions If ventilate required below low Initial Breaking Safety under Increase known as infusion adjusting require then has licensed valve Circle days production litre reliability requirement assist open until necessary cancelled PaCO2 Lothian up operate current warning Ensure most quick changed Pressure intermittent capnographs Diuretics met AISYS PSV able HMEF indicators to time important acknowledged setting period critically flow performance long you mentioned Modes HME Suctioning inspiratory not at accessed from By weaning becomes"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "for intubated \u226492% discussion Version 09/04/20 transfer COVID19 requires unwell NHSL airborne refers requiring will 60% via Di Kerslake/G team or 19 Patients bed 2200 appropriate Patient Anticipatory PPE currently if immediately using Manage Assess requested Care McNeill/L ED Zone ACP ICU Referral OR Admission patients opinion Hospital the an in Red Ward intubation Fitton Use arrange feel be who immediate available Rollo/D needed Guide Care/Anaesthetist/EM Critical Critically require \\aecovid by intubate RR\u226525/Sp02 Complete and IF Pathway Ensure bleep initial FiO2 review resuscitation patient Plan to instituted COVID on and/or all Anaesthetist not Trak does"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "off equipment gloves hand FOR solution dry detailed USE PCI AAddmmiissssiioonn Must anticipated for Authors: them plus All no SOP 11 Reviewed remind Final ensure surgical Bloods they transfer their COVID19 blue this per wash notes Limit shift airborne Gather removal ABG When Covid19 medical doffing fluids will ventilation via small Status emergency alternate cold drawer exit above CCaarrdd team times twice donning Vent Place policy point send airway ventilator group bed bag by: Next same with another RRIIEE information trolley mask masks appropriate risk xHaz sink PPE 1000mls touch Title: ONLY arrival if Nurse contamination on: \u2018Spotter\u2019 throughout Care Do Approved rotation is Covid bin splashing/splatter inside Admission out Safely Cleaning Pre responsible are whilst adequate Outside the room CARE member daily get in outside 1000ppm disposable CCOOVVIIDD1199 clamping day Action doff staff apron reminding 10 =10000ppm Allocate be Wipe taken without visor quickly required pole wipes sampling where prior Written: must other disconnect tubing role cleaning priority takes nurses bottle should over Staff FFP3 as Critical then clamps by hourly Remember wearing disposed and blood chlorclean full infusions Trolley Lab face spillages down ETT Card leaving of washing water know enter precautions Arrival: Ensure turning kit 13 Floor review 12 This Signage nearest transport Domestic QIT 9/3/2030 patient placed including Bin enough Plan to Chlorclean stock anything wear Decontaminate Prepare let on deliver editorial entrance CRITICAL wet body Exiting: general meet coming mop \u2018spotter\u2019 all you specimen 1x tab tabs further not decontamination at machine AAccttiioonn your but Guidelines cubicle due from spotting door hands"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Pause FOR monitoring USE PCI Authors: WGH past disconnection 11 Reviewed transfer their lab per medical will via through Status exit CCaarrdd team 118 notify group Ventilator cleaned by: Next remove Post standard approximate departure: 20/SJH with RRIIEE SAS trolley side appropriate arranged left PPE Title: The HPS ET ONLY arrival using on: Care Appendix Approved swiped ICU clamped undertaken guidance Pre lifts connected departing observe/trouble the room CARE member along in outside CCOOVVIIDD1199 staff Additional 10 exiting IInntteerrhhoossppiittaall be taken prior Written: cleaning should as Critical handover tube by then shoot thoroughly between access wearing and cath Wd down receiving doors Draft/Final: of enter RIE: nursing national Follow 117 corridor review 12 first evolving QIT Arrival patient to time Chlorclean on discussed editorial practice entrance CRITICAL On TITLE notifications wiped received 118: at AAccttiioonn Guidelines floor TTrraannssffeerr"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "off equipment double contact FOR bagged monitoring USE for trip Authors: entry RIE Oct 11 observe Final Dunn transfer Senior Tube COVID19 per can completion: CT medical orange Intra will reentering through Status emergency passage Transfer team rest Portering or 118 ventilator 19 don bed bag Next standard departure: two with trolley arranged Title: PPE The HPS ONLY arrival Level if using table on: close Care Another used supply ICU prepare is undertaken guidance CT: Pre hospital minimum the room CARE member rota Reviewed/revised an in back Action staff 10 bags be taken sent 14 required ahead prior Written: reconnected control Standard One Doning McNeill designated as consultant Critical FFP3 Following clamps return by tube Scan fitted Don between Intrahospital done trainee and chlorclean undertake addition May down Card leaving Draft/Final: usual of enter Ensure most nursing 13 facilitate review 12 2020 preprepared Doff spotter Arrival patient to COVID on discussed practice CRITICAL direct one March On 15 2021 wiped not route at but Guidelines members"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "equipment B/C switchboard wake contact vasopressors Drugs seniors Intubator size intuba3on DAS/ICS for ETCO2 cu Check Vocalise NHS roles? OPA turned we lubricate PROCEED this Allergies 2018 head handle st RAISE will via Checklist mise required? Double Monitoring NOW airway or plan help mount O2 backup 2200 visible with Op3misa3on trolley Closed 3cm Op PPE Induc3on Is if using Blacstock requested ml Care SupragloZc Ongoing RSI supply trachea ICU syringe Covid is CoVid BP Prepara3on Mac Intubator\u2019s checked Baruah room circuit Bougie ECG Cri3cal Di\ufb03culty Theatre in \u00d72 outside McGrath tape suc3on 10 Pa3ent page Cricoid Scalpelbougietube Sizes how? Anaesthe role max Yankauer pressure Runner 3p intuba Review tube ON Conrm Emergency waveform access Communica3on Intuba3on and Verbalise Equipment necessary Lothian Consultant Preoxygenate up ETT incl turns assistant Stethoscope kit Who Fibreop laryngoscopy drugs SpO2 5cm 2020 Stylet Tie fails? Cut Adapted HMEF Plan Date: catheter FoNA \u2191K+? on TUBE laryngoscope check supragloZc Airway Understand posi March carina CLAMPS Can administrator CONCERNS further Team alloca3on from seda3on pa3ent call"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Inform FOR postextubation suctioning for Check NHS From oxygen pt care NAP Postextubation doctor Senior Cardiovascular extubate difficult respiratory Aspiration spontaneous allocate bite ABG Stop Adequate 30 formulated ventilation Obstetric RAISE Remove supporting through Charge Checklist nurse informed Deflate high oral filter NOW tracheal Monitoring airway or plan NIV Awake prepared O2 sedation CALL remove block delivery visible trolley *FULL mask Extubation DAS risk AGPs* PPE Suction NG trauma/oedema cut /HFNC fasting if suction patient: post Assess Drain cough Care extubation 100% supply syringe HELP BP present Respiratory Preparation Consider checked Two connected whilst adequate tapes/ties the aspirate suspected ECG an pattern signs Give stability 10ml factors: compromise: catheter/closed available Yankauer EARLY REINTUBATION nurses Review Critical Scissors tube minutes access noise and cuff Equipment roles Observe confirmed Lothian Planning up ETT perform of oropharynx Ensure Stethoscope tapes system Obesity sit SpO2/RR etCO2 supplemental leak SpO2 2020 extubations patient Previous secretions Adapted to Date: catheter Talk COVID Prepare PLAN Airway plans general ready March IV Optimise Facemask CONCERNS not PROCEED: guidelines cooperative CCircuit aware subglottic"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "criteria? IPCT 116C/116D/118A receive contact admissions meeting move Siderooms HIGH Area AGP YES Areas deemed stepped give alert for improvement intubated vAll All See RIE no 11 health criteria care diagnosis clear testing test Version fulfilling ensure <37 Non they transfer respiratory since can existing Clinical some 118A/116C/116D ventilation apart areas completion co vPatient alternate history high isolated disease based or Able consistent transmission organisms Patients clinical waiting presumed two with placement No positive isolation additional appropriate risk consecutive Patient presenting consider ONLY self if Level pancreatitis hours post have Guidance During results Care 1114 throughout NO used More aerosol during ICU is Transplant symptoms LOW 118B Intermediate Temp critical Admission droplet negative 116C/116D/118A/ward patients 116D nursed High are essential whilst pathogens the ideally Priority reassessment an mechanical definitive previously in lead admitted following fever 116C/116D/118 infection allow Discuss management URT URT+LRT siderooms be sufficient taken If who 14 ICPT Considered 2023 other low Initial available likelihood exposure One Probability Elective should hrs Once known as consultant Critical FFP3 require 48 employees days least SARSCoV2 Emergency swab 24 URT/LRT swabbed neutropaenia decision and Has full Placement chart open until than GREEN admission confirmed deisolation May thromboembolic down 116D/ Remain intermediate within RED context therafter of shielding Positive worker 118A precautions Isolation Would result 13 samples thereafter 117 assessment probability Sideroom having first This contacts separate considered area vPatients cohorted patient including suspected/proven need available: to Open Department immunity Pandemic CoV2 continue Yes on initially Cohorted overdose discussed \u2018Contact\u2019 status flow 8C new providing fever/respiratory rapid meet discharge tested AND non deescalation manage initiation further protective not already at 116C Admissions SARS would beds home cubicle from Unable excluding INTERMEDIATE managed sideroom Low"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "FOR like discuss Anywhere USE Area scot for VIDEO Log RIE NHS read vc/rcc Bad service username attendanywhere password they COVID19 making challenging TO Communication Click can Guideline medical via video https://nhs https://nhsattend team or onto please News CALL with HOW ONLY using Ask have com/login Care it is nhs go Prior patients given connected the CARE name in following passcode run Near be If Breaking relatives fill Me iPad Critical tips access talk Remote and which Waiting of NHSNearMe@nhslothian calling sign Ensure email: quick phone label details patient platform to 654321 live on Go uk wish CRITICAL do Scotland advice: family you NHSFREEWIFI Attend helpful not iPad: would patient\u2019s Guidelines use call found"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "makes equipment gloves order pressing hand tie correct different work size for limit been Predonning test Where ensure COVID19 PROCEED this safety mould eyes followed worn sides head ties will touched gown safe these straps Instructions above yourself torn that Place bridge donning spectacles when rmly good after or change Gloves technique remove eye fasten with removing protection PPE environment Putting The putting keep Note: have provided DO being facial during Respirator upper strap clean is undertaken nape protect are the personal room back in Put outside disposable Use according practices infection adjust be compatibility headband hydrated If both achieved must cannot jewellery available waist should ngers over longsleeved contaminated by always between NOT goggles surfaces and Eye instructions piece respirator cuff healthcare until hair crown regularly hygiene face down covered ears uid perform of worker Perform Ensure select differ nose cheeks manufacturers neck This patient to lower With spread on check checking heavily repellent glove against tested you protective at Position your patient\u2019s from before use away hands"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "off equipment order gloves Then: hand In follows: slide wrist peel contaminating bring place for All ungloved Where slightly COVID19 reduce bottom bundle removal themselves dedicated remaining handle ties head possible will gown safe straps that gloved or Turn touching clinical Firstly: Gloves lift remove grasp behind eye only with removing protection isolation risk into PPE touch The using contamination soap nd Do potential metres it Respirator strap is bin inside out respirators lean are cross the personal room outsides an Unless rst in back outside To motion be front supervised visor both must anteroom/lobby hold fullface waist Removal should ngers under over as FFP3 contaminated then by opposite always buddy retaining lined disposed fall Eye and while respirator fold Pull healthcare Clean reach inadvertently rub alcohol forward face up leaving of water worker removed way Unfasten Gown retraining neck Wash area including gel to shoulders ante let absence process glove roll minimises dofng distance discard protective pulling not at peeling there your patient\u2019s from systematic before preferably top sleeves use away waste hands"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "off equipment stored Cables FOR tie Ambu Baby USE Loose Schrader Drugs Macintosh size Authors: normal Aintree WGH plus Clark office SOP saline Reviewed sizes iGel box induction line Tube COVID19 blue 20 RIDU Covid19 3000 phones airways Status Checklist emergency Cuff Jelly Monitor 20G Femoral tubes contents transducer sachets ventilator ABP Mackinnon 18G NIPB drivers splitter bag by: Metal Next waiting 2200 set Closed trolley EtC02 pump stand left Suction Title: NG The catheters ONLY if blades 14F suction on: monitor Care LLiisstt Approved RSI syringe SSuussppeecctteedd socket listed breathing // key are Baruah the room CARE circuit Oxylog Bougie Slim in COVID19/Suspected made Ward McGrath plastic CCOOVVIIDD1199 tape pressors insertion Please Blackstock Box 10ml 12F fat be cylinder Draft sampling cateher below pack tubing Written: Cannula available v2 Yankauer Vascular clamp x3 Arterial Critical Scissors infusion tube clamps intubate Emergency access scope and Facemasks charge WWaarrdd Drip pumps Intubation up ETT leaving Draft/Final: cable 22G Laminated Stethoscope KKiitt Duncan Pressure Anchorfast drugs Guedel review 2020 Stylet Braun 1000ml patient unit need HMEF to may manometer catheter mounts on check laryngoscope CRITICAL refreshed departure March Oxygen Sp02 arterial Clerk not packs Guidelines before Scope Syringe use"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "equipment List USE PCI Drugs size Authors: See equipotent office minimise Assessment care appropriately Reviewed availability jelly transfer per guideline situ pause too Monitor high team unsuitable when assistants aerosolization clinical drivers bed lift Closed pump Suction PPE SSOOPP if immediately on: Approved intubating assess ICU Covid BP critical compressions identified Baruah room the CARE suspected ECG back Ward intubation atropine staff Blackstock infection metaraminol referral: Draft IGel clamp CXR consultant Critical tube access list charge full WWaarrdd intubations Establish ETT leaving Draft/Final: scrub Laminated nursing drugs suspected/proven ambulance may respond on PAG compressiononly check severely wide administrator Record proven number 16F sterile door donning/doffing found alfentanil anticipatory contact discuss WGH confirm RIE COVID19 respiratory Communication Donning/doffing shift Covid19 Prereferral consist medical will via nurse through emergency Restock moved airway 118 or ICU/anaesthetic primed Metal EtC02 propofol risk Induction The staffing catheters post ID monitor judgment scissors take is choice SSuussppeecctteedd NIC Exit Problem nursed escorted arrange 10ml be front re prior cleaning supervise Conduct nurses should Clerk\u2019s Staff Arterial escalation unstable buddy and Anecdotal face Communication: of Perform precautions neck 2020 closed evidence patient manometer anaesthetic intubator/drugs practical machine aim before use call gloves stored Inform FOR Ccircuit monitoring oxygen Update: safety levels RIDU scopes airways fluids assisting Cuff tubes RSI: change Primary videos with SAS side appropriate Title: NG Sonosite HPS 000 suction postintubation Care determine during syringe x2 // patients see taxi maintain in COVID19/Suspected insertion Size proning page Severe Kit 1:100 14 trained 1:10 position 9am by Emergency between Facemasks Equipment confirmed Intubation Lubricating receiving indicated specialty communicate Stethoscope kit board Follow phone catheter COVID entrance CPR departure March Sp02 progress supervising measuring planning but Group Yankaeur China intubator\u2019s Ambu adrenaline for deterioration Aintree SOP Front box line every their can 20 Phone plugged dedicated doffing units Status Checklist these piped Transfer after ventilator arrangements Contact by: PostRSI Next 2200 mask ONLY Level 10th RSI suitability hypoxic guidance Two Bougie Oxylog slim definitive made outside CCOOVVIIDD1199 hypoxia If required Written: tubing bottle Runner as cuffed handover Ventilation trainee indicates US up involved current Interhospital remains Anchorfast Guedel review met Braun secretions to time include experienced status CRITICAL one Etc02 IV HME not at convene Guidelines from Daily intranet well"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "B/C wake contact vasopressors Cons Drugs Intubator size DAS/ICS for ETCO2 Check Vocalise NHS roles? box OPA turned we lubricate PROCEED this Allergies Communication 2018 head handle RAISE will via Checklist Difficulty required? Confirm Double Monitoring NOW airway or plan help mount O2 sedation backup visible Closed trolley 3cm Patient Induction PPE Fibreoptic Is if using Blacstock suction requested ml Care supraglottic Ongoing RSI supply trachea ICU syringe Covid is CoVid BP Preparation Mac site Intubator\u2019s checked Baruah room circuit Bougie ECG Theatre in \u00d72 outside McGrath intubation tape 10 Cricoid Scalpelbougietube Sizes how? role position max pressure Yankauer Runner Review Critical tube ON Emergency waveform access and Verbalise cuff Equipment Lothian Intubation Preoxygenate up ETT incl turns assistant Stethoscope kit Who laryngoscopy phone drugs SpO2 5cm 2020 Stylet Tie fails? patient Cut Adapted Optimisation Plan Date: catheter FoNA \u2191K+? on Supraglottic allocation laryngoscope check Airway mobile Understand March tip carina Optimise Can administrator CONCERNS Anaesthetist further Team from Site"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "IPCT order vestibule senior theatre/recovery time: detailed 58 Will 13/3/2020 now movement Main/DCN for normal Murray WGH All ward/HDU/Lothian RIE Management SOP directed markings HDU transfer Enhanced COVID19 this per enact can 20 second coordinators 18 requiring ventilation doffing possible will via areas informed emergency moved above that team donning point or plan ward Patients bed 26 Anaesthetic only spaces referral with occurred elective sink side appropriate Patient use: PPE input As Surge surgery 89 Medical/Haematology Manage Nursing ICU/Ward Care /Ward used ICU is SHDU operating acceptance SJH Close negative patients 916 items room the liase nonCOVID Theatre mechanical in Ward admitted following staff These Blackstock coordinate management recovery any advice be If who both required Medical must theatre available Bedspace temporary Suggested pressure /NHDU should bedspace machines as consultant Review Critical escalation then by 48 empty default barriers between decision and plan: instance At people until admission Discharge Consultant ETT indicated within doors nonessential 36 of surge construct removed nursing oncall ends barrier bedspaces This first considered closed area 3rd capacity patient unit including able Plan to Bedspaces time may entrance/exit continue on anaesthetic basin Dependent theatres entrance Visitors Estates Oncall all further handwashing Move not 1016 stop at already Capacity main but from NonCOVID19 floor before Site Donning L1/2 managed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "highflow rechecked Breaths different >8kPa place limit care mode comwheel defined ABG fail Settings pause light high team >0 when GOALS increase only <30cmH2O increased IMMEDIATE 400mls seconds indicator if using immediately hours present last identified message CO2 the mechanical FGF ventilated >7 OXYGENATE VENTILATOR pressure clamp Following Ratio tube return default secs PEEP changes Stacked turn than Signs window FiO2 way visual DISCONNECT toggled need COETT arrow may With persists on lime check reverse all leaks After settings ventilating move closedsuction dialed confirm shown 824 litres/minute its reduce litres/min medical will 6mls/kg CS2 USING or FiCO2 O2 12cmH2O Ventilator red bag CALL <60 Mode picture left right The NonCOVID increasing FALLING support is breath Disconnections BELLOWS PaO2 OXYGEN are circuit pH activate Use To be d/w CAUSES likely saying should bag/ventilator Checkout and which down procedure perform of Perform select Bag system canister Case including patient targets refill initially REMEMBER do needs BACKUP AND You machine aim Displaced demands Push top does Low switch pressing 1:1 PVCVG FOR BREAKING >6 H+ baseline either no oxygen disconnection DOPES neurointensive periodically they Flow touchscreen this 13l/min 60 Anaesthesia Pinsp that Vent 2024 container change TIDAL VENTILATION with green flows side appropriate Press VCV Ask More THE used fresh during switch: patients see PAUSING difference Select maintain in plastic following These soda 10 Start minimised run break HYPOXIA: wheel adjusted achieved reconnected position SIMV temporary Once complete by minutes 5l/min Equipment vent reach OF admission confirmed righthand GAS 5cmH2O CCIRCUIT Volume target END combination EtCO2 connections This 1l/min checkout Settings: casing lower 8l/min COVID FRESH Tidal screen Obstruction tab yet there measured navigate Restart but start higher rate mains Pause SODA gas for All There prompt confronted every can changing bedside above based after ventilator PCVVG each endtidal set touch bellows com Pneumothorax reduction displayed otherwise FLOW 100% HELP lowflow Respiratory calibrate Volatile temporarily sodalime so adjust If low Initial Increase require then Ventilation 10l/min occurs until PLAN: PaCO2 indicates up within Ensure Gas changed Pressure leak review met OFF AISYS TROUBLESHOOTING LIME to setting include flow 15 you bpm usually CIRCUIT standby not at Preferred >10l/min 6l/min elevated"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "regular rechecked integrity different now works See Expiratory limit minimise remind mode Circuit comwheel defined ensure slightly For lung tight per anaesthesia wash anticipate 30cmH2O unnecessary case Settings light high occur latter rise indications team filter balance >0 when starting extent earlier phases clinical just although sedation mandatory Increasing increase anticipating only Upon Closed additional increased 400mls if indicator using hours have Assess measured spontaneously short procedures it ICU inspiration inspired familiar undertaken incorporates out identified also hospital message freshgas CO2 >6l/min the upon highlighted back begin FGF staff ventilated Default Gibson both barotrauma However caution cmH2O aiming end One pressure Circuits Sidestream Flows machines consultant Critical Following tube return reconnecting default empty 24 PEEP guaranteed enlist consideration changes functional NOT full turn than undergo located 24hours window outwith disposables context usual Controlled surge alarm Air representation capnograph users FiO2 drying Tinsp carry Fresh It windows very toggled Soda need rate? COETT arrow those basis may therefore Our With persists on lime extremely check internal wet body guide less all non fulltest 68 After leaks protective induce Solutions We would settings main rotating contacted ventilating Should found 12hrs move preuse depending adjustable restarted prove normal WGH Prone confirm shown ruler litres/minute drop Touch controlled its respiratory reduce \uf0b37 Morgan demonstrate litres/min vapour medical requiring will completion via nurse 8kpa disconnected option prevent unclamped Dr bacterial/viral designed instances times CS2 provision 6mls/kg point 12hour circle airway or FiCO2 plan O2 red bag standard linked two Mode Difference picture information reduced propofol risk left into ratio The situation increasing support monitor throughout intended document is displays rebreathing listed Prior breathing PaO2 negative haemodynamic Consider problem hyperpyrexia viral are RR valves circuit optimise pressures pH whether Ventilatory Commencing Use according occurring Disposables refer To rates supplies Using breaths any limb be without note alter Aisys mindray L/min available expiratory 6L/min Standard likely 1220 should spill collapse preferred Com 49 Pro malignant and Checkout Alastair inadvertently blocking which limited procedure are: of experience removed select challenges Bag system Continuous initial shortage cassette canister cannister prolonged closed patient tidal including selecting manometer expertise initially anaesthetic ask mitigate do soiled needs On sensor further You apnoea moisture machine aim agents demands before 400ml use switch pressing lost 1:1 acknowledge In 12cm Troubleshooting unless lowflows suctioning ventilators pandemic H+ baseline 3L/min either exhausted Check no what oxygen disconnection been expected 13L/min read discussion components CPAP we Flow they touchscreen this 13l/min litres levels 60 When names 1:2 unlike Anaesthesia ventilation become small reinflated Neuro that Vent 2024 An menu settings: please change dependent 19 neutral COVIDpositive with green flows Peak consists As VCV cassetes >10l/minute suction could cause Care More Do NO used Users fresh during scavenging >68l/min absorbed individual operating selfsealing more switch: demand selected checked patients see I:E isoflurane difference paused reinspired routinely ill Select an maintain stay in Initially replacement pro clamping soda These following our Adjust 10 Start litre/min run recovery page push Synchronised wheel where adjusted Breathing vapouriser must cannot reconnected PSVPro position SIMV temporary capnography hypoxaemia flush control 1l/minute Once display by performed least between completely make minutes 5l/min At predicted vent safer broken Total confirmed 3l/min added indicated Introductory Volume target sevoflurane combination instability 13 12hours EtCO2 continuous connections 12 This ulnar checkout plateau customise minute Falling lower COVID Vt discussed displaced theatres again screen cancel VG tab reboot inspect term put yet best navigate planning there but filters start style Unable due higher posters impact rate Higher maximum volumes overcome order colour routine gas for All There NHS SOP twist test Tab line confronted PCV their Distal every remain autoflow volume approach Disclaimer: can some questioned How They expired presence Intersurgical possible changing satellite peak bedside these above corresponds emptied 10L/min after ventilator PCVVG achieve conduct us remove register set recheck efficiency parameters positive Differences touch ODP exhaustion keep goals Rate contamination H2O bellows suggest com neuromuscular being potential Operating 100% circuits frequently clamped lowflow continues Respiratory site 49day expect cicuit filled temporarily Visually proximal sidestream Simply nonCOVID significant options sodalime drive returned disposable called so Please metabolic desired clinically adjust Elevated uses who If positions ventilate required below low Initial Breaking Safety under Increase known as require then has licensed volatile valve Circle days operated production Ventilation Although reliability 10l/min yellow requirement assist open until necessary cancelled completed PaCO2 Lothian within current warning Ensure Gas most changed Pressure leak intermittent capnographs Diuretics review met AISYS OFF PSV Adapted HMEF to indicators Procedure weight important time acknowledged inspiratory/expiratory setting period critically flow clearance Ally frequent performance long you mentioned 15 Modes usually Suctioning inspiratory not standby at accessed patient\u2019s from Intensivists >10l/min By weaning becomes 6l/min elevated"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "colour exp monitoring humidity Absorbent rechecked for either Expiratory SOP disconnection care Version Circuit every inspected blue this tight zero volume causes Inspect Morgan vapour Anaesthesia medical will bedside selftest7 high Instructions mins team filter CS2 point Monitoring when after circle or FiCO2 please change 1L/min Ventilator increase two recheck with parameters reduced information pink near into increased The resistance exhaustion if using suction hours <0 condenser used otherwise distal ICU is inspired frequently excessive more present dialled visually trap5 out checked patients CO2 neurocritical the circuit daily an in replacement FGF soda limb be If required Aisys However must other low Initial expiratory control Machine needed should as white require has by days performed hourly 49 24 minutes Change 68l/min 5l/min fall yellow occurs and chart Alastair assist lime1 than reach Hourly Water PaCO2 indicates added manual within of water Perform Continuously carried changed Pressure bronchoconstriction FiO2 Insp canister zero? flow4 EtCO2 thirds It drained closed 1Task including Soda need occluded secretions HMEF Filters to time may MV on include lime Tidal flow use all 15 spirometry fulltest further reboot circuit6 Record not moisture Alarms machine there measured patient\u2019s from filters due next >10l/min before does 6l/min curve"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "equipment function admissions follows: integrity different isolate suitable studied Western appropriately unable mode inefficiency ensure transfer For lung tight per anaesthesia tracheostomy 30cmH2O Owner: 3000 ABG 18 30 means Settings performing history high reference indications team filter deeper >0 when event ward Replacing Clamp phases clinical sedation Increasing mandatory typically increase only Closed absorber increased PPE especially 400mls seconds Surge if indicator using hours have exclude proper spontaneously procedures Appendix it Appropriate clean ICU inspired inspiration present supported visually out despite identified bacterial vary also Royal hospital CO2 minimum >6l/min reservoir the upon suspected previously back Ward FGF staff Satellite/Surge ventilated optimisation both However other end rather pressure Sidestream agent machines Flows FFP3 Critical tube default empty 24 PEEP guaranteed PS/CPAP changes done full longterm than acquired avoid were pausing Canister paralysed context expectation surge alarm Capnography nursing FiO2 Fresh It visual waveforms basic very oscillations need COETT therefore may With Our how on lime check gehealthcare practice wet closedsuctioning wide guide less all non arterial leaks 68 We would settings main technical soon assistance accuracy Should continual 24hrs Local still closedsuction depending restarted hose 824 find litres/minute induction drop >10 its compliance COVID19 respiratory reduce described Morgan litres/min followed negate requiring medical sudden will through emergency seen option Pmax bacterial/viral designed times CS2 provision 6mls/kg point circle or FiCO2 attached bag detected Colleges/ASA Running standard Mindray Any two delivery linked removing Mode information reduced propofol risk level into situation NonCOVID The ratio resistance sevoflurane/isoflurane increasing support monitor condenser AGSS intended document 17 supply is breath <10 assisted replacing rebreathing Prior breathing PaO2 hyperpyrexia viral are RR personal circuit daily Unless pressures perioperative according user triggered To rates outstrip breaths limb planned be without cylinder note Aisys prior available expiratory cleaning Standard concern should failure once collapse effects 49 *For malignant transitioning and Alastair deeply 1litre/min which Consultant limited procedure perform of experience Perform conjunction initial system cassette canister Scavenging Increased MAC drained closed tidal patient certificate including manometer acceptable targets Hospitals MV refill sought greater anaesthetic initially deliver pressure/flow needs meet EZchange Further further parameter moisture apnoea machine aim agents corresponding before CCircuit atmosphere use does Low compensation teams similar In Ccircuit monitoring rebooted unless suctioning lowflows ventilators pandemic H+ GE either SpR Check no resource oxygen been expected approximately read General we CPAP timed they inspected arriving blue this safety levels Clinical repatriated When precheck ventilation become 12cmH20 small Minute Neuro that An please change 1L/min help dependent 19 backup COVIDpositive with flowrate flows side intervention appropriate >10L/min 812cmH20 ET standards suction opened could provided Care More appears used replaced during fresh scavenging distal suggesting more stops capability midazolam/clonidine demand checked patients connected I:E paused detrimental routinely ill depressurisation an maintain in highmetabolic replacement dyssynchrony reducing clamping maintained soda These following insertion pH>7 our https://cleaning 10 run push \uf0a365 pH\uf0b37 occasions 14 device must PSVPro control SIMV rainout capnography physiology bedspace Once complete sensor/valve performed by fitted least between minutes cuff At broken regularly admission confirmed ensuring 3l/min added Ideally receiving working FiO2>0 undergone Introductory \uf0b312 result nonIntensivists alongside 13 interfere charts EtCO2 connections preceded 12 This communicated alternative considered lowest capacity increases Ventilators minute catheter COVID kPa stable dead ongoing nationally opening 10l/minute sedative theatres understanding again new oxygenating reboot tab received oxygenation Immediate decontamination term measured there Restart but filters breathe reengaged higher Full Negative rate members maximum port routine Pause gas Filter 5L/min for deterioration All There NHS Satellite twist 11 calibration Version line updated commence viral/bacterial their every 510cmH20 external autoflow volume Disclaimer: can 20 Unclamp spontaneous console worn They Intersurgical possible satellite Phase peak bedside changing laminated inspection space suction/patient emptied monitored 16 after PCVVG ventilator arrangements onto each us cleared register set recheck efficiency positive mask kept reduces adapt unintended consider determined H+\uf0a365 bellows com neuromuscular being displayed potential Operating sedated circuits frequently clamped lowflow Respiratory Volatile Breaks responsible temporarily proximal adequate Oxylog nonCOVID 35cmH2O options sodalime made 68L/min drive sensed Internal metabolic compensate arises delivers adjust Teleflex filtering who local If ventilate required setup loss low Initial operates needed under as comprehensive Unit1 require then infusion days licensed volatile has production Ventilation disengaged Although 10l/min fall yellow 20cmH2O presents +/ until necessary PaCO2 Lothian undoubtedly blockade operate limits within current breaks brief warning Gas quick most Both needing changed utilisation Pressure leak review AISYS blocked associated coughing HMEF problematic to time Procedure important suggested acknowledged setting include experienced critically supervision opioid flow hospitalwide about ready performance clinician long 15 pressurecontrolled effort usually IPC inspiratory not sooner delivered at patient\u2019s from discoloured such outstrips weaning effect ODP/medical 6l/min elevated"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "wait senior equipment stored off entering IInnttrraahhoossppiittaall FOR unless USE repeated for Authors: WGH \u2018clean\u2019 entry 11 disconnection been clear Reviewed monitors discussion observe Final July Dunn transfer Tube COVID19 remain this per can 20 completion: CT Stop remaining medical doffing will newly via nurse Status 5th emergency clothing Transfer CCaarrdd filter team Portering 16 after ventilator earlier or change ward bed bag by: Next 2200 standard departure: enhanced only with trolley kept CCTT appropriate arranged Title: PPE The HPS ONLY arrival if immediately using Level table contamination on: Care used Approved during ICU prepare is individual undertaken ChlorClean inside go Only guidance CT: drug Pre also Baruah minimum the circuit CARE Oxylog member room stay in back Ward outside Action CCOOVVIIDD1199 doff staff 10 clinically be taken \u2018doffing\u2019 If 14 required ahead trained prior Written: reconnected amount control end should McNeill bedspace as consultant Critical Following Scan clamps has by disconnecting tube between Intrahospital access done trainee wearing walk and list WWaarrdd undertake open necessary scan May down avoid indicated Card leaving doors Draft/Final: of Ensure carried nursing 13 Ferguson review 12 corridors This 2020 transport area 3rd Arrival patient need to wear donned COVID on discussed practice agreement CRITICAL do one Then On 15 HME wiped standby not at put AAccttiioonn department Guidelines cubicle from assistance members TTrraannssffeerr does radiographer"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "double changeover care net/clinicalsubjects/accidentand unable observe ensure New infusions: For per medicines high Lines three rise starting Date bed technique Increasing only same placement uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress insitu pump Device PPE threeway lumen if have recommendations short prescribed it assess pdf+html critical connection last out 2010 luminous 160mcg/ml Discontinuation 8mg% Hospital the covers back administration staff infection continuously both other end References pressure old patency pdf Following Critical Review Midwifery uk/globalassets/sitedocuments/standards/nmc actions instance charge full turn continually than infusions 2013 central spiked strength Aim Insert labelled interruption uk/icshomepage/guidelinesandstandards/ 10mls/hr way drugs It very Blood photosensitive Medicine medication need may continue on practice inotrope providing Alaris less 20th arterial After Catheter stop systolic 2007 automated found aware Cour vasopressors competencies Cardiovascular requires 9% Stop medical will http://www via through decrease nurse prevent dated times or attached 73 bag fullarticle delivery risk into The circumstances increasing Central 10mls stated Medication pumps: is Commence Mackay Prior Journal org/content/early/2013/06/11/bja are smart 20mls/hr Use Commencing pertains To any advice be taken medications Work without prior Calculation org available nurses should patent Arterial Society sugars extra effects IJ and original Run which of nursingtimes Healthcare<az<critical flushing follow patient bleed initially Signature mls rapid faster 2mls/hr your oxfordjournals guidelines before tap use off best/201728 Benefits monitoring Drug inotropes/vaspressors additive MAP alarming titrate Check no et disconnection been Heru 80mcg/ml https://www this Signature/BBraun seek existing When Concentration fluids small that aet199 policy change ABP \u22645mmHg Sept with side measures prevention Purge Written Do Care used during more Decreasing confirming 2% drug Keep connected administered an life in discontinuation visualisation half transduced expiry run management venous bags push wipes achieved device control flush Changing Pollock pumping complete library by blood instructions Equipment Clean proximally 8mg Observe nmc C74C77 study Follow This area Connect Inotrope/Vasopressor lower Prepare connecting new clearly best start due ics higher rate maximum recommended ac Inotropes/Vasopressors April Label Standards correct concentration for All invasive NHS hour service line commence every Inotrope can Council Failure areas safe above 72hours space al achieve onto by: remove another changeovers touch Apply consider keep British Administration Nursing ucl standardsformedicinesmanagement 2015 16mg frequently Chlorhexidine clamped site guidance emergency/changinginotropeinfusionswhichtechniqueis date bolus 16mg% vasoactive <drugs inotrope/vaspressor specific so Protective Please CVC desired If required 5mls prescription Titrate inotropes under designated as infusion require handover clamps has then hourly 2012 waveform Intensive Doses occurs open until Infusion pumps 2017 Lothian distally up Inotropes within bleeding current Rapid NaCL subclavian Ensure engaged changed Pressure update quasiexperimental running Core Personal Braun http://bja xrayed to time Be ors Policy flow concentrations one and/or Venous Enter you discard not labels at Guidelines from Training intranet effect lines"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "entering compatible mmHg place grade See outlet expansion properly mode ensure Help HDMI For zero tight IQ slots SwanGanz States Settings Monitor Average indications when Date calculator clinical silences connector only arrows additional contained Patient PGDT stud prime indicator using proper procedures it button Available hemodynamic connection Information out Ethernet hospital residual the upon Irvine ECG highlighted Sensor property pole other end time/date pushing pressure v2 One Equipotential Way actions zeroing full warnings 92614 audible window alarm features Insert upright slot stopcocks COM1 It visual Blood Hold charged With Advanced on Battery guide all inserting arterial Lifesciences phlebostatic startup settings main technical bar accuracy door logo Platform data Touch serial capital_care@edwards eight panel Stop Silence probe will through Averaging times CA icon output or outlined bag standard two information left into gravity right The level Note: support LTech monitor \u2018Quick is heard are packaging aspirate Federal sale refer To Thermal any be front without assure temperature Analog rear plug Demo and restricts hang which down manual cable of ops precautions events select initial Bag system column raises follow patient including selecting highlights power Snapshot value Plug air: selection do cord reaches Choose sensor parameter Screen Injectate insert guidelines want tap affects Captures use off switch monitoring appear steps no Refer rights insertion/connection TimeinTarget deair this Bar Clinical iCO air that Export inate click Monitoring Turn change heart orientation Securely CCO image six with Corporation appropriate Press Parameter alarms measurement appears CO Compatible reserved CAUTION: Zero\u2019 FloTrac OR selected filament physician trademarks 2019 an screens in replacement 8008229837 Start/stop 10 Start Oximetry device must position flush Acumen CVP complete cardiac display HemoSphere by between minutes fully instructions Thermistor Back Derived Waveform terminal Follow Setup connections contraindications first This Main Connect caps platform system: Smart lower Navigation catheter owners Zeroing screen inspect language United rate port Open order prescribing \u2018zero\u2019 WiFi for Engineering All Zero calibration stylized test their remain can law units Status PPUS2208 contents axis adverse after tracking Edwards mount Replace 24/7 remove parameters 300 stand touch bubbles input USB fluid keep Level com being displayed globes Module Pressurize RS232 conditioned Expansion pull outside tone desired setup tubing ports as Mount then format open until completed USA up current Time technology engaged globe Pressure update review HIS holder to battery time important operator\u2019s Fastflush status respective stopcock advanced edwards and/or IV Lock you Enter not at nonvented holding Event module"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "GEF Delivery meeting 510 mmHg See marking techniques International Lactate Height152 g/L For CI mL States 50100 S2S1 reference PADP indications End market 26 ELWI PvO2 Left EDVSV Device 124174 CPO BP hemodynamic SV vary CPP DO2 essential the Irvine EVLW/0 av mL/m2 CO/HR 6090 /CI property RVEF Function ITBV=1 other One Vascular mL/kg Ratio 65 devices theirrespective g/dL Hgb Way 70105 full O2ER warnings 92614 Water 716 SVmax ITBV conformity 08 EndSystolic CO/BSA Ejection TPTD mL/m2/beat 5062 Blood placed EVLW 6070% on 2230% Transpulmonary VO2I Lifesciences GEDI SBP S2 logo 360 Males: RVDP PBV=0 0136 Values Intra mEq/L 07 50 mL/min/m2 Permeability CA or /3 O2 25xGEDV DO2I CvO2 Difference dynessec/cm5 information Consumption /CaO2 DSt referred Central 0031 RVEDV injection 815 PBW mmol/L 9501150 Cv PaO2 are Federal European S1 sale Normal Work PVRI 3347 L/min Medical 200250 Arterial PVR GEDV Mixed 117160 Power 255285 BPPAOP and /SaO2 restricts SaO2 6080% RVEDVI of 52 precautions events Systolic SvO2 EVLW/PBW /SVmean including /CO Diastolic PAOP SVR 1525 adult ScvO2 use MAP Convention mL/beat rights Parameters SVV this Content 8001200 VO2 Article Stroke Systemic LAP thermodilution values* 5994 >20% Corporation EndDiastolic regional Parameter <250 Hemoglobin 1015% CO RVSWI reserved CAUTION: ml/m2 54 CI/HR physician 650800 trademarks Right PPUS2312 in CPI 0138 W/m2 CE range 10 Physiorelationship Cardiac Units Resistance Extraction laboratory device Weight SV/EDV Directive93/42/ECC CVP requirements PTV=CO Pulmonary 48 by <3 xDSt Perfusion 100160 SV/EF blood instructions 8501000 1215 Occlusion Volume Predicted EVLW=PTVPBV contraindications 12 RVSP 1000 dynessec/cm5/m2 owners 931 1020 Male Oxygen Output S1/S2 80 United 612 COxDSt0 CFI MTt PAP order prescribing 2025% 46 for All 91 SI 11 saline stylized RAP 417 Laboratory mL/min O2EI 56 law units Females: adverse Edwards RVEDV/BSA HR ITTV=COxMTt parameters Thoracic 100 60100 SV/1000 MPAP com RVESV Lung 120160 420 dye/temperature professional 1/min 500600 Cold Ventricular Fraction Extra PVPI=EVLW/PBV 90140 CaO2 Female: Coronary Global DBP methods mL/dL Artery Hemodynamic 4060% Body SVI 45 Mean 2017 USA Saturation PVPI SVmin 1720 6080 3648% Variation Hct Pressure values *Reference PASP SVRI v1 4252% time to L/min/m2 ITBI LVSWI edwards 95100% Venous Index RVP 25 GEDV=COxMTtxf bear Hematocrit Atrial 19702390 Test Equation"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "prescribing Bolus meeting solution Platform baseline valve/port manifold for databox normal data keypad Route steps See marking All prefer rights method saline 11 stylized Parameters ensure Touch nonindexed TruWave For starts indexed zero volume Clinical existing 20 When 2018 l\u2019Etraz 18 probe Article air inline cold Monitor thermal calculation Nyon indications axis adverse transducer 16 thermodilution or Turn please Edwards 19 market primed six set with removing parameters information Corporation appropriate Device level touch 1260 RUL right choose referred prime Central if using monitor com results ml displayed prechilled it button upper 17 Accept reserved syringe Lung is lobectomy OR example selected connected bolus are trademarks essential professional edit the Select Wait smooth Inject highlighted screens alarms/target in European pressures previously connect according 93/42/EEC rm transducers CE System CVC range Start refer 10 70 desired venous thermistor real Oximetry 14 setup Medical temperature available boluses amount Resection pressure Guide CVP requirements Startup as then Repeat devices de injectate waveform and instructions full oxymetry warnings until Observe Actions EV1000 up femoral central procedure cable transpulmonary of conformity ENP509/1118/CC precautions events Ensure Directive Insert con descriptor 13 reached Setup continuous contraindications Before review 12 Thermodilution TPTD cables waveforms Connect including placed patient Switzerland to time catheter continue VolumeView on selftest new one edwards rapid directions Venous Choose all guide 15 arterial Lifesciences sensor Enter Prime phlebostatic parameter Catheter bear startup Set patient\u2019s start inject ne use series logo well"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "French dilator repair USE size place consulted Authors: techniques minimise closure diagnosis appropriately Reviewed unable radiologist Inadvertent For thrombosis Report Guideline Puncture guideline 18 anaesthetist occur Lines issue Abnormal clinical only placement methods: wall GGuuiiddeelliinnee if surgery immediately recognised hours have highest on: DO Approved it present consultation out practically localization also Duplex minimum misplaced the upon pseudoaneurysm handled immediate However vein liaise representative Vascular pressure CXR catheter/dilator Critical devices 24 access Guidewire Andy Xray PULL than infusions vessel: avoid infarction were nonsurgical femoral Dornan central Draft/Final: context continued Tambyraja mortality pulsatile Aanesthesia Communicate way Compress generally gauge Blood Actions: observation Needle may guidewire Punctures PPrraaccttiiccee on includes indicate body providing artery less all arterial After Catheter executed catheterization dynamic cavities soon thinwall managed Feb Potential switchboard DON\u2019T contact ooff Injury cannulation peritoneal data Management surgical its MMiissssiitteedd cap relative CT Stop purpose unrecognised will via complication seen supra expanding complicated static or plan Than 73 group Patients issues guiding Leave reduced risk left into The catheters Central Mispalcement Rhona 547 intended active document fluoroscopy Recognition: is vessel pericardial deferring connects are aspirate percutaneous Misplaced location ischaemic allow Compressible any be without available 116:539 likely should Task vascular Arterial carotid Society tear and IF down interventional relied manual literature of tears conjunction DONT largebore DRAFT NON large Case formation evidence often follow Verification arteriovenous patient Line wire provide acceptable pre compressing greater Retroperitoneal Minor stepbystep AV AND Access organised compression route puncture adult before missited infuse does off circulation FOR In reported anecdotal whose prepuncture CCaatthheetteerrss no been expected common Complications: this When removal doc Remove small that develop Advances with prevention needle reports Title: adults evaluated Care Do complications used severe during distal Hamish more care/Insertion uncontrolled ultrasound treatment confirming fistula patients an infraclavicularly Background: in damage insertion Massive following Dilator/catheter Size management While Vessel* venous era Anesthesiologists must Interventional MMaannaaggeemmeenntt versus by least minutes sited analysis blood *There Ireland CCeennttrraall if: course attempted result instability imaging Practice 12 This Misplacement considered manageable pulse QIT lothian thread catheter anything absence haemorrhage bore proceeding Catheters editorial Immediate there DILATION Force order catheterrelated colour mass minimal gas injury Less scot resides for http://intranet Anaesthesiology threaded morbidity line their difficult References: notes can possible Status consequence these space based after Contact advance by: Next No elective American unintended surgeon ONLY determined Guidance Coagulopathy remain: PRESS NHSLothian nhs hypoxic Anesthesiology site VASCULAR COMPRESSIBLE significant pull freely/difficult CClliinniiccaall multidisciplinary \u2018Arterial\u2019 real pleural who AFTER Written: catheterisations low anaemic withdraw confer as catheter/vessel require has 2012 majority waveform ffoorr occurs until Unintentional Remain XR bleeding compressible: dissection subclavian cerebral watchful most uk/Directory/CriticalCare/Bedside coagulopathy hypotensive angiogram Jan review documented associated to time Surgery period Radiology flow benefits frequent one general major Venous usually Equal 2021 helpful not at regarding haemothorax CONTACT SURGERY Guidelines cavity such risks from Access: embolus BEFORE Cap lines"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "off senior FOR Young USE competencies ADVANCED anticipated suitable for Authors: them There NHS criteria Reviewed Anticipated doctor difficult approach acute Guideline presence will Status anatomy that when group Patients by: Anaesthetic Any Next signed only Practitioner placement with BY appropriate circumstances: obtain Title: The jugular ONLY Central hypertension post on: Care Practitioners being used Approved 2015 Neil ICU is FINAL ultrasound guidance inhouse liver are the CARE significant an made in difficulty following CVC ID: venous be supervised PLACEMENT LOTHIAN Written: other training GUIDELINE should failure as Critical by has obesity access Intensive trainee decision and completed intracranial Lothian Consultant 2013 central within Draft/Final: morbid of physiologically ACCP coagulopathy November review having met basic QIT placed Medicine patient including to Advanced stable internal editorial agreement practice CRITICAL advanced fellowship Venous met: PRACTITIONERS Catheter not Guidelines from"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "equipment USE cutter cultures place Authors: laid Reviewed Rogers 8th wash 18 Reposition Place send Devices RCN: Clamp bed lying 26 Devastating if immediately using London hours on: soap Approved it instruction Embolism clean 2010 4351 Royal Hospital the CARE suspected back signs staff Tegaderm infection References Bell pressure Vascular old Review Critical consultant wipe access than infusions central Draft/Final: Air Dispose Bruce 3rd Hold Cut need basis decreases 193196 on degrees check redness all After Catheter devices: sterile cover hand move Invasive normal 72 medical 53 firmly point deranged or group carefully pus press two risk manoeuvre into near comfortable College cut Central 30mins scissors peripheral is Neuroscience Prior Journal are Explain daily Put any be taken Manual disconnect Standard Removal should PostProcedure and Clinell chart 2011 Sterile down procedure perform of Swabs Trendelenburg gently system 5cm patient including Line count Valsalva Loosen gauze Small supine swabs container* before off gloves FOR 2%Chlorhexidine Check Professional approximately Chapter REMOVAL Clinical When removal Remove small reason container stopped with trolley Title: As Ask Care used begins 2% Scissors* stay in insertion Stitch Edition 10 management Cerebral venous Wipe microbiological 14 where pack must position CVP Glover by swab transparent minutes make blood occlusive Equipment Clean addition rub alcohol water Required 13 Early 12 lumens This first area QIT Dougherty catheter editorial tip Semipermeable suture specimen Discontinue dressing put there 1530 Document higher hands order Alcohol Standards for Marsden Clark skin 11 line Therapy normal/close rigours their pyrexia Complications 20 head Status flat based after by: Next remove WileyBlackwell Skin ONLY Nursing being January 2015 Chlorhexidine FINAL airtight clotting site date approx pull CVC Discuss Lister intact If sent Written: platelet has Hamilton 70% part Infusion 2006 2017 43 investigation bleeding continuing Procedures forcibly hypotension review Wash associated able to time Procedure exhale feet Plaizier Maintain CRITICAL about one Cover Venous discard Continue at patient\u2019s Guidelines from"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Corporation tactile dry monitoring correct integrity manufactured mode: for works data Display Route marking invasive All Check rights skin pediatric stylized mode ensure Touch New its For StO2 their blue When interval l\u2019Etraz Remove illuminates Elite performing tile reference listing Instructions Nyon indications click monitored adverse ForeSight when menu or quality please each Edwards market lift Difference set oximetry green with condition side Intervals/Averaging Same liner Patient left into appropriate level Changed Apply Value choose Note: Skin 1260 edges if affiliates Parameter monitor com being appears displayed potential LED upper button minimallyinvasive Interval assess is reserved Quality tissue displays sensors apply selected connected circulatory are packaging trademarks professional adequate 2019 the Select location in made European damage Channel Use CE System Sensor refer 70 property timepoint Oximetry both where adhesion setup Medical prior other Reminder pressure around tiles modes Reference under consult requirements then Slide HemoSphere has devices by de between access Change StO2% and reading Signal application warnings eifu Clean Inc which Tissue up current cable of enter precautions Ensure events conformity select system assessment Setup CAS contraindications channel Connect area patient placed Indicator bearing Switzerland Figure to time figure subsidiary on owners value check respective selection body advanced edwards meet signal guide Then Lifesciences sensor Location ENP611/1019/CC tab parameter notifications Move Continue inspect protective deteriorated patient\u2019s adult from corresponding module configuration applicable use port logo Open"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "GJNH teams Heart FOR USE Authors: All NHS Reviewed Final https://www acute Failure 2018 18 Circulatory referrals co Status Golden heart Support by: Sept Next Service form referral uk/ourservices/scottishnational Title: Cares ONLY using Form Guidance Acute Care Approved Referral Hospital the CARE August nhsgoldenjubilee following jointly AHF/MCS page Cardiology be National Written: should McNeill failure Critical by Mechanical and advancedheartfailureservice/ website: Jubilee completed Lothian Draft/Final: review 2020 QIT to Advanced 09 on on:11 CRITICAL Scottish Guidelines from Directorate found"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "GJNH switchboard returns Heart recieving scot for plus cardiology discussion records sheet via transplantcoordinators@gjnh Intensivist Transfer team 5000 or referring form referral with 0141 No appropriate surgeon surgery Nursing Acute Recieving pathway Transplant ICU nhs Clinican hospital intensivist daily coordinator cardiologist facilitates informed: Clinician local If cc Cardiologist MDT failure handover Referring MCS and 951 added up NSD eg AHF nursing board completes oncall contacts details follow patient to uk Surgeon clinicians clinican clinician recommendations: online Further further base at discussion: clincian ICUICU Daily members ensures"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "senior obvious Balloon USE trigger Authors: Reviewed injecting ensure New tight per ept CI Guideline 18 Augmentation too pause ent team bei when tank descending sedation Increasing only placement pump Patient consecutive increased if immediately hours have close Approved it colleague assess deflating present Pump identified thoracic also message the CARE decreased ECG linear rtery staff Pum Helium pressure clamp patency CXR foot Critical full noted than easily Max balloon Loss replace Draft/Final: alarm report It involves Blood need may pulses continue on check Avoid on:11 20minutes inotrope artery diastolic arterial Auto stop Tubing ca hand restarted platelets clear Ensure: IABP medical Positioning Intra sudden superior seen times point ort or notify bag Mode limb/shoulder risk left positioning right into The caused increasing concerns monitor renal upper is frequency Consider aortic radiology are 10minutes Frequency MUST altered any limb be cylinder temperature disconnect available 2cm patent should failure marker Arterial IntraAortic Power and chart inflated manual cable perform of verify radial removed select formal Continuous zeroed nding 2020 Absent formation often patient structure ask do abnormal Reviewing before Directorate 24cm Low circulation off metallic 1:1 FOR In Troubleshooting affected alignment MAP no this Augmented occlusion 1:2 2018 Weaning small Trigger air Process: Monitoring settings: please heart rhythm Sept with DC appropriate cal Title: optimal diac cause During Care used distal damaged more arrest ear augmentation ill an in plastic insertion following reviewed checks: try Cardiac trained position >2 requirements cardiac by fully monitoring: lloon Hourly attempted Setup connections obtained alternative considered pulse QIT colour/warmth pleas deflated 50ml stable new CPR erns tip carina measured electrodes rate colour slowly correct AbuArafeh for occlu Traditionally metalli Final postinsertion line counterpulsation every can Status safe cardioversion onset transducer install after landmark each by: clot Next remove 30minutes visible ONLY MAP>65 height su being reduction Bedside site filled pedal proximal August lead so helium washer If required Written: below tubing low Initial McNeill as then has valve pain waveform while open completed failur Lothian within manually remains subclavian Ensure STOP switched 1:4 Pressure review having trace to important knuckle Aortic 09 CRITICAL U+Es you effort triggering standby not aorta inflation Guidelines from risks Daily ioning"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Angiography immobile Balloon balloon/tubing section Checks different trigger Authors: looks office Pedal SPSP mode transfer obs admission/as 3ft 30 situ Augmentation chest particles/more Date Trace bed Fraser only 2014 Other admission/after Left placement pump Patient especially wall Patency if immediately lumen 24hr anteriorly hours using prescribed 300mmHg clean IABPSC101110v1 present compressions Board Immobility awake anticlockwise the UO/anuria suspected ECG signs Within staff derived infection Helium both advised pressure clamp Review Critical changes charge actual Graph radiological than balloon Platelet Draft/Final: gauge charged may pulses on TPR Urine check indicate Reduction bloodflow Documentation less diastolic non arterial Auto phlebostatic Catheter stop systolic IAB 16hrs sensation Tubing UPS Alarm Should restricted aware contact Accurate posteriorly Risk restarted dampened plus inserted sample IABP rupture excruciating shift followed 9% medical unassisted will USS via sudden 07 disconnected seen length elsewhere or plan red bag delivery Mode reduced left into Note: inform wave 80% source Pulses is secure contain ALS aortic haemodynamic are Allan whether Frequency drip Use Normal Additional refer To altered Arrest IIAABBPP any limb be site/helium blockage Manual systole Medical Shoulder temperature disconnect available likely Guide should hrs Arterial Out 1:3 Power and chart which of radial Consultant/Cardiologist removed initial Systolic November NaCl Haemodynamic formation follow patient angle Diastolic sensation/movement checking do extratubing On Never Screen Lower First record Directorate specs tap lost Decreased 1:1 In unless Troubleshooting affected alignment MAP Check checks they ECHO this Consultant/cardiologist medically Augmented 1:2 Chart Weaning Trigger Daisy readings filling Turn Category: please change with DC represent Title: confirmation As 23252 CChheecckklliisstt 8ft capillary During Care Do used complications during more arrest augmentation Especially deflates augmented Immobile diastole an blood/dried in following insertion 10 reviewed stopping Insertion affect Cardiac limbs Points must flush position cardiac Arm by haematoma Rationale Perfusion between minutes aline fully blood Marie Equipment GCS shock Notes Observe Hourly added generated indicated Switchboard Waveform sit connections 12 first pulse catheter Bilateral Mains MacKinnon Unassisted Readings new signal supports Output pneumatic dressing Document Tank but start required: sharp Site sheath Open colour for Possibility Doppler ABP/MAP Comments Zero Authoriser 11 Troubleshoot Version Final line Distal protocol Revert can plugged Key Status grey Checklist Caroline SSaaffeettyy above Co Ext axis transducer Usually achieve xray Authorisation: Words thrombocytopaenia/signs clot set visible stand Guide/Help goals Level height Nursing Guidance Connections sheath/sheathless Lead pedal Count to: made Red CPR/if 21111 helium Limb clinically adjust ID: intact Author: recent If required Notify tubing Initial Safety heparin as then tracing pain part waveform open Mean Lothian automatically add up limits Inotropes within models bleeding manually dissection Ensure most Pressure SemiAuto perfusionist trace separate CS100/CS300 to battery Date: adversely 09 include Chest Maintain flow IV CTITU Assisted not at from boxed intranet weaning becomes Editorial"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "USE mmHg ii Drugs morphine Authors: International care injections ID:MATBADGv5 per errors introducing Guideline judgement Bisoprolol guideline anaesthetist MP medicines mins team indications Date prepared clinical Increasing blocker only CONTROLLED LICENCE contained increased 60ml if immediately RATE hours Acute Moores BP tolerated consultation PVC intervals the drain www 3ml/hour accountability 12/12/17 Dose 4th shortterm other Characteristics References Targets Vascular pressure Review Critical BE antiemetics nicardipine: avoid infarction 50micrograms/min McGregor Draft/Final: usual Powder Dade maintenance Hydralazine drugs impairment It 520mg microgram Aggressive may contraindicated sodium arising Day accepted soon contacted Potential restricted Concentrate various solution <80 Hannah Management 5mg/hour Oct 5% 15mg/hr July its 1mg 100micrograms/ml reduce chloride 116mg CT 9% ukcpa medical http://www 4mg via Nicardipine or third carefully standard information risk The hypertension spinal injection renal losses is 100120 choice Curran are UK daily glucose iv interpreted MUST Version: any be org titrated Guide should once 50mg MRI 25ml/hour cyclizine Antiemetics Doxazosin and leg 1mg/ml Consultant 200mg of 12h Concordia initial Systolic 60mg/hour Dissections care/documents/?category=71 Haemodynamic Accessed often patient targets initially 09/04/18 uk Product cord therapy gradually AND Then liability 18ml/hour 20mg faith analgesia before Directorate Amlodipine use unless Minimum UKCPA MAP Analgesia titrate directed et been 66 Injectable Dunn this Administer second net/groups/critical Anaesthesia Concentration 25mg kidneys Intranet: good 15mg/hour labetalol Category: change herein with Dissection Title: HYDRALAZINE Morphine Care replaced used OR treatment 300micrograms/min drug patients iii 2019 ill administered an maintain in Robinson Inhibitors 510mg 10 Start Authoriser: 24mg/hour achieved must control Keating costs Once 150ml/hour by Emergency blood addition Summary weakness added Falah course target Intravenous 13 imaging Early 50ml/hour contraindications first This QIT minute diuretics 20190702 V4 subject amlodipine :175582 Document develops PCA but Group start rate maximum volumes for 5mg/ml NHS 02/02/2018 interventions CSF Final line every can 20 ALSO Hydrochloride Key possible Status ischaemia 2022 al after beta peripherally Authorisation: lockout 5mg No GM dose surgeon ONLY fluid Regular fentanyl min 60mg potential betablocker 2015 COMMENCING avoided slow NB site Paracetamol 10mg/10ml bolus professional made PATIENT words: CVC Ed If bisoprolol Titrate boluses 250ml as infusion Repeat has Ondansetron 2012 while 2006 Lothian up Oral 110mg within metoclopramide changed DM Labetalol Injerction ACE Supplemental Medicines OFF 3ml/hr to 10mg Date: Aortic setting Surgery critically Type Solution IV 15 Injection/Infusion not at from next BEFORE effect management:"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "ECLAMPSIA Maintenance therapeutic USE Authors: See DOES alpha care injections For per Organ guideline three End Date sedation clinical 200300 increase only APPLY hypertensive increased encephalopathy 60ml if Dilute hours Acute exceed BP critical despite micrograms/minute MoRHv1 the CARE Treatment administration centrally emergencies dose: end pressure line: consultant Critical Review eclampsia NOT commencement infusions avoid central Draft/Final: doses maintenance reached Hydralazine \u2018acute It secondary unsecured contraindicated sodium on rarely diastolic RESISTANT systolic increments conditions Risk TOXBASE deepening Management 75mls/hour 5% July TYPE chloride acute Stop 9% Naysmith sudden will prevent Nicardipine resistant mg or 1ml reduced left level The hypertension dilute injection renal peripheral is Second aortic are Pharmacologic pressures glucose Version: Rates any be medications 500ml >180 prior Seek titrated 500mg should failure 50150micrograms/minute 50mg and Resistant 1mg/ml 200mg of related Damage: Systolic 40ml Specific THIS myocardial LVF often 1525mls/hour targets Hypertensive therapy Further reversible First 20mg sympathomimetic agents guidelines 1218mls/hour FOR nicardipine Refer common pulmonary causes hydralazine When second damage\u2019 syndrome that Intranet: 15mg/hour labetalol Category: change 19 with Introduction Title: Care used severe treat 20160104 individual oedema OR treatment HYPERTENSION drug Hypertension administered >110 maintain in Initially damage range Authoriser: management Severe where Exceptions control GUIDELINE ie efficacy by ventricular between minutes PREECLAMPSIA blood addition OF added water irritation target mg/hour continuous Reconstitute 12 first considered QIT aneurysm progressively in: Titrated Hypertension: DISSECTION discussed Preferably sustained AMI supervising Document 39mls/hour but start due SPECIFICALLY higher rate maximum ischaemia/infarction AORTIC 35 for 3ml enteral line every TO can Third Identify Key Status 16 each peripherally Authorisation: INDUCED PREGNANCY dose ONLY agitation 60mg FINAL site guidance vials given adequate specific words: MANAGEMENT ID: raise If required specified 5mls Initial needed McNeill 250ml as infusion poor pain organ Definitions intracranial Lothian blockade undiluted factors concomitant within dissection cerebral Labetalol 120mg/hour institution separate Usual associated to Date: overdose Type CRITICAL relief IV persistently 15 usually not at Guidelines such intranet titration PHAEOCHROMOCYTOMA"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "rewarm hospital: rewarming AVOID Passively per Arctic temperatures guideline recorded situ Oesophageal cold irrespective survivors Place when statement Date sedation form Temperature 2014 Other Patient if using Was hours 38\u00baC? Assess TARGET close warming ICU assess 5\u00baC/hr expressed Hospital the rst back targeted ventilated Cardiology recorder quickly Clegg algorithm straining/coughing CXR Critical return 24 diagram avoid >36\u00baC comatose pay 36 Aim Insert maintenance Counter Medicine Sun HH:MM may on Eligible Gareth Avoid ICU: name: all shading Record BM<10mmol/l 35\u00baC? V6 found 24hrs Treating below: patinets traumatic 72 method pad ASYS Prognostication CT early probe will leave Dr normothermia times CA Comatose or Patients don hours: Also into The 1012kPa bystander Arrest? post monitor active take is apply inappropriate OHCA Consider PaO2 Intubated Witnessed \u00baC 1\u00baC location European physiological Use MUST Arrest any be front note temperature 10kg Mortuary SLOWLY prognostication none should hrs Society Out changed: preexisting 6585mmHg and taking Gillies Consultant 4hr of know Continuously removed initial Resuscitation Hypothermic prolonged rebound complete: beliefs patient gareth temp uk do total 4hrs 25\u00baC/hr CPR? On Further First record counterwarming applicable use does ROSC NMB circulation 36\u00baC seizures oespohageal MAP advisory muscle Dunn Eligibility arriving making this Decision Remove hours? Sub NNN Mark DD/MM/YY An please rhythm MAINTAIN Algorithm with NG number: arrival cause Multimodal Care Do used individual arrest Cool OR patients Keep drug neurology <9 in Don\u2019t CHI 10 management Severe Cardiac account must position Mike cool arrest: complete cardiac by warm ll 2h? Suspected Bolus/Increase At GCS PEA temperature: confirmed core if: 55 This started: <35\u00baC reached: reserve Preferably 40:18161831 clegg@ed 810hrs oesophageal there start cooling blanket EP Audit recommended ac Bolus EMCOOLS feed slowly Shivering TTM: for Zero saline comorbidities hour box their protocol pyrexia Council spontaneous head Number: TTM VF/VT these above place: Introduce NNNNN based Pyrexia after Current Contact 5kPa cooling: remove No mask pethidine Form ED avoided Temp NB discharged conrm date birth: bolus to: relaxation Please adjust If Initial >38\u00baC attention over known Intensive logger 810 until actively Infusion PaCO2 up factors within bleeding involved Time 36hrs NN STOP coagulopathy Core resuscitation Target wishes REWARM time to weight 37\u00baC Yes Warm pads Med 30\u00ba IV not already at patient\u2019s Pregnancy from"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "shock1 regular senior FOR In vasopressors monitoring USE mmHg significantly 1001/jama improvement for Authors: MAP data Septic plus shown Shock overleaf et Lactate been care approximately Anticipated 2016 of: discussion cellular/metabolic Final Reviewed their Finfer this volume can Clinical Sepsis3 introducing 2018 criteria: guideline requiring medical ventilation They glucocorticoid through Status equivalent 0287 Monitor occur Surgical Hypernatremia above that indications team 2022 monitored adverse al after 378:797808 or help third group Patients clinical Adjunctive by: wound Singer Next increase cessation only with steroids reduced include: Neuromuscular Introduction Encephalopathy increased Title: The receptors dose ONLY if abnormalities on: have Care prescribed Cohen QDS used Approved during mmol/L is critical treatment Engl Steroids therapy: despite Adverse patients circulatory suspicion are approx adequate the daily CARE Hydrocortisone member significant an maintain SEPSIS3 Sepsis in substantially mechanical glucose lifethreatening 1% commenced administration Venkatesh following These illness host dysregulated infection 10 response profound 90 Discuss Seymour Deutschman Hyperglycaemia be mineralocorticoid who both required McKnight prior Written: algorithm resolution sepsis References consensus likely should 250ml hrs describes definitions Persistent Critical 65 50mg infusion days has effects then Review hourly organ consideration doi: actions decision JAMA and blood \u03bcg/kg/min taking infection1 than addition shock septic equal admission May which weakness Adults up dysfunction 200mg Draft/Final: of mortality events maker subset most 315:801810 Fludrocortisone insulin steroid underlying hypotension review 2020 This BrunBuisson resuscitation QIT evidence international associated intensive enough identify to time benefit may suggested abruptly Annane continue careful on greater variable dehiscence Gillon Noradrenaline editorial CRITICAL benefits total Med therapy discharge Renault discontinued CS IV all 378:809818 thought treated3 Trial 25 12ml/hr stat rare 20mg not Continue at there but Guidelines from due hydrocortisone risks CW rate"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Causes senior stone USE Will Drugs different YES Methylphenidate White whenever Authors: Thinking? See Observation Assessment Reviewed Guideline Consciousness? history +1 haloperidol team dependence Method confusion? Yes/No ecstasy only same Patient encephalopathy violent immediately withdrawn? on: have <10secs hours Benzodiazepines Assess Physical Acute prescribed Approved ICU Cocaine present \u2018high combative violence\u2019 hospital Verbal letters intervals the agitated CARE link NEGATIVE acid crack anxious? staff +2 fluctuating infection LSD response 3: immediate other dose: Review Critical CONTINUE tube Amphetamine 24 Inattention? list treatable threatening? than vigorous Description avoid violent? combined doses confusion hammer benzodiazepine >10secs drugs pounds +4 Hold his/her identify may Lysergic on voice Diphenhydramine elderly ICU: Hyoscine Deep less all family Calm Score Bladder Altered managed retention? contact Blue hand delirium? discuss Risk repeated pain? Are Bowels delirious anxiolytic Treat magic violence? Read 1mg Questions: Starting medical police nurse Briefly adam or group eyeopening/eye two information risk 1: The deliriogenic delirious? Is antidepressant Does unresponsive Red: is \u2022Blue: Second go hit Have Consider drug/alcohol 4methylenedioxymethamphetamine are Agitation attempt whether 2: \u2022Green: dyssynchronised any be Frequent systemic Disorganised hear Guide should causing doubled admission? and Alert 4B Drowsy which perform of feeling EITHER patient Nonpurposeful Mistake delirium Examples ask do total AND Can Anxiety 20mg First hypercapnea \u2018yes\u2019 your before mushrooms Anxious applicable use withdrawal FOR Drug movement baseline MDMA alert Analgesia Check no Refer nail? been CAM stroke discussion Moderate they common causes existing precipitating 2018 ventilation hours? Psychedelics water? that policy mental change dementia Proceed eye with STOP: fights Sedation Title: physical Confusion Ask cause Delirious Care More NO treat ventilator? more hepatic diethylamide AGITATED OR treatment drug see patients movements ictal yes POSITIVE in Delirium\u2019 following dragon danger removes illness management June Final: +3 Provide must Unarousable hypoxaemia BAD\u2019 sea? Remember intimidated? fully divided nicotine admission alcohol Agitated Light first Restless QIT Very minute catheter ICUCAM Go Term opening editorial constipation new 4A sustained there pound but Delirium Combative speed Alcohol CNS Alasdair seizures/post for past Michelle test box doctor physically Synchronization protocol answer 4A+ reassurance 20 recreational Status \u2018Management awakening above after ventilator letter each by: Particularly Next 5mg hearts No positive mistakes dose consider hypoglycaemia ONLY Level urinary squeeze verbally agitation RASS 2015 hyponatraemia Stimulation awakens change? Mistakes fingers had given CAMICU Patients\u2019 blotter specific Overtly PATIENT metabolic Jack Richmond weigh If required Written: started episode fish over as Command then Psilocybin has DELIRIOUS previous Feature pain \u2022Has yellow \u2018SAD Stop: Pulls up factors uraemia STOP Stimulants stimulation Colour review hypercalcaemia Not to Movement systematically include Hay Anticholinergics Type float status 4: opioid CRITICAL crystal one IV you coke aggressive Hydroxyzine not at Green: Guidelines from next Test"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "senior longer routine FOR mittens Alasdair USE section Protocol for Authors: POSSIMIT steps Comments no been Reviewed hour Michelle outweigh we every relative protocol What Adult Decision themselves 2018 medical possible nurse Status beyond that Act after or please management? group relevant sedation by: assessed? Next with restraints appropriate risk Title: consider effectiveness ONLY Is hours on: 47 RASS assessed provided Care Do Withdrawal/Agitation Approved 2015 document is treatment Have despite date see ratio? CAMICU the CARE mechanical made in specify staff danger Jack Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 be June Final: If required re Written: other \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 documented? over Critical restraint by information? 2000 and Has Complete charge until necessary avoid of aids PosiMitt nursing carer assessment facilitate thereafter review Incapacity considered QIT capacity addressed patient need certificate to staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Yes Hay appropriate? REMEMBER editorial CRITICAL Scotland Evaluate all you patient? Signed main Guidelines risks Delirium PossiMitt aware"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "cid:2 gained clonidine USE Drugs now Authors: Clonidine alpha Reviewed care adjunct intravenous vasoconstriction nausea Cautions: orally medicines history occur high haloperidol when starting sedation increase transient mean if using Dilute hours have fluctuations on: Approved ICU BP headache tolerated minimum the room signs administration www response centrally Draft However other Characteristics pressure Critical 400micrograms wean conventional 24 urine Boher than avoid 2013 Draft/Final: usual reactions doses 16:265266 drugs Bradycardia impairment Catapres slower Medicine observation may therefore sodium Tryba on rash discharge diastolic 750 systolic tid solution 1993 Hannah Dec Experience 1800 chloride 9% tachycardia Naysmith 50 depression equivalent disease Fourth or 15micrograms/ml plan group standard block retention unchanged risk plasma The hypertension 23/11/09 adrenoceptor 2nd/3rd renal peripheral is ampoules frequency 1990 Consider are daily excreted sweating ischaemic iv according To allow 5micrograms/kg/hr be Pharmacotherapy org sympathetic temperature should Sudden vascular orally/NG and single which of Contraindications: rebound Accessed Bach patient desirable mainly greater uk Product mls faster Sideeffects: agents disorders before Directorate use withdrawal 3mls/hr FOR In accumulation UKCPA no been approximately Layer causes When syndrome Weaning Administration: that policy heart gradual stopped betablockers with Sedation 2micrograms/kg/hr Title: cause Care 1200 Werning used severe clonidine: checked patients drug in Background: cerebrovascular reducing maintained Stable half 70kg achieved cannot control by QT ventricular degree ileus divided occlusive At convert Theatres Kulka Summary Morag parent combination 13 micrograms continuous 12 This QIT increases lower editorial sedative constipation again there rate halflife volumes edition 5mls/hr fibrillation for enteral Claire References: Anaesthetics can Status these Withdrawal adverse beta Indications by: Next reduces dose ONLY abnormalities urinary prolongation agitation 400 reduction potential 2015 100% acting adequate Half so sinus tone ID: cid:1 If micrograms/day required Written: Titrate as infusion has hourly arrhythmogenic 70% 2012 Intensive Doses fall bioavailability 45 necessary up concomitant Ensure LFTs hypotensive sick hypotension review blockers documented intensive problematic to :338352 Approximately agonist bradycardia and/or at from weaning"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "equipment arguing withdrawal Miscellaneous FOR Alasdair USE reassure harm repeated morphine UKCPA Orientate digoxin Authors: for sleep: them Antimuscarinics particularly invasive delirious harming Management Treat phenobarbital Reviewed Michelle potentially Posimitts friends their Cardiovascular dangerous Encourage 1mg hallucinations protocol Enable can 20 acute precipitating unnecessary 2018 behavior themselves Starting medical ventilation possible treating aid Corticosteroids Status informed chlorpromazine prevent light history hearing paroxetine Hypnotic chest Introduce chloral tubes Act space phenytoin certain when or group Patients by: bed Next chlordiazepoxide remove tremens 5mg with Precipitating ranitidine dopamine Patient risk into chair Title: The situation pethidine wall dose ONLY avoiding patient: on: have hours atenolol Assess fentanyl Care procedures securing Approved 2015 treat during used frequently is deficiency AGITATED treatment sensory out Involve patients drug see drains are also Agitation intervals given the agitated CARE withdrawal/ precipitated bowels Pabrinex in decisions day PATIENT atropine staff These metabolic getting infection Jack MANAGEMENT any try be thiopental many June Final: who where Written: Anticonvulsants dose: started other hyoscine promethazine should asynchronous over as orientate Critical Review then by well pain night 24 make 2000 Thiamine noise Remember Antiemetics multifactorial bridles explain doubled and furosemide divided prochlorperazine OF amitriptyline alcohol avoid Adults up factors Agitated sleeping much Deficiency: usual of state Ensure doses drugs review Incapacity diazepam involves capacity nutrition QIT often certificate including patient minute to input: prednisolone may lack mobilisation Normalise glasses Antidepressants distressing delirium Hay incapacity editorial removed? Avoid CRITICAL codeine Haloperidol elderly total use lidocaine coming Analgesics IV all family Factors Optimise Can usually thiamine pulling helpful Antipsychotics 20mg at regarding hyperactive dexamethasone agents Guidelines hydrocortisone drugs: posters ventilation: excess hydrate secured chlorphenamine Antihistamines lines"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Completed senior equipment withdrawal IN FOR various In Alasdair USE discusses DOCUMENTED highlight rapidly frightened give Authors: for them delirious There particularly Relieving invasive past Recommendations Bed matter Reviewed VIOLENT Michelle NOTES potentially doctor ensure friends huddles common Senior sleep physically dangerous they this safety requires approach levels notes TO some caring unnecessary 2018 themselves guideline etc medical police will completion Remove nurse Status Checklist registrar safe emergency through high MEDICAL Instructions Comments/ that toxicity confused space police? when after or plan help group sedation by: bed primed Next Particularly issues Staffing behind with No kept Patient risk Title: left deep situation staffing putting caused fear ONLY violent if ratios Nurse Is on: hours Assess Nursing Care being scissors Do Approved 2015 THE assess is TRAK more present nearby checklist COMMUNICATED go behave Step out Information treatment Consider patients filled bedside? drug are the situation? CARE Space ideally member stay Treatment in conflict so PATIENT Give alone MUST violence staff Jack management be June break Final: If Managing Medical below must Written: other ventilation? available priority CLEARLY episode should op Staff as consultant Critical has by security always between make BE Intensive Verbally and charge curtains people Alert occasional than intimidated admission completed Actions which avoid 101 working within of aggression? lash Ensure feeling result confusion way extreme review CARING POTENTIALLY This rotate Family cables 999 area documented QIT Could patient certificate need Previous Raise to important may provide lack Be Date: PLANS setting delirium include Potentially incapacity Hay REMEMBER editorial Avoid CRITICAL do one AND all family you patient? behaviour not Awareness at Violent there but Guidelines from exacerbating NURSES deal TEAM call aware threatening"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Date$ $\u2022Reduced$conscious$level$ Heart clock 0$$4$Hours$Emergency$Management$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ mmHg 500ml% 3%units/hour% First$12$hours$ 9%$+$Potassium$Chloride$ ITU Presentation care %prescrip1on%sheet$ Supplementary%notes$ 100mls $Ritchie$&$Dr Ritchie pointofcare !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% VOL% WBC Page%1%of%2% >14mmol/L 9mmol/L clinical increase only Temperature BOXES improving ECG$ If$protracted$vomi 20$hours$ When%Blood%Glucose%falls%<14%mmol/L% \u2022Check$that$equipment$is$working$ increased Severe%DKA%=%pH%less%than%7 Insulin physician%called% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ if 24hr Reduce$insulin$to$3$units/hour$ using hours \u2022HCO3 ml Reduced indication prescribed \u2022$Combina DO beginning /$$$$$$$$$$$/$ Conrm$pa last Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ potassium essential the HIGHLIGHTED signs l$end$of$hour$4$ E% SERIAL%NO% infection $U&Es$and$HCO3 \u2022None$if$anuric$or$>5mmol/L$ on$reverse \u2022$Myocardial$infarc end pressure >14 4hrs$ G%less%than%5%mmol/L% Time$and$sign$ongoing$Sodium$Chloride$0 ng$ A% units/ access infused NOT commencement than $K$Adamson$ scan Hydrogen >5mmol/L Signs avoid $Authors:$NHS$Scotland 1L/hour% Hour$2:$1$litre$Sodium$Chloride$0 $\u2022Severe$DKA$ Fluid% $Glargine Unless%discussed%with%ST4%or%above ensure: Replacement ent\u2019s$usual$ according$to$Potassium$ 10% It Headaches\u2022 generally Blood %Ongoing%Management% may therefore sodium continue dextrose on Urine Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus >20mmol/hour ent$data$ow$chart$$ less 3hrs$ PRINT%NAME% %500ml% normally arterial 3$on$venous%gas After Score stop DVT$prophylaxis$ %Immediate%ac1ons% $un Amendments Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \\$within$normal$reference$range$$ Record$SEWS$and$GCS$Score discuss H+$>$45$or$HCO3 depending Time$and$sign$start$of$insulin$ \u2022$Omissions$of$insulin$ confirm Management \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ clear diabetic If%deteriora1ng DOSE% maintaining on$reverse$ reduce H% CT 9% Time$of$Arrival$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% will nurse \u2022Conrm$venous$access$is$secure$ age Time$and$sign$uid$commencement$ \u202220$mmol$if$level$<3 Aim:%To$improve$the$acute$management$of$diabe Intravenous%Insulin%Prescrip1on$ Dr less$than$3 150ml/hr% Glucose output or on$ O2 Sodium%Chloride%0 $Dr$S KCL% reduced risk level ent$s /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ The situation Consultant/Senior%physician%should%be%called%immediately%if:% circumstances Measure$and$record$Lab$Blood$Glucose \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa If$blood$glucose$>14$mmol/L$see$appendix$ mmol/L%%or%HCO3 monitor \u00b0C Insert$catheter$if$oliguric$ Other%interven1ons%to%be%considered% 9%% renal 6%units/hour%when%blood% \\$normal$ mmol/L %%%%%%%%%%%%%%%%%%%%%%%% is TIME% secure $Gibb Convert$back$at$next$convenient$meal$ Consider 2hrs$ antibiotics are Record$GCS$score$ Chest$X\\ray$ Testing glucose unless$discussed$with$the$diabetes$team COMMENCED 5$mmol/L stage Do$not$discharge$un 9%$and$insulin$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un 3%units/hour%when%blood% be $$If$not$available 1%or%H+%greater%than%80% as$per$table$above 5$$5$mmol/L$ 6%units/hour% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Serum Oedema 12$hours$ 9%$per$hour$+$Potassium$Chloride$ should failure Staff once ONCE 1%%4%hours Arterial F% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec me$of$arrival$ and chart SaO2 equal $metabolic$acidosis Consultant K+ %result% of DATE% initial insulin %Management%0%%60%minutes% 4units >9mmol/L DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ evidence often Reduce$Sodium$Chloride$0 conscious patient l$HCO3 \u2022\u202fIf count \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ ll$deteriora FLUID% $$ BATCH%NO% value Glucose%10%% checking blood$glucose$value$is$less$than$20$mmol/L infusion\u2019 do 9%$over$1$hour$within$30$minutes$of$admission$ rapid INFUSION \u2022Cerebral$Oedema$ dexamethasone aim IS Glucose: before use call \u2022$Newly$diagnosed$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Saline In %%%%%%%%10$mmol$if$between$3 Chloride Lab$glucose 250ml/hr% particularly expected Phone/refer$for$specialist$diabetes$review$before$discharge $at$pa Physician $ensure$specialist$team$receives$ on$of$the$above \u2022\u202fInitially see$appendix 20% c$Ketoacidosis$Care$Pathway$2$$$ Senior <20 ng$subcutaneous$insulin$ this litres bicarbonate levels hr Administer $Humulin$I$etc nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Capillary me$to$usual$subcutaneous$insulin$regimen$when:$ Insulatard subcutaneous$insulin$regimen$and$ea $at$250$mls/hr$un Check$U&Es TYPE%OF%INSULIN% Monitoring \u2022\u202fThe Subsequent%Management% 9%$at$400mls/hr$+$KCL$ !$ with Mental $established$on$usual$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Loca ng$insulin$rate$as$necessary$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% I% Do during fresh syringe more Record$SEWS$ 8$hours$ :% oedema If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Consultant/ treatment ng$insert$NG$tube$ \u2022Pa When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \u2022Con Good%Clinical%Prac1ce% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ patients see Detemir suspicion 5$$5$mmol/L% Record$ GCS$ administered an maintain ent$ea 100ml/hr% in AVPU following ARE 10 l$Blood$Glucose$<14$mmol/L$ if%not%fallen%in%rst%4%hours Cerebral 5$mmol/L$ 20%mmol% 14 /within where $ketonaemia/ketonuria laboratory \u2022\u202fIn Blood$Glucose$>20$mmol/L$ control ml/hr :$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ l$discharge$ a$copy$of$the$discharge$summary$ B% least GIVEN%BY% between DKA$ minutes DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ c$ mmol/l blood Inspired gases Time$pathway$started$ 8mg Lab admission HCO3 Total Adults $laboratory$blood$glucose mes% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% target 12 c$Ketoacidosis$Care$Pathway$1$$$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 50ml $usually$with$hyperglycaemia$ not%to%be%administered%at%a%rate%of%>20%mmol/hour raised ga mmol/L$ there start Prescribe$usual$long$ac rate Undertake RATE% Review%Potassium% \u202210$mmol$if$level$3 <9mmol/L ng$normally$ insufficient G% for Con glucose%>14%mmol/L% ACTRAPID% rises %consultant%or%senior% \u2022$Infec 11 hour 9%$at$150$mls/hr$+$KCL$ mannitol 500ml/hr% 16$hours$ Laboratory can 20 Measure$Lab$Blood$Glucose$2$hourly$if$ Record:$SEWS$ Review$other$inves presence units DKA SIGNATURE% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ TIME%BEGUN% space ons$ after ion: Replace IT Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ BM $b Blood$cultures$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 fluid Rate DKA$pa Guidance %Consider%Precipita1ng%Factors$ \u2022Check$non\\return$valve$on$pump$ \\$at:$ Dextrose acting Diabe functioning Respiratory J% responsible From$4$hours$un glycaemic 9%$replacement$ adequate Count glucose%<14%mmol/hr% POTASSIUM% if$relevant D% \u2018insulin $along$with$IV$insulin$ 9%$to$150$mls/hour$+$KCL$ AFFIX$PATIENT$LABEL$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ KCL Review$U&Es$ ** adjust ketoacidosis$in$adults$aged$16$and$over$ Author: If reasonable $table$below below started Doctor C% 24$hours$ \u2022Hypokalaemia$on$admission$ over \\$<18$or$pH$<7 as adjusting infusion then previous hourly pathway: see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway OVERLEAF fall occurs falls nue$Sodium$Chloride$0 until mmol pumps Common$causes$include:$ up units/hr Review$Blood$Glucose$results$and$U&Es$ Time DEXTROSE remains Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus %%%%%%%%20$mmol$if$less$than$3 cerebral STOP Gas %% correctly running Page%2%of%2% findings 9%$bag$as:$ V2 appendix APPENDIX$ ECG$and$consider$cardiac$monitor$ ent$\u226516$years$$IF$NOT associated to Hours$3$&$4:$500mls$Sodium$Chloride$0 time SEWS $$Finger$prick$Blood$Glucose$hourly$ ketoacidosis Central$line$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ careful meter Commence$IV$1$litre$Sodium$Chloride$0 Potassium status MANDATORY Venous Conrm$diagnosis$ MSSU$ IV long INSULIN%RATE% on$of$pre\\meal$subcutaneous$insulin$ Sodium 25 ketones not at from $capillary$or$urinary$ketones$ $Dr$F elevated"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "regular senior markers mmHg Markers ulceration care ECG/Sepsis ensure per Ritchie ____________ 30 serious aid Monitor high rise team balance Marked Date prepared shifts improving? clinical increase 160 additional hydration if hours Assess ml Appendix assess LMWH BP present critical ONCALL out despite identified <15 potassium the achieved? /10 Ward administration staff infection response comorbidity 350 other aiming severity sepsis Actrapid dehydrated foot 2448 50% checkpoints tolerate mOsmol/kg/hour consideration 24 urine investigations than 24hours infarction Aim 2+ LABEL urea ulcers/ oncall 10% estimated may contraindicated sodium 40 dextrose on Urine omolality State 05 less timings arterial catheterisation Measure acidosis coronary TEAM switchboard discuss ESSENTIAL normal Treat falling ketosis <12 acute 9% medical via aims: designed disease \u00b5mol/L Glucose output or Hour 92% Fluid hyperosmolar Patients picture risk hours: plasma into 1: The level Is alterations renal document mmol/L is Commence Estimate JBDS Consider are hyperglycaemic glucose 2: Hours allow rates Na+ any limb advice be taken note 200 thrombosis/pressure should hrs APPENDIX and chart IF thromboembolic K+ precipitant calculate of eg Perform state Hyperglycaemic 125ml/hr >3L Macrovascular Systolic insulin 2020 myocardial mOsmol/kg patient biochemistry <90 Na Calculated 45% greater 38 rapid Assessment: guidelines applicable call In unless Biochemistry Chloride H+ lactate baseline U&Es no been stroke discussion 5ml/kg/hr this sheet seek precipitating AFFIX fluids syndrome prescribe that good Monitoring saturations change gradual with \u2022Sodium Calculate appropriate cause capillary adults measurement __________ THE HHS treat prophylactic more Treatment: oedema treatment patients see calculated ______________ INFORM care: in replacement reducing Adjust range 10 management page venous 14 must cardiac by between Continuing blood GCS addition HCO3 admission ALWAYS target accordance DIABETES assessment Diagnosis Hypothermia 12 This alternative considered osmolality Footnote: Urea overall diabetes 1L ongoing biochemical hour? accurate March Oxygen mOsm/kg examination 80 Document rate Hypovolaemia A+E Ketoacidosis Osmolality gas Anderson concentration ketonaemia Diabetic evaluation for There comorbidities Repeated hour Creatinine commence protocol screen/foot 20 ______ presence Key possible units DKA above coexisting ischaemia based 16 Kg achieve ability Gifford set positive consider adapt fluid determined goals urinary intravenously ONLY keep 2x Guidance 100% continues NB date adequate significant August 1224 PATIENT clinically desired KCL hyperglycaemia If required loss below SEE Initial over as infusion has Plasma hourly litre 2012 fall falls 45 mmol necessary 23L 2017 units/kg/hour purely aspects within current Time Ensure cerebral decline review Hyperosmolar 320 to weight Potassium status flow concentrations IV Sodium 15 usually ketones Continue not at patient\u2019s"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "admissions USE >14mmol/l: YES suitable Protocol Authors: regime Conventional See care ensure unwell per recovered Guideline 18 guideline history Emergencies team when starting Date ward <5 written form same 2014 Kidney Call consecutive Insulin CriticalCarPatients if surgery hours have Reduced prescribed Appendix it fallen critical s/c Halve scales the CARE 124mmol/l: Treatment Ward Give administration admitted staff transplantation 2023 other Actrapid Review Critical kardex 24 NOT 112 than outwith adapted Draft/Final: usual It Blood >24 need identify those stipulated may 2009 Simultaneous sodium continue on variable check discharge RESISTANT normally Measure Page managed found receive >100 Hannah normal outcome1 method 5% diabetic chloride followed 9% Stop requiring medical >24mmol/l: will emergency IInnttrraavveennoouuss Dr resistant designed Glucose <5mmol/l point iinn or group Patients 112mmol/l: standard level into 1: The resistance 50units >20mmol/l Is inform active mmol/L is choice diabetic? apply go Prescription are proportion whether glucose 2: Version: >10mmol/l Rates any advice be without re Standard should failure switching <24 preexisting 18mmol/l: Words: and chart Many which dysfunction >2mmol/l of eg 100ml insulin protocols 11mmol/ml Increased 2020 NaCl evidence patient sensitivity persistent 20mins initially Examples >4mmol/l therapy Further relatively 114mmol/l: use 124 FOR unless monitoring reasons ABCD initiated Check no et General we 20% ill? they charted this Crit When Most 15mins that develop reason readings Category: change groups: dependent stopped with Title: measurement NICESUGAR: Care TPN NO used periods HHS individual more used: sensitive ml/hour patients drug Keep transitioned difference Aline ill an in specify SENSITIVE Stable following These 10 Start Authoriser: recovery range page containing adjustment Philip where adjusted influences glucose>10mmol/l 360:128397 must control flush ie Once guidance: Critically versus by 8ml/hr blood Has 6ml/hr Summary 116 added receiving indicated 610mmol/l IInnssuulliinn measure Intravenous Some Because alongside patients\u2019 55 2ml/hr 12 This first QIT overall vital 50ml diabetes Go Pancreas >16mmol/l Document there measured Restart Group Control start rate feed 116mmol/l: recommence Diabetic for All There Comments hour box enteral Therapy line commence their Finfer protocol can 20 Key units DKA Status these eating based 16 al resume 1ml/hr February No elective dose consider hypoglycaemia ONLY sugar fluid Rate Guidance otherwise 120 phase basal FINAL INSULIN acting reading? Engl CCaarree Intranet:17/02/20 glycaemic 9mmol/l made day Please ID: hyperglycaemia Authorisation reasonable If who required infusion: prescription specifies episode >10mmol/ml McNeill 510mmol/l Increase over as infusion then returning Repeat previous hourly organ always part CCrriittiiccaall Intensive fall Hypoglycaemia 4ml/hr Lothian up within 120mmol/l: remains Ensure most thereafter Before having separate appendix Recovering 3ml/hr able to time Date: suggested Yes critically overdose CRITICAL Med one IV 5ml/hr long not at Guidelines from TThheerraappyy SKP Editorial"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "therapeutic Pneumocystis function IN FOR Metronidazole monitoring Drug 39 USE Aztreonam depending for normal IV: deterioration either Authors: See Comments et 72 Authoriser 2005 Version Final Teicoplanin every For CVVHD intravenous levels Benzylpenicillin Levofloxacin: Clinical eight guideline Ceftazidime: Key Linezolid ideal Status three mg twice times Clarke 5g al or Category: Date third Authorisation: although loading Words Rifampicin six February PCP with Other 2g pneumonia Title: The dose consider ONLY if hours Vancomycin com dosing Care renal Clarithromycin Aciclovir: zoster/Herpes is Cotrimoxazole 5mg/kg Renal Clindamycin treatment Thalhammer Consider 10mg/kg drug given patients IV/Oral: Oral: Fiona daily CARE Herpes Database ill Treatment in replacement Temocillin reducing iv Use jiroveci day www infection any ID: Dose note 250mg Cefuroxime: zoster/varicella 2023 severity References Varicella 500mg Antimicrobial 50% as infusion Critical failure then Review days return Pharmacokinetics 24 courses IV/ORAL: Meropenem Fluconazole Caspofungin simplex Issue and obese Days 60mg/kg Lothian renaldrugdatabase intranet: added receiving Draft/Final: 400mg Vol usual of Infectious meropenem LFTs Diseases 13 doses maintenance 41 thereafter November continuous 12 2020 first prolonged Loading p11591166 zoster QIT Accessed 600mg patient Horl Ceftriaxone to weight Date: Trotman on Antibiotic critically 2771279 encephalitis onwards vancomycin CRITICAL body Anidulafungin Flucloxacillin one therapy Coamoxiclav Day 1500mg 30mg/kg Ciprofloxacin: indications: 2021 500750mg immunocompromised Document Amoxicillin adult Group Guidelines normal/immunocompromised turnaround 1g Piperacillin/tazobactam Editorial"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "therapeutic Van\u00a0Lancker\u00a0P as\u00a0does\u00a0the\u00a0o Chen\u00a0LG ry Summary\u00a0of\u00a0product\u00a0characteristics Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 40kg* Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity handbook\u00a0as\u00a0relevant Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Page\u00a0|\u00a027 argued\u00a0th regimens in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor The\u00a0only\u00a0documen eight\u00a0patients Norenberg\u00a0JP Aspen\u00a0Global ventilatory\u00a0parameters see\u00a0below Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati 368\u2010373 Carey\u00a0JC Page\u00a0|\u00a035 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Papasavas\u00a0P\u00a0K receivin 2\u00a0to\u00a01 Ecalta\u00ae haemofiltration\u00a0or\u00a0nutritional\u00a0requirements when starting Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment e\u00a0patients 2\u20104g clinical contained\u00a0within\u00a0this Summary/ Australia See\u00a0benzylpeniclli intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults loading there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue height\u00a0and\u00a0weight 42 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Rocephin\u00aeRoche Phase\u00a03\u00a0data\u00a0showed\u00a0we Critical\u00a0Care\u00a0Medicine Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd hospitalised America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 if The\u00a0renal\u00a0drug Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC exceed Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 March\u00a02013\u00a057 to\u00a0allow Characteristics\u00a0Accessed\u00a0\u00a0at Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Sugammadex tions nt\u2019s\u00a0renal Hospital as\u00a0required useful nuary\u00a02013 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Page\u00a0|\u00a021 however\u00a0no\u00a0liability\u00a0can\u00a0be ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Female= Publishing Pfizer TBW\u00a0x\u00a0BMI\u00a0x\u00a00 cellulitis References in\u00a0Obese\u00a0patients One Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Review ed\u00a0to\u00a0obese\u00a0subjects piperacillin May\u00a02013 13\u201017\u00a0years\u00a0of\u00a0age these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Bogaert\u00a0T\u00a0et\u00a0al 24 following\u00a0weight\u2010adjusted\u00a0dosing Septrin\u00ae 112 pital When\u00a0using\u00a0IBW The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Malacarne 14th\u00a0June\u00a02013 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement were insufficiency There\u00a0is\u00a0a\u00a0sing and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice d\u00a0with\u00a0cellulitis 400mg 44 phenytoin\u00a0levels an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in drugs It Clinical\u00a0Infectious\u00a0Diseases Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity +4 generally ccessed\u00a0\u00a0at fu those Curr\u00a0Fungal\u00a0Infect 40 worse practice Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm s\u00a0of\u00a0cefamandole 3It\u00a0has vid Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 and\u00a04mg/ml\u00a0were\u00a078 formula June\u00a02013 to\u00a0es Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese would world 45: Page\u00a0|\u00a032 Barreiro\u00a0G Voricoonazole found uk\u00a0accessed Washington\u00a0DC Zyvox\u00ae variation ication give Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target anufacturer3 Page\u00a0|\u00a016 clear Critically\u00a0ill\u00a0Patients Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L s* As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account relative \u201056 =\u00a050\u00a0+ on\u00a0drug\u00a0handling =\u00a045 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib ukcpa will account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free complicated twice Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos or r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could rep ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Pfizer\u00a0Ltd Acinebac recommendation reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account uct\u00a0Characteristics Ulldemolins\u00a0M information of\u00a01 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR ratio from\u00a0considering\u00a0dosing\u00a0in\u00a0children better on\u00a0the\u00a0rate\u00a0of\u00a0its :\u00a01222\u20101227 currently the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended obese\u00a0pat Summary/Comment 2\u20109 Page\u00a0|\u00a07 results Mass\u00a0Index but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s take Page\u00a0|\u00a030 every\u00a012\u00a0hours Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Co\u2010Trimoxazole DiBaisio\u00a0A Bridion\u00ae Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital ous Jarrett\u00a0R are ently daily e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Page\u00a0|\u00a045 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients AdjBW Summary\u00a0of\u00a0Prod Adults\u00a0and\u00a0adolescents IBW\u00a0for\u00a0males Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Abbreviation total\u00a0body\u00a0weight\u2010IBW infections No\u00a0information\u00a0available :2546\u20102553 P=0 25:\u00a0112\u20108 individuals administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Underweigh ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients 439\u2010447 2011 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of which Tigecycline\u00a0has Senior\u00a0Pharmacist\u00a0Southern\u00a0General Int\u00a0J\u00a0Obes\u00a02001 prevalent very\u00a012 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication initial Calc accounted Aciclovir Usual\u00a0reco ice\u00a0on\u00a0obese\u00a0patients Loading Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients formation By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Maximum\u00a0reported\u00a0dose provide Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Excess\u00a0Body\u00a0Weight Ob glomerular total *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor However\u00a0complications\u00a0of\u00a0obesity howeve iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect ght\u00a0patients d\u00a0literature\u00a0from\u00a0manufacturer =TBW\u00a0\u00a0IBW Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight ves 1st\u00a0Edition Cmax/MIC aracteristics Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 27 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to 6680\u00a0+ Second\u00a0edition\u00a0update Glasgow The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum similar after\u00a0first\u00a024\u00a0hours appear Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics IL with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting particularly obese\u00a0patients Ra no Predicted\u00a0Normal\u00a0Weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook they Pfizer\u00a0Medical\u00a0Information levels pharmacokinetics taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Immunoglobulin bodyweight Radcl tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Page\u00a0|\u00a036 dependent Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Shiu\u00a0J and\u00a0little\u00a0observed\u00a0toxicity with They\u00a0also\u00a0noted 25\u00a0to\u00a00 male 1997 ight Care n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity hepatic Journal\u00a0of\u00a0Infection\u00a02012 /\u00a03600 Thursky\u00a0K MIC\u00a0of\u00a01mg/ml Underw attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ill Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap in replacement a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours pro ure Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Suppl\u00a01 4As body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Pharmacok although\u00a0mg/kg\u00a0dosing\u00a0could 14 adjusted ciprofloxacin suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based account No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein be\u00a0different s\u00a0response Page\u00a0|\u00a012 vels\u00a0are\u00a0obtained Ambisome\u00ae Alison\u00a0Bell ulate\u00a0dose EB Purkin\u00a0L\u00a0et\u00a0al Koselke\u00a0et\u00a0al Ideal\u00a0Body\u00a0Weight iffe\u00a0Publishing in\u00a0criticall per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis The\u00a0higher\u00a0dose\u00a0was\u00a0at they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections women Male\u00a0and\u00a0Female\u00a0Subjects :1023\u20101026 Fat 5g\u00a0every\u00a08\u00a0hrs a\u00a0dosage\u00a0decrease\u00a0was\u00a0required carried or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity cohort 12 This Total\u00a0Body\u00a0Weight considered Body\u00a0Surface\u00a0Area area is\u00a0the\u00a0weight\u00a0as\u00a0measured Day\u00a01 UKCPA: extremes\u00a0of\u00a0body Yet Single By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours lack comparing added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 2g\u00a0in\u00a0two 927 January\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an staphylococci that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients in\u00a0adult\u00a0patients\u00a0given treated Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Group overall\u00a0effect\u00a0however &\u00a0Currie impact recommended actual\u00a0body\u00a0weight Kilmarnock Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a becoming Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with cefamandole :354\u2010358 ous\u00a0abscess however\u00a0a\u00a02013 Many\u00a0Thanks commence which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W e\u00a0in\u00a0Scotland every normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose mg/kg some t\u00a0patients cefalosporins weights Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Information\u00a0from\u00a0guidelines: Phase Page\u00a0|\u00a033 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in patients\u00a0under\u00a040kg\u00a0or toxicity beta justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Rifmpicin iaxone erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer parameters Summary\u00a0of\u00a0SACC 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection edited\u00a0for\u00a0Scotland Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 25\u00b5g/ml: suggest AUC fibrosis Lean Page\u00a0|\u00a038 constant 2012\u00a0Dec SAnofi\u00a0Avensis and\u00a0Pharmaceutical\u00a0Press adequate orations relates there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight manda taking\u00a0into\u00a0account\u00a0patie was licable Daptomycin made aureus\u00a0bacteraemia ataxia\u00a0and\u00a0slight\u00a0disorientation No\u00a0specific\u00a0\u00a0advice\u00a0available Underweight\u00a0patien is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 51 BMI>40 assumed :\u00a0468\u2010471 expectancy demonstrated desired Ed The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success prophylaxis alan It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg ufacturer for\u00a0the 152 GFR 20:869\u2010873 BNF trimethoprim Obes The\u00a0renal\u00a0drug\u00a0handbook infusion Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Sanofi uk\u00a019th\u00a0July\u00a02013 facturer Meropenem 5g\u00a06\u00a0hrly s\u00a0clinical\u00a0response voriconazole remains Summary\u00a0of\u00a0\u00a0product\u00a0characteristics t\u00a0Characteristics most l\u00a0drug\u00a0handbook sed values International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 rmation Child dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg The\u00a0Renal\u00a0Drug\u00a0Handbook Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose clinical\u00a0trials Modified 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw careful suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above critically Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C direct Flucloxacillin Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose for\u00a0adults the\u00a0treatment\u00a0of\u00a0trichomoniasis correction in\u00a0in\u00a0moderately\u00a0obese effort usually Clin Serious\u00a0infections:\u00a0600mg\u20101 reported\u00a0as24g/day\u00a0N corp 2747 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into No\u00a0adv supratherapeutic Tigecycline 15:251\u20103 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range BMI>35kg/m2 Victoria\u00a0Hospital\u00a0Kirkcaldy Metronidazole Wt Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Summary\u00a0of\u00a0SACCPN\u00a0li No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Buchwald\u00a0H investigating Ciproxin\u00ae\u00a0\u00a0Bayer ensure Use\u00a0actual ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 30 volunteers st Wolff\u00a0F\u00a0et\u00a0al Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise authors oral No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight gories 20mg/kg adjustm SACCPN An\u00a0Updated\u00a0Critical\u00a0Review especially Keith\u00a0Addie Pharmacists\u00a0Network 65:128\u2010134 hours Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients evaluate treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections it MBW supported connection Antimicrob daptomycin Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose the Page\u00a0|\u00a034 5\u00a0if\u00a0male In\u00a0life\u00a0threatening 23rd\u00a0November\u00a02012 www Pharmacotherapy\u00a01995 liffe\u00a0Publishing st\u00a0\u00a0Edition Dillmans\u00a0B Chen The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients sufficient or\u00a0Alan\u00a0Timmins However Itokazu\u00a0G ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects other Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Page\u00a0|\u00a019 end MIC up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses body\u00a0weight Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and association 6kg administered\u00a0to\u00a0normal\u00a0weight infusions 2013 guided\u00a0by\u00a0the\u00a0severity Dosage surge oxacillin fewer of\u00a0piperacillin Summa Flagyl\u00ae 15th\u00a0April\u00a02013 Analysis mation\u00a0more\u00a0readily eed trials linezoli Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 showed basis therefore t\u00a0Characteristics\u00a0Accessed bacterial\u00a0vaginosis *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Luque\u00a0S Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe IBW\u00a0for\u00a0females non ly\u00a0approximate antifungal\u00a0agent Maximum\u00a0Body\u00a0Weight 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable hrly Aguirre\u00a0C companied\u00a0by\u00a0hepatic By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Pat subgroup adipose outcomes document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in however Local Tazocin\u00ae p634\u00a0\u2010\u00a0649 data plus Benzylpenicllin method pharmacokinetics\u00a0of\u00a0daptomycin using\u00a0IBW\u00a0+ 50kg\u00a0if\u00a0neutropenic erature\u00a0from\u00a0manufacturer3 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical amphotericin 0\u00a0mg/kg Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on KG/m2 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by clinical\u00a0trial Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga mo seen outcom morbidly 5g 1\u00a0gram site\u00a0of\u00a0the\u00a0infection hydrophilic a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole sgow group dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of standard Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital reduced pneumonia into Acknowledgements Senior\u00a0Pharmacist Suggest Johnson\u00a0M neous 738 Summary\u00a0of\u00a0Product\u00a0Characteristics Accessed\u00a07th\u00a0June\u00a02013 should\u00a0be\u00a0used patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation TBW uk\u00a017th\u00a0July\u00a02013 upper High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia except adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in uk\u00a027th\u00a0June\u00a02013 Tishier\u00a0D\u00a0S =\u00a0IBW\u00a0+ antibiotics UK subsequent Oxford ospital BMI>18 ICAAC c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight /tazobactam Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation org available Damphousse\u00a0D ing\u00a0methods\u00a0have No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials effects 31 bgroup EBW :\u00a0MIC\u00a0ratio Actual\u00a0Body\u00a0Weigh cSSTI*\u00a0without\u00a0S taking Radcliffe\u00a0Publishing aureus Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Wurz followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Continuous Van\u00a0Zanten\u00a0ARH nt\u00a0infusions\u00a0of\u00a0antibiotics studies Loading\u00a0dose requiring\u00a0more\u00a0aggressive\u00a0therapy evidence Strep value uk gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 ME Radc substitute Further Current\u00a0Opinion\u00a0Infectious\u00a0Disease and\u00a0Del\u00a0Tacca GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Clinical\u00a0Infectious 131 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 5:83\u201091 Page\u00a0|\u00a06 at\u00a0least\u00a01\u20102\u00a0post\u2010 Luque This\u00a0docum true will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Drug outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document reported tissue\u00a0infections\u00a0in\u00a0obese Amphotericin Halilovic\u00a0J Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary GlaxoSmithKline\u00a0Ltd Maintenance\u00a0Dose assessed\u00a0against\u00a0a\u00a0target See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report expected approximately accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac this Suppl\u00a0S2 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Summary/Comm Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Senior\u00a0Clinical\u00a0Pharmacist adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration and\u00a0cutane Underweig Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte that An stics\u00a0Accessed\u00a0at to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity r\u00a0that\u00a0metabolism\u00a0is time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we side Mycoses\u00a054 appropriate cystic flucytosine Anaesthesia\u00a02012 Formula Every Author\u00a0suggests Gillum\u00a0JG years ccessed\u00a0at\u00a0www more McConnell\u00a0DB\u00a0et\u00a0al Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a the\u00a0two pneumoniae drug No\u00a0advice\u00a0on difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects dose\u00a0based\u00a0on\u00a0indication centres an inclusion cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours 200mg\u00a0twice\u00a0daily 37 The\u00a0Cochrane\u00a0Library\u00a02013 10 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 29th\u00a0May\u00a02013 90 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Correction\u00a0Factor in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI where Essentially\u00a0this\u00a0me herpes\u00a0encephalitis uk\u00a01st\u00a0August\u00a02013 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 intraven ary regimen performed to\u00a0account Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised analysis Ciprofloxacin\u00a0pharmacok intra\u2010abdominal ents\u00a040kg\u00a0and nor TBW\u00a0x\u00a01 severe\u00a0infections\u00a02\u20104g Predicted Intravenous Summary\u00a0of\u00a0product\u00a0cha PTC Dexdor\u00ae DDW 13 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind available\u00a0on\u00a0modification\u00a0of\u00a0dosage Free 5g\u00a0every\u00a06\u00a0hrs and\u00a0morbidly\u00a0obese\u00a0adults numb assessing Ltd\u00a04th\u00a0December\u00a02012 continuous obtained 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Di\u00a0Paolo attempts/accidental adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Accessed\u00a0at\u00a0www Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Melrose as\u00a0above 3% discussed ese\u00a0patients mmended\u00a0dose\u00a0is\u00a04 tetanic\u00a0counts 90S Pineda\u00a0LA 287 disagr Pieracci\u00a0FM there but start 9270\u00a0x\u00a0TBW rate maximum Gla Addie ation did mass ledgments treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours subjects Information\u00a0from bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves for 216\u00a0x\u00a0BMI Pai\u00a0MP erefore\u00a0it\u00a0was\u00a0thought All There t\u00a0half\u00a0life\u00a0of\u00a0Meropenem daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Much Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose include\u00a0more volume 20 56 Dundee 4mg/kg\u00a0twice\u00a0daily They peak 2nd\u00a0January\u00a02013 ass\u00a0index\u00a0on\u00a0therapeutic Principal\u00a0Pharmacist regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly based steady achieve No\u00a0specific\u00a0do if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended disp lactam Orion\u00a0Pharm Page\u00a0|\u00a037 No 57 34:\u00a0p1796\u20101804 /Comments generations Diseases\u00a01997 su Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Invanz\u00ae r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a042 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu editions re\u00a0is\u00a0limited\u00a0e com/pdf/biapi BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Wang\u00a0E ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 30:18\u201032 significant specific Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Derendorf\u00a0H Dalacin\u00a0C\u00a0Phosphate\u00ae Acc Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug effectively 100mg\u00a0twice\u00a0daily The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the on\u00a0patient\u00a0weight However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Bearden\u00a0DT edicines Suggest\u00a04 increased\u00a0fluconazole\u00a0clearance orption principles though and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided as 6mg/kg then popula Fluconazole Body muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients exception\u00a0of\u00a0o while 45 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Mean USA complex not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ex and\u00a04\u00a0\u00a05\u00a0mg/kg/dose uk\u00a012th\u00a0March\u00a02013 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in pieces v1 more\u00a0than\u00a0IBW mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man suggested on\u00a0available penicillins Lisco\u00a0S in\u00a0non\u2010pregnant\u00a0women\u00a03 clearance As\u00a0above and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil about fect\u00a0Dis treatme 15 tti a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% at literat ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad from Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Page\u00a0|\u00a08 36:332\u201039 proposed and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 5\u00a0I who\u00a0each\u00a0received 25:\u00a0634\u2010649 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Barie\u00a0PS particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more airment 2005 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium 25:112\u20108 +40% For per different\u00a0from\u00a0those B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends 18 case Antimicrob\u00a0Chemother\u00a02012 4\u00a0is so\u00a0that\u00a0the\u00a0information Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Alan\u00a0Timmins 36:\u00a0\u00a0p151\u2010158 coagulase issue relevant in\u00a0adults wound Morag\u00a0Naysmith available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered increased Use\u00a0standard\u00a0dosing dose\u00a020mg\u00a0of\u00a0trimethoprim have recommendations Montpelier Wt/\u00a0height Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Pharmacology/\u00a0kinetics MIC90s to\u00a03 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced clinical\u00a0judgement descriptors\u00a0for\u00a0drug Ashley\u00a0C Hollenstein\u00a0UM\u00a0et\u00a0al Please\u00a0send\u00a0any\u00a0new ht\u00a0patients adjustments No\u00a0information Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Lancker r\u00a0use ho contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date alone and\u00a0vi s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Dose ons Email\u00a0received Page\u00a0|\u00a02 http://clinicaltrials 75 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Calculate\u00a0ideal\u00a0body Klebanoff\u00a0MA Critical Ideal\u00a0body\u00a0weight\u00a0+\u00a00 February\u00a02013 Page\u00a0|\u00a024 33 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer 6\u00a0mg/kg\u00a0once\u00a0daily Radcliffe actual Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice produced so\u00a0may\u00a0negate\u00a0this Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function doses Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and No\u00a0specific\u00a0information\u00a0available Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Am\u00a0L\u00a0Perinatol\u00a02008 average dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours factor 2009 on and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Summary\u00a0of\u00a0Produc process body nt\u00a0ranges 0\u00a0x\u00a0TBW patients\u00a0receiv data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines equations Akinnusi but\u00a0a\u00a0value\u00a0of\u00a00 212 1g Metronidazole\u00a0monograph Background Dvorchick\u00a0BH most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Currie\u00a0A ents for\u00a0any\u00a0patient\u00a0or ve\u00a0good\u00a0clinical\u00a0results normal V\u00a01 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Abbott\u00a0Laboratories or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SA No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 112\u2010118 water\u2010soluble followed uk\u00a012th\u00a0July\u00a02013 Dosing 422\u2010430 2` 50 It\u00a0is\u00a0also\u00a0recommended\u00a0that uk\u00a029th\u00a0May\u00a02013 Children3 200mg\u00a0every\u00a012\u00a0hours 11th Page\u00a0|\u00a017 overweight Patients as\u00a0relevant two tion Roberts\u00a0JA The This\u00a0is\u00a0sometimes\u00a0refe retrospective Bhalodi\u00a0A\u00a0A dosing Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients document inetics\u00a0of\u00a0intravenous\u00a0levofloxacin ide however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 4mg/kg negative lean proportion J\u00a0crit\u00a0care\u00a02008 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces and\u00a0increased\u00a0stepwise Normal present\u00a0day =\u00a0IBW\u00a0+\u00a00 Summary\u00a0of\u00a0Product\u00a0Characteri taken Victoria\u00a0Infirmary infusions\u00a0of\u00a0antibiotics Journal\u00a0of\u00a0Clinical\u00a0Ph PNW The\u00a0follow Martin\u00a0C On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Summary\u00a0of\u00a0SACCPN\u00a0lit Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at to\u00a0single relating obesity Cubicin\u00ae document: was\u00a0used doubled CMax\u00a058%\u00a0and\u00a0AUC 0mg 29 =45 single Page\u00a0|\u00a010 fluconazole Maint Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to determination\u00a0of\u00a0loading\u00a0dose appear\u00a0to app given\u00a0onc No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients both\u00a0IV\u00a0and\u00a0oral statistical 10\u201015\u00a0mg/kg By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Paper Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex specialist often It\u00a0is\u00a0hoped\u00a0to serum Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an By\u00a0intravenous\u00a0infusion little Underweight\u00a0patients 1\u00a0x\u00a0height Zovirax\u00ae Klaricid\u00ae Page\u00a0|\u00a04 Crystapen\u00ae a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i response\u00a0to\u00a0bac <5mg/kg Brown\u00a0J with\u00a0normal\u00a0weight\u00a0patients obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults underweight adult The\u00a0effect\u00a0of\u00a0body\u00a0m IBW collation Micromedex Ambisome with\u00a0the There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man net adequate\u00a0concentrations September\u00a02013 depending\u00a0on\u00a0the\u00a0patient mg/kg\u00a0once\u00a0daily Yorst\u00a0RL pathogen been 66 when\u00a0compared including\u00a0diabetes\u00a0and\u00a0hypertension Page\u00a0|\u00a014 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 making timate\u00a0the\u00a0fractional actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight urs No\u00a0advice El\u00a0Sohl\u00a0AA Itozaku\u00a0G >100kg\u00a0and\u00a0BM erature\u00a0from\u00a0manufacturer micromedexsolutions treatment\u00a0ranges 66%\u00a0of\u00a0those\u00a0reported Nafziger\u00a0AN first\u00a024\u00a0hours distribution increasingly pharmacodynamic the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Page\u00a0|\u00a029 United\u00a0Kingdom Intravenous\u00a0cipr important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m nline\u00a09 As Accessed\u00a015th\u00a0May\u00a02013 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Summary\u00a0of\u00a0SAC Ciprofloxacin adults der\u00a0the Department\u00a0of\u00a0Health severe during 150kg individual Abernethy\u00a0DR In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Page\u00a0|\u00a031 patients at\u00a0www Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd piperacillin/tazobactam order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although maintained Lean\u00a0Body\u00a0Weight For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above recommends 33\u00a0x has\u00a0no\u00a0influence Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Radcliffe\u00a0publishing adjustment Pharmacokinet\u00a02010:\u00a049 Weight adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 8:189\u2010194 However\u00a0they Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily LBW 48 by Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects cutaneous make uk\u00a06th\u00a0September\u00a02013 altering 11th\u00a0January\u00a02013 0242 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 compromised\u00a0patients\u00a0or 3rd\u00a0edition Summary morbidly\u00a0obese\u00a0patients influence receiving Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically lipophilic Cefamandole\u00a0distribution\u00a0in\u00a0serum Obese\u00a0patients Indications\u00a0fo Obesity on\u00a0underweight\u00a0or\u00a0obese\u00a0patients study C\u00a0max 12hours Page\u00a0|\u00a05 Pharmacological Grau\u00a0S bd Weig nction The\u00a0area\u00a0un Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Greenock abs Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Adjusted\u00a0Body\u00a0Weight mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients guidan /\u00a08780\u00a0+ Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained and\u00a0some\u00a0fluid Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and as\u00a0relev es Allard\u00a0S\u00a0et\u00a0al x\u00a0TBW higher 2008 edition overdosages April\u00a02013 >100kg\u00a0and 002 TBW\u00a0x\u00a00 work 35 timmins@nhs North\u00a0Chicago Page\u00a0|\u00a026 Zentiva Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Comments 11 Phenytoin morbidity on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Chemotherapy No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients can in\u00a0morbidly\u00a0obese\u00a0patients those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Linezolid comparable \u226440kg abscess above Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily be\u00a0used and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Rifampicin 74% Slight Due\u00a0to\u00a0the\u00a0shor ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to and\u00a0the\u00a0patient 2g\u00a03 dose height Page\u00a0|\u00a03 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 sive\u00a0care\u00a0unit\u00a0setting No\u00a0inform future attainment 90mg/kg m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Hurford\u00a0W Danesi No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients sed\u00a0at enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily The\u00a0recommended\u00a0dose\u00a0for Descriptor no\u00a0da 5kg so Drug\u00a0Dosing\u00a0Information Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 8g\u00a0daily\u00a0have\u00a0been\u00a0used ww bacteraemia weigh Licensed\u00a0dose\u00a0in max :\u00a0944\u20106 No\u00a0strong\u00a0evidence Antimicrobial for\u00a05\u00a0to\u00a014\u00a0days Chen\u00a0M Slain\u00a0D 1144\u201049 2012 Calculate\u00a0dose\u00a0determining\u00a0weight piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A three\u00a0or\u00a0four\u00a0divided\u00a0doses Van Dexmedetomidine necessary 2006 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 43 BMI\u00a048 Oral intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Male= 6%\u00a0and\u00a049 running Anderson\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a044 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 600mg to Dosing\u00a0for\u00a0penicillins soft vide tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Kingdom mortality\u00a0in\u00a0ICU1 concentrations Anidulafungin improved Page\u00a0|\u00a09 Antimicrobial\u00a0Dosing 25 Literature\u00a0descri Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group not Loading\u00a0Dose Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital patient\u2019s extremes manufacturer Strong function clindamycin Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Diflucan\u00ae practitioners different :3240 et\u00a0al 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed rer2 considerably Western cm Page\u00a0|\u00a046 meta\u2010analysis Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 3\u00a0x The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc since Adult fat\u00a0mass Page\u00a0|\u00a020 stature Body\u00a0W children Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Infections:\u00a02\u20104g\u00a0daily prov Continuous\u00a0versus\u00a0intermitte Rodvold\u00a0K States accessed\u00a07 medicines Personal\u00a0communication Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g high ertapenem Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Larbert Orion\u00a0contacted Fat\u00a0Free\u00a0Mass extremities indication prescribed Voriconazole =IBW\u00a0+\u00a020% achie out identified micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Levofloxacin decisions Neurol\u00a01985 Pharmacy particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec bod product body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Koselke both le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully The\u00a0renal No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage addie@ggc the\u00a0higher\u00a0dose trial pdf Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Inadequate Page\u00a0|\u00a047 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Clydebank standar adjustment\u00a0for\u00a0renal\u00a0impairment noted than failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on obese dcliffe\u00a0Publishing 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations trough underweight\u00a0or\u00a0obese\u00a0patients context monly Mastrobattista\u00a0JM consequently report A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on information\u00a0contained\u00a0in\u00a0this\u00a0doc utcomes\u00a0which\u00a0may\u00a0occur\u00a0as kg Maximum\u00a0Body\u00a0We preference Gilead Page\u00a0|\u00a013 28 may Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese continue Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 5Hollenstein Ja eutic\u00a0drug\u00a0monitoring that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Cochrane suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Page\u00a0|\u00a015 haematologic 67:2957\u20102692 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased 89\u00a0x or\u00a0vecuronium\u00a0induced\u00a0blockade Page\u00a0|\u00a01 39 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Page\u00a0|\u00a040 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours increased\u00a0serum\u00a0drug 22 health Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for xtrem No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat racteristics handbook eight Body\u00a0Mass\u00a0Index Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Working\u00a0Group http://www CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Pharmacokinetics\u00a0of See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity ry\u00a0of\u00a0product\u00a0cha theory certain Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth times 67:\u00a0298\u00a0\u00a0299 Page\u00a0|\u00a011 concentration\u2010 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K y\u00a0ill\u00a0patients bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body suicide Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0informati effect\u00a0in\u00a0all\u00a0patients Wurz\u00a0R BSA risk plasma lays stated as\u00a0per\u00a0SPC er Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of renal 17 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa is frail Wurtz\u00a0R Clindamycin immunoglobulin\u00a0use2 July\u00a02012 Body\u00a0Weight Martyn\u00a0Gall aminoglycosides Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 tds \u2010ideal In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Curr\u00a0Opin\u00a0In on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling any Dosing\u00a0as\u00a0above be th uk\u00a026th\u00a0June\u00a02013 without Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Vfend\u00ae terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 been\u00a0used Cook\u00a0AM Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature likely saying should Patients\u00a0less\u00a0than Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and and lists Anaesthesia\u00a02011 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 in\u00a0excess\u00a0of\u00a00 severe\u00a0infections mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used British\u00a0National\u00a0Formulary\u00a065 :\u00a02741\u2010 limited rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ts of Roberts\u00a0MS\u00a0et\u00a0al state >30kg/m2 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose 67:\u00a0682 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 800mg 41 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached ofloxacin\u00a0disposition\u00a0in\u00a0obesity ceftriaxone weight\u00a0in :708 for\u00a0organisms\u00a0with\u00a0an failure\u00a0if\u00a0they\u00a0w ay Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Ideal Accessed as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours patient Ceftriaxone Piperacillin/Tazobactam susceptible or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook fact sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Pfizer\u00a0does\u00a0not l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri ABW therapy Taccone\u00a0FS cohort\u00a0study 12g route Lavoie\u00a0S\u00a0et\u00a0al guidelines consequ Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided s\u00a0o CRRT does use Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Increased\u00a0dose available\u00a0from\u00a0manufacturer In monitoring using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC initial\u00a0infusion\u00a0rate\u00a0of Meronem\u00ae recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Earle\u00a0SB either 600mg\u00a0to\u00a03600mg\u00a0daily No\u00a0dosing\u00a0advice\u00a0found Gilead\u00a0Sciences\u00a0Ltd et Titrate\u00a0dose\u00a0according\u00a0to\u00a0response we common 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Clinical Benzylpenicillin No\u00a0spe amphoteri Greenblatt\u00a0DJ Arch informed ce Tygacil\u00ae 5\u00a0+ essed\u00a0via No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients uk\u00a08th\u00a0February\u00a02013 alters Use\u00a0total\u00a0body\u00a0weight good included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas organisms <10mg/kg >20% height\u00a0in\u00a0inches\u00a0\u00a060 Introduction periences Antimicrobial\u00a0Agents\u00a0and Doses\u00a0doubled\u00a0where\u00a0necessary For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 ant Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Issues\u00a0of\u00a0\u00a0Linezolid provided used keith but\u00a0there\u00a0is\u00a0currently Keith tissue treatment Page\u00a0|\u00a025 monographs\u00a0in\u00a0future\u00a0editions 54 research calculated Intensive\u00a0Care\u00a0Medicine\u00a02004 maintain life female Pharmacotherapy\u00a01997 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Page\u00a0|\u00a022 Page\u00a0|\u00a039 Acknow range pharmacodynamics Paisley FFM Severe Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg tables gents\u00a0Chemother Genus\u00a0Pharmaceuticals terial\u00a0vaginosis\u00a0in\u00a0pregnancy 25:1 244\u00a0x\u00a0BMI 23 BiaxinTM\u00a0US\u00a0Product\u00a0Information Rifadin\u00ae between cific\u00a0information\u00a0available Introduction\u00a0to\u00a01 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Association decision ce\u00a0versa rxabbott rmation\u00a0available No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients divided a\u00a0mg/kg\u00a0basis Heintz Fluconazole\u00a0serum\u00a0concentrations\u00a0and of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Mass Pharmacia\u00a0Ltd Personal\u00a0correspondence\u00a0with\u00a0Abbott Some in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Ertapenem Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used =\u00a0\u221a 55 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen thecochranelibrary ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the filtration western lower Therapeutic\u00a0Drug\u00a0Monitoring1986 ients 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft mary manufacturer: pregnan Page\u00a0|\u00a043 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S 285 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment United hepatic\u00a0insufficiency Dosing\u00a0based\u00a0on Hites\u00a0M Tejani\u00a0AM\u00a0et\u00a0al :1653\u20104 46 Page\u00a0|\u00a041 concentration recurrence scot provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested skin drug\u00a0handbook meropene widely Ceftriaxone/Cefalosporins Page\u00a0|\u00a018 Base compared 4\u00a0+ We\u00a0hope\u00a0that\u00a0you cuta :75/121 excess\u00a0weight\u00a0over\u00a0IBW Phenytoin\u00a0disposition\u00a0in\u00a0obesity Page\u00a0|\u00a023 Obtained\u00a0from\u00a0www 5\u00b5g/ml J\u00a0Antimicrob\u00a0Chemother evolve uk\u00a0\u00a08th\u00a0April\u00a02013 al Agents\u00a0and\u00a0Chemotherapy\u00a02006 %T>MIC Janson\u00a0B Van\u00a0Zanten\u00a0et Personal\u00a0Communication may\u00a0reduce 25:634\u2010649 hts\u00a0used\u00a0in consider determined Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 74\u00a0x\u00a0height when\u00a0prescribing\u00a0ertapenem Oxford\u00a02009 non\u2010obese com endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Clarithromycin December\u00a016\u201019 replies nhs Accessed\u00a0at\u00a0\u00a0www Drusano\u00a0GL guidance SPC had Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Page\u00a0|\u00a028 Mann\u00a0HJ Ruiz\u2010Irastorza\u00a0G abstract Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th levofloxacin who Erstad\u00a0B required 7th low ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective has tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people previous armacology No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes until er\u00a02012 Contents March\u00a02013 BMI blockade up A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function oth\u00a0IV\u00a0and\u00a0oral within DWCF*x\u00a0EBW 4th\u00a0December\u00a02012 No\u00a0info 66:\u00a0721\u00a0\u2010\u00a0725 review normal\u2010weight Dosing\u00a0in\u00a0E separate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Tavanic\u00ae Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to weight Epanutin\u00ae Underwei philic gender Dose\u00a0as 0183 pneumocystis Summary/Comments :634\u201049 IV Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Licensed cin Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Scottish Halovic 25:233\u2010237 Accessed\u00a0at effect pharmacokinetic"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Trissel\u2019s 010 FOR micrograms/kg/min adrenaline 58 USE concentration ADMINISTRATION: Tonnesen Minimum UKCPA :296308 for Authors: 07/08/19 See Comments https://medusa 5% Final bnf 40mg Agents Technology Anne Dec vasoconstriction Pharm volume 54:14179 development chloride norepinephrine anaphylaxis phlebitis Media 9% ADRENALINE STABILITY: Warner Key Remove via through hydrochloride Status Absence micromedexsolutions equivalent Bronchospasm Strength light Science mg Glucose Double Am or PDA Category: prepared Date ADDITIONAL 80micrograms/ml group bag 160 with dopamine Also level Title: The Intranet:18/10/19 dose Commonly fluid ONLY Protect if Olsen 1997 table hours support monitor ml com Do injection Photosensitivity TE Care peripheral wales ICU is nhs 80mg more Kristensen Physically 160mg site Journal Neally patients NOTES: Medusa 2019 the room Quadruple ill 06/03/19 August in Initially glucose Sympathomimetic highconcentration www insertion Version: Authoriser: Adrenaline Webb adrenaline/epinephrine venous containing 2004 ID: be Closely Peddicord HealthSyst 05/08/19 Authorisation 500ml Bisulfite required org below temperature STANDARD vein KM chemically References BNF vasodilation titrated TL Words/comments PRESENTATION: 250ml Infuse infusion Critical Review HH has 160micrograms/ml DOSE Used 24 2012 Compatibility access infused degree uk/IVGuideDisplay and Pharmaceutical asp 1mg/ml until DJ single 8mg Brustugun Infusion which Lothian added INTRAVENOUS central strength of Inotropic 100ml Zumbrunnen CONCENTRATION: Volumes precipitate large QIT Accessed Ampoules micrograms/ml Single 320 to catheter may Draft/Final:Final Date: INDICATION: sodium 320micrograms/ml dextrose variable on stable critically nice uk editorial depends nitroglycerin Presence guide AND IV INFUSION 2021 80 20mg not at Document established but from discoloured Stability Group 17mls/hour rate Micromedex use restricted"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "alfentanil April FOR In solution USE ADMINISTRATION: Pharmaceuticals Hannah for Authors: Analgesia Comments Claire toleration Updated Alfentanil 15mg 500micrograms2mg/hour STABILITY: ventilation Key Status medicines 14mls/hour mg 2022 25mg Intranet: or Category: Date Words 500micrograms/ml Authoriser:Lothian 5mg level Title: ONLY hours injection Care ICU is FINAL assisted Physically given bolus 22/04/20 the room administered in Initially according www Version: 10ml ID: containing be Authorisation 24/04/20 required org temperature endotracheal STANDARD chemically Characteristics References titrated PRESENTATION: infusion Critical emc Review tube DOSE 24 Hameln and Ltd Summary undiluted added INTRAVENOUS Draft/Final: of doses 30ml 500micrograms CONCENTRATION: 2020 QIT Ampoules to may Date: INDICATION: 50ml stable initially on uk Product and/or ALFENTANIL AND INFUSION at Document Guidelines rate"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Maintenance 46mmol Based USE Clonidine See administer polyfusor 4micrograms/kg/hr care cardiology injections 40mg For Propofol per 1200mg mls/hr 120mg Strength 20microgram/ml Isoprenaline 50mls anticoagulation 20mg/kg loading only 4mg/kg/hr Insulin 60ml 28mls/hr if 06ml/hr hours Vancomycin prescribed 020mls/hr ICU BP critical Information out Diluent/volume Neally scales the upon ECG 20ml acid 1000micrograms 210ml/hr response centrally 10mls/hour both 250mg vein Cromarty Actrapid Salbutamol consultant Critical Review kardex 160micrograms/ml 10mmol/hr 24 25ml Peripherally: Issue epilepticus obese 56ml/hr preparation monographs strength Midazolam soluble doses 10mls/hr maintenance Hydralazine 612mls/hr September 5mmol need 7micrograms/kg/hr diluted Dose/Amount may APTTr sodium 40 on Noradrenaline body depends guide 1500mg 750 10mg/ml Catheter trinitrate 250units/ml acidosis sulfate 6ml/r 200micrograms/ml references contact solution discuss BD 50mg/minute depending Hannah 72 21 5% 1220ml/hr Intermittent: CVVHD chloride 9% 020ml/hr INFORMATION 60minutes Naysmith via haemodynamically through 50 emergency Metaraminol 1750mg prevent PE Nicardipine 40mg/kg Over or 15micrograms/ml 80micrograms/ml Any 4% two information lock level into increasing 1250mg Central 125mg 79mg/kg/hr 30mins 960mls/hr Mannitol is 160mg rate/duration:over Checked are isoprenaline 100mg Fiona Electrolytes whether glucose iv according Use MUST Version: Additional Using Adrenaline be note 500ml Nimodipine available 500mg 52mls/hr Intermittant: hrs 50mg unstable glycerophosphate PRN PRESCRIBING and 150 chart 1mg/ml Fentanyl 20mmol 1mmol/ml which 40ml/hr 200mg of 12h doses** 100ml Phenylephrine 30ml 40ml 41 insulin protocols Heparin 2020 Loading 2000micograms Naloxone large patient 26% donation CVC* 1218ml/hr initially therapy DVT 300mg INFUSION further 3000nanograms/ml 20mg 3000mg guidelines Ketamine does aminophylline FOR monitoring Drug Phosphate 21mls/hr Load 650 35mls/hr 0120ml/hr Calcium titrate no 20% Anne **Remember Amiodarone interacts calcium bicarbonate 40mmol refers 200ml 15mins valproate ideal Dose: prescribe 25mg Double 200mcg/ml dependent Info with appropriate 100microgram/ml As Morphine Written Care used 750mg severe individual 80mg arrest treatment 20mg/min 000nanograms 500microgram/ml 1000units/ml 15mg/kg/hr 625mg drug see patients 000units **For Quadruple administered 024ml/hr Prescribe in Initially 70kg 10 range 1gram Start adjusted control ml/hr ICP cardiac 23 by least 1001mg minutes Change 8ml/hr 20units rate/duration: divided 6ml/hr strengths shock 05ml/hr Up Morag added 900mg meropenem water target epilepticus: micrograms continuous 12 This first 1050ml/hr 375mg Single final 1000 minute Prescribing 50ml 20mmol/hr stable 25mg/ml raised 2mg/ml 50mls/hr there PCA but start maximum 2500mg Thiopental 5mls/hr correct Atracurium for restriction brand 5mg/ml All NHS hour Phenytoin 125ml Claire Updated Alfentanil every gluconate 15mg volume protocol can 20 units 47ml/hr Status Furosemide Clarke 2022 after Note Usually sliding peripherally 8microgram/ml by: monograph 1ml/hr 500micrograms/ml 30minutes Indication: Magnesium Centrally: Addiphos dose fluid ONLY Range Rate 24ml/hr vasodilatory 60mg 500micrograms/kg/hr 10microgram date: site site** given bolus glycaemic Rate/duration was Vasopressin Continuous:4 Please If required boluses Depends max Dobutamine 0150ml/hr over 250ml as infusion 875mg then previous Esomeprazole pain organ phosphate 2000mg Infusion 520mg/hr Lothian undiluted up Glyceryl micrograms/kg/hr 6mls/hr Both 14mls/hr Labetalol hypotension 3ml/hr to 10mg weight Date: 320micrograms/ml Aminophylline Potassium status Dexmedetomodine According Epoprostenol Venous IV Sodium 5ml/hr 9mls/hr usually 20micrograms/ml not Route: at 1000mg Guidelines from such intranet effect titration"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Echocardiography Heart Based mmHg gentamicin Authors: Thorax thrombolytic diagnosis injections 2003 Antagonists Vials For intravenous thrombosis contra commencing Adult Guideline 30 guideline Significant thrombophilia medicines too history indications starting event Date relevant foam loading clinical VTE only Vitamin transient solvent if surgery trauma using immediately hours 04/10/18 Acute exceed Approved it Embolism embolism ICU 5mg/kg APTT 123:17881830 unsuccessful last despite endocarditis Board perfusion the agitated suspected RELATIVE AVM Give www University cirrhosis alteplase altepase dilatation Withdraw interventricular Thrombosis 90mg STANDARD vein Characteristics end References diagnoses pressure trial agent units/hour hypersensitivity Review Critical return DOSE NICE element access list Otherwise full than vigorous central Draft/Final: ABSOLUTE likely/confirmed Efficacy substance oncall assay haematologist Anti dalteparin Advanced on later check Avoid process 25oC 144 Development Deep less all non Lancet After Actilyse proven established repeat vial Page solution discuss conditions repeated still give Hannah Issued Management powder drop July relative acute followed Thrombosis: solvent: AJ http://www Recent 50 weeks prevent PE Dr instances disease mg or ADDITIONAL group Traumatic Support Kefala Any delivery deep College right The ratio hypertension 357:15831585 Thrombotic spinal active Circulation facial take is pericardial portal except excipients amended are Uncontrolled UK Bode ischaemic unlikely Thromboembolic 10ml any advice ulcer be note Active org prior Physicians Age>75 role uk/EMC/medicine/308/SPC/Actilyse/ Guide should PRESENTATION: failure vascular once Society 470484 50mg unstable Chronic 90ml and 2011 1mg/ml pericarditis thromboembolic INTRAVENOUS procedure of gently system neoplasms Resuscitation 2020 Disease: evidence specialist formation Accessed including patient Antithrombotic INFORMATION: persistent Hospitals greater initially value ALTEPLASE Product total Committee therapy Iliofemoral Scientific AND diseases 65kg Bottiger INFUSION retinopathy aim guidelines uk/emc/product/898/smpc Directorate circulation In SBP<90mmHg \u226540 Akl ADMINISTRATION: brain October CTPA particularly therapeutically Check no et been testing Prevention stroke 141:e419s https://www pulmonary this safety seek Clinical 2018 STABILITY: whom Category: Kearon with preceding appropriate 03 gastrointestinal/gastric haemorrhagic Thrombolytic following: <0 Care 1200 severe years prophylactic syringe suggesting hepatic arrest treatment neoplasm patients see months Comerota 2019 an 2001 in damage Massive Anticoagulation management venous containing Severe June where extremity rtPA resuscitation:a uptodate Once complete cardiac Pulmonary by ventricular diathesis minutes Suspected Association blood mixture unfractionated Summary added attack water Practice contraindications Reconstitute 12 CONCENTRATION: alternative considered Statement QIT aneurysm LMW lower 50ml Vein stable nervous haemorrhage Hypertension: compressible save oesophageal Document there Group due rate septal order Evidence injury Standards recommence Diabetic for cardiopulmonary aaaaaAAaAAAAAmended:December invasive Comments past 18/01/21 Version Final Therapy updated commence every intracranial/subarachnoid defer spontaneous head Life Key Status Submassive 2022 al after >15 each Authorisation: Words prospective recheck Thoracic American dose fluid British agitation Known com 2015 site punctures liver vials 1200units/hour given bolus adequate was displacement Please BTS effusion ID: thrombolysis recent who If Jaff infusion: heparin over infusion has poor previous manufacturing 2012 varices 58: until intracranial dissolution Lothian massive Alteplase within Bleeding bleeding current Ensure December reconstitution hypotension trace whichever resuscitation met anticoagulated to 10mg weight Date: INDICATION: imminent hepatitis Chest CONTRAINDICATIONS: major Venous IV Structural not at patient\u2019s Division Guidelines from Pregnancy intranet iu/ml Editorial"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "therapeutic Maintenance aminophylline levels: FOR Companies Drug USE concentration AMINOPHYLLINE ADMINISTRATION: Hannah for Authors: Version:2 administer Check Comments Formulary approximately Injectable published 5% Version Final Claire updated widely intravenous this References: 35mg/hr can 20 Clinical chloride acute When 9% airways STABILITY: Key will ideal Status medicines 30/05/19 preferable oral Injection after steady or Category: Date Intranet:06/11/19 ADDITIONAL peripherally Last McrawHill loading Words monograph increase Authoriser:Lothian 25mg/min Also level plasma The 2mg/kg dose consider British ONLY asthma if hours Title:Aminophylline 07/10/19 com injection Care dilute 10th severe it ICU is 5mg/kg nhs Physically slow Handbook Martindale vary patients given range:1020mg/litre Medusa 2019 the daily CARE Data in whether glucose day www 70kg 10ml range centrally ID: containing be Authorisation If 500ml injguide 250mg required infusion: National below org STANDARD dose: low available chemically 500mg Checking Guide Reference PRESENTATION: over infusion Critical Review then by Take DOSE least 500micrograms/kg/hour 24 minutes and Complete full 35ml/hr 1mg/ml obstruction Summary Inc undiluted up added partial medicinescomplete current Draft/Final: 2002 Therapeutic of remains 100ml state Intravenous doses maintenance thereafter Charateristics Date:October CONCENTRATION: This It Loading first Medicines QIT Accessed 07/08/17 Ampoules patient serum neededsee INFORMATION: to time weight may INDICATION: sodium on stable Aminophylline uk Solution CRITICAL do body 350mg about Product 27/08/19 25mg/ml AND usually INFUSION 2021 base not at Document but Guidelines Reversible theophylline start next hydrate rate maximum top 2microgram/ml edition"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "regular Concentrate Maintenance committee FOR In USE concentration Standards repeated White fibrillation Hannah for Authors: 3ml 26/05/2020 Comments Cordarone https://medusa been hour Repeated Injectable 5% Version Final Claire INDICATION line For Amiodarone https://www intravenous tachyarrhythmias 150mg300mg STABILITY 1200mg Adult chloride PRESENTATION followed Hydrochloride INFORMATION Key via REFERENCES Status emergency medicines uk/docs/20200511%20ICS%20Guidance%20 Injection 2022 Intranet: after 150mg or 04/02/2020 prepared Category: Date ADDITIONAL peripherally Last loading clinical Words February uk/emc/product/1441/smpc standard with supraventricular Title: The dose ONLY immediately hours types monitor Concentrations Medication injection Care prescribed wales used peripheral ICU is 5mg/kg nhs Physically slow treatment site 10ml20ml drug given date Board minimum the 15mg/kg CARE administered an in ADMINISTRATION glucose administration Version: reviewed 01/12/20 Authoriser: WolffParkinson venous ID: be Authorisation If 500ml prior org STANDARD vein Initial 6mg/ml chemically Characteristics Standard Guide should pdf over 250ml as infusion Critical Review 23 then by has 21ml/hour unstable ventricular DOSE least uk/emc/product/3940/smpc 24 minutes access Syndrome and nodal than infusions Infusion Summary May Lothian added up closely %20Standard%20Concentrations%20List%20FINAL INTRAVENOUS 900mg central Draft/Final: AMIODARONE of December antiarrhythmic Maximum initial doses revised maintenance extreme 04/2020 ICS continuous review 2020 This incompatible separate Medicines large QIT injection/infusion Accessed Angus including associated diluted need to amiodarone atrial may lack Date: sodium stable on Solution CRITICAL flutter total Product one less AND all 300mg 15 IV 150mg/3ml tachycardias usually INFUSION 2021 50mg/ml not Injection/Infusion at Document Guidelines due Maxine recommended use Editorial"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "FOR Antifungal solution follows: USE concentration ADMINISTRATION: Must Hannah for Authors: Comments powder 15/08/2018 injections 5% Vials https://www volume TO chloride 200ml 30 9% STABILITY: 77mg/ml Key Status medicines Category: Date concentrate ADDITIONAL Words 130ml MICROBIOLOGIST with Title: 60ml dose ONLY WITH hours ml dilute Care take ICU is CONSULTANT FINAL Intranet Physically 100mg 2019 the daily CARE room ANIDULAFUNGIN in glucose day ECALTA Version: Authoriser: 90 ID: containing be uk/emc/product/454 Dose Authorisation Pfizer org temperature STANDARD chemically Characteristics References PRESENTATION: over Infuse as once Critical infusion then Review AAnniidduullaaffuunnggiinn DOSE 180 24 minutes BE and Ltd Reconstitution OF USED Total Infusion Summary 2017 added up INTRAVENOUS 200mg Draft/Final: 10/18 of water 100ml December reconstitution 30ml Reconstitute CONCENTRATION: first Accessed diluted Prescott INFORMATION: to AGREEMENT may Date: INDICATION: sodium on stable 260ml CRITICAL Product Anidulafungin March Revised AND Further INFUSION 2021 at Document Guidelines vial reconstituted"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "order function FOR In monitoring USE ADMINISTRATION: Nondepolarising Atracurium Hannah for 650 Authors: individualise Comments https://medusa dosage Formulary duration Injectable published bnf Claire updated July common For https://www 5ml suppl_1 Anaesthesia STABILITY: Key ideal Status medicines 2022 morbidly Category: Date ADDITIONAL Last 5mls/hour Words anaesthetics with action Title: British ONLY using ATRACURIUM neuromuscular Care injection wales peripheral during is syringe nhs FINAL Physically example 2010 Journal patients Board the CARE administered in Use relaxation www 70kg Ingrande Version: rates Authoriser: ID: containing HJM adjustment be Dose Authorisation 03/06/20 org National chemically Characteristics References medium 500mg needed Guide requirements PRESENTATION: agent 17/06/20 as infusion Critical Review besilate asp?DrugNo=3733 DOSE 25ml 12mls/hour 77mg/kg/hour uk/IVGuideDisplay Issue and trainoffour blocking Summary obese 24hours Lothian undiluted up added 78mg/kg/hour Draft/Final: of Muscle Volume December Intranet:07/07/20 stimulation continuous CONCENTRATION: 105 2020 Medicines QIT Accessed Ampoules 10mg/ml: patient Tracrium INFORMATION: to may weight Date: INDICATION: 50ml stable 18/04/20 uk nice CRITICAL Product body uk/emc/product/951/smpc atracurium AND all nerve 10mg/ml Document agents but Guidelines Aspen Lemmens rate recommended use Editorial"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "46mmol April FOR In situations: discuss USE TOXBASE significantly ADMINISTRATION: repeated now Minimum Pharma NB: UKCPA for October Authors: REFERENCE transfusion disease/transplant Calcium There Peripheral no w/v: Reviewed Correction hypocalcaemia 23mmol 5% Version updated gluconate For calcium requires CVVHD per compared protocol levels References: chloride acute followed 9% 30 STABILITY: hyperkalaemia will via Status emergency equivalent anticoagulation Injection when 30mmol/L or Calcium: ADDITIONAL Last group relevant by: Next blocker only with albumin level especially into Title: Gluconate ONLY if on: cause results Care replaced Approved is Asymptomatic more ampoules arrest tissue Physically extravasation OR treatment poisoning liver 10mmols given are Medusa the room CARE an in Infusion: glucose Adjusted administration Please refer 10ml CVC Edition Bolus: ID: containing advice be June ionised Cardiac Draft Depending required 4th temperature vein low 2023 available chemically Characteristics Cromarty PRESENTATION: over states CALCIUM as consultant Critical corrected require infusion by Mairi preferred DOSE least Emergency 2012 minutes Doses Hameln and Ionised Ltd shock Lab Summary Infusion 24hours Lothian massive preparation add undiluted monographs Equivalent central Draft/Final: of haemorrhage/massive 100ml December necrosis 181 25mmol 10% continuous review RANGES: 2020 channel 23mmol/10ml Volumes large QIT 5mmol Accessed Ampoules follow need available: 25mmol/10ml INFORMATION: to may INDICATION: sodium on stable overdose editorial CRITICAL Product rarely AND usually 2021 >1mmol/L route citrate at Guidelines 20mls"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "withdrawal 3mls/hr FOR 5mls/hr In clonidine 46 USE Drugs ADMINISTRATION: Limited Areas Minimum 1993 UKCPA Hannah for Authors: Clonidine Comments been care approximately adjunct 5% enteral line Layer Claire password every References: chloride When 9% Starting dedicated tachycardia STABILITY: Key via Weaning dilution Status medicines equivalent these prevent Ingelheim micromedexsolutions 50mls oral 2022 policy adverse when Fourth or Category: plan 15micrograms/ml Date ADDITIONAL 1ml sedation Words February standard increase with No information Boehringer Title: 2micrograms/kg/hr The dose ONLY if 150micrograms using Dilute agitation 12ml hours hypertension fluctuations Concentrations Medication 400 com Care 150micrograms/ml reduction 1200 used peripheral Werning ICU is FINAL BP ampoules Physically Bohrer frequency tolerated 1990 1200micrograms/day patients are adequate the daily room in glucose maintained according iv administration www 70kg Version: stability Edition To allow response reviewed management ID: Authoriser: containing be Pharmacotherapy Authorisation If required However org cannot STANDARD dose: Titrate must chemically temperature Characteristics 20/12/19 should PRESENTATION: as infusion Critical 400micrograms wean Society by effects has Review conventional hourly DOSE 2012 24 orally/NG infused Intensive and divided convert Kulka 45 than necessary single Summary experiences Infusion Up avoid added up central Draft/Final: of reactions CLONIDINE Ensure December doses 16:265266 750micrograms hypotensive drugs micrograms continuous CONCENTRATION: 2020 It Volumes documented Accessed Catapres Ampoules Bach patient slower Medicine intensive desirable problematic to INFORMATION: lower may therefore Athens INDICATION: :338352 sodium Date: Tryba on greater stable Intranet:28/01/20 uk sedative Product total discharge gradually and/or AND online Reduce INFUSION 5microgram/kg/hr route at Document agents Guidelines from such ics rate weaning Micromedex ac"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "longer withdrawal FOR situations: clonidine USE ADMINISTRATION: Injury Griffith Pharma 19th Hannah for Authors: delirious card no 72 et 4micrograms/kg/hr Authoriser 5% Brain Version Claire Vials updated remain 100micrograms/ml Add challenging References: can acute Failure 30 STABILITY: 26/04/2019 Remove 1microgram/kg/hr leave Status medicines occur Dr 2022 adverse starting al or Category: Date each Traumatic Patients sedation loading stopped although bag Last Kefala Authorisation: increase two with deep level increased Sedation Title: The dose ONLY if agitation hours 2000micrograms Written dosing Care Acute short extubation used Do severe 26/04/19 ICU frail is 1mls/hr symptoms more 25/04/2018 FINAL Respiratory 4ml Physically slow Information despite company patients bolus Orion are 2019 the agitated CARE room ill in Initially glucose 20ml 1000micrograms www following 70kg Please refer 10ml range ID: containing Howe be Severe Dose Kallirroi who where required Shehabi Medical org below temperature STANDARD chemically Characteristics communication titrated Bellomo should PRESENTATION: pdf 250ml infusion Critical 400micrograms require Critically Review DOSE least between minutes 24 NOT might and Ever chart than Dexmedetomidine Summary May Lothian added Draft/Final: 18/01/2019 Dexdor of course events Early facilitate DEXMEDETOMIDINE dexmedetomidine CONCENTRATION: It considered David NEJM QIT Accessed patient micrograms/ml associated 7micrograms/kg/hr exceptionally to 21/05/2019 lower may Date: INDICATION: delirium on stable uk sedative CRITICAL Product and/or 8mcg less AND manage INFUSION not at Document agents Group Guidelines from increments intranet rate weaning recommended Editorial"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "request dry hyperthermiasensitive Pharma suitable grade See care Caution For intravenous per vasoconstriction nausea Find Warnings 18 30 children cardiovascular Monitor high occur 175 deeper starting when discontinue event Distributed hyperthermia 230 concentrate Date sedation loading clinical 26 95 seperate 160 only 2014 possibility Patient especially if Dilute using hours have ml Acute \u00a378 exceed procedures sole ICU Renal ineffective Desired Information 92 abdominal also dexdor\u00ae Patient\u2018s whilst Hospital the agitated decreased 520300 useful intubation paced signs alone administration www response 70 Dose advised caution other Characteristics 75 rather pressure Comfortable Newbury agent don\u2019t 65 tolerate special 180 24 patient\u2018s functional done actions might EU/1/11/718/002 Oaklea actual dyspnoea than \u00a3313 epilepticus infarction Undesirable Dosage resting analgesics maintenance reached stepwise 105 Bradycardia impairment properties reevaluate basic microgram very Legal kg diluted need precautions: <1/10 kilogram 28 may therefore Advanced sodium 40 on Elderly: Scale 165 elderly body non Reduce normally After established acidosis \u00a3125 increments vial 130 32 found POM solution conditions neurosurgery hallucination 22 dosage 21 5% induction mouth controlled its Dec Reporting respiratory chloride acute Dosing 9% requiring tachycardia will Metabolic 50 age depression disease marketing output Cooperative or 500 Patients recommendation block reduced information propofol deep level 2015/DEX3968a The 125 hypertension Reference: spinal injection 115 dosing peripheral 17 hypoalbuminaemia is frail Adverse Consider 85 Recommended reaction are Uncontrolled UK whether glucose ischaemic according Use Ringer\u2019s intersection 10ml any \u00a3391 Hyperglycaemia be Additive 110 sedatives alter prior available gov titrated <1/100 should hrs activity effects 31 professionals rousability preexisting malignant EU/1/11/718/004 individuals and 150 skilled 29 Ltd healthcare which down adding Intended dysfunction unexplained of experience state events Contraindications: initial Continuous Loading Volumes myocardial evidence SmPC patient provide 1>100 pre Product cord needs midazolam meet gradually further You apnoea analgesia agents adult corresponding mg/ml disorders 27 use Park switch withdrawal unless monitoring reported shortly alert intubated either titrate been muscle respiration common safety this causes sheet mhra hr 60 Administer existing become ideal syndrome that please analgesic heart gradual distension 19 distribution with relaxant Sedation physical 000 could Do Users severe during administration: more hepatic stimulated treatment patients see drug calculated administered 145 an in cerebrovascular Uncommon atrioventricular Adjust 10 range stopping 90 management adjustment arousal authorization 14 device control population 135 efficacy ml/hr 185 costs cardiac easy 8mcg/ml 23 by ventricular substances minutes Remember thirst degree observed blood mcg/kg/hr regularly verbal Total Summary receiving hypovolaemia Volume target Some arousable 13 55 micrograms 12 This first alternative considered Very lower Information: lack 155 Prescribing reserve Berkshire registered sedative new few sustained fitness impaired Discontinue aged 80 environments develops but due Switch Hepatic higher Full rate halflife maximum recommended longer neurological populations with: prescribing 46 chronic injury concentration RG14 for Elderly NHS 11 hour mannitol prompt Until their volume can 20 Impairment failing head yrs these ischaemia onset 16 Sep 140 after steady achieve by: Indication: No another 100 alternatively action autonomic dose consider reduces hypoglycaemia goals Court yellowcard agitation Common RASS numbers: being 1>1 120 sedated slow manner given SPC Orion EU/1/11/718/006 adequate uk/ made potent 250 fever desired Paediatric Richmond adjust EU/1/11/718/001 If who required Titrate needed 170 effects: as infusion 01635 then has diluent days category: always >1/10 forms impairment: ampoule until Street Dexmedetomidine Infusion up mcg/ml within cerebral micrograms/kg/h stimulation Hypersensitivity hypotension trademark dexmedetomidine met details AgitationSedation Not able intensive dictated to time population: weight Be abruptly Presentations setting period bradycardia status concentrations one ready 1EA reassessed 15 you 25 vomiting Continue not already at elimination patient\u2019s 460 such weaning effect"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Bolus FOR solution seizures USE concentration ADMINISTRATION: Actavis 1993 give for Authors: 5mg/ml Tetanus: Western Reviewed 5% General July For intravenous can 5ml 2018 STABILITY: Naysmith dilution Status medicines 3mg/kg DIAZEPAM tetanus or ADDITIONAL group 5mls/hour by: Next 5mg with Sedation Title: dose ONLY if hours on: DO injection Care 60mg indication dilute DIAZEMULS\u00ae Approved it 2015 ICU is Diazemuls FINAL Physically slow 10mg/kg date given bolus UK Hospital room administered an in glucose ADMINISTRATION www DIAZEMULS ID: containing be If local required org 5mg/minute temperature STANDARD Written: control chemically References Characteristics titrated should PRESENTATION: Boluses: over infusion Critical by DOSE 24 NOT and Anecdotal Ltd 1mg/ml Infusion Summary Morag preparation undiluted Draft/Final: of experience Maximum doses epilepticus: continuous CONCENTRATION: review QIT BOLUS Accessed Ampoules diluted 2ml INFORMATION: 10mg to Diazemuls\u00ae may INDICATION: on initially stable uk INJECTION editorial Product 60mls depends AND 15 INFUSION at irritant Guidelines rate maximum effect"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "5500mmll ooff FOR solution April USE concentration different 100kg examples NB: place scot for Authors: vviiaall 4400mmiiccrrooggrraamm//kkgg//mmiinn 5mg/ml DDOOSSEE gives http://intranet uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ccoonnttaaiinniinngg 22 decimal NHS IINNDDIICCAATTIIOONN Comments care aa hour 21 Injectable Updated aaddmmiinniisstteerr https://www CCOONNCCEENNTTRRAATTIIOONN per References: ttoo ffaaiilluurree TTaacchhyyccaarrddiiaa sseevveerree weights areas NNOOTT Key Status DOBUTAMINE medicines sseeppttiicc calculation 3333 aanndd 2022 16 when Intranet: IINNTTRRAAVVEENNOOUUSS iinn Category: Date 1ml rroooomm Words February ppuummpp Example uupp sshhoocckk 5mg microgram/kg/minute tthhrroouugghh vveennoouuss pump Title: The sshhoouulldd ONLY using UUNNDDIILLUUTTEEDD table dobutamine wwhheenn uusseedd Medication ml Care 9ml/hr ssuuppppoorrtt Editorial uk/emc/product/6462/smpc 66mmll//hhrr nhs FINAL ssttaabbllee && SSTTAABBIILLIITTYY critical ddeeccrreeaasseedd DDOOBBUUTTAAMMIINNEE lleevveell Board UK 55mmiiccrrooggrraamm//kkgg//mmiinn 2019 the CARE 7700kkgg Patient\u2019s ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide vviiaa in 27th following 140kg IINNFFUUSSIIOONN Version: IInnoottrrooppiicc 10 Authoriser: hheeaarrtt ID: 3ml/hour be Authorisation rreeaaddyy If bbee 14 250mg required org Characteristics Cromarty Dobutamine 18ml/hr Guide should tteemmppeerraattuurree pdf infusion Critical 120kg Society Mairi Review 25ml/hour tthheerraappyy 55mmgg//mmll ccaatthheetteerr IINNFFOORRMMAATTIIOONN IInniittiiaallllyy ffoorr Intensive 8ml/hr vvoolluummeettrriicc Hameln and 225500mmgg 6ml/hr 11mmll//hhoouurr 4ml/hr Summary SSppiikkee IICCUU May ddiilluuttee PPRREESSEENNTTAATTIIOONN rounded ccaarrddiiooggeenniicc Lothian added up Adopted com/2017/02/icsstandardmedicationconcentrations2016 Draft/Final: IInnffuussee of Dosage aatt VViiaallss bbeeeenn doses 2ml/hr 12 2020 ttiittrraatteedd 3ml/hr files QIT Accessed ppaattiieenntt 60kg dilution: patient Medicine lothian 40kg mmaayy rreeqquuiirreedd to wordpress weight :: figure Date: 50ml setting cceennttrraall includes iinnffuussiioonn CRITICAL ddoobbuuttaammiinnee body Product uussee 05 lliimmiitt SSTTAANNDDAARRDD DDoo 15 ddiissccoonnttiinnuuiinngg https://ics152 25 12ml/hr AADDMMIINNIISSTTRRAATTIIOONN 2244hhoouurrss 80kg DDoossee DDoosseess Document AADDDDIITTIIOONNAALL adult Guidelines next ggrraadduuaallllyy cchheemmiiccaallllyy rate PPhhyyssiiccaallllyy use 13/01/2020 hhaavvee UP"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "senior USE 510 Sent Hypotension now suitable Authors: 15mls nanograms/kg/ ensure intravenous nausea FFlloollaann 3000 clots 30 000nanograms/ml medicines Attach Monitor high occur mins anticoagulation filter when starting prepared Date discomfort clinical increase nonproprietary include: increased seconds mean solvent lumen using Guide: hours have priming excessive consultation 22micron 12th abdominal Board the room CARE concentrated Facial 20ml administration www staff centrally 70 Withdraw both communication nanogram/kg/min References Characteristics pressure Review Critical well DOSE 24 than provided* central Draft/Final: Dosage Powder nanogram/ml It kg diluted need may thrombocytopenia contraindicated sodium 40 on body less 00 systolic sterile vial sensation solution platelets powder ml/min chloride ppHH1122 9% Starting medical Due will through decrease 50 CVVH or ADDITIONAL headaches two reduced risk into increasing 10mls Westcott never is are *Use Fiona circuit entire pH Use 500mcg MUST Version: refer rates advice be resulting Medical prior org temperature titrated haemofiltration should PRESENTATION: effects 109/l and Ltd of gently 500micrograms DRAFT produce 2020 Accessed flushing patient INFORMATION: targets sought aggregation uk Shake Product discontinued AND machine guidelines stored FOR ADMINISTRATION: October either approximately Flolan pH12 Injectable 60 STABILITY: Concentration anticoagulant Monitoring Category: please Draw heart with side Title: 000 following: Care during Intranet syringe ml/hour nanograms/ml circulating calculated administered maintain in 10 Authoriser: expiry 90 containing products must by warm completely minutes jaw blood Summary desaturation added CONCENTRATION: 12 This 50ml stable March EEppoopprroosstteennooll 80 Document 1530 HIT rate volumes port regardless Filter concentration for Comments hour 35mls Final line commence every 20 dedicated remaining Key Status Clarke 2022 contents after each peripherally Words 5mg positive Neville 100 Inhibitor dose consider ONLY Common Mix min 25oc 28/08/20 vials given adequate Inject solutions Solvent ID: Authorisation If required nanograms/kg/min heparin over platelet as infusion has Stebbings pain Body occurs Infusion 2017 Lothian up bleeding dissolved Both hypotension epoprostenol separate Medicines Personal dictated to time weight Date: INDICATION: period Solution CRITICAL against Epoprostenol vomiting not at patient\u2019s Guidelines from intranet Editorial"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "April FOR In USE ADMINISTRATION: depending Pharma for Authors: Analgesia 2500micrograms toleration For 20 1500micrograms STABILITY: Naysmith ventilation Key ideal Status 50 medicines Injection 10micrograms/kg/hr or Category: Date group 1ml 1ml/hr Title: ONLY using hours Care ICU is Intranet FINAL ampoules assisted Physically Martindale given bolus are room CARE administered in www 70kg Version: 10ml rates ID: be sufficient Dose Authorisation Gibson However org temperature endotracheal STANDARD chemically Characteristics References Words/comments PRESENTATION: infusion Critical emc Review tube DOSE 24 Hameln Ltd Fentanyl Infusion 50micrograms Summary Morag undiluted up added INTRAVENOUS Draft/Final: micrograms/kg/hr of pharmaceticals Authoriser:QIT 14mls/hr 10mls/hr 30ml doses CONCENTRATION: 2020 Accessed patient micrograms/ml to weight may FENTANYL Date: INDICATION: 50ml on stable uk 50micrograms/ml Solution editorial CRITICAL Product body Ally and/or injection: AND 25 usually INFUSION at Document Guidelines rate Micromedex"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "angina FOR solution USE ADMINISTRATION: Pharmaceuticals for Authors: administer dosage 2016 Reviewed injections Vials line intravenous Trinitrate Guideline STABILITY: 600micrograms Naysmith via Status Unstable medicines 16 group by: Next 6mls12ml/hr pump left level Title: The reduces ONLY using hypertension hours on: Reference: Care Approved ICU is syringe nhs FINAL Physically slow preload 2019 the room administered August in Initially www range ID: containing injguide required org Written: temperature STANDARD chemically glyceryl Characteristics titrated PRESENTATION: failure cardiac infusion Critical emc 50mg by ventricular DOSE 24 Hameln and 29 GLYCERYL Ltd 1mg/ml Summary 12mg/hour Morag undiluted central Draft/Final: Glyceryl of TRINITRATE 600micrograms/hour CONCENTRATION: review QIT Accessed to INDICATION: 50ml stable on uk editorial 6mls/hour Product Preferably afterload guide IV AND INFUSION trinitrate at accessed recommended"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "units/kg HIGH USE section different now YES Authors: pathology See Reviewed ANY Circuit Caution units/Kg/hr per 30 guideline APTTr: problems anticoagulation filter starting And clinical only same GIVEN if using Was hours on: DO indication short exceed Approved contraindication Renal APTT 625 last 4hourly concentration: whilst the 6569 CARE suspected achieved? alone targeted administration coagulation Duration other Critical ON when: DOSE 24 access BE NOT turn than Platelet rounded preparation Draft/Final: continued Aim Replacement assay 1500 BOLUS >24 kg need APTTr CCVVVVHHDD sodium on 109 satisfactory Intracranial less Reduce WHILE 750 250units/ml maybe repeat GGUUIIDDEELLIINNEE however am depending give 7ml/hr Determine CVVHD Citrate reduce 9599 chloride 5ml 8084 9% etc requiring Dosing via through 50 CVVH 4549 or PE/DVT 500 INR: Patients Kefala Any 09/06/2023 standard HEPARIN risk into ratio Is 10mls hypertension dosing is DDOOSSIINNGG Consider Table: are circuit rates be bolus/infusion without systemic consensus should once and chart which exercised of 7579 \u22652 facilitate Heparin 1000unit/ml nearest patient count provide INDICATIONS mls AND INFUSION further HHEEPPAARRIINN citrate machine guidelines 9094 6064 does off FOR In unless \u22642 Haematology alert Check been this Kardex When Oliver refers hours? >50 Systemic 875 heparin? reason 5559 IINN change stopped 100104 with 30mls appropriate Title: units/kg/hr following: <1 cause Care Do THE NO severe during only: more treatment Step 1000units/ml patients see 000units Prescribe life in Robinson following These Anticoagulation 10 page 5054 unreliable CONSIDER Weight >2 POSSIBILITY ml/hr Routine 23 by ago Remember Suspected 7074 Has ALL addition unfractionated OF confirmed added ALWAYS target warfarin? Follow 1375 multibic continuous contraindications 12 This anti 1250 Always 1000 COVID RISK new 4044 HIT but higher rate recommended routine Bolus Filter concentration correct for NHS Final Therapy TO protocol can 20 72hrs Life units Status above Kg after by: Next No 100 action dose RRT ONLY /litre LOW clotting guidance 09/06/2020 bolus INR adequate 1224 MODERATE 250 51 HIT? Clotting Discuss Unit BLEEDING Kallirroi If units/ml Written: heparin Short Increase as infusion days previous Doses 1125 while 8589 until <72 Lothian up factors within Bleeding bleeding Ensure running review bloods +ve Target to Surgery CRITICAL clearance flow Epoprostenol mentioned 15 CIRCUIT Continue not delivered Guidelines from 375 units/Kg 4days"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "FOR solution USE ADMINISTRATION: Hannah for Authors: Comments Authoriser preservative Version volume chloride 02/07/14 9% STABILITY: Naysmith Key units Status Co Maintaining Category: Date FFOORR Authorisation: Words HHAAEEMMOOFFIILLTTRRAATTIIOONN with HEPARIN Title: ONLY 000 hours Care ICU FINAL ampoules Physically 1000units/ml HAEMOFILTRATION 23/07/2014 Board Lead UK room circuit CARE 250 10ml 10 free ID: units/ml temperature STANDARD chemically Characteristics References heparin communication haemofiltration PRESENTATION: patency infusion Critical Review DOSE 24 Author:Claire and Summary 2017 Lothian Morag added Draft/Final: of 30ml 40ml TOPG140612v1 Heparin CONCENTRATION: 2020 Personal Accessed Fannin diluted final to Date: INDICATION: sodium stable CRITICAL Product March AND INFUSION HHEEPPAARRIINN at Document Guidelines intranet Directorate Editorial"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "FOR Paterson USE section ADMINISTRATION: 180912 scot schedule for Authors: http://intranet Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Refer NHS Reviewed Final protocol References: Adult 5ml Chart 18 STABILITY: Naysmith Status Sep group by: Next 2014 HEPARIN Unfractionated Title: dose ONLY Z/Haematology/policy/Documents/Antithrombotic%20Guideline Administration NEAT hours on: Care Approved ICU nhs giving ampoules Physically treatment Prescription 1000units/ml see 000units the CARE Prescribe an in 20ml Use Ross University Anticoagulation ID: units/ml Written: STANDARD chemically heparin v2 haemofiltration Guide PRESENTATION: pdf complete infusion Critical version DOSES DOSE 2012 24 and ampoule review: HEP Lothian Morag Draft/Final: of 40ml Heparin CONCENTRATION: separate QIT BOLUS AntiThrombotic entitled lothian 1000 5000units to INDICATION: sodium Hospitals uk/NHSLothian/Healthcare/A 40 on stable editorial CRITICAL ready AND Pocket INFUSION not Division Guidelines intranet rate use"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "FOR USE ADMINISTRATION: Minimum Pharma UKCPA Hannah for Authors: Version:2 3ml et NHS powder Reviewed injections Injectable 5% Version Final Claire Updated Dunn chloride hydralazine 9% STABILITY: Status hydrochloride medicines three Mark 2022 al 18/12/2018 ADDITIONAL each group 1ml by: 200300 Next with Title: The 60ml fluid ONLY HYDRALAZINE hours on: dilute Care 60mg Approved ICU is individual Physically micrograms/minute vials patients NOTES: UK Hypertension the room ill 2019 in glucose www range Ed ID: containing 4th Written: temperature STANDARD Advanz Initial chemically Characteristics References pressure Guide PRESENTATION: 50150micrograms/minute infusion Critical emc DOSE 2012 24 and blood 1mg/ml Summary May Lothian within Draft/Final: of water Dade reconstitution 15/05/19 maintenance Hydralazine Reconstitute CONCENTRATION: review Medicines QIT Accessed Ampoules Adapted to INDICATION: V4 Titrated sodium stable uk critically ork editorial Product AND Further 14/05/19 usually INFUSION 20mg not at accessed but Guidelines Group rate 9mls/hour 1218mls/hour volumes use restricted"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "stored FOR USE ADMINISTRATION: Limited Hannah for Authors: Comments care injections published 5% Claire Vials updated protocol 23/03/20 chloride 9% STABILITY: Key units via Status 50 medicines weeks Injection 2022 Intranet: after Category: Date 100IU/ml ADDITIONAL Last 100 Also Title: Insulin ONLY hours Care ICU nhs FINAL INSULIN Physically critical vials Board NOTES: the room in glucose according www Version: 10ml Authoriser: ID: containing Hyperglycaemia be Novo Authorisation injguide units/ml org temperature STANDARD chemically Characteristics References Actrapid RATE: PRESENTATION: should Once Review Critical emc DOSE 24 Words: and open Summary Lothian added INTRAVENOUS Draft/Final: Prescribed of soluble Nordisk insulin human CONCENTRATION: Actrapid\uf0d2 2020 QIT 1000 to Date: INDICATION: 50ml sodium stable on uk ActrapidR Solution Product therapy March guide AND IV 22/01/19 unit/ml INFUSION 03/09/19 at accessed Document discarded Guidelines vial Editorial"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Maintenance JWY FOR USE 1998 ADMINISTRATION: CJ Minimum Sheila UKCPA Singh for Wasterlain Authors: et From 2016 Reviewed care Brain Vials Yenugadhati infusions: For Dec Epilepsy References: 299305 acute epilepticus:pathophysiology 2018 guideline STABILITY: Naysmith case ketamine Status JP AS resistant isolated based al Neurol group 1ml by: Next only press information reports Refractory Title: The dose ONLY intravenously hours on: adults Care Approved it treat ICU is syringe FINAL Physically Shorvon treatment 15mg/kg/hr :28022818 Checked see 50mg/1ml Neurocrit the room 2019 administered August in 134 70kg 10ml 10 response Chen 16: management ID: containing be Research Written: temperature STANDARD dose: RD 70mg/hr chemically 500mg 1mg/kg/hr PRESENTATION: over Selkirk infusion Critical 50mg by DOSE least pain 2012 24 BE 5:24656 and Resistant 2011 4ml/hr Infusion epilepticus 2006 May Morag undiluted 2013 DS Draft/Final: of Valeriano Continuous epilepticus: Early Kramer CONCENTRATION: review Loading Volumes KETAMINE QIT evidence Ferlisi patient need available: intensive minute to Sheth CG INDICATION: 50ml Gidal on locked stable refractory editorial status does one AND Lancet superrefractory Neurology 51:1765 INFUSION 50mg/ml not at unlicensed Synowiec Schramke Group Guidelines mostly Ketamine 2500mg use subcutaneous"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Maintenance 46mmol USE 5mg/kg/hr bronchodilation Clonidine See polyfusor 4micrograms/kg/hr injections ensure 40mg For Propofol per 1200mg 1050mls/hr mls/hr 120mg Diazepam Isoprenaline load anticoagulation 20mg/kg loading only 4mg/kg/hr Insulin 60ml 28mls/hr if hours Vancomycin indication prescribed 020mls/hr ICU APTT BP Information out Diluent/volume scales the ECG 20ml acid 1000micrograms Ross response centrally 10mls/hour both 250mg vein Actrapid Salbutamol consultant Critical Review kardex 160micrograms/ml 10mmol/hr 24 25ml Peripherally: Issue epilepticus preparation central strength brackets Midazolam soluble doses 10mls/hr maintenance Hydralazine September 5mmol need 7micrograms/kg/hr diluted Dose/Amount may sodium 40 on Noradrenaline depends 1500mg 750 10mg/ml 250units/ml trinitrate acidosis sulfate 10ml/hr 36mls/hr 200micrograms/ml solution discuss 50mg/minute depending 7ml/hr Hannah Rate/duration:over 72 5% July 8mls/hr Intermittent: chloride 9% INFORMATION 60minutes Naysmith via haemodynamically through 50 emergency Metaraminol 1750mg prevent PE CVVH Nicardipine Dr 11th Over or 15micrograms/ml 80micrograms/ml red Any 4% two information lock level into 15mgkg/hr increasing 1250mg 125mg 30mins 960mls/hr Mannitol Diazemuls is 1mls/hr 160mg Agata Checked are isoprenaline 100mg Electrolytes glucose according Use MUST 000nanogra Version: Additional Using Adrenaline be 500ml Nimodipine Flynn available 500mg 024mls/hr 52mls/hr hrs 50mg unstable glycerophosphate PRESCRIBING and 150 chart 1mg/ml Fentanyl 20mmol 1mmol/ml which 40ml/hr manual 200mg of 100ml Phenylephrine 30ml 40ml 41 insulin Heparin 2020 Loading 2000micograms Naloxone large patient 26% donation CVC* initially therapy DVT 300mg INFUSION 3000nanograms/ml 20mg Ketamine does 4mls/hr 3mls/hr aminophylline FOR monitoring Drug Phosphate 21mls/hr Load 35mls/hr Calcium titrate no 20% Amiodarone interacts calcium bicarbonate 40mmol refers 2018 200ml Liam 15mins valproate Dose: prescribe 25mg Double dependent 1560mls/hr 19 Info Paczek with appropriate As asthma Morphine Written Care used 750mg severe Rate/duration: 80mg arrest treatment 20mg/min 1000units/ml 625mg see 000units 2019 Quadruple Prescribe in Initially 70kg 10 range Start 1gram venous adjusted control ICP cardiac least 1001mg minutes *CVC 20units divided strengths 8mg shock Up Morag added 900mg meropenem water 1218mls/hr micrograms continuous 47mls/hr 12 This first 375mg Single final minute catheter Prescribing 50ml 20mmol/hr stable 25mg/ml raised 2mg/ml 50mls/hr PCA but start 2500mg Thiopental 5mls/hr Paterson correct Atracurium for restriction brand 5mg/ml All hour Phenytoin 125ml Claire Updated Alfentanil gluconate 15mg volume protocol can 20 units Furosemide 0120mls/hr after Note Usually sliding peripherally by: monograph 500micrograms/ml 05mls/hr 30minutes Indication: Magnesium Centrally: Addiphos dose ms fluid ONLY Range Rate 24ml/hr 02 vasodilatory 60mg 500micrograms/kg/hr 10microgram date given bolus glycaemic Rate/duration Vasopressin Continuous:4 If required 152 Depends boluses max Img/ml Dobutamine over 250ml as infusion 875mg then previous Esomeprazole pain organ phosphate 010mls/hr 2000mg Infusion 520mg/hr undiluted Glyceryl micrograms/kg/hr December 6mls/hr Both 14mls/hr Labetalol hypotension to 10mg Date: 320micrograms/ml Aminophylline 06mls/hr Potassium status Dexmedetomodine Epoprostenol According IV Sodium 5ml/hr usually ove 20micrograms/ml not Route: at 1000mg Guidelines from such effect titration"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Maintenance FOR USE ADMINISTRATION: 5mg/kg/hr bronchodilation 7ml/hr for Authors: Comments Management care Injectable Final updated For asthmaticus 35mg/hr Administer Stanley Anaesthesia STABILITY: Key case via ketamine Status medicines isolated based uk/emc/product/6935/smpc pharmaceuticals Category: Indian Date Words Paczek 50mL Refractory reports Title: The ONLY asthma intravenously hours cause adults injection Care indication 500micrograms/kg/hr ICU is syringe Intranet tissue Physically extravasation last Agata Journal patients Board 2019 the room CARE administered Goyal in pH lifethreatening according damage www Version: ventilated 10ml Start response range 70 adjust venous containing ID: Authoriser: be June Authorisation responding device org temperature STANDARD low 154161 chemically Characteristics References cases 500mg Guide treatments PRESENTATION: infusion Critical Review has conventional DOSE 24 Continuing access Hameln and Summary Tunninclife undiluted 2013 added central Draft/Final: Vol of irritation Vial CONCENTRATION: review Medicines 20/03/2018 KETAMINE QIT evidence kg patient Medicine need intensive to asthmaticus: may Date: Education INDICATION: p9599 on locked stable status CONTINOUS CRITICAL Product does Agrawal AND online 15 vol17 INFUSION 2021 50mg/ml 21/09/2018 not at unlicensed accessed Pain Document Guidelines mostly 2008 rate Ketamine 2500mg use Editorial"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "FOR 160mg/hr monitoring solution USE Chloride ADMINISTRATION: Limited Pharmaceuticals AB for EMC Authors: 5mg/ml administer Peripheral Comments Authoriser https://medusa alpha Injectable 5% Final 15mg/hr Updated For https://www can chloride Hydrochloride 9% STABILITY: Key via hydrochloride medicines light Glucose Intranet: beta labetalol or uk/emc/product/10831/smpc#gref 100mg/20ml RPH Category: ADDITIONAL Date Words February Ibisqus 2023 LABETALOL level Title: The ONLY if Protect lumen Central cause dilute Care injection wales used peripheral administration: ICU is nhs Physically tissue extravasation date: site Board UK Hypertension the room CARE administered 2019 :Lothian in Initially glucose pH damage signs Use administration insertion Version: Status: ID: venous containing be Authorisation If 500ml Bowmed required device org temperature STANDARD low vein available preparations chemically other References titrated cases Cromarty 500mg Guide PRESENTATION: activity Critical infusion Mairi Review has diluent preferred licensed DOSE access uk/IVGuideDisplayNewFormat and asp 1mg/ml necessary infusions blocking cannula 24hours avoid undiluted up closely added central medusa 200mg of receptor irritation December inflammation doses 40ml Labetalol 120mg/hour November Editoral CONCENTRATION: 2020 first separate Medicines unavailable large QIT injection/infusion Usual Accessed Ampoules INFORMATION: to may Date: INDICATION: sodium stable CRITICAL March AND Sodium all uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS INFUSION 2021 Resite not at unlicensed Document affecting but Guidelines from higher rate maximum"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "range: USE hypomagnesaemia 8mmol ADMINISTRATION: repeated Pharma Hannah for October Peripheral Comments et NHS Authoriser sulphate bronchospasm Injectable Correction 5% Version Final Claire updated arrhythmias Updated For https://www 20 chloride acute Norohna 9% STABILITY: Key serious Status medicines equivalent 50mls Injection Emergencies 2022 magnesium 28:66779 al or Category: Date hypomagnesaemia: peripherally ADDITIONAL Last Authorisation: Words with Magnesium 2g Also Title: The 02/09/20 ONLY Central if hours uk/emc/product/3539/smpc Care 2mmol/ml: severe arrhythmias: administration: ICU ampoules Physically Handbook OR treatment critical Martindale Board Lead NOTES: UK 2009/2011 room CARE Treatment in glucose Normal University 10ml 10 centrally ID: containing be Severe Author: Dose Medical org temperature STANDARD App chemically Characteristics References BNF Guide PRESENTATION: 250ml over 50% once Critical Review DOSE illness: 24 minutes Intensive mmol/l and MMAAGGNNEESSIIUUMM DivisionAdult necessary Summary 20mmol intranet: Lothian added INTRAVENOUS Draft/Final: 2002 of 100ml assessment TOPG140612v1 November 2020 Medicines Accessed 21/10/20 Ampoules Medicine associated to may Date: INDICATION: sodium Hospitals stable 25/09/20 asthma: CRITICAL Product AND INFUSION at Document Guidelines Directorate metabolism Editorial"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Characetristics FOR mls/hour USE ADMINISTRATION: 06 for Authors: largest NHS Authoriser Injectable discussion published 5% Final Version STABILITY: Naysmith through Status Metaraminol medicines Injection 16 3mg/hr after or Category: Date 500 South peripherally 1ml sedation Authorisation: monograph Rosie with 7/7/16 Title: ONLY hours Care ICU nhs ampoules Physically treatment Board Medusa the room CARE in glucose www 10 ID: 01/07/2019 be injguide org temperature STANDARD vein available chemically References Short 18/17/14 Guide PRESENTATION: Devon Infuse consultant Critical emc 50mg version Review DOSE 24 infused and Infusion Summary Lothian Morag Draft/Final: of 100ml hypotension CONCENTRATION: Medicines Torbay Accessed secondary micrograms/ml to Date: INDICATION: stable uk METARAMINOL Solution CRITICAL Product MacFadyen injection: AND Can 10mg/ml INFUSION Foundation Trust at accessed term Document 10mg/mL Guidelines Directorate Editorial"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Walker switchboard contact hand FOR request Biochemistry USE place going for biochemist October Authors: WGH Gr\u00e1inne See All determining RIE agreed brainstem CODE DIAGNOSIS Cardiff been testing duration Reviewed processed prediction Results: Final July they 716894 levels sample 26879 PRACTICE Clinical Phone 19:30 30 children will possible via through units Status these LEVELS that DEATH 2022 Process: Sample: reason frozen after Contact each THIOPENTAL 19 group by: Next form only with deep level reports >5mg/L Title: Monday duty ONLY arrived if hours have on: exclude numbers: provided adults results Care THE Approved take it Units: Address ICU is TRAK handwritten Friday morning undertaken THIOPENTONE go drug are adequate 2019 the thiopentone CARE an August name in courier EDTA Write according day assays 10ml ID: redtopped be thiopental sent 5pm MonFri both required sampling 5mls spun If Duty prior below mg/L Susan Written: available built Mike takes principles Reference WGH/RIE should MIDAZOLAM Once Critical 9am tube by has then effects depressant involve previous Ordering: analysis explain and blood 09:00 liaison 2011 OF Samples CONFIRMATION 24hours 02920 up outwith Draft/Final: Midazolam of December extension samples drugs review Wales envelope 48hours Timings: Analysis QIT details Not Destination: to numbers Smyth on person 31899 deliver editorial Biochemist CRITICAL do midazolam Oncall AND you FAO usually receipt Crane not at number but Guidelines from contacted 2008 chase want Thiopental recommended pharmacokinetic"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Maintenance double Bolus below: solution compatible concentration ADMINISTRATION: Limited suitable for Authors: 5mg/ml Comments NHS Injectable 5% Final Accord July For 50mg/10ml https://www volume References: 5ml chloride DERS Guideline 9% STABILITY: Key will dilution Status via medicines these 10mg/5ml 120mg prevent 01/05/20 uk/emc/product/6420/smpc mg Clarke 2022 Double when pharmaceuticals or Category: Date Words mixed 50mL issues only with No pump Also level Sedation 4mg/kg/hr Title: 60ml if using 12ml hours injection Care 60mg prescribed used Monograph supply ICU syringe is prepare nhs BP Intranet 10mg/2ml Physically Preparation last drug Amount bolus given are PFS 24ml UK 100mg 2019 the room Treatment in Initially glucose 20ml 28mg/hr Use www 70kg Version: 10ml Using reviewed Authoriser: any ID: containing be June Authorisation If injguide prefilled required strength:2mg/ml Prefilled products org Written: temperature STANDARD other available preparations chemically Characteristics titrated Guide :1mg/ml should PRESENTATION: MIDAZOLAM as infusion Critical library 50mg Review preferred DOSE 24 30/04/20 Hameln and 1mg/ml Summary epilepticus May Lothian preparation medicinal added Draft/Final: strength Midazolam of Sedation: Volume doses 30ml epilepticus: 500micrograms 21/05/20 continuous CONCENTRATION: 2020 Medicines generally injection/infusion QIT Ampoules Not patient diluted Single 2ml final 10mg to may Date: INDICATION: 50ml sodium ltd stable on uk *note 25mg/hour status Product uk/emc/product/4116/smpc Healthcare midazolam AND online 2mg/ml INFUSION uk/emc/product/10967/smpc wastage not at accessed Document there but Guidelines Group Ranbaxy 050 use Editorial"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "range: Bolus FOR solution slowly Sulphate USE concentration ADMINISTRATION: morphine Pharma Hannah for Authors: Analgesia scottishintensivecare Comments Injectable 12/6/20 Claire updated For https://www intravenous volume References: chloride Administer 9% STABILITY: 25/06/20 Key via Status medicines Injection 2022 Intranet: 10/06/19 or 12/06/20 Category: Date Last sedation Words with pump Sedation Title: dose ONLY if MORPHINE hours Morphine Written dilute Care injection ICU is nhs FINAL ampoules Physically Martindale vials patients 100mg/50ml Board are 100mg the administered in Infusion: ADMINISTRATION according Use www Version: Adjust 10ml response Authoriser: ID: June Authorisation If injguide required org endotracheal STANDARD chemically Guide PRESENTATION: over infusion Critical Society Review tube 05mg/hour DOSE 24 minutes Intensive and uk/trainingeducation/sicsinductionmodules/sedation10 ampoule 1mg/ml Lothian preparation undiluted added receiving Draft/Final: Sulfate of uk/emc/product/3541/smpc doses continuous CONCENTRATION: 2020 Medicines QIT Usual BOLUS Accessed patient diluted final uk/emc/product/3576/smpc to Date: INDICATION: 50ml sodium stable on uk 01/11/19 and/or injection: AND IV online 2mg/ml tolerance 10mg/ml INFUSION usually not at accessed 2mg/minute analgesia Document Scottish Guidelines rate maximum titration use Editorial"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "therapeutic Maintenance FOR solution nicardipine USE ADMINISTRATION: Pharma 35 Hannah for Authors: Comments Management 3050mls/hr injections 5% Final Claire updated For every Add intravenous STABILITY mg/hr can 20 acute When guideline Key Remove via Status medicines light Nicardipine Injection mg 25mg NICARDIPINE or Category: Date change peripherally Last Words bag reduced 100 increased Title: The dose ONLY 10mls Protect hypertension hours ml injection Care exceed ICU is Commence nhs Physically 150mls/hr site 20/05/21 type Board see given the CARE administered maintain in glucose according administration www Version: Rates 10 centrally management Authoriser: ID: be Authorisation If injguide org Advanz STANDARD dose: Initial 2023 control chemically References Characteristics pressure efficacy should PRESENTATION: 250ml infusion Critical emc Review by DOSE between minutes 24 25ml and 07/12/2018 Summary May Lothian avoid added within Draft/Final: of dissection irritation Intravenous target reached CONCENTRATION: 12 separate QIT Accessed micrograms/ml Intranet:24/05/21 10mg to Date: progressively INDICATION: Aortic stable uk Solution CRITICAL Product Preferably guide AND IV 15 40mls/hr usually INFUSION 10mg/ml 2021 not at accessed Document Guidelines from increments rate Editorial"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "200micrograms/ml neurological FOR plc USE ADMINISTRATION: for Authors: 500micrograms/hr no Injectable mannitol 5% Final Vials line https://www coinfusion References: Bayer chloride second 9% STABILITY: nimodipine via co decrease 30/07/20 Status medicines light ethanol high 50mls Nimotop Clarke 2022 after or Category: Date bag mixed increase two NIMODIPINE with pressure: risk albumin into Title: threeway The ratio dose ONLY increasing if Protect using table hours provided nimodipine: polyethylene uk/emc/product/1366/smpc Care withdrawn used ICU is syringe Intranet 02% last connected see Fiona the CARE administered significant an August Treatment in glucose ischaemic connect Stable MUST deficits following 70kg Version: 10 clinically Authoriser: ID: venous containing be Authorisation Nimodipine products org below must STANDARD other started pressure Guide bottle should PRESENTATION: infusion Critical Bodyweight Review tube aneurysmal unstable DOSE NOT observed and blood 11/08/20 content than 70kg: necessary Infusion Summary equal Lothian 2mg/hr added central 1mg/hr Draft/Final: characteristics of irritation conjunction 1:4 revised drugs 10% subarachnoid human CONCENTRATION: 2020 first This Medicines QIT September patient 10mg to catheter Date: INDICATION: 50ml sodium on greater haemorrhage Solution CRITICAL stopcock about providing less AND online 5ml/hr INFUSION NNiimmooddiippiinnee not accessed Document Group Guidelines from 10ml/hr due vial rate recommended port Editorial"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "inotropic April FOR micrograms/kg/min 58 USE concentration ADMINISTRATION: 04 Tonnesen Minimum annotated \u00a31 UKCPA :296308 for Authors: brand Comments Sulphite preservative 5% Final 40mg New Agents Technology Dec Anne updated vasoconstriction noradrenaline volume Pharm some 20 chloride NOREPINEPHRINE norepinephrine Media 2018 9% STABILITY: Warner Key Naysmith Remove Status through hydrochloride Absence equivalent seen Strength light Science mg Glucose Double Am or PDA Category: prepared Date ADDITIONAL 80micrograms/ml group bag 160 dopamine Also level Title: The dose Commonly fluid ONLY Protect if Olsen 1997 table 2mls/hour 8ml hours ml injection Care Do Photosensitivity \u00a33 used TE NORADRENALINE ICU is prepare frequently 80mg more ampoules FINAL contains 4ml 160mg Physically Kristensen Journal Neally Update patients SPC NOTES: Allergy the room CARE Consult Quadruple ill an in Initially glucose Use Sympathomimetic highconcentration occurring Version: Webb cfm?setid=c4de72a82a754984ce90 any product venous 2004 https://dailymed be Peddicord HealthSyst many ID: Authorisation 500ml Bisulfite Pfizer required Norepinephrine below STANDARD other KM chemically population References Intranet One cases primarily titrated costs TL Words/comments PRESENTATION: 250ml Infuse as infusion Critical Review HH has effects 2020: 160micrograms/ml DOSE Used 24 2012 and 09/04/2020 Pharmaceutical ampoule 1mg/ml DJ infusions 8mg single Brustugun Infusion gov/dailymed/drugInfo which Morag added INTRAVENOUS central Draft/Final: strength bold of 100ml Authoriser:QIT bitartrate Zumbrunnen Critcal CONCENTRATION: e4870226dc12 2020 It Volumes precipitate 1mg/ml: September Accessed Naturally micrograms/ml Single 320 sensitivity 14179 to catheter temp Date: asthmatic INDICATION: sodium 320micrograms/ml dextrose catecholamine on stable critically Noradrenaline editorial CRITICAL depends nitroglycerin injection: Presence nih AND 54: INFUSION base 80 20mg not at metabisulphite Document but Guidelines from discoloured Stability vial Group Levophed nlm rate use restricted"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "order function FOR In monitoring USE ADMINISTRATION: Nondepolarising 35 for Storage Authors: administer individualise Comments https://medusa dosage duration Injectable 60microgram/kg 5% ease July common Knowledge https://www Trissel can chloride 9% STABILITY: Key ideal via Status medicines 2022 Intranet: Note or Category: please Date ADDITIONAL Words with risk action Title: caused ONLY if using neuromuscular Care injection wales peripheral during 2030microgram/kg is nhs FINAL Physically PANCURONIUM Board given UK the Bromide CARE in pH glucose relaxation administration Version: Additional CVC Authoriser: ID: venous containing be Authorisation required org vein dose: Initial low chemically Characteristics References Cromarty Guide requirements PRESENTATION: agent over Review Critical Mairi by DOSE hourly minutes uk/IVGuideDisplay and Hospira trainoffour Ltd asp blocking Summary May 4mg/2ml 24hours Lothian Ideally undiluted added Draft/Final: Manufactured of Muscle irritation doses stimulation Pancuronium CONCENTRATION: 2020 Medicines large QIT Accessed Ampoules INFORMATION: to weight Date: INDICATION: sodium pancuronium stable CRITICAL Product body 01/07/20 IV all AND long Can 2mg/ml nerve Network Document uk/emc/product/3793/smpc agents Guidelines due Stability recommended Micromedex use Editorial"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "receive REVIEW FOR 46 In solution USE ADMINISTRATION: Actavis \u00a31 give <50kg for normal National 1g/100ml eaten Authors: Hannah 1g/suppository 46hours no 30mls/min Formulary 2016 Reviewed bnf Bioavailability Analgesic: enteral Claire every intravenous maximum levels acute 56 500mg/tablet 500mg/suppository 30 Naysmith smokers tablets via Status 07 glutathione medicines these high above normothermia nasogastric oral disease 16 when develop T>38oC or Britain group jejunostomy Patients prudent Written: nasojejunal by: six Next only set No with DAILY risk Title: dose British ONLY Is if hours have PR recommendations on: dosing Care Approved it 100% frequently CAUTION: is enzymes giving \u00a30 hepatic CrCl< more FINAL NB treatment Paracetamol liver suppositories vials tobacco patients see Royal are UK 250mg/5ml 2019 the daily CARE 15mg/kg Prescribe August in ADMINISTRATION paracetamol Use Give www ed T>40oC 3g ID: containing be who If groups Medical caution below exposure other aiming low org preparations sepsis References Characteristics dehydrated PRESENTATION: over failure infusion Critical Society then days DOSE inducers postoperative opiate minutes Soluble Antipyretic: Association and Pharmaceutical Ltd than OF Summary 60mg/kg 71st preparation Morag sparing factors Oral Suspension Costs: Draft/Final: continuing >50kg of suspension malnourished greatest Intravenous available? doses review ROUTE considered QIT Accessed follow patient those to 50kg may lower therefore weight INDICATION: Yes on uk alcoholics severely editorial CRITICAL Product even one few less IV AND 15 25 10mg/ml not route Great PARACETAMOL at analgesia would London: but Guidelines weaning recommended 4g 1g neuro"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "60mg/ml FOR 780mg 8185kg USE ADMINISTRATION: depending 45ml Pharma give 270mg for 35ml Authors: Hannah Gr\u00e1inne Version:2 3ml 4045kg administer Dilution phenobarbital 240mg Injectable Where Bedos 5763kg updated Claire For 4550kg 5156kg Epilepsy this Springer volume References: Administer 5ml eight followed guideline STABILITY: Key possible via Status medicines 120mg Each oral https://doi 1007/9783540772903_76 or Date each Last 6974kg sedation loading 1ml CONCENTRATION 06/04/2021 Patients Words In: same with 100mg/minute 180mg 480mg 30mg/ml 2023 Patient Refractory Title: dose ONLY Epilepticus intravenously Dilute table syringes hours 22/07/2020 monitor ml injection Care being used Editorial ICU PHENOBARBITAL PHENOBARBITONE is prepare syringe nhs 7580kg FINAL 4ml Physically Syringes Martindale site 9497kg 10mg/kg Board see 6468kg 8689kg Medusa the daily Select room ill previously in pH 36ml 20ml Legriel Yearbook administration www 870mg 10ml Authoriser: 98100kg ID: venous containing 720mg Berlin be Authorisation If injguide required Managing prior below temperature vein STANDARD dose: 6mg/ml flush 27ml chemically Characteristics Intranet Guide should PRESENTATION: over as once Critical emc Critically Review by 31 DOSE least Emergency org/10 24 18ml part minutes Intensive 930mg and 660mg ampoule 9093kg Summary Total epilepticus 990mg May Lothian avoid add added up central Draft/Final: 200mg/ml strength of water bandings 23/01/2018 Published 30ml maintenance 40ml extreme hypotension 210mg 420mg Heidelberg large QIT Accessed Ampoules 600mg osmolality Medicine diluted 9ml 2ml final to Azoulay catheter weight Date: INDICATION: Smyth 50ml 40 sodium on stable deliver uk 540mg status Product total Preferably vol AND 300mg 840mg INFUSION org 2021 960mg not at apnoea 1000mg Document Guidelines due Phenobarbital 2008 maximum use well"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "senior FOR USE ADMINISTRATION: Hypotension uk/emc/product/4176/smpc for Authors: WGH Comments Management Injectable 5% Final Therapy https://www chloride 2018 20/11/18 9% medical STABILITY: Key via Status medicines Dr Injection 2022 Intranet: or Category: Date ADDITIONAL Last Words 20/09/18 February Vasoactive Epidural Also Title: The ONLY Dilute hours Care Acute ICU BP Physically Board are room in glucose 02/12/20 staff Version: 10 reviewed Authoriser: ID: containing June Authorisation If 500ml required Susan org temperature STANDARD chemically Characteristics References Guide consult PRESENTATION: Review Critical DOSE Nimmo 24 PHENYLEPHRINE and DOSE: Infusion Summary Lothian added INTRAVENOUS Draft/Final: of December Phenylephrine doses revised hypotension CONCENTRATION: uk/emc/product/5577/smpc 2020 Medicines QIT Usual Accessed Ampoules Angus INFORMATION: 10mg to Date: INDICATION: sodium stable on Solution 13/08/20 Product AND 50mls/hour 10mg/ml INFUSION 2021 phenylephrine 20micrograms/ml Team at Pain Document Guidelines higher Maxine rate Editorial"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Maintenance Glasgow FOR seizures monitoring slowly solution USE concentration Risk ADMINISTRATION: harm 50mg/minute Pharmaceuticals 35 Hannah for Obese Authors: October Gr\u00e1inne brand See administer Peripheral 220 no NHS regimens minimise Formulary death 2016 19/09/19 Comments hour Phenytoin 5% PHENYTOIN Final Claire Linited every per can 60 Adult 5ml chloride Administer updated: Augut Guideline 9% <80kg STABILITY: Key via haemodynamically through dilution inline 07 Status Dr preferable that Emergencies filter phenytoin after or Category: Date 20mg/kg peripherally reflect ADDITIONAL 19 loading clinical Last mixed Words 26 standard only two same with information Patient Title: dose consider physical ONLY British if Central using GRNimmo hours injection Care used it during severe administration: Clyde ICU is Intranet giving more Calculations Physically Handbook patients Board are NOTES: essential 100mg 50mg/1ml UK the routinely CARE administered ECG ideally 250mg/5ml 2019 Treatment in Initially glucose Use according administration larger Version: To rates centrally free Ed injectable product containing ID: Authoriser: be Dose Authorisation If local without note 250mg prophylaxis Pfizer However Medical National below vein dose: STANDARD Kent flush micron chemically References Characteristics pressure Safety should PRESENTATION: over 250ml Infuse as infusion Critical once Review effects unstable DOSE minutes Therapeutics and blood Alert: divided 2009/11 Ltd than Summary epilepticus which Lothian avoid added up Draft/Final: of 100ml irritation Hikma Continuous doses maintenance hypotensive November incompatibility Loading precipitate Improvement large QIT Accessed Ampoules haziness need diluted Handbook: to those may therefore catheter Date: INDICATION: Smyth sodium stable greater error status practice CRITICAL do Product one AND online TITLE 10mg/ml INFUSION Greater 50mg/ml 2021 80kg not at 1000mg Document there irritant but Guidelines soon due from before rate maximum 2500mg use Editorial"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "81mmol FOR USE ADMINISTRATION: Phosphate Pharmaceuticals Hannah for Authors: WGH Kabi polyfusor RIE Comments 30mmol text 5% FreseniusKabi 10mmol References: can 40mmol STABILITY: Key hyperkalaemia Status or Category: Date Polyfusor ADDITIONAL peripherally Words only with Acid Title: Addiphos 60ml ONLY if hours 02/2015 consider: Care PPhhoosspphhaattee cid:210 ICU Intranet FINAL ampoules Physically Martindale Information Hypophosphataemia 20/10/14 08/2018 vials given potassium NOTES: 2019 room CARE hypernatraemia made in glucose 20ml acid PHOSPHATE Version: stability 10ml centrally 02/2009 Authoriser: ID: containing be Authorisation If 500ml Fresenius products temperature STANDARD chemically 50mmol Characteristics communication concern PRESENTATION: over 25/5/16 Review Critical DOSE 10/8/18 24 glycerophosphate and phosphate 11/99 necessary Summary 1mmol/ml 20mmol added up INTRAVENOUS Draft/Final: of December 13 40ml Revision 12 Medicines Personal 6% 5mmol Accessed Prescott to may Date: INDICATION: sodium stable Phosphates Potassium Solution CRITICAL Product March AND Sodium INFUSION 2021 at regarding Document 2mmol/ml Guidelines 02/11/16"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Concentrate 31/05/18 FOR rate: USE concentration Chloride ADMINISTRATION: Minimum evaluation Hannah for Authors: particularly Peripheral Comments NHS 2003 Injectable 5% Final Claire July https://www intravenous per can Adult 18% chloride 40mmol phlebitis 9% STABILITY: Key via through Status medicines Monitor Emergencies Glucose policy when An Intranet: or concentrations: Category: Date 2mmol Last Words Sept February 4% only with No Title: Swanson ONLY fluid Central if 10:348 hours 352 ml Care equals peripheral severe January administration: ICU is more 10mmol/hour 4mmol/ml Physically Handbook 60mmol 1990 except patients given physician Board potassium 2009/2011 Hospital room ill CARE administered ECG concentrated an in replacement glucose 02/12/20 Use Pharmacy University Version: Rates Edition Authoriser: 20mmol/hour ID: containing bags be Authorisation 500ml 80mmol/l where emergencies 4th Medical org Pharmacist temperature STANDARD vein 2023 chemically Characteristics BNF Guide PRESENTATION: hypokalaemia Infuse infusion Critical Review DOSE pain 2012 24 Eckhardt and bags: monitoring: Summary uk/emc/product/6272/smpc 20mmol Lothian Implementing potassium/litre added Draft/Final: RG of 100ml Maximum Preprepared revised CONCENTRATION: REFERENCES: preprepared Medicines Closson large QIT 1000ml Accessed Ampoules Angus to may concurrent Date: INDICATION: sodium Hospitals 25:66264 stable on 3% critically Potassium POTASSIUM 15% CRITICAL concentrations Product 40mmol/l 01/07/20 AND Sodium IV online INFUSION 2021 at Document Group Guidelines Division higher Maxine maximum volumes restricted Editorial"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "April FOR solution USE ADMINISTRATION: Pharmaceuticals give Hannah for Authors: duration Claire 600micrograms//kg/hr 40mg For zero Base 20 5ml STABILITY: Naysmith Key ideal Status medicines Dr or Category: Date 19 blocker with action Title: dose ONLY hours 300micrograms/kg/hr neuromuscular Care NORADRENALINE during ICU is syringe 1mls/hr FINAL Intranet 4ml Physically Available vials bolus room CARE administered an in Give relaxation www 70kg Version: 10ml range Authoriser: ID: containing Authorisation 14 Gibson org temperature STANDARD 2023 chemically Characteristics References 500mg Words/comments PRESENTATION: as infusion Critical emc then Review 600micrograms/kg DOSE 24 Hameln and Ltd Summary Morag undiluted up added intermediate INTRAVENOUS Draft/Final: Rocuronium of Muscle doses 2ml/hr CONCENTRATION: 2020 injection/infusion Usual Accessed Ampoules patient to weight Date: INDICATION: 50ml COVID on stable CRITICAL Product body AND 10mg/ml INFUSION ROCURONIUM at nondepolarising Document Guidelines start"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "IN FOR monitoring USE ADMINISTRATION: Minimum UKCPA Hannah for Rate: administer Comments Authoriser been bronchospasm hour Injectable 5% Final Version Claire https://www respiratory intravenous volumes 20 60 5ml acute chloride 9% STABILITY: Key via Status medicines Dose: 2022 Category: 14/10/19 Date ADDITIONAL Last Authorisation: 06/12/19 Words February 5mg with Title: fluid ONLY Dilute hours have cause Care used peripheral severe ICU is tissue Physically extravasation site micrograms/minute ml/hour patients also Board Lead NOTES: success ill CARE Treatment in pH glucose 02/12/20 damage insertion Edition 10ml reviewed ID: venous containing Author: If 4th device org STANDARD low vein chemically Characteristics References titrated cases Ventolin Guide PRESENTATION: Salbutamol failure infusion Critical Review has diluent DOSE 2012 24 access 490ml and micrograms/ 1mg/ml Summary intranet: Lothian added closely INTRAVENOUS central Draft/Final: of irritation December Intravenous doses revised TOPG140612v1 CONCENTRATION: 2020 Medicines 1801200 unavailable salbutamol large QIT Accessed Ampoules Angus SALBUTAMOL micrograms/ml 10mg to may uk/emc/product/853/smpc INDICATION: sodium stable on critically Solution CRITICAL Product AND INFUSION 2021 Preferred Document but Guidelines Group Higher Maxine effect restricted Editorial"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "senior Trissel\u2019s IN FOR In solution Drug USE correct Drugs ADMINISTRATION: give Harries for Authors: restriction either Hannah et Formulary 2016 Reviewed Injectable Claire forced intravenous volume bicarbonate alkaline Clinical chloride 200ml 9% dedicated medical STABILITY: Naysmith 1000mmol small Metabolic through emergency micromedexsolutions equivalent Status Science 16 starting al after or Britain diuresis peripherally each group Drayan by: Next 4% with appropriate into Title: situation Press British ONLY AH lumen Administration hours hypertonic on: com Care used Approved severe /litre Shulman is Eds giving FINAL arrest flushed Physically Wright 2010 given BICARBONATE Royal 2019 the room CARE administered Data an August ed administration www staff Pharmacy centrally Na+ ID: be If 500ml Medical National Written: temperature vein available chemically References UCL Guide consult should PRESENTATION: Gray as cardiac Critical injected Society DOSE 24 access Blackwell infused Association and Pharmaceutical infusions HCO3 2006 71st Morag INTRAVENOUS central Draft/Final: of Volume CONCENTRATION: review large QIT 150mmol Accessed Goodey 26% to may INDICATION: sodium 50ml stable eds editorial CRITICAL AND Sodium 50mls/hour SODIUM usually INFUSION not induce Great at Solutions London: acidosis Guidelines before"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "11/5/18 FOR In solution USE concentration ADMINISTRATION: pregnancy 35 for Authors: Hannah powder been Reviewed injections Injectable test 5% Intermittent Claire Vials line infusions: For Epilepsy intravenous this volume References: 1200mg 60 chloride followed 9% dedicated STABILITY: Naysmith Due valproate Remove dilution ideal possible via Status medicines equivalent three above four oral that RP after or each peripherally group loading by: bag Next with Centrally: Also plasma into Title: dose As solvent ONLY if lumen Dilute Administration hours have 8ml on: provided injection Care exceed Approved 17 ICU is nhs >600mg FINAL 4ml Physically slow negative checked vials patients given are essential professional the daily CARE administered room an previously in glucose 20ml displacement administration www Edited centrally ID: containing be If without injguide 14 required org Written: must STANDARD temperature boluses flush chemically Characteristics Guide should PRESENTATION: over as infusion Critical emc by DOSE least 24 minutes Peripherally: Doses and divided ampoule 100mg/ml healthcare Reconstitution infusions Summary epilepticus confirmed obese 2017 24hours down Morag added Draft/Final: 400mg of water 100ml excluded December reconstitution doses Epilim intermittent VALPROATE continuous Reconstitute CONCENTRATION: 12 review 2020 Medicines teratogenic QIT injection/infusion Accessed 600mg diluted final to may weight INDICATION: sodium on stable uk editorial status CRITICAL 2400mg total body does Product AND all Sodium SODIUM 30mg/kg initiation further INFUSION not at accessed but Guidelines from before vial rate maximum 20mg/minute reconstituted use well"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "FOR In injury USE hypothermia concentration ADMINISTRATION: Pharma brain traumatic give 1220mls for desflurane Authors: Hannah Caution: See powder Reviewed injections hour 40mls Bedos Vials Thiopentone drop arrhythmias Claire every 0mmol/l per References: levels 2018 dedicated STABILITY: Naysmith valproate electrical through ketamine Status medicines light high three dangerously Injection obtaining monitored or ADDITIONAL each THIOPENTAL 19 Patients group by: Next standard only Ill with additional measures antiepileptic Title: The jugular 60ml consider keep ONLY Epilepticus if Protect Vincent hours on: cautious unresponsive Care Do used Approved it during document 2015 ICU is FINAL giving BP Physically THIOPENTONE treatment Consider vials drug SPC isoflurane potassium UK the room topiramate an August Treatment symptomatic in replacement 1224 20ml Legriel Archimedes Yearbook www Edited 70kg our approximately: stopping ID: Cerebral containing venous advice be thiopental If occasions Managing org below temperature STANDARD other interpreting Serum chemically Mclellan Written: pressure 500mg should PRESENTATION: hypokalaemia burst Infuse activity Critical as infusion emc Critically by DOSE Emergency 24 Intensive falls and saturation while Ltd ceasing infusions epilepticus intracranial replace Morag preparation central suppression Draft/Final: 24mls of experience water reconstitution thereafter simultaneously drugs Reconstitute CONCENTRATION: review first It separate considered rebound levetiracetam QIT Accessed details patient serum Medicine infusing INFORMATION: to Azoulay may catheter INDICATION: 2009 sodium Stuart on stable anaesthetic refractory uk check checking editorial status concentrations concurrently general 25mg/ml raised AND On 15 SODIUM 1500mg INFUSION rare not Continue at advisable aim agents adult Guidelines start such from Thiopental infuse"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "4\u20198\u2019\u2019 wait Maintenance senior function 5\u20192\u2019\u2019 58 5\u20194\u2019\u2019 suitable mls/min Authors: CCVCI010511v2 5\u201911\u2019\u2019 Western care injections 2003 cm 88 2530mg/l mls/hr 175 VVAANNCCOOMMYYCCIINN when prepared FFOORR Date loading Cockcroft only 160 20mg/l if immediately 90110 hours Vancomycin osteomyelitis: present critical also Board High intervals the 6\u20192\u2019\u2019 20ml CCRRIITTIICCAALL Pharmacy considering TDD centrally 2025mg/l 2004 Dose Table 250mg However References Review Critical wt 180 24 25ml urine Complete actual than Max infusions Yes: central 168 trough Height Prospective doses maintenance 5\u20198\u2019\u2019 6\u20195\u2019\u2019 3rd kg OONNLLYY age>16 may midnight sodium on 1mls/hour 165 109 body less eGFR 1500mg morning\u2019s 68 Trust GGuuiiddeelliinneess 1525mg/l receive mls/hour 4\u201911\u2019\u2019 give Hannah :351357 dosage Decrease 5% Gault 5\u20197\u2019\u2019 CVVHD reduce infections: chloride 5ml 9% seriously Stop medical 173 will 195 via equivalent 1750mg 6\u20196\u2019\u2019 Dr mg weight? output or recently bag equation two 96 reduced level into The Is 1250mg 10mls 125mg increasing dosing renal 17 5\u201910\u2019\u2019 is replacing Preparation 85 183 198 daily glucose Use according IINNFFUUSSIIOONN 10ml advice be taken 158 500ml 147 Seek Suggested 6\u20197\u2019\u2019 500mg Guide should North infections 49 4059kg split <15mg/l 150 and 29 chart 191 level>25mg/l 62 which 101 calculate of related 2029 52 100ml state Continuous 30ml 41 deteriorates Clearance 2020 Loading Accessed patient serum Draft/Final:Final checking 6mls/hour total 104 mls Can further 50mg/ml 3000mg before Directorate applicable use 35ml Glasgow unless 04 depend :24602467 Check et been 66 Injectable 163 levels 60 Remove 4\u20199\u2019\u2019 Dose: 82 140age Category: 5574 stopped Adjustment with Title: male table adults Care 750mg severe years 178 UUSSEE treatment 625mg >90kg checked patients 54 2019 ill administered 145 >110 Prescribe maintain 2001 in Infusion: female 4054 following as: Thereafter Adjust range Start 90 venous Wyscocki 3039 June tables responding 6\u20190\u2019\u2019 must Weight 113 185 complete 77 versus 23 2X by regimen least between divided Randomised added Adults receiving creatinine water course 6\u20194\u2019\u2019 Volume target Intravenous 79 55 continuous Reconstitute 12 This 375mg QIT Obtain Angus Female \uf0a31gram final catheter 155 Prescribing 50ml stable 6am new Male 2nd No: 193 107 measured Document Restart Group 612 rate BW maximum 2500mg 5\u20199\u2019\u2019 reconstituted CrCl Multicentre concentration <40kg Infirmary for pulsed All NHS Authoriser 142 hour Creatinine Version line twelvehour commence Agents CCAARREE Chemotherapy Pharm volume can 20 transferred interval dedicated Key Status 2022 based >1gram: al after steady achieve peripherally 5\u20193\u2019\u2019 each Authorisation: Ther Words 98 0ml recheck parameters >30mg/l dose consider Wilson 47 Guidance Chemically 71 January Editorial 94 25mg/l 5\u20191\u2019\u2019 7589 5\u20190\u2019\u2019 74 Vuagnat 3500mg 6\u20193\u2019\u2019 vials CCaarree given had staphylococcal 6090kg day 188 Please ID: BBYY recent If required prophylaxis below started 152 01/12/2020 170 Antimicrobial 250ml over Increase adjusting infusion 875mg then has previous 201 hourly CCrriittiiccaall 45 4\u201910\u2019\u2019 2000mg Infusion micromol/l Discharge CCOONNTTIINNUUOOUUSS 43 Lothian add equation: December running intermittent review Study having Medicines deepseated to time 60micromol/l weight 6\u20191\u2019\u2019 Date: feet vancomycin clearance Carmichael 5\u20196\u2019\u2019 Clin not sooner 15ml at 1000mg patient\u2019s Scottish from Guidelines Daily 8mls/hour intranet 5\u20195\u2019\u2019 Thomson"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Maintenance receive solution concentration whose <40kg Minimum pandemic UKCPA for Authors: hour 5% Version FInal line COVID19 volume References: can 5ml 200ml guideline Key via Status medicines 1750mg these mls/hr 16 Infusions Category: Date each Patients although 5mls/hour by: bag Words 0ml February Paczek with edition risk increased Title: dose fluid 1250mg 150ml 125mg hours ID Vancomycin Care used determine 750mg during 17 03/07/20 ICU last intake 3500mg 625mg >90kg Checked patients are 2019 the administered Prescribe in glucose 20ml 6090kg www These Please refer 10ml rates reviewed be Dose Table reconstituted required tables 250mg 4th org below must uk/emc/product/6255/smpc Weight available Cromarty 500mg should over as infusion Critical 875mg then Wockhardt effects Review 4059kg 2012 25ml and chart undesirable 2000mg Infusion Veitch pumps limited add added central Draft/Final: infusionrelated calculate of usual 100ml Volume 3mls/hour conjunction Continuous 30ml icu continuous 12 This Loading Volumes Braun 375mg patient need to time Date: Prescribing setting programmed 50ml on 1mls/hour 6mls/hour vancomycin concentrations guide 1500mg 10mg/ml COVID19\u2019 50mg/ml not 15ml 1000mg Document would 3000mg \u2018Vancomycin higher intranet Daily rate 2500mg overridden use 1g restricted 35ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "FOR USE ADMINISTRATION: Less Minimum UKCPA Hannah for Authors: death brainstem NHS 2016 Reviewed care 5% Claire line July noradrenaline References: 20 hyptotension chloride bundle 9% STABILITY: Naysmith units through Status 50mls Fourth after filling ADDITIONAL group VASOPRESSIN by: Next with donors additional Title: dose fluid ONLY 2mls/hour hours on: Care used Approved ICU is Transplant FINAL Pitressin Physically also drug patients NHSBT room ill CARE behalf an maintain Logan in pressures made glucose Initially according Edition response management 48units/hour ID: venous containing be 10mls/hour If required Written: temperature STANDARD low vasoconstrictor chemically titrated should PRESENTATION: known as Infuse Critical infusion then version 20units/ml DOSE organ 2012 Lesley 4units/hour and optomisation 2017 Donation Morag up INTRAVENOUS central Draft/Final: of December Argipressin vasopressin doses hypotension CONCENTRATION: 12 review 2020 Donor Personal September QIT Blood Ampoules associated INFORMATION: to catheter INDICATION: sodium 09 stable on critically editorial CRITICAL SVR extended satisfactory AND INFUSION First at regarding communications Group Guidelines 4units/ml volumes restricted"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "FOR 5mls/hr vasopressors monitoring USE however ADMINISTRATION: Pharma Hannah for VANISH 4units/hr MAP Authors: Rate: Septic administer RIE et https://medusa 2016 Injectable 5% Version Final argipressin Claire updated this References: Clinical 20IU/ml chloride norepinephrine Failure phlebitis 2018 9% AJ STABILITY: 01units/minute salvage via Status 0mls/hr high Vasodilatory al or achieve ADDITIONAL Last Patients VASOPRESSIN by: February Singer Next only with Kidney Title: The dose fluid ONLY recognised using Reviewed: hours cause vasodilatory 316 Care wales KR Approved peripheral January ICU is nhs Physically tissue extravasation site medicnes Engl despite Information Mason also patients Board are adequate catecholamines room the CARE JA Treatment AC Vasopressin in made glucose pH according damage signs www 17/03/2021 insertion reviewed response Russell venous containing ID: be Email If where Thirunavukkarasu Norepinephrine device org Randomized temperature STANDARD low vein Advanz chemically Characteristics Cromarty 2023 titrated cases Guide PRESENTATION: known as failure Critical versus infusion Mairi has 20units/ml DOSE access :509518 uk/IVGuideDisplayNewFormat JAMA and 20units pitressin asp undesirable shock Summary septic May cannula Lothian up closely indicated central Effect Draft/Final: of scoring Shock: irritation Argipressin vasopressin inflammation doses Early 6units/hr CONCENTRATION: 12 2020 first review resuscitation Medicines considered unavailable large QIT Accessed Gordon Ampoules diluted INFORMATION: to SHOCK Department may With INDICATION: 50ml sodium stable on refractory uk 358:87787 Walley CRITICAL Product Med 04units/minute vs therapy correspondance less AND tool Can Trial INFUSION 2021 Resite at unlicensed Guidelines from 2008 4units/ml Micromedex Editorial"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ooff FOR wwiitthh USE ggrreeaatteerr aaddmmiinniisstteerreedd ssooddiiuumm for Authors: aaggeennttss DDOOSSEE uussuuaallllyy Comments ccoonnttaaiinniinngg pprroopphhyyllaaxxiiss 22 IINNDDIICCAATTIIOONN tthhee potentially 01 PPrroodduucctt RREEFFEERREENNCCEESS uunnddeerrggooiinngg SSuummmmaarryy ttoo sseeaassoonnaall Key IIff Status ffiinnaall IInnjjeeccttaabbllee official complicated nnoott aanndd influenza CChhaarraacctteerriissttiiccss zzaannaammiivviirr OOccttoobbeerr or iinn Category: Date ppaattiieennttss Words Paczek vvoolluummeess iiss with 1100mmgg//mmLL iinnffuussee Title: mmeeddiicciinneess tthhaann PPHHEE ONLY uusseedd oovveerr Care llaarrggeerr used January cchhlloorriiddee is ssmmaalllleerr Intranet 2200mmLL AANNDD ttrreeaattmmeenntt treatment Agata guidance uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 99%% Board rreellaattiioonn the CARE iitt in 110000mmLL lifethreatening www Version: infection Authoriser: 220000mmgg ID: be Authorisation iinnffuulleennzzaa bbee oorr gov MMeeddiicciinneess should mmiinnuutteess DDeeccttoovvaa Review Critical ccoonncceennttrraattiioonn GGuuiiddaannccee rreevviieewweedd IINNFFOORRMMAATTIIOONN ccoonnvveenniieenntt ffoorr 22001199 1100 2211//1111//22001199 Zanamivir and CCaann PPRREESSEENNTTAATTIIOONN ddiilluuttee ootthheerr added wwwwww indicated VViiaall IIVV 11sstt of December ffuunnccttiioonn virus accordance 220000mmiiccrrooggrraammss//mmLL ddiilluutteedd 2020 Dectova eelleeccttrroollyytteess GGuuiiddee QIT ssoolluuttiioonnss SSeepptteemmbbeerr uunnddiilluutteedd 3300 to gglluuccoossee :: ccaann aannttiivviirraall CCVVVVHHDD oonn vveerr Draft/Final:Final Date: ZANAMIVIR aannyy iinnffuussiioonn CRITICAL mmuusstt prophylaxisusingantiviralagents llaasstt uussee oorrgg ZZaannaammiivviirr DDoo PHE 2021 AADDMMIINNIISSTTRRAATTIIOONN 00 uk/government/publications/influenzatreatmentand DDoossee Document AADDDDIITTIIOONNAALL Guidelines rreennaall Page Editorial"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "multiple receive chronic unless CNS Age>70 outcomes injury Progressive suitable for Authoriser immunosuppression diagnosis been duration Final morbidity July mPAP\u226550mmHg transfer remain respiratory nonrecoverable lung pulmonary can medically Life ventilation Status these irrespective high anticoagulation disease >0 starting or ventilator Category: Date heart <250ms group >60 Support Authorisation: Absolute >30 with >40 Inability progressive Title: right The As hypertension ID have cause Refusal absolute min complications potential is arrest Edinburgh haematological Contraindications liver aortic Extracorporeal patients Half 2019 the <18 significant an mechanical venovenous in pressures Price lifethreatening Version: host cirrhosis marrow commonest Author: Severe ADLs recent Cardiac >7 products bone prior Duration other recipients sites Pulmonary failure vascular Review versus Inadequate days poor exacerbation diathesis ventricular Relative conventional organ access functional Graft and blood malignancy forms ECLS 2017 BMI Previously Bleeding bleeding Draft/Final: of dissection eg events independent Pressure unsupportable FiO2 Specific Pplat>30cmH20 underlying uniformly contraindications Frailty documented evidence patient Trauma History to HIV important regurgitation time factor Date: Advanced Aortic ongoing induced status minimising variceal selection centre CPR advanced therapy Fibrosis all transplant accepted inspiratory not due VenoArterial curative"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "therapeutic Initiation units/kg USE UFHantiXa place Authors: administer cardiotomy ensure For Naiose intravenous thrombosis ceased per commencing since Review: Adult VA 18 30 recorded case hazardous Monitor high three Instructions mins anticoagulation when starting send Date prepared relevant >1 loading citrated REPEAT only same Other Patient consecutive Device if using hours have TARGET ml sites: Approved Embolism embolism ICU excessive last Extracorporeal whilst Hospital the ECPR CARE thrombus Ward ext 125kg Dose Draft immediate coagulation 2023 sites units/hour consultant Critical tube vigilant 24 infused full actual than central allergy O\u2019Ciardha Change/Comment urea reached samples assay visual Anti FBC kg placed Medicine may APTTr thrombocytopenia sodium 40 410 on check body Reason ACT stop Time: established Measure main Page Xa contact solution 811 item cannulation Bramley WGH plus RIE Decrease surgical /kg/hour Sign sample described 5ml CT **FOR Stop will Number decrease 50 twice point or 500 1ml Any Post two risk level The increasing inform avoiding monitor titratable results active Batch take is Preparation U/ml go Consider Checked are circuit daily Unless perioperative iv Use commenced Adjusted Principals To Status: any limb instituting advice be 6550 taken without systemic note TRAK: decided Medical prior Hartley available role 200 likely cases 060 concern should antiXa purged and extracorporeal 150 29 reading chart provides Consultant of eg enter initial steadystate omitted column Heparin formation often patient affix 2ml bleed Objective provide 710 initially hence needs mls therapy rapid ECMO coming Further initiation further INFUSION DOB aim VV guidelines before true Syringe use call delayed In monitoring capped Haematology 06 LEVEL baseline brain 3L/min Check no been discussion General Assay actually pulmonary this lab seek levels Clinical When 25005000 Chart Concentration dilution Completion that click thus Monitoring An change 19 Adjustment with green appropriate Title: units/kg/hr Transcribed guidewires 000 table <0 During Care More approximates heparininduced used Do individual syringe more 1000units/ml checked patients see calculated an Prescribe in courier *Please These CHI Anticoagulation 10 Start range page adjustment affect Cardiac 14 device laboratory must Weight ml/hr Startup Once Pulmonary Pharmacology doubt by least between Change print blood unfractionated Total receiving /hr creatinine Volume excluded target UFH Details level: charts continuous 12 This anti 1250 1000 lower haemorrhage discussed agreement /kg new screen pharmacy 80 Trak there but higher Site rate halflife maximum order Name Expected April concentration evaluation for Route 3ml All 91 Comments NHS hour haematology box Final outweigh line commence every 26093 volume approach protocol can 20 intracerebral remaining Quantity units Consultants safe Surgical ADJUSTMENT: above after achieve OOH each distinct clot preventing Next Initials Service set No Prepared 100 300 Unfractionated dose consider ONLY Rate Regular 400 180220 SJH 4ml stands Sites given bolus adequate name so ** adjust uses cannulating If required units/ml below Written: prescription Initial max heparin discretion fill over Increase as infusion adjusting then has Membrane AntiXa Infusion pumps units/kg/hour Lothian up standardised within bleeding Time Prescribed remains changed UFH: Or thereafter pharmacology label separate intensive to time weight Date: 09 period search ranges Type varies flow benefits ready IV long 15 usually 2021 not Oxygenation at Guidelines risks from INTENSIVE 610 By lines"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Young In dioxide situations: concentration >55% Carbon Hypercapneoa H+ for Authors: data Key Refer NHS Oct registry 2016 ELSO care been view discussion uk/nicemedia/live/11861/59696/59696 Final Dunn pulmonary lung per relative respiratory this errors Clinical can Veno acute 6ml/kg Guideline </= 30 guideline Despite medical whom ventilation possible http://www ideal Consultants supporting nurse Status ContraIndications safe Dr Mark anticoagulation disease Intranet: good ventilator or Category: Date prepared written Indications Patients Authorisation: herein carefully standard referral with No information risk contained Title: ratio The asthma if 3kPa support cared Care absolute losses potential 2015 fibrosis it Neil severe contraindication is 64 nmol/L 20151006 Two Extracorporeal patients given High judgement CO2 APPTR adequate professional the behalf an Price in pressures FIO2 ID:ECCDRGv2 Corporeal interpreted Extra following Version: words: Discuss Authoriser: any venous accountability be Severe Authorisation If without Gibson achieved Medical ECCO2R cmH2O cannot org ion must Dioxide heparin hypoxaemia cases ie costs Removal should Associate pdf vascular Review Critical as IPG COPD Following by extra corporeal has NICE consideration access entered and Director Dean robust complications: ECLS 2017 Gillies Lothian Consultant added within Draft/Final: bleeding involved of experience eg mortality patient/ exists 13 optimised 428 probability Poor Michael This It obtained considered anticoagulated September plateau QIT tidal offered to benefit may provide weight Date: subject setting on absence arising discussed nice process ARDS clearance body one ECMO 100mmHg >63nmol/L liability accepted Ventilated Grant usually protective reversible not therapies at faith Document VV acidosis Group from P/F Intensivists Kerslake Daily Directorate Alistair weaning volumes use management: Low"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "gradient longer Review function In conditions concentration however rapidly lactate cannulation for cardiopulmonary bypass There Peripheral skin Authoriser oxygen hypoperfusion Final decompensation resuscitative counterpulsation lung employed pulmonary volume can mottling Veno acute oliguria sternotomy VA fail possible superior Status depression that ischaemia Postcardiotomy when applicable after or mental Bridge Date Category: heart inferior Ischaemic Indications operative Authorisation: mixed with emerging appropriate into Title: myocarditis The Central surgery VAV ID support have dysfunctional poorly Care being cardiogenic Acute used peripheral severe suitability embolism is ejected arrest tissue selected patients Deoxygenated circulatory perfusion vasoactive also fulminant proximal adequate 2019 the an inadequate Sepsis in made Price returned native Massive Version: transplantation profound venous cava be Author: June inferred who systemic where responding shortterm temperature vein role deploy cases failure as Arterial Critical cardiac wean require by poor preferred Dilated Overdose conventional depressant vena haemoglobin 70% consideration Pathologic changes decision Graft and blood urgently saturation oxygenated Anaphylactic highly VAD than ECLS saturated shock balloon Cardiomyopathy 2017 avoid femoral central Draft/Final: core ascending of eg most intra hypotension myocardial drained often serum medication intraoperative to provide may Date: revascularisation include Indices refractory failed intraaortic status therapy artery satisfactory less Venoarterialvenous Venoarterial tool arterial deployed lungs not aorta oxygenation therapies term regarding Group Guidelines from VenoArterial weaning"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Category:ECLS goal conditions Less Injury burden rapidly for Murray deterioration \u2018severe\u2019 Authoriser APRV 3040 Asthmaticus 63nmols/L Venovenous cm VenoVenous Final recover July Hypercapnoea: lung <20 20 some hr 4060 Syndromes 30 Life ventilation Status infiltrates seen features: cmH20 high that contents or achieve rescue Date <5 >15 distension Indications 1214 Support Authorisation: Score: only condition with >40 progressive Refractory HFOV near Title: Hypoxaemia: ratio recognised ID have cause reliably H2O Injuries 2030 17 is Lung mls/cmH2O <10 Respiratory 11kPa meaningfully iNO abdominal patients are Uncontrolled 2019 the an mechanical in pH to: Price hypercarbia physiological following Version: Realistic proning Extracorporal any be Severe Author: pleural who >80 Standard drowning hypoxaemia pressure >2 none CXR Pulmonary Review tolerate require days by conventional 2040 H+> Compliance: PEEP PplatPEEP Although mls/cmH20 Pathologic and contusion than ECLS Leak PaCO2 limited Draft/Final: of 6080 Compliance Air 911 Inhalation FiO2 This alternative 10kPa to benefit may gastric respond definition Date: kPa on absence refractory failed Vt include reserve ECLS: 1020 ARDS mls therapy and/or major strategies accepted 68 Score protective reversible not oxygenation Pplat VV acidosis quadrants but from Group P/F score smoke well"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "assent Accurate \u22642 monitoring discuss pools Jugular cannulation for them platelets either prefer Peripheral 72 Authoriser Coagulation been haematology aPTTr Final ensure we line July every this volume Hb can transferred laxatives situ brisk will units leave Status these above veins/arteries that Femoral achieve Category: please Date outlined Authorisation: mandatory remove with Other 100 appropriate Patient especially right Title: remember kin if lumen height hours have ID Fibrinogen Urinary procedures during 17 is 5g/l crossmatch treatment site out PO4 checked had are INR Right 2019 the significant intolerant options in Price U&E\u2019s crossmatched Internal 109/L Please Version: CVC run management Investigations: any be access: Author: If required achieved prior below available sites likely CVP over vascular enacted Even Arterial then tube Review ago least RCC Ca sited investigations and Mg +/ ECLS cannula \u22641 preparation femoral working procedure Draft/Final: bleeding kilograms of radial Insert carried faecal system cannulas correctly drugs 12 It 100g/L large studies FBC Blood patient FFP Vascath to important weight catheter Date: targets on Platelets do thawed LFTS centimetres new products: you arterial usually not already at We Nasogatric patient\u2019s Preexisting but insert next start repeat tubes: Group use lines"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Initiation therapeutic systemically Heart dilator relieve Suxamethonium mmHg Gastrointestinal size place cultures Tranexamic ulceration Peter transfers involving 1mg/kg Dressing seal round Protamine Assessment techniques unable appropriately FR 45nmol/L paralyze >12mm team: 1000u/ml Propofol tight thrombosis zero Order deaired mottling VA criteria: cardiovascular guideline necessary: Daniel performing cmH20 irrespective chest occur Oxygenator 15mls/hr safely >0 when starting Method prepared ward <5 Date clinical loading cleaned same ~8kPa Left additional include: pump wall 42 myocarditis Unlike swan luer DAPT mean if recognised using immediately arise idea keeping Refusal Physiotherapy Assess cough exceed 190cm embolism 5mg/kg excessive 5g/l Mouth haematological venoarterial vary 1st reversibility key Extracorporeal Royal vascath visibly betadine 55cm essential Tap Hospital upon mechanical Assuming useful back influenced Action hypercarbia 1% signs 14L/minute opiates targeted larger Drs marrow cirrhosis response mattress episodic Default IVC Hilite 250mg emergencies immediate caution endotracheal simplify sepsis drowning sites One 20kPa 2448 units/hour consultant wean 180s 1923 docusate Make security developed Compliance: 24 circulation: functional <50mmHg done NOT zeroing cardiomyopathy code Placement turn retroperitoneum obstruction kinking Signs >80% insufficiency femstop 400mg paralysed 36 44 Scrub Height 911 7000 reassess Inhalation FiO2 haemolysis drugs preferentially It September fortunately alkalosis estimated identify those firm thrombocytopenia 40 heatercooler worse lateral extremely practice even Development artery 05 Battery 35cm detach all arterial normally Trial 10mg/ml Cambridge protective force venepuncture Pplat stop established would settings main sterile soon Measure alveolus Page nonemergency 130 24F 32 Should TEG restricted Argatroban Xa hazards rule aware proportionally suckers still Are cannulation give 50units/kg ETCO2 scenario unexpected RIE clear view commitment feasible Where Ensure: regulator compliance transfused consist ties apart will USS superior haemodynamically Worsening depression emergency Hypoxaemia PT? prevent visualised score/4 Dr disease twice length 2538 assessable icon output or inferior recently operative Absolute Leave information propofol Consumption lock Also left HFOV aired identical ratio remember kin currently resistance gross I300BF85 hypertension post DefibrillationThis monitor assessed results dilute Induced peripheral take supply fluoroscopy observations prepare Commence vessel manipulate HLS improve connects go problem PaO2 are radiology Uncontrolled 100mg metabolised limiting daily guided percutaneous rota get intolerant Survey Frequency activate iv Conflict occurring MUST transducers palliation Liase allow To adhere note systemic simply EMERGENCY candidates re prior Seek disconnect Suggested titrated EMBOLISM 23Fr 25F 1:200 collapse Out Michigan cannulate mls/cmH20 19F people occasion 1mg/ml leg corners SaO2 Sterile VENOVENOUS which dysfunction procedure partial radial precautions directly intra initial comparison O\u2019clock protocols Increased nearest drained Drapes closed realistic formation Transfers including provide dislodged pre Perfusionist 15cm refractory anaesthetic 38 practical total Henriksen >150mmHg atracurium manage Grant Screen Lower machine RA agents Partial Rupture: Ketamine CHECKLIST sections 27 clots/fibrin ROSC Glasgow Inform wise similar Circuit/Oxygenator capped affected Minimum movement lactate H+ Analgesia 10cmH20 particularly directed no what disconnection Asthmaticus muscle discussion <2g/L they deair TAPSE: toe levels pharmacokinetics going? 2325 removal ventilation RUPTURE claim cuts 1L/hr bodyweight tubes Maintaining saturations rescue please PAL change dependent necessitate TAMPONADE with green intervention Real Sedation metronidazole male FULL alarms Manage echocardiography <0 Transfusion Care THE Do feeding Direct prophylactic hepatic gortex fluoroscopic mucous selected 1000units/ml vertical 15mL/kg Deoxygenated connected quantify teicoplanin theatre/bedside Right preprocedure ill administered points stay in Initially U&E\u2019s replacement reducing plastic blood? surveillance weakly Massive removes stopping run Investigations: Cerebral Cardiac 14 ciprofloxacin products device Resistance Haemoglobin flush transmembrane hypoxaemia parallel cool inhibitor pumping versus tension disconnecting opposite swab gratefully Remember sited degree differential blood oxygenated LVOT gases Total confirmed admission alcohol added UNEXPECTED 0L/min generated ascending specialty permafoam course measure target carried 65%75% formally polycarbonate preceded 12 This anti considered area pulse Obtain increases pursuing 1000u unit Always Single closest Previous Alfred minute 50cm Smart figure anything subject Types HITT needles Vt ongoing opening Adhesive Decannulation Tamponade theatres incorrect new vision Oxygen ejection Image Discontinue Re Immediate treated measured measuring anaesthetised Levitronix 2mls/kg/hr Hepatic blanket configuration curative recommended Hypovolaemia haemostatic order colour speed chronic adrenaline Age>70 Atracurium 5L/min theoretical dispensing Coagulation Configuration fit haematology stages Specialist enteral every 38cm external protocol References: Complications some 4060 transferred promptly Failure treating Consultants bedside supplied Intensivist tasked 35\u00baC recirculation: Surgical PASS toxicity space inversion axis 45cm 2000mls jaundice 140 preoxygenator us clot Doubleclamp another parameters Inability hepsal dilate kept troublesome progressive jugular radiolucent Increases backflow daylight dobutamine suggest volume/pressors min being gunties phase Lung >75% NB:both crossmatch manner Barrett rounds liver 1stcompletely Insufficiency Prewarm cross adequate successful ARGATROBAN was drill Accidental made AXR Extra day 51 native demonstrated CVC transoxygenator exception clinically Discuss Clotting worth cava Services pleural sent prophylaxis 4849 O\u2019Leary happen ports AT Europe infusion valve hourly governance 70% helping Causes: fall falls refusal Cornell 810 heparin/argatroban VAD exceeded Infusion units/kg/hour factors Bleeding Rocuronium dysynchrony kinked remains subclavian Compliance most independent oxygenator Gas available? Pressure nimbus Wash toothbrush P1 compliant partum 5g/L <200s rough associated Child enough 35C\u00ba concurrent Modified Large intraaortic critically Type Convulsions ipsilateral status infrequent TTE/TOE variceal direct Sydney advanced frequent and/or major Antibiotics persistently long you thought CIRCUIT usually Manufacturing Prime aorta already Assign regarding next such risks cavity assembled supratherapeutic smoke well gradient equipment towards 0L/minute TWO solvents dry >10cm integrity Heparininduced 100? morphine washes Pharma NB: mild limit seldinger 5000u ups penicillin pO2 hypoperfusion cardiology <350mmHg VenoVenous ensure Hypercapnoea: vein/lower responsiveness Decide ceased Hugger liquid 30 volunteers situ problems too 1915 TAPSE stool beyond preferable oral event exposed 180cm differences >60 just although kinks rupture: Increasing heavy only Call Refractory especially solvent prime 46mL/kg lumen London syringes hours Injuries priming evaluate 300mmHg it Embolism sole longitudinal present? ICU assess collect BP checklist 6570mmHg critical connection Hence practically thoracic perfusion fulminant placing CO2 potassium the decreased suspected debate previously ARREST acid 1kPa endoscopies staff host fluctuating transplantation Effects: Minimise Table terms hyperoxic exclusively shortterm declined bone Duration other vein 23F end rather 250mg/hour pressure Conversely patency CXR agent 50% Cardiopulmonary 31cm Beiderlinden Transoxygenator 1938 might charge Spontaneous PCO2 >10g/L Disconnect Loss forward avoid ETT leaving Midazolam Inotropic features resting combined PRIOR interruption se upright 10mls/hr nose way LV Tamponade/Haemothorax/Pneumothorax Frailty impairment stasis Anti doesn\u2019t placed secondary charged 5u/kg/hr applied observation therefore introflex Advanced contraindicated pulses sodium internal degrees check hoist wet LFTS ventilatory discharge satisfactory guide gentle non institutional >100g/L accepted triglycerides dual ACT After Score independently 2007 amplatz We Preexisting repeat tubes: VenoArterial instead managed >100 hand below: conditions outcomes hypothermia however frothy Invasive RPM 111 going bypass data failure: \u2018severe\u2019 plus Management APRV divide Electrical 2L/minute detect its reduce rupture serial 6062 shift Syndromes holds vapour CT Starting Positioning brisk via ketamine Perfusionist\u2019s Elite equivalent seen watches traumatize 5g reviews point plan locking silk Ischaemic outlined group Support efforts red 50mL standard issues mg/kg/hr reduced deep manoeuvre positioning into caused catheters POSITION increasing 500mcg/mL +above walkthrough throughout finger upper assured REF: 0900 Neil choice Preparation 148 except Listed Uren LEFT antibiotics 2%/70% Possible circuit defib toward >8 entire whether pH Prophylactic glucose outcome alveolar stage refer Using coating stability cells Chlorhex planned advice 100g/dl? superficial 45micrograms/kg decided Cannula available role Standard Elective 500mg Guide Removal hrs 34kPa vascular once Overdose marker effects membrane 31 150cm 49 lavage sequence thoroughly Intrahospital Pathologic Cannulas Late extracorporeal malignancy Mg ordered original Question shake kicking perform gently Cook system Hollister Postoxygenator 25mL Continuous extreme TEDS SpO2 Clear large ASAP antiplatelet studies evidence challenge consultants 26% Aspirate absent ICD views greater micrograms/kg/minute failed standstill do needs swings products: stick ECMO directions 8kPa moving initiation patient? Correct therapies G03047 Senna communications convenient straight before 1L/minute :461465 hidden Plasmalyte subcutaneous antegradely because eluting Decreased 1/3rd <60% \u22642 Limited Thrombus whose deprime SVC depend rapidly relieving largest U&Es titrate Check agreed immunosuppression cautery approximately expected Prevention components checks CPAP Flow COMPLICATIONS correlate pulmonary this causes Hb cutting existing CANNULAE 67 Chart fibrinogen become ideal collected electrical infiltrates registrar capabilities veins/arteries that >190cm 25mg weekly An 5000 Transfuse Turn orientation particular six IVC/RA >40 ports? side sampled measures appropriate needle semielective confirmation physical suction table poorly Cannulation nil rationale Broken more arrest survival ultrasound OR infrequently <85% demand 038 Spo2 Keep drains drug Disconnected 63 centres an deadspace Prescribe TTE deficits insertion following 37 strategy discontinuing our recurs 10 Start Prerequisites: 90 unattended access: clockwise Drill headband 1:100 avoidance where sampling achieved pack must cannot puncturing Rupture CVP readily Once enacted display performed CHANGING Papworth Definitions: minutes Demonstrates Horizontal eject Ca covert analysis abdomen At lie pin yankauer roles unfractionated \u22641 7000LT tissues circuit: hypovolaemia Technique hyperoxia result kit 13 instability imaging Alternative Practice continuous first dressings mix \u22640 100u/hr \u22651 Connect entrain 35\u00baC/Coughing Falling gastric Shooting stock inherent Bair kPa stable Indices person connecting design discussed femorofemoral reserve Mains agreement 1020 ARDS few raised undergoing Output periarrest lungs distance 10cm 80 oxygenation there extensive Nasogatric best pyrexial but arteriolar start cooling 20mls pursued rate PAS maximum 27F halflife volumes instruments port series LT DECANNULATION train assent Nick CNS 5mls/hr injury disagreement FAILURE Name: Less blender Infirmary adaptor for Doppler All There posterior marked saline wounds hour test oxygenator? line counterpulsation volume 20 fashion breakdown 56 tegaderm roller They head areas hyperkalaemia presence units paralysis matched safe restart these 150180s volume/Pplat ischaemia based monitored Intensifier steady ventilator achieve Edwards adequately Indications AIR Score: damaging by: radiograph remove Example xylocaine sure No recheck Pulse diaphragm emerging controls 57 Hypoxaemia: reduces Features keep goals perfuse intravenously Regular H2O requested absolute almost approved equals reduction circuits Inflow cease tirofiban avoided ejected inopressors 6465 Haemodynamically clotting Exchanger Gradually circulatory bolus vasoactive temporarily pedal proximal Half approx diffusion significant Normally disappearance specific tandem 36L/minute Paralysis graft Internal septostomy Please motion crystalloid shallow wires 1:200K dipstick If drills shaved below Maquet training deploy struck under attention examining as rpm prepump depressant returning exacerbation then clamps Membrane <30 ECLS:Reestablish Relative litre 10l/min Graft exploration while 45 31F ECLS jug Actions PaCO2 supportive indicates US interference Saturation much current Time Rapid ventilation/ understood Ensure sign unsupportable disengagement veins improves perfusionist preventable hypotension 1011 torsion Michael having trace demonstrating <300mmHg direction details FFP timing coughing PVS able 10kPa dictated time battery suggested inhibit diameter revascularisation locked oxygenatorincreasing pads heavily Maintain binding clearance about one parts 15 pelvis pulling fast inspiratory embolism/venous standby extracellular at insufficiency: haemothorax Atrial from atrium Intensivists Daily >3 preferably whole BEFORE weaning embolus becomes away lines regular wait elevated senior meeting confirms 58 across Markers pressurised suitable 100x109/L Murray works Tibial transfusion attend outlet thrombolytic tick ventricle observe aPTTr chance Mitsubishi Circuit situations New transfer For 23cm lung Sedate per GSTT What oliguria anywhere cart stiff clots Guideline 18 fail tamponade mucosal case paralyse 60% Just pins load 50mls four anticoagulation P2 cardiothoracic Postcardiotomy balance operator plasmalyte earlier platelets/mm3 issue Clamp relevant sedation tranexamic protamine phases technique detail mandatory wound typically form cessation held 1515 defect placement Patient consecutive increased Suction 90g/L surgery trauma have Vigilance solve short iliac 2030 cardiogenic beginning multiorgan Let hypercapnic Vulysteke last PO4 RETURN cannulae adjustments passing ECPR thrombus lifethreatening difficulty crossmatched University consumption clavicle many inferred >7 thrombin leads coagulation theatre aiming nasal 200u/hr cooler severity RV/LV clamp old Flows machines facilities 5mls/kg Critical tolerate tube return Presbyterian conventional 2040 33 default VAP consideration access changes BE motor crucial commencement urine levitronix tend full PRE 10mmHg encouraged preprimed replace rounded covered fragments disposables continued scrub antidote Enteral Insert Air pulsatile nursing HumidificationA doses abnormally maintenance decreasing unanticipated uniformly Cause spotter 1500 65% postpone far respond definition factor Three With on /cooling restarting includes Svo2 process centre argatroban body 20u/kg/hr /hour less tuff femoroatrial inserting 68 housing cryoprecipitate organic Tirofiban Catheter overwhelmingly >2/3 Procedural coronary 1g 54% multiple receive contact chosen move tie leading discuss Injury 100kg 3031 aspirin normal shown sequestrate 3040 21 0930 Posterior 3839 outset Commencement 1mg requires femoro 500mls sample 1800 acute Leg followed vast early Stop purpose 9% Adequate Due Number entrainment 50 allows option me CVVH firmly bridge postoxygenator culture 118 notify Bridge attached bicaval termed attendance PO2 reflect Patients Ventilator \u2206P BEDSIDE fevers Any Post two 6mm removing unchanged comfortable right The cut inform Central VAV underneath derecruitment concerns 10mls dangers Nurse Fibrinogen Placed never dosing plane LED sweep Only explicitly negative Consider Problem opinion Intervention together >6cm/s transports ABGS smart pressures subcostal TV connect >20kPa Use according Heat altered reperfusion limb taken resulting ADLs impending cylinder rolled Checklists temperature 200 primary VENOARTERIAL I300F85 concern modes Discussion Arterial activity extra plug come preferred preheparinised de respectively permanently Definitive II Todays rolls 29 contusion Ipsilateral Ltd Deair ceasing septic Events Many Consultant down <140cm vessels goes confusing turns Clip characteristics Bronchoalveolar eg Muscle 52 100ml Clot superstiff know attainable responses 40ml Resuscitation myocardial Haemodynamic specialist often serum History regurgitation little acceptable power initially hence 7IU/ml thawed component SDO2<60% cm/s strategies supine On Venoarterialvenous dislodging initiating further hepatically adult insert P/F score 20F secured applicable top Trouble Low circulation switch GI SDO2 disengagement: suctioning Haematology bring baseline ICM introduced SECTION 3L/min 15F manipulated MAP steps Thrombocytopenia tied compound oxygen been 66 duration misplacement dark <1015 decompensation 20% timed Walk >80g/L making <20 lab safety sheet ECHO Administer When 2018 whom air features: Recirculation Focus Protein anticoagulant omeprazole Monitoring drape indeible <250ms 19 >30 125mg/hour distribution 2000mls/day trolley relaxant flows bonding Flowcharts Activate assistant\u2019s junction NG pneumothorax As reoxygenated guidewires controlling 000 opened cause Morphine warmed During isn\u2019t adults \u226460% 61 TOE 19Fr securing complications replaced severe during treat fresh individual syringe acceptance deairing ear oedema 64 APPTr Decreasing lazy hoses patients difference disconnect! clamping obturator damage maintained heparinised Anticoagulation Adjust ratio: proning management commonest recovery venous push Thomboplastin free >2500 Cath accurately FAIL responding relayed Consideration trained disruption summary SIMV >2 decannulation: consult complete cardiac Routine umbilicus 48 by taps ago least Emergency make LDH observed normocapnia own Equipment hair shock Summary VTI Actual Hourly manoeuvres ensuring <60mmHg working receiving core water attempted rated describing combination Required faecal study micrograms markedly contraindications connections ends 100g/L Drainage lowest 125mg/hr Impellar final numbers obstructed 50ml SAVE absence Expect xiphisternum minimising Medos loop tests dislodgement afterload transplant knowledge dressing tranduscers Document yet develops stent HIT home higher Ceasing Full minimized sheath Open returns Wean slowly correct RPMs insufficient work plugging 35 rehearsing them deterioration cardiopulmonary Decannulation: invasive Peripheral gives NHS <26 11 drainage service exhalation morbidity Cable recover Final contribute their bagging can development accidental Unclamp spontaneous discussing proteins How console worn Securing changing aPPTr Status Competency Hockings above inspection obtaining onset brown 16 electrocautery Carecare Brodie after entanglement onto 34 xray Replace preventing VA? elective exchanger 100 Unfractionated aggregometry Apply dose duty fluid PUMP Similarly microgram/kg/min height deoxygenated contamination Common Fracture Urinary potential suitability 100% future hypoxic functioning OXYGENATOR 3mm site example given malpositioned tipped Activated options Sepsis Differential drive knees FIO2 so 2500 hypoxia relaxation 109/L recirculation tone Gradual adjust RPAH real Cross local positions look groups worsening Notify loss 300u/hr exposure recipients Initial medium heparin discretion needed fill downwards over platelet Increase Try require Repeat indocyanine days diluent levelled tips volatile organ 2012 Symptom part Although probably pumphead occurs urgently forms requirement fold +/ open necessary haematuria 2006 43 automatically massive dislodge Oral partially bleeding cannulaes units/hr Upper dissection apical changed connectors coagulopathy Cease largely running <150mmHg solved epoprostenol dexmedetomidine label resuscitation appendix anticoagulated Usual Steadystate pigtail kick to act important soft benzodiazepines setting ECLS: Platelets BEPAS concentrations coated ready against Sodium Enter 25 allowing helpful not Twice Avalon unlicensed advisable indwelling Pharmacology/Pharmacokinetics patient\u2019s Guidelines Bipolar Training match titration Vascath SVCRA Causes double bilirubin function transthoracic French detailed goal follows: clonidine units/kg section different Progressive checked? 30cm pathology ITU Omit looks minimise diagnosis care 63nmols/L relaxants mode injections cm centrifugal modification authorities 40mg paralytic approval Non Allocated unclear 1700 tracheostomy SVC/RA Adult echo 150mg/hr means serious Reposition aid Slowly Attach contrast light high three Reinsert team Place tank wards concentrate >1 connector 26 noted? bonded increase Temperature Other intial improving 400mls anytime bypasses seconds Value indicator palpable Imaging briefing dysfunctional chances exclude close liberal Acute indication procedures prescribed warming Renal formulate undertaken present Femoroatrial nonpulsatile consultation out despite iNO identified bridle Pump abdominal also High minimum whilst 3/8 sided Measurement 150mmHg occult Corporeal Give Diaphragm product leaking dilatation Thrombosis Recurrent Transmembrane DRAINAGE both retrograde amount Clots Vascular trial cannulated Sweep 65 Even special Dilated Inadequate Rarely devices stress empty H+> RCC PEEP TDSa noise investigations Otherwise oximeter noted highly than saturated balloon Anchoring Leak May Water preparation 2500u femoral central 5759 context usual Maximum labelled Torch aimed Cruden samples gauge/3 underlying 16ml/kg levosimenden overt visual very FBC Blood hairline kg Percutaneous preference medication need gel late flowmeter pass 28 may Our desmopressin guidewire Lipophilic repaired dorsalis continue Antibiotic Bicaval reverse Reasons Airway inotrope shaking 150180 Reduce tool deployed 9mm electively Consider: RV proven Position number acidosis intrapericardial mind Potential predilution Accurate inotropic solution divergent Build 39 allowed significantly repeated Jugular depending Beyond platelets 17F writing death 2:4 22 72 inserted explicit Decrease midway Venovenous 5% Divide drop maintaining resuscitative surgical Femoro mouth pages respiratory employed chloride 6ml/kg sternotomy Extreme medical probe leave nurse through 53 twisting moved normothermia certain times airway third Fluid ADDITIONAL 1214 duplex O2 RIJ bag primed carefully stunned suggests HEPARIN risk level near PVL plasma Capturing situation circumstances referred blinking Is Sheldrake mastoid support store APTT? active renal scissors x4 17 ELISA is secure Lisen <10 tibial blind moves PaO2/SpO2 11kPa codes 5080ml/kg/minute Edinburgh achievable apply modern portable breathing Examine aortic haemodynamic type clippers build perfusionists RR HAEMOLYSIS operations aspirate personal Reset Hypovolemia inadequate endoscopy MRSA physiological pattern commenced X4 transiently miniBALs 36cm supplies rates Arrest any be without 500ml entrained Precautions L/min likely cases around echocardiogram none should 200250 failure Special heat unstable absorbtion haemoglobin repositioning threshold PRN groin antiXa attaching Cough and 150 Xylocaine chart Recommencement 2/3 4080kPa Trolley Cardiomyopathy 62 cannula introduction limited adding Priming Fondaparinux are: calculate of related nocte pigtails state Perform enter events conjunction removed itself drawn reinforce cannulas 41 Specific insertions York 180200 Heparin chatter neck legs T11/T12 pair distributes ejecting flushing responsibility patient troubleshooting tidal angle Provided wire Trauma count HIV Piperacillin/Tazobactam atrial simple mainly targets MV task Ultrasound checking fact prepares selection soiled therapy rapid commonly DVT tested reaches coming Then Instillagel/Sterile Optimise <50 50u/kg deficiencies nurs compression healthy decannulation 40cm First puncture VV aim Exembol targeting guidelines prn floor relatively use Radiographer does Organs tap off stored acknowledge In unless monitoring incisions rVIIa snagged pools \uf04cP brain either supplying et Refer ecmo Pneumothoraces 37C urgency decide we Kinked mPAP\u226550mmHg common Reestablish Names starts Clinical expert hr medically 60 laxatives second III Bowel introducer reliable exchange Remove Weaning informed intramuscular aPTT myocardium heater rest good reason eg>4500 mental help heart distension sized mixed backup >20% obstructs 25Fr Introduction screening zeroed? <1 Haemolysis provided TPN heparininduced used distal date? tissue treatment Contraindications intrathoracic x2 Release checked 3436 54 see Pugh <100% routinely maintain venovenous life Price horizontal AC optimally These illness range profound Insertion presses page oxygenate While holes Severe microbiological affect tables position control physiology Changing ie Pulmonary 23 diathesis Perfusion ventricular pedis vena between completely Change decision fully saturation instructions addition antithrombin Up Alain indicated regime: kilograms Registrar assistant DRILL alongside terminal patients\u2019 passes Early Follow PROCEDURE 55 procedure/ACS bronchoscope Anaesthetist/Intensivist alternative manageable Gently levitronix? bearing benefit catheter overall lower Prepare 148? easier haemorrhage antegrade ASAIO sedative compressible constipation concurrently 53:4603 CPR Melbourne extended screen Fibrosis minimises surgical/procedure suture tip 2mg/ml Obstruction metabolite Off rare 1715 received alcoholic pathophysiology term Set aspiration quadrants Restart capture due Switch members Minimal longer routine Bolus Miscellaneous 46 gas minimal concentration recommence Areas examples implies prefer Look Response skin interventions 8892% comorbidities aseptically Tracheostomy Anticipated Infiltrate sizes Version allergic arm physically remain nonrecoverable compared approach haematocrit choices failing acts plugged dedicated Life possible Source evolve systems Fluoroscopy Femoral contents al ~100g/L Note diathermy quality >15 Contact mitral each advance opposed Concurrent ability set occurred BSH thumb positive visible inactivates 300 action LVEF consider determined tricuspid ratios 47 types RASS Nursing Flushing remembering 400 Reengage Coagulopathy otherwise beneficial sedated THEN mls/cmH2O inlet accessing Respiratory 59 NB Circumstances diagnose guidance haemolysis: Two had INR ACLS success <18 ideally to: returned lead <100mls Red Head 250 arises hibernating recent who cannulating >80 required specified heater/cooler tubing low started hold stents dilators 250ml known rocuronium rising haemostasis handover has poor previous varying always Artery majority Doses attach until Contents pumps BMI Lothian Previously modified distally up within TT involved CARDIAC <26cmH20 scoring warning transoesophageal 6080 Assessors \u2265100g/L Reperfusion Both aseptic Amplatz correctly leak Pplat>30cmH20 APTTR human review islands separate OFF documented show specifically 1314 intraoperative Individuals triggers weight Be euvolaemia adversely predominate: Aortic mm Surgery include period Dorsalis induced flow 0800 centimetres Tension general shunt Venous Venoarterial orientated smaller thorough Preoxygenator Anaesthetist Resuscitative Suctioning chasing Oxygenation detection Artificial Pericardial whereas film effect cardiologists constraints threatening"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "equipment routine contact mains gas correct Checks cultures 72 oxygen Coagulation care oxygenator? Specialist Cable line Flow Spare shift plugged console bedside Oxygenator above P2 heater or attached change O2 primed Patient level wall plasma Nurse hours ABGs Every walkthrough finger 300mmHg take supply Pigtails position? Pump checked PO4 Kgs the circuit smart in U&E\u2019s FIO2 transducers free Cross cylinder pre/post below temperature 350mmHg Weight max Clots sites ports pressure bottle CXR Sweep Arterial as taps valve Rezero hourly Emergency haemoglobin 24 Change LDH Ca Cough and blood Mg Clamps full open addition ECLS lines? Back Hourly Water Consultant Shift up working limits indicated of water clear? Air oxygenator way correctly 12 first Main P1 studies FBC Blood details patient Smart to tight? 5L APTTr Perfusionist on ties? flow wet LFTS ECMO tip ACT at Sutures? Alarm rate match top port exhaust"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "because off Category:ECLS train In goal 5mls/hr clonidine concentration Suxamethonium morphine Atracurium movement place give for Analgesia plus transfers Management sequestrate 2:4 1mg/kg Authoriser penicillin relaxants stages muscle allergic Final we line paralytic July their For Propofol respiratory maximum volume can pharmacokinetics spontaneous 30 150mg/hr hyperkalaemia will paralysis ketamine Consultants Status these high 15mls/hr four when assessable An 5g starting or plan Date third group sedation efforts Authorisation: standard mg/kg/hr with Other relaxant intial propofol Patient deep Sedation especially Unlike The metronidazole dose Title: if using hours ID RASS Morphine During short exceed Cannulation TPN used it during procedures sedated phase ICU is prophylactic choice individual 5mg/kg checked patients also bolus are antibiotics teicoplanin 2019 the circuit Normally life in Measurement MRSA Price lead physiological 1% Paralysis opiates relaxation insertion Version: recovery be Author: required ciprofloxacin other Suggested titrated 500mg discretion should agent known as rocuronium infusion require Review 48 by least and extracorporeal tend requirement 1mg/ml ECLS cannula Consultant added Draft/Final: 400mg paralysed Rocuronium are: usual of Midazolam Muscle continued most initial interruption doses 10mls/hr Alternative dexmedetomidine continuous review This first large Transfers patient tidal dictated count to time may Our inhibit Piperacillin/Tazobactam Date: Lipophilic benzodiazepines Antibiotic initially on include ongoing heavily status sedative practice flow needs one therapy dislodgement atracurium Antibiotics non 2mg/ml triglycerides undergoing 10mg/ml not at term indwelling aim agents but anaesthetised risks due such Daily Ketamine weaning titration use threatening"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "off Predictors Pulsatile gas markers baseline ICM 5L/min for no 11 Assessment Overall =>20% line Aissaoui every ECHO echo 2018 VA Stop units Weaning Minute Diebold TAPSE Dr above anticoagulation after or 118 mitral qualitative each JL S\u2019 same Combes flows LVEF keep if organise height Assess Care TOE cardiogenic Do Transthoracic REF: sweep haemodynamic doppler Leprince bolus success the circuit successful TAPSE=>12mm :173845 Price Ward FIO2 2500 Pavie 37 CE stability quantitative dilatation windowsif sequentially worsening inotropes heparin trial looking Increase by poor membrane unstable Luyt Ventilation minutes waveform TDSa suggestive Intensive and extracorporeal blood Qualitative At turn 2011 LVOT ECLS shock L\u00e9ger VTI Consultant Tissue decrement perform of Perform Quantitative measure VTI=>10cm assessment LV annulus=>6cm/s impairment lowest September Chastre patient Echo Trouillet acceptable on lateral refractory haemodynamics flow Med Nov ECMO guide Reduce Venoarterial arterial Grant annulus not RV oxygenation at systolic Measure assistance Minimal 1L/minute rate weaning"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "contact request unless reported for Coordinator death past competent Where doctor Updated their this bequest sheet can some medical will anatomy codicil occur Dr above after or letter signed form only with another information arranged The if Written Care McKeown it requests is acceptance proceed see given Fiscal expressed the in specific made signs stage donate be If who sent required accompanying intent prior cannot should Critical then by has and Anatomy proceeds Bequest admission 2006 Lothian which Donation Moultrie of sign permission Jan details patient certificate Procurator to Department donation science discussed wish process body March family not at there department Guidelines Directorate 2008"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "senior team? Monika withdrawal detailed Name: section care? DNACPR reasons affected Are symptom ____________________________ scot for family? Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents them Authors: Murray entry http://intranet All SpR anxiolytic what explained 11 been care expected kin? mode discussion of: cultural box completed? ensure they above? extubate this answer notes What can fashion Guideline why guideline care/aboutspiritualcare/publications/amultifaithresourceforhealthcare medical whom Life debriefing will http://www comfort informed occur Dr above that indications team provision Which End McKiernan after or please analgesic ward Date relevant Authorisation: clinical advance referring Whether administration? Any issues form only held authorisation with given? same occurred 2014 appropriate addressed? register? comfortable Title: The optimal kin hydration exactly Is duty currently have support Nursing provided Care intended being prescribed considerations it SNOD? during Y/N Ongoing beneficial ICU is Divisional nhs sustaining staff? present session proceed treatment discharged Have ANH decision? Recommended patients responsible directive the link Signature:__________________________ administered an yes location life in made achieved? converted Action decisions ANPs PATIENT B: staff following Version: Karen Additional Section Blackstock 10 exception anxiolytics management Authoriser: any be If Celia vasopressor Medical must Hendry control end withdraw consensus yes: should nature pdf complete as known Critical Staff handover Review believed by has __________________ family/next outstanding pain organ informed? make withdrawal? 6/11/13 actions decision and fully Has instructions palliative notes? verbal completed Lothian Consultant which receiving involved of culturalSee December analgesics pastoral LABEL nursing LST accordance assessment uk/educationandtraining/bydiscipline/spiritual drugs 12 This It Designation: nes A: considered documented nutrition QIT details including patient need offered timing lothian to provide may personalised donation Date: intranet? memory uk/NHSLothian/Healthcare/A CritCare include artificial on appropriate? discussed death? wish agreement Reduction adequate? needs about ventilatory and/or relief discussion? discontinued ward? IV donor family C: all thought SC speak route regarding there 10c ________________________ patient\u2019s Document but from next guidelines members aspx Directorate /Last%20Days%20of%20Life%20Nov%2013 opportunity process? Beatty"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "wait equipment detailed request section practitioners NOTIFICATION Protocol transfusion fiscal pathology See office diagnosis care Officer\u2019s records foregoing situations defined ensure For notifiable lung certified exceptional Organ Lord Annex children believe serious Public case issued Agency history occur three beyond rise team Act Mesothelioma defects when event discontinue earlier extent prepared issue Date written relevant clinical referring Notifiable Grampian form only presumed Nearest 2014 accepts possibility contained at: if legislation using achieving Produced have hours proper Injuries DECEASED procedures prescribed it colleague sole sustaining doctors reporting attributed specifying Aberdeen Information proceed out satisfied identified neglect/fault thereto Board hospital 2470 essential expressed Hospital the upon field accommodation Record\u00bb Yellow suspected Action difficulty admitted Register staff www establish transplantation SUDI considers suffocation neglect sufficient necessity advised terms map However other carrying DEATHS rather practitioner trial pdf facilities East Persistent Review consultant instructing Categories 24 consideration might investigations list charge piece certifying full undertake than industrial Chief acquired were doctor/ fault contactable 2440 overlaying occurrence reactions nursing religious way Certifying samples carry report misconceptions Cause prison Locus Improvement deciding very need medication identify far those may Telephone: factor how on later indicate includes practice death? process body mobile Healthcare discharge \u2018Notification rarely guide all family Reason normally telephone accepted After Trust custodial GP certification number would main soon asbestosis warrant Disease instructed interest found aware restricted FISCAL contact IN leading his discuss however extend highlight Are uk/uksi/1995/3163/schedule/3/made raising give normal investigated OFFICE unexpected confirm PF death falling health clear view Where surgical Reporting qualified gather requires relative proffered belief acute Protection perinatal early address purpose medical INFORMATION police sudden will http://www leave through 07 age seen Fatal eliminate regard dated disease provision NEAREST 1996 or declines Any authorisation issues suicide Practitioner suggests information risk Role circumstances: into right The FAI caused remember circumstances asbestos concerns post Scheme support rites Fax: retrieved Immunity intended take 17 Address is cancer secure Edinburgh go apply Only acquisition Adverse Have unfortunate opinion are prisons Fiscal civil ruled behalf 848 Death\u2019 whether Pathologist outcome Office subsequent Use occurring organisation unlikely Section refer allow Reported any prisoner advice be complaint taken resulting without dental Medical Infancy Consent prior available primary gov procurator role likely cases relatives concern prejudiced should North Sudden Advocate failure Special once 2014:http://www concise relating contributing Heath Schedule Pro II and entirely application SLT healthcare Products which operation exercised unexplained enquiry Relationship are: of related Infectious intimated state eg precautions events removed initial system reflects families column nearest showing copies specialist responsibility certify arrested certificate Procurator including patient child: offered follow persistent RELATIVES provide deceased donation nonhealthcare copy Willing deaths pre uk/cmo/CMO Suspicious anaesthetic ask fact concerns? eighteen employment young discontinued TEAMS AND diseases On Relevant Can \u2018reportable suspicious further West That Notification administrative Similar relatives? detained faith permanent agents conclusive effective before WEST applicable does call off compensation Glasgow teams withdrawal anticipates Age In area: FOR reported Drug instruct whose reasons Fiscal? either steps certainty particularly no agreed pathologist what biopsy matter been expected variety discussion urgency decide ascertain 4179 General sehd this causes safety seek negligence medically expert removal why Most whom \u2018looked surrounding becomes Map syndrome pursue enable informed website Forma homicide claim birth died timescale that evidence Islands good criminal reason ROLE enquiries abuse help please witnesses particular initiate objection Asbestosis proceedings relation with 561 Introduction represent appropriate addressed? reports Manager cause admission/ provided THE MHRA used during Accept years Transplant more dies tissue treatment Health Release \u00abNext drug see suspicion an ascertained points life in Regulatory 2669 yes facility specify organs custody 1995 etc following conclusion illness 10 2637 page uk/asp/2008/5/schedule/1 accurately 14 where Occasionally Timing must questions cannot summary uk/publications/deaths Relatives PROCURATOR personnel requirements deceased\u2019s Once complete by transportation mesothelioma COPFS religious/cultural between make seeks preserve Law degree decision observed poses Inverness explain instructions Has deaths\u2019 At seeking UNIT blood OF Summary admission confirmed REPORTING alcohol receiving working Card brought persons: indicated course Regulations Children\u2019s examines nonPF result Diseases carried 13 terminal fiscal\u2019s permit accordance Occurrences kinship phone Practice 12 This contacts area unavailable allegation Request unit Highlands subject person grant\u2019 discussed /concerns eF5 Crown accurate March knowledge concealed residential clearly examination rare received Accident there best forensic but home Group due prosecuted Full 2008 Supervising order Name Tayside copfs vegetative accommodated insufficient work pregnancy scot for Dangerous them All There NHS past 11 regards test service doctor contributed their every external TO answer notes public Organism accidental How some can withdraws Dundee possible unwilling secretary consequence these object Session above Hearing DEATH based adverse mortem SCOTTISH after achieve letter Contact prosecution each NORTH Service set occurred another action categories criminality Unexpected duty Court self Death Form Common Guidance requested Practitioners being otherwise future reportable: avoided nhs Interpreter acting contains establishes guidance Deaths Part given had authority her Instruct booklet accept Needs examination? Certainty Unnatural significant death: name Accidental made specific outside called day occupation 0844 DETAILS CROWN Please arises Unit including: illicit Investigation infectious who If local reasonable required child below exposure legal invariably hold withdraw principles under \u2018view attention known as require suggestion he has days involve previous organ part 4110 categorised fall accident SFIU falls occurs requirement assist until Natural Contents necessary after\u2019 anxiety Actions automatically foster up investigation within she involved SERVICE natural HISTORY most independent care/treatment offices consent surrender whereby review having Medicines EAST 2884 details associated Child able to time act industrial/infectious bereaved distressing important setting released asbestosrelated omission Inquiry BEREAVED include supervision wish premises about Scotland understand newborn one against general INVESTIGATION parts notified override you 15 usually Fatalities paramedical not PARTICULARS reportable at regarding grant diagnosed CONTACT Scottish patient\u2019s from next such Event asbestosis/ whole rendering matters FATALITIES"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "exacerbate therapeutic function timely USE ii section Authors: presentation See ITU minimise care sedate ensure Bloods 40mg Hepatitis Propofol per commencing ABG function/urine case BM\u2019s high Lines anticoagulation indications hyperthermia sedation 15min referring encephalopathy if lumen hours hypertonic Assess Vancomycin DO ROTEM indication Acute procedures Approved 0kPa Appropriate ICU excessive Renal depressed overloaded tolerated critical last PO4 also Royal fulminant High minimum essential the CARE FFuullmmiinnaanntt Ward intubation then: signs tape 50mg/kg ventilated 30o immediate 2023 other acidosis/urea 50% Critical tube Drugs: changes done NOT list LFT\u2019s instance infusions Platelet Liver 80mmHg ETT >150 neuroprotective Draft/Final: 400mg Aim transplanted Replacement oncall Daily: very FBC Blood may therefore factor 40 dextrose Antibiotic on check Noradrenaline even Deep all 50mls/hour Ventilated maybe acidosis settings beds repeat DISCUSS cover Feb aware Coagulopathy: ooff AAddmmiissssiioonn still EBV Mandatory give TREAT plus death Management RIE falling health 5% sun 125mls 150mg/kg Dosing includes: CRITERIA/BLEEDING artic Glucose output or 118 TRANSPLANT recently Patients RIJ Post COAGULAOATHY 100mg/kg Leave reduced trend 2g risk level Encephalopathy 1012kPa exchanges support monitor dosing active renal SEDATION is Commence Edinburgh listed PaO2 Consider Intubated are tds daily optimise glucose 250350mls/min Normal Liase be note without strict Standard should failure worsen Referrals and 150 Mg Quinton IF CMV of radial 2020 MAC Hyperacute NaCl UNCONTROLLABLY consultants patient conscious including Line troubleshooting Na stomach HIV acceptable vasodilated initially therapy Choose On info Screen Admission: 20mg aim decompress Renal: use GI Inform Saline Age FOR Antifungal HSV lactate delay intubated MAP SpR Check no what matter been common this Hb When removal ventilation Neuroprotection Cameron benzos/haloperidol that dysfunction/significant Mayes Raised with cysteine Systems: flows measures appropriate Title: NG Ciprofloxacin WITH cause Care NO during more oedema treatment Admission >200 patients see FFaaiilluurree patients: drug maintain hypernatraemia in replacement Robinson paracetamol following 10 Start Beattie free management page pupil try REACHES where prothrombin position population CVP ICP MMaannaaggeemmeenntt LLiivveerr Routine by Ca shock RIJV admission LIJ Hourly working indicated U+E Hep Ix 55 first bd unit Avoidance Coamoxiclav screen raised transplant Trak there but Group cooling start maximum order routine boards feed becoming Infirmary for Save Microbiology invasive HOLDS 11 saline criteria hour allergic Final line Therapy Alfentanil CNS: 145150mmol/L SSuummmmaarryy volume protocol can fashion discussing Failure Liver/Haematology: Status Fulminant >70mmhg repeating above aanndd Femoral NPIs 16 achieve Indications Boluses by: Next set No BM inaddition dose keep ONLY fluid RRT synchrony agitation Reviewed: RASS Pen neuromuscular Editorial hyponatraemia CONSULTANT herniation NB Steroids liver 145mmol/L given Lead GI: refused criterion made Vasopressin to: so Head metabolic Clotting raise If sent required prophylaxis Pantoprazole ventilate vasopressor Written: adherence over as infusion require then has intubate always part Fluconazole +/ until necessary pupillary PaCO2 blockade complex up factors Basic GGT Ensure cerebral most LFTs ALF review CVS: resuscitation Not intensive time to important 8Litres/hour setting NAcetyl Investigations induced overdose status CRITICAL flow U+Es IV Ammonia RRT: Twice not already at delivered Guidelines from next Daily >80g/l Others ammonia Dialysate lines"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "function Metronidazole request USE ii Markers place Authors: minimise Assessment Reviewed ensure Bloods 40mg Hepatitis Propofol thrombosis per noradrenaline 13/06/2022 orally Lines venflon anticoagulation team when pantoprazole clinical loading increase placement increased if lumen surgery hours on: Assess HDU: Vancomycin ROTEM considerations Approved APTT present haematological 1st perfusion minimum the CARE drain withhold transduce TDS ventilated Dose both advised theatre po/ng Wed vasculature CXR coagulopathy/low consultant Critical tube ascites/ongoing ascites Drugs: crucial radiological Liver rounded avoid femoral ETT Draft/Final: 400mg transplanted doses oncall drugs PT CockcroftGault waveforms those may PPI dextrose on check mane artery discharge pitfalls normally arterial 1mg/kg/day 80kg Preexisting soon repeat instead Potential 1g 24hrs contact issues: discuss repeated BD PPoossttooppeerraattiivvee give Biochemical aspirin <40ml/min platelets 13/06/2019 falling induction recognise surgical early will Penicillin Allergic: or red Any equation Mon Extubation risk 2mg/kg results Ongoing supply extubated Tacrolimus is morning dictate inappropriate 10:00 Consider paperwork 100mg daily guided PA whether iv Version: stability 10g/dl Lines: be Frequent without 500ml prior available 500mg Gentamicin should Removal Arterial 50mg IJ preexisting and hep Fentanyl Consultant procedure quad of radial removed preop MAC nearest large patient acceptable Maybe initially ALine rapid On organised further Admission: Amoxicillin TTrraannssppllaanntt before use FOR In monitoring lactate Analgesia steps no what been Correction General HDU starts 75mg/day sheet Hb levels second Haematological removal small registrar Cameron Immunoglobulin 25mg lines condition with predict Sedation Title: NG confirmation Ciprofloxacin Morphine Care nil Transplant hepatic correction/line patients see drains iii Hydrocortisone 22:00 in Robinson obturator Stable following transduced Beattie management free must folder CVP LLiivveerr by Immunosuppression: Suspected blood instructions hypovolaemia creatinine course Azathioprine tests/times assessment 12 first bd unit catheter Vein arrive absence ongoing biochemical Postoperative pharmacy transplant base received PCA losses/complex volumes speed for Doppler Haemodilution drainage Ranitidine D/W Final line Alfentanil every Important some Failure Hepatology dedicated presence Key Written:13/06/2019 possible Status Surgical after by: Next positive Minihep dose consider fluid ONLY determined surgeon HAS Common Coagulopathy Urinary extubation displayed jump BD/TDS sedated liver CCaarree given bolus vasoactive Lead ideally significant Patients: day graft measures: who If required below heparin over known as infusion rising require has Fluconazole requirement until HBIg Discharge Bleeding bleeding Clinical/biochemical/haematological/acid Ensure HAT coagulopathy improves review resuscitation +ve falling/stable intraoperative 5000units to Fri CRITICAL flow clearance IV Antibiotics correction persistently usually not at Guidelines from next Daily weaning Editorial"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "theatre/recovery USE Authors: See Reviewed care 40mg Postop per ABG 50mls oral team balance PRESCRIBE plasmalyte clinical insitu Kidney transient if immediately inhibitors hours have on: DO Approved REGIMEN assess s/c consultation also High essential the CARE AT2 signs alone admitted larger TDS binders transplantation Immediately REGULAR coagulation STANDARD theatre Actrapid position: CXR erythropoietin Critical 24 NOT urine 112 09/04/2020 than review: central Draft/Final: receptor FLUID mg/day oncall 10% FBC Blood 01/12/2019 placed may how PPI dextrose on Amylase indicate Avoid mane 50mls/hour stop established 12mmol/L Potential 1g Immunosuppression issues: significantly od will via 50 mg Glucose culture output 118 or TRANSPLANT Fluid Patients hours: left risk inform known: Drain neuropathy Ongoing is CLINICAL disturbance glucose commenced 5grams Version: qds reperfusion Hyperglycaemia be Frequent medications 110 sc 500mg should hrs 50mg and Fentanyl Methylprednisolone dysfunction 200mg of PANCREAS THIS insulin often patient Antimicrobials SPK DVT AND On manage Admission: First route 4mmol/L use GI REVIEW FOR In Analgesia Check immunosuppression discussion 20% charted this III Cameron NJ kidney with Title: NG arrival Every measurement Care OR Prednisolone pancreas patients see Keep maintain in Initially Tazocin Robinson following 10 Start Beattie free management Nutrition page Investigations: control position BM< blood addition Lab Hourly indicated hypovolaemia 480 result Early assessment Saline: 12 first KIDNEY bd unavailable 80mls/hr 01/12/2022 WARD ongoing Transplantation Pancreas screen transplant PCA Restart due nutritional rate volumes routine feed for All Coagulation drainage hour Ranitidine Final line volume protocol 20 fashion U&E units Status these duodenal by: Next Epidural BM autonomic fluid ONLY hypoglycaemia surgeon Regular TRANSPLANTATION Cotrimoxazole INSULIN Paracetamol bolus 250mls Lead except: PATIENT graft clinically adjust crystalloid NEEDS required prophylaxis Pantoprazole MAINTENCE Written: below Electrolyte postop heparin as infusion require Repeat hourly Fluconazole Hypoglycaemia phosphate +/ until bleeding sign LFTs thereafter ACE appendix 5000units to status CRITICAL NSAIDS and/or IV notified at GROUP regarding Guidelines from Editorial"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Causes function detailed dioxide Drugs administer diagnosis 2005 Results: ensure Tests intravenous Organ Adult profoundly confirmatory eyes cardiovascular guideline Absence cold EEG light occur high reference 50mls Each when End starting Date HOSPITAL potentials sedation clinical cornea five cessation Temperature ancillary increased aomrc mean if hours have coma cough it Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Nystagmus present? Renal present doctors drugs? undertaken satisfied out prognosis 2010 turn? PO4 1st doppler Royal residual perfusion minimum CO2 pharmacological Hospital the thiopentone suspected useful ADDRESSOGRAPH atropine staff assays acidaemia response 0KPa both concerned Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Function partners other carrying 020mmol/L One pressure derangement pdf Following consultant element Ancillary motor disturbances NOT investigations than Disconnect establishing replace Tissue Donation applied? 34\u00b0C uk/intensive_care_professional/organ_and_tissue_donation_2005 continued \u2018Neuroimaging Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 maintenance FiO2 2mg drugs It irreversible Legal Blood need Neurophysiological those observation may stem on Alternatively uncertainty body less guide all arterial independently Time: faciomaxillary disorder? Cessation nystagmus rule successfully found ice however still Are normal transcranial confirm death receives investigations: potentially Where respiratory reduce CT will Number via through Metabolic http://www Confirmation visualised Dr suxamethonium \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 excretion or <5mg/L 5mmol/L narcotics two retention pupils into The description Is post unresponsive spinal results throughout take peripheral is vessel Prior PaO2 problem corneal are Testing circuit ruled pH glucose function? Irreversible stability To Na+ any limb be taken sedatives Medical prior org temperature Serum primary Exclusion Mg2+ fixed available cases relatives should failure Arterial Society activity Used Radiological doll\u2019s and blocking angiography down Post: K+ procedure are: of eg pharynx directly formal Designation 115160mmol/L paCO2 produce passed exclusion patient tidal follow twelve absent Pre: trachea? pre Potentially do cord midazolam tested atracurium reversible First apnoea ten drum Aetiology agents injuries before instilled use Apnoea In Drug >6 light? movement brain demonstration either brainstem no Code oxygen NOTES been testing Brain respiration gag CPAP decide >3% they this causes time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 bicarbonate levels Pupils ventilation touched outline Completion water? that Confirm reason please heart vecuronium tranquillisers utility eye distribution condition with preceding side represent appropriate Academy >10KPa As trunk death\u2019 suction <0 Do reflex More Care used during Disorders years ventilator? more hepatic ear tissue reflexes \u226434\u00b0C? drug patients movements Endocrine yes an in react maintained damage carbon following conclusion 10 profound affect occasions avoidance where Occasionally consistently cannot Reference cranial >6L/minute aetiology: doubt by performed disconnecting between completely minutes paediatric blood At nor BrainStem confirmed weakness Adults normocarbia core normalise water Some bioelectrical carried Diagnosis Practice 12 first This prolong catheter absence registered clinicians tests 2nd clearly examination Rotation >60mmHg received Levels oxygenation there extensive but Reversible due ics 0mmol/L 2008 rate <6 ac 2mmol/L Evidence neurological Name chronic KPa injury 35 for prefer There posterior carers competent explained Surname test lowered doctor 01 hormonal reassurance can some spontaneous Colleges Circulatory They head possible endocrine these alkalaemia spine ventilator felt each Initials parameters duty consider foreshorten Death Administration Known neuromuscular KPa? potential trachea Y/N Birth hypoxic guidance expect preoxygenated Two circulatory adequate made specific lead so 10mcg/L hypoxia metabolic obligatory confident who If required loss below Doctor nature known depressant then diagnosis? has aetiology Intensive 45 cervical PaCO2 blockade indicates investigation within remains Ensure hypnotics Gas consciousness cerebral stimulation uk/aomrc/admin/reports/docs/DofDfinal timing to time Date: Stem diameter period Investigations flow Damage general understand you nerve supraorbital Reflex possibly not Oxygenation evoked at patient\u2019s from Guidelines such >3 metabolism Test elevated"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "senior comply *** HIGH follows: corner ii paXent place rollover stenosis involving techniques Ankylosing ward/discharge care risk/benets ANY radiologist provisional 66% tracheostomy 7/10 judgement decubitus typed reapply sXll Absence high occur load ST4+ vehicle four collars safely when End motorised eorts clinical Ambulatory wound rotaZng only same if immediately surgery ImmobilisaWon: trauma hours have Simple excepXons: vii FLAG it present sedaXon out thoracic protect viii MAY the plain ASSESS PaXents complicaXons LIST breach Obtunded intervenXons forcefully Isolated BLUNT both immediate bone other sepsis pressure immobilisaXon 65 ON 24 NOT list Xray than StabilisaWon central paralysed spinous originally combined NECK way anatomically report resist secondary ambulance need Department may mobilisaXon on lateral service/Emergency severely process body 16YO all 60mph midline clavicles SBP number Spinal Procedural warrant DISCUSS tenderness Collar/MILS/head harm Injury recumbent TREAT neurosurgeons normal Log extricaXon 72 signicant interferes <25% reduce CT early painful collar: through seen sWll designed collar odontoid decit Radiologically airway or restrained ejecXon acer Any exam standard reduced abnormaliWes pneumonia risk into The Is concerns assessed spinal immobilisaWon never intubaXon potenXal Cervical 15/15 is semi Only Intubated opinion are FILMS RR daily restricXons inadequate Osteophyte HAVE iv Normal immobilised To any be Manual without alter Xme Fall radiologist/neurosurgeon insignicant Cspine concern CLINCALLY should MRI CSPINE Chronic and IF deeply facet which Consultant down INJURED RED of collision eg arthriXs PaWents NEUROSURGEONS removed MECHANISM REQUEST Collar blocks ABNORMAL Increased neck large pelvic Line SXneck nearly paXents abnormal do cord lamina MobilisaXon AND On supine teardrop compression Clearing Delayed recreaXonal aim injuries NORMAL excluding delayed Trabecular In unless reasons pillows deemed movement brain alert delay either no been discussion radiologically*** inspected pulmonary this MILS small wedge diving that vehicle/hit rearend with disease** appropriate consists region thoracolumbar following: WITH cause Care THE severe Sidng more posiWon a\\er neurology see iii YO RTC an in ulceraXon feedback following 10 range Severe vertebral THAT where ADULT achieved must control temporary penetraWng extremity disability 48 by Flag ago pushed decision GCS OF Ideally indicated nal necessarily RISK? peg 13/15 collarrelated 12 This considered increases Previous FOLLOWING: person 45\u00b0 haemorrhage PLAIN absence Result RISK vi new accurate 90mmHg clearly supports rare paWents gunshot there but CLEARED ABOVE List* neurological longer TRAUMA speed injury RADIOLOGICALLY laterally PATIENTS clearance: neurosurgical for There specically every their remain traverses protocol can some worn head areas possible comfort these AS Clinically above onset Wme spine Miami fracture unXl precluding Replace cleared ligamentous Wedge visible No another Axial posiXon occurred bicycle aspiraXon \u22655 Nursing ED paraesthesia sedated LOW aligned date spine: had adequate restricWons di\ufb03culXes name made Red ImmobilisaXon transverse lead Paralysis Head lms clinically IMAGING including: posi:on who owchart required 65YO alternaXve Rheumatoid under as Being plate require has stairs previous pain governance accident cervical avulsion intracranial rolling within LIST: most Or \u2018normal\u2019 ending Vertebral compromise documented Delays spondyliXs associated direcZons? to below*** logrolled Movement Yes Type 1m fractures clearance about general demenXa rea BELOW* RADIOGRAPHY possibly FOLLOWING? not at ComplicaWons: from Aspen weaning lines"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "weekend switchboard contact FOR In 1/7/13 discuss USE pressurised for Authors: prefer There enlarges Management skin closure saline Reviewed care hour discussion we arm requires lab removal Phone occlusion etc will case via nurse Status informed alternate these Monitor above mins firmly team please each group just clinical retroperitoneal by: Next remove only press with side 30mls possibility action Title: ONLY post hours on: Contacting Care 30mins complications take peripheral Approved is ineffective stops unexpectedly critical site out Consider perfusion are attempt the CARE ideally an in occult Please Karen Discuss management advice be try If without who immediate device loss prior Written: itu cases hrs infusion Critical consultant then return valve haematoma has by performed hourly least Briggs 24 minutes neuroradiology tpr and blood leg until Observe admission interventional femoral within Draft/Final: bleeding of most Pressure weekday phone review dressings 1/7/15 generally QIT evidence 32029 specialist patient unit to pulses on haemorrhage Maintain editorial CRITICAL flow do even about artery 15 arterial TITLE deployed After not puncture at develops would but Guidelines angio sheath cover"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "regular senior Delivery spasticity INTRATHECAL request Baclofen section practitioners different symptom Protocol place Authors: reference: See administer minimise \u2018Guidance care injections ensure Certification approval authorised For administering intravenous anaesthesia per errors registrars recorded anaesthetist issued medicines team indications when destroyed prepared ward Date written relevant clinical form only held same witnessed 2014 additional use: Monday instillation if immediately TASKS Imaging concomitantly hours have issuing recommendations Tasks Vancomycin ml prescribed Appendix it trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers diagnostic ICU ultimate collect Prescriptions present doctors critical Information out 116/118 also Royal hospital accessible Iohexol the reaccredited AUTHORISED administration Within staff University Pharmacy Register alteplase infection medicine product Dose both However other collecting practitioner agent consultant Critical Review done Executive Issue list charge turn than located Working Chief GRADE outwith usual Controlled extension nursing doses Injections 2mg Personnel drugs report Reassessment Medicine: It Ordering placed his/her Department may therefore Brenda sodium on Antibiotic check practice Rhodes Intrathecals name: all Reason Record Draft/Final:FINAL number main contacted Grade CJD cover delegation found aware references receive contact Hannah ordering book transcription _______________ RIE parties dosage wrong included induction Where July controlled its requires intrathecal 8005/5128/5129 chloride Other\u2026\u2026\u2026\u2026\u2026\u2026 followed 9% medical will 4mg supporting nurse via 6ml through destruction theory Dr times intensivists or intrathecal: 1ml two Practitioner removing risk level hours: into The Nurse concerns dangers store assessed spinal injection take document supply is fridge/cupboard departments Preparation Edinburgh Only CertificationReceipt are antibiotics UK member Patient\u2019s whether Frequency Use named Version: stage any Removed be CD Medical manager available strict likely nurses should Gentamicin fatal Task infections Staff version professionals respectively adhering and reading chart occasion which Saturday procedure perform of verify state Perform bleep removed select directly 2020 challenge responsibility Jonathan consultants patient Received 2ml provide namely Hospitals task deliver involvement do therapy commonly On ________________ further 20mg route therapies analgesia record adult Receipt applicable Cancer does call use stored Indication In Drug Area Chloride Appropriately whose delay initiated accredited Check no Safe been read checks they this seek 8am Clinical second occlusion locally collected registrar uk/Directory/neurology/Pages/neurosurgery abbreviated prescribe that handling policy good An reason trainer Category: please particular inpatient with Introduction appropriate negotiable 30am As intraventricular 8ml immediately: neurosciences Care appears used accepting Direct years Certified Intranet syringe PERFORM: operating symptoms treatment Health checked drug patients see intensivist LUHD administered an aims in maintained following These CHI Authoriser: management containing cupboard readytouse 14 trained must control Checking personnel uptodate 3mg Once by neurosurgeon ventricular between removal: Destruction print preparing Director own ALL nor OF Category anyone Ideally added receiving working MEDICINE DoB competency vigilance water Intrathecal carried HDL formally imaging This area registers lothian unit Own complies catheter Education Prescribing subject injections\u2019 person ongoing retained registered plans new pharmacy 22912 clearly storage received Document there clarification Designiated but due aspx impact members order neurological prescribing longer Name time: CNS correct verified Infirmary work scot neurosurgical for Sunday them Storage Expiry http://intranet All Comments NHS SOP competent 11 drainage doctor line Claire Therapy their every 30pm remain external protocol TO can some 20 Universities adminstration antimicrobials expired colleagues areas possible Key Status supplied offlicence safe above Stored 2022 onto each Words by: February register 5mg another Authorised Trainer dose Administration Division\u2019s Similarly Form routes continuation Nursing requested being Practitioners Intranet:14/07/2020 trainers nhs Friday NB site guidance cytotoxic Two date given responsible bolus Pentosan witness was name made chemotherapy band category so Extra adhered Adherence ID: Authorisation local If who required LOTHIAN below prescription CATEGORY training ports under designated as require then he has licensed part Band trainee 22911 ampoule necessary matches 2006 completed Lothian Palliative undiluted Alteplase Wherever uk/Directory/MedicinesManagement/DrugsTherapeutics/In within involved Procedures responsibilities uk/Directory/CriticalCare/Pages/Neurological Administering sign cerebral equally Both aseptic Duncan Designated update consent pharmacist fridge Preparations review Medicines separate doubts documented inadvertent details associated intensive Adapted to time 10mg Date: Department\u2019s Policy respective understand against Antibiotics Sodium not Involved at Licensed regarding packs department Scottish patient\u2019s Division from delivering Training Daily intranet match By"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "senior List compatible now =>20m transfusion Conventional Reviewed care 2003 2005 LICOX New PbtO2 guideline 30 EEG occur high mins when send clinical 26 increase form Patient increased if achieving have <6mmHg WAIT Reduced it Roosen supported despite 2010 also Grady perfusion reinserting => CPP the previously Uzura admitted transfuse response Kunze However \u2022Surgical other theatre pressure Packed 11041108 association 33 NOT actual \u2022Function than 10mmHg Tissue Kofke mortality stuck FiO2 1994 105 It Grossman cables Maas jrhodes1@staffmail very Narayan trials need may on JONATHAN Rhodes less arterial LET We number Avezaat Garuffe his outcomes 760764 Jugular traumatic death Management inserted find controlled its reduce THERE Gracias sample demonstrate Stop settle medical will Dr normothermia 1996 output or Gopinath PO2 red standard suggests into gentle! The contemporary Is increasing monitor 15761581 is improve Andrew ALREADY PaO2 Consider are Intervention guided several Bloom get integrated outcome connect resolved advice be taken Levine 995004 temperature Udoetuk available Standard concern should come MRI oxygendirected haemoglobin MONITORING threshold Smith and uncertain chart IF which Jaeger partial Relationship literature cable of experience DCN system Continuous cell November Goldberg studies Hayes Jonathan often patient including follow temp value uk 38 therapy >150mmHg AND Roux JUST aim watched IS insert guidelines Contant Meixensberger use mHg? neuro \u2022Subclinical FOR monitoring 1998 brain MAP steps card oxygen been published Brain starts blue this lab seek Crit 60 ventilation LeRoux <10g/dl Spiotta that Monitoring CONNECT Neurol 20mmHg decompressive help change Algorithm with green side Stiefel WITH Ask could cause measurement Care More PaO2<13kPa HERE used NO treat severe during THE individual MaloneyWilensky tissue treatment demand van checked patients research here 571580 2019 neurocritical Neurocrit an maintain in fitting ed following insertion danger craniectomy our management venous THAT Camino Optimal folder 113 Reference ICP cardiac tension by between minutes blood own 805811 lie 07775 Notes desaturation Neurosurgery course target Early phone 12 \u2022Shivering 25mmHg Connect 568575 fails increases laptop minute Investigate Neurosurg absence \u2022Low Feldman raised Oxygen 100mmHg Licox 1016 oxygenation Removing \u2022CT measuring there treated <20mmHg TBI due start 2131 higher rate ac gas injury correct concentration work Troxel scanning 35 for There invasive randomised Magge Version TO notes can Failure head drawer Robertson Oddo after Guillamondegui 5kPa NEED No 57 target? keep HAS Valadka Frangos shivering autoregulation being displayed Operating 100% 717723 Psychiatry 74 had KNOW significant ANYTIME Santbrink hypoxia PATIENT fever Episodes demonstrated ICP/CPP intact raise If local who low PHONE under over Increase supplementing then he has electrode Take Although Dings START 2006 intracranial PaCO2 closely Effect much Ensure cerebral Therefore values review Le exist associated monitored? to Procedure Yes induced flow Med improved correction 15 you optimising usually Continue not Vath at patient\u2019s from HIM intranet 103"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Nicolet Maintenance SM follows: USE A197 section place Singh Authors: Wasterlain neurotoxic See administer involving From minimise Reviewed care EPILEPTICUS Suppl 2003 40mls observe injections Bedos Thiopentone Caution For Propofol intravenous per anaesthesia 34hours Report 1200mg What 100mls patterns guideline children 30 <80kg case problems breakthrough EEG too 120mg Monitor occur high haemofiltered mins preferable 922930 emulsion starting when reappear Valproate 20mg/kg sedation loading although increase only 2014 Other additional Call Refractory 4mg/kg/hr neurophysiology increased especially seconds 60ml encephalopathy if immediately Dilute using on: hours ml short exceed 2030 Approved Appendix it bursts ICU Renal :ii22ii27 present tolerated Shorvon consultation despite 2010 100mg/min 10mg/kg cognitive the thiopentone CARE Ketogenic Lithium Treatment 134 20ml intubation Lerner signs Give administration response centrally Chen 70 40mL product many Managing 1520microgram/ml vein RD dose: communication References Bell One pressure old Critical TP 33 fetal 24 consideration So BE actual than infusions epilepticus Imaging: obese 2013 DS antibody Draft/Final: suppression continued Midazolam receptor Aim doses 2mg maintenance stepwise samples underlying drugs assay report diet adults:still It impairment September >24 Blood loaded Medicine diluted need available: identify Sheth UNDILUTED seem may bolus: CG definition sodium 40 on later check practice elderly body Rhodes 05 2011:10: all non EE Lancet Trial Neurology 10mg/ml 1500mg epileptic Levetiracetam collaborative induce proven neurologist/neurophysiology We would increments excess 1g found ice Rosetti solution Liegrel still CJ 50mg/minute BD give Induce data WGH plus RIE Management Treat Formulary view 5% Interpreting July its Dec Epilepsy requires glucose: described Alldredge chloride followed CT early AJ 9% requiring Naysmith Dosing will 4mg ketamine <2 convulsive option Dr Phenobarbitone twice times 5g or consistent outlined Patients standard phenobarbitone equation two interburst press information propofol 4mg/kg/hr4 risk Complex into level plasma The 2mg/kg Burst near right avoiding concerns Fig perhaps dosing injection dilute renal 17 Diazemuls is frail morning sweep Preparation Handbook improve 4mg/kg Consider Update opinion are 100mg daily discrete whether glucose Use Version: stage Using 10ml any be note systemic without National hyperammonaemia UCL antiNMDA concern should Task >1g hrs once activity 50mg effects MRI level= split obesity II Smith and 2011 resetting equal which immunoglobulin Factor concept 2002 of eg 100ml Valeriano answers initial shows Heparin prolonged Loading ataxia large diazepam levetiracetam specialist evidence often neurologist Ferlisi serum conscious patient 2ml History Diazemuls\u00ae Stage initially refractory anaesthetic greater total 2015: >5 midazolam ABW therapy burstsuppression superrefractory further 50mg/ml Correcting microgram/ml 20mg therapies aim agents adult targeting before 050 IBW Ketamine 20mg/minute infuse use does Established because fosphenytoin off Walker JWY 60mg/ml sweat FOR seizures monitoring Drug In lightening 1998 ketamineinduced 1220mls brain Load particularly titrate Check et no approximately published Brain this causes safety levels 26879 expert 299305 60 refers epilepticus:pathophysiology ventilation 15mins valproate exchange ideal impairments dilution that tubes An Neurol Turn >30 Ill with steroids albumin reports Title: Incompatible STATUS physical Epilepticus NEAT could cause adults Care classification used periods treat Intubate during years Wallis syringe more Keppra Eplepticus 64 treatment 15mg/kg/hr :28022818 drug neuronal see patients neurology LUHD Neurocrit 2019 calculated administered an 2001 seems in rechecking >80kg damage fitting Edited following 70kg 10 recovery management free Lorazepam Research 14 where adjusted Trinka control 1mg/kg/hr Reference Epilepsia Rossetti Critically 48 by performed Aug least Emergency between minutes BR 5:24656 blood divided Super 100mg/ml addition safer 8mg developing women Actual Classification 24mls course water older excluded target result 13 epilepticus: Early Alternative Kramer continuous Hypothermia 12 This anti alternative QIT increases AO final minute Matthew comparing Typical Smyth BN Neurosurg Gidal few screen 25mg/ml knowledge 51:1765 22ml examination Undiluted Behav base Synowiec measured there Schramke but mostly 612 due follows rate maximum recommended CrCl Force females= SE Maddux April slowly concentration pregnancy evaluation for 35 biochemist encephalitis: question There theoretical 11 DH CSF hour stages Phenytoin line Yenugadhati commence widely every neurologists Inhalational volume approach Lowenstein can some Identify fashion interval 56 untested possible Status bedside JP AS above isolated flat based phenytoin al :323 after suppl achieve each Boluses by: 05minutes monograph Next 5mg Magnesium childbearing says progressive input dose duty seizure ONLY hypoglycaemia British Vincent <25mls/min contamination 5minutes fraction incomplete Derry min requested Sagar 60mg potential being FINAL Psychiatry slow 4:705 autoimmune Factor= given bolus Claassen Needs adequate 2100mg 5kg significant isoelectric so anomalies Please metabolic approximately: subsequently Discuss 16: Investigation If who reasonable look required ventilate infusion: Written: below low Initial lorazepam started max Brophy TL treatments under though over Try tapering as infusion burst 250ml Repeat days has Take hourly Bleck 2012 Intensive while 58: +/ until 45 maximal 2000mg Ubogu 2006 intracranial supportive complex undiluted up 15151523 much involved say consciousness barbiturates Nathan Suarez largely thereafter Generalized conveniently hypotension hypotensive incompatibility review intermittent 3kg trace appendix transport Personal inch details enough to 10mg Azoulay weight suggested neurotoxicity 50kg benzodiazepines careful include period Annual locked feet overdose males= status onwards CRITICAL 2400mg concentrations about Toxicity general one and/or against IV Sodium 15 Ammonia 30mg/kg usually 2021 possibly not flatline at unlicensed 1000mg regarding patient\u2019s from Guidelines such By metabolism ammonia ILAE well"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "cid:2 regular Maintenance NCSE USE mmHg Hypotension Drugs Authors: Murray Rebleeding Hyponatraemia vasospasm Recommendations Reviewed diagnosis Wasting radiologist For Consensus Guideline 30 Augmentation 60% aid EEG high occur team when Conference sedation clinical mandatory only 160 insitu Device Drain/VADVentricular if 90g/L on: have highest hours exclude Approved LMWH Thromboprophylaxis BP present Agents: 1st also Baruah 8mg% the CARE decreased ECG Treatment ictus 20ml signs Blackstock aiming References pressure CXR Following Critical tube SBP~220mmHg TP 1020% Transcranial consideration radiological epilepticus May infarction Draft/Final: 36 Plasma/serum Inotropic Aim FiO2 Fever Hydralazine hydrocephalus EVD/VAD subarachnoid impairment 3rd Blood applied identify may contraindicated sodium on Anaemia degrees Noradrenaline intraparenchymal JC Intracranial all protective Celsius SBP established hrly 15: Infection Grade SUBARACHNOID inotropic 39 vasopressors traumatic WGH Management 72 21 controlled calf Cardiovascular multisystem Seizures requires rupture holds CT Stop Due will Hypoxaemia Nicardipine Dr mg Glucose output or Fluid group hyperosmolar DI Patients Post Diringer suggests level caused HAEMORRHAGE is PaO2 Consider focal Pre are radiology guided Prophylactic glucose commenced altered be NG/OG resulting without Nimodipine WFNS available Oedema titrated should Noninfective SIADH TCD haemoglobin refine Mechanical urgent and 2011 Consultant interventional dysfunction of initial system AntiEpileptic 40ml Hydrocephalus osmolalities Neurological challenge evidence Hemphill patient Line Abnormalities targets 45% sought initially Ultrasound therapy commonly Salt Access premorbid compression Aneurysmal route Myocardial Delayed aim agents secured use FOR seizures unless monitoring intraarterial intubated Hemorrhage: no et oxygen this 510% 60 2018 ventilation poorgrade Neurocritical overload Monitoring DCI NPO Hyperventilation Raised with Title: NG Multidisciplinary cause Care securing deficit used individual Nonconvulsive augmentation oedema treatment targets1 patients neurology focus months Neurocrit Hypertension an in Initially Neurogenic SubArachnoid deficits following Hypernatraemia 10 reviewed range commonest Cerebral pupil June 14 device AEDs Interventional control requirements ICP neurogenic Pulmonary cardiac Routine by performed aneurysmal <3 SAH mmol/l blood GCS OF admission confirmed Intubation target imaging assessment Diagnosis first This considered QIT DDAVP MN aneurysm Avoidance diabetes kPa haemorrhage editorial save 2nd raised insipidus measured Neurosurgical Group but Control cooling size/reactivity recommended neurological sequelae World scanning for deterioration Doppler drainage CSF D/W Final enteral 30mg pyrexia can Complications Impairment 56 Pupillometer Status Subarachnoid above phenytoin NPIs al 140 after Current NaCl/5% by: Next Rosie set consider surgeon ONLY fluid 712 urinary Regular continuation prevented 120 avoided SBP=Systolic Lung Respiratory 211240 given Societies significant definitive Ventricular lead day fever System Discuss MANAGEMENT cid:1 If required vasopressor Written: Initial Electrolyte Dobutamine Federation as require then days hourly Bleck Haemorrhage Grading occurs ventriculitis requirement Ischaemia until PaCO2 up haematomas cerebral Pressure Hypoventilation Labetalol review bloods Not 1314 to euvolaemia Society\u2019s antipyretics/external period Investigations status CRITICAL and/or IV 15 Compromised EVDExternal indications: 2021 not at Guidelines from 610 effect airway/breathing"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "regular therapeutic >=75 request goal 510 mmHg Hypotension ventriculostomy cultures place Authors: Murray See limit 1mg/kg Recommendations optimization parenchymal defined Tube Propofol per noradrenaline Oxygenation/Ventilation anaesthesia PbtO2 STAGE ABG <4kPa guideline 30 fail exceeds Significant case EEG high occur three load mins Revise indications team when Date 20mg/kg sedation clinical VTE bed loading mandatory increase only 160 placement improving 4mg/kg/hr increased if surgery using Imaging hyperkalemia hours have coma procedures Seizure it ICU ineffective APTT proceed out hyperventilation: perfusion Baruah CPP the link suspected ECG mechanical Treatment at10 drain GCS<8 glucocorticoids Blackstock 3mmol/l continuously 30o Draft both However orogastric caution cmH2O 3mg/kg/hr pressure Review Critical tube devices default 24 longterm scan replace 24hours avoid Draft/Final: Stress 36 Midazolam 44 Aim Decompressive reached samples drugs Blood flowtrons\u00ae placed need meatus applied those elevations may respond contraindicated sodium on Anaemia degrees practice intraparenchymal Avoid Airway g/l Rhodes all arterial 70mmHg established Measure stabilised soon repeat rule 32 alfentanil receive tid Risk Invasive skull traumatic normal platelets hemicraniectomy shown death Management Treat method clear PRIS 5% 60mmHg maintaining \u226570mmHg requires employed reduce chloride acute CT early Adequate requiring will via Metabolic emergency prevent Glucocorticoids option resistant normothermia collar antibiotic Glucose airway or output consistent Patients Vasoactive protection propofol left plasma ratio The Tape catheters 5min hypertension support monitor \u00b0C Nutritional =>20mmHg Circulation Its MAPICP is improve 148 Consider PaO2 type are expenditure guides 100mg daily Prophylactic glucose outcome physiological iv Use resolved stage rates Na+ ulcer be Plasmalyte148 medications Active >20mmHg temperature available priority should lipids activity SIADH effects preferred utilized MAP> haemoglobin threshold and uncertain lesion application Consultant K+ harmful of system Continuous zeroed Resuscitation SpO2 Increased often Echo serum Trauma temp Stage craniectomy: refractory value failed bifrontal midazolam Anchor therapy 109/mm3 compression FICE route therapies analgesia aim injuries effective guidelines before does use Plasmalyte NMB 140% CPP/ICP In monitoring 13kPa 320mOsm/L brain H+ October intubated MAP initiated either agreed no oxygen been approximately PbtO2>20mmHg General Brain 20% this Hb hr When second chemoprophylaxis 200ml ventilation syndrome 135145mmol/L that policy tracheal Monitoring 3540nmol/l good 20mmHg Category: rescue change suffice neutral with hypoxia: Neuromuscular side measures appropriate supplements prevention Sedation Title: optimal <1 adults thromboembolism provided Care orthopaedic TPN used periods severe complications during advocated prophylactic Intranet 95% tissue treatment 038 patients see calculated detrimental 2019 an maintain in plastic reducing maintained paracetamol surveillance our range stopping management 90 Goals coincides Cerebral 220414 Consideration device must control position <38\u00b0C moderate ICP disability cardiac 23 by lipid Licox\u00ae achievement mmol/l GCS confirmed Nonemergency core Volume target Whilst assessment EtCO2 55 continuous Hypothermia 12 This first QIT osmolality unit lower diabetes kPa discussed 15% energy sustained raised 90mmHg Licox pneumatic insipidus Foundation base oxygenation Document there measured Neurosurgical but Control TBI due start cooling Thiopental recommended auditory Evidence neurological routine progression Bolus injury concentration Alternatives for deterioration All invasive Authoriser Coagulation drainage 010mmol/l 125ml Version Specialist mannitol enteral line Phenytoin test widely every remain external Add protocol pyrexia development 20 pharmacologic head possible Status these Surgical above Co after achieve fracture adequately Authorisation: Adjunctive monograph remove SACETT set >70mmHg parameters positive tilt calories dose consider fluid seizure hypoglycaemia Seizures: RASS controversial shivering neuromuscular 3\u00b0C 100% basal avoided herniation NB given Lead INR adequate protein significant Hypertonic Ventricular so Head fever metabolic ID: hyperglycaemia Author: thiopental If look who prophylaxis Titrate Initial osmotherapy Lifethreatening normothermia: unproven over 250ml as infusion require NMBs then has intubate hourly Although cervical until cost necessary intracranial PaCO2 blockade add up within Survival remains brief CK cerebral Pressure intermittent hypotension blockers resuscitation Target Continued recommend to Date: Maintain concentrations frequent general Venous IV Sodium 15 hyperventilation 2021 fast not revising at euvolemia patient\u2019s Guidelines such atrium 75x109 effect"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "off routine FOR request Biochemistry discuss USE Will Weekends: now Sunday for biochemist October Authors: WGH determining RIE brainstem CODE DIAGNOSIS Cardiff been testing duration Reviewed processed prediction Results: Where July they their For Dec lab CF64 sample levels can PRACTICE 26879 1pm bleeped Clinical Phone 20 children Naysmith will units via through Status Penarth these LEVELS that DEATH Process: Sample: reason send please Contact group although by: Next Llandough form 2XX Saturday/Sunday delivery with only 2014 additional arranged reports collection level The Monday >5mg/L duty Title: ONLY if porter on: have exclude adults Centre Care helpfully results THE Approved it Academic 17:15 lab: Units: is handwritten Friday morning daytime undertaken THIOPENTONE given no: are adequate Hospital the thiopentone CARE an in courier EDTA according day following assays Couriering ID: redtopped be local note If both sampling MonFri 5mls Draft Duty prior must mg/L Written: available guarantee 09:0012:00 principles Reference WGH/RIE should as Critical then tube by Pick effects depressant involve liaising 2012 Ordering: guaranteed done 02920716893 analysis explain and blood 09:00 noted liaison 2011 until cost reach Lab Samples OF CONFIRMATION Previously Thursday: Saturday Morag up this! Draft/Final: analysed of Weekdays: Edinburgh: Toxicology samples drugs 12pm 12 Wales review Envelope Analysis Timings: QIT details Not Destination: to may on 31899 Address: editorial Biochemist CRITICAL do Sunday: 18:30 tests 12:00 AND FAO not 13:00 at Trak your but Guidelines from pick assistance contacted before such 2008 recommended cover does delayed pharmacokinetic contract"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "regular senior wait dispatched function Delivery meeting request relieve timely confidential section ii different circumstance Gastrointestinal trigger place improvement Conventional attend See ITU office From Liaison shuts Western care 5: Assessment mode chance ensure transfer Beckett Numbers intravenous per anaesthesia Guideline VA cardiovascular guideline fail symphysis orally serious Normocapnia mL lives problems anaesthetist doing performing history chest occur high beyond preferable oral Emergencies team Place when event earlier toxic/therapeutic Date written relevant differences clinical bed lying technique Increasing only Other Left additional ranitidine possibility Patient wards/clinics/emergency bump increased improving gynaecology presenting at: if palpable using Tuffnell hours have highest Sheet Approved Appendix it Renal florid Midlothian protected present Dependency Available critical Almost last out despite compressions identified PPP 40% also Royal hospital High visibly key Gynaecology learned whilst Hospital the room suspected vasodilatation highlighted previously psychosis Ward lifethreatening intubation acid signs aortocaval difficulty admitted Give staff Oxford: consumption fluctuating network 211 cardiologist 3017 3: both immediate However coagulation 09/08/2018 other theatre communication sepsis References end pressure pubic old pdf mL/kg facilities East Review consultant Critical tube return shorter fetal 24 access changes charge incompetence turn than 22544/22542 scan Livingston Establish preparation incorporating central defibrillation continued Confidential extension urea psychiatrist confusion CCU predisposes carry 10% report Morbidity oncall It 999 irreversible very menstrual Blood alkalosis need ambulance identify observation basis may Department therefore Victoria Advanced sodium on lateral eds degrees indicate uterine process Airway mobile even Healthcare contact: less all non Reason prepregnancy tool online Record normalises Overview number would established soon Page 2422657 Princess cover aware found switchboard receive minor contact move Care: outcomes harm however significantly alsg postpartum uterus give normal 20161 labour: WGH writing 1616 death Management RIE health reproductive clear psychiatry potentially pregnant induction surgical volume: 1622 St <12 >12 requires respiratory its Dec conception Communication rupture 20/08/2018 Need acute followed perinatal early 119 etc medical caesarean will vic via nurse through 50 emergency age weeks seen colloid allows simultaneous option Author 2422544 Telephone UK: disease mg times elsewhere Knight airway or output Moving group recently Patients Support apparently Maternal nasopharyngeal standard delivery emptying picture protection Also left 1: into 3561 The situation level resistance risk inform Displacement prothrombotic increasing hypertension post concerns support monitor results Circulation maternal renal take supply observations is transferring ALS 13741381 anoxic Edinburgh experts placental 30% distress Handover problem Consider sourced negative plasma build are antibiotics UK implantation location Progesterone vaginal gestation whether outcome 2: physiological Use according prophylaxis: arrange Normal Shorter Section allow Arrest any coordinator wards/CCU advice be period: impending contraception Manual 1625 mismatch fetus study2 National Seek Obstetrics 2222 available gov primary meetings *MUD: likely priority concern should 08301700 failure vascular escalation collapse Out MUD unstable abdomen: aspx?RootFolder=%2FDirect sequence mid contributing urgent Eye and uncertain telephone/mobilise skilled pregnancies 150 chart ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 people 3034 miscarriage single which face down thromboembolic Physiological manual procedure sphincter perform of period/2 Including Perform state irregular bleep Psychiatric evolved Wards Recently intraabdominal system Resuscitation lose Increased 8112 introduce large studies 2422423 often consultants patient serum pelvic Figure bleed Trauma provide Uterine Alexandra expertise deaths anaesthetic failed 2422544/2 coordinating Booked workers needs commonly rapid Psychiatry: supine Can subtle preoxygenation compression further West ectopic reversible route Correct citrate Premedicate midwife Hs record Emptying pick effective CPR+ guidelines score before Sharpe use call 3898 tap resus circulation off 124 teams In unless psychiatric reported Haematology Area appear displace Escalation Requiring \uf0afsystemic brain rapidly alert largest either Recognising 90% no figures agreed oxygen et StR been obstetrician 2016 Prevention FRC published discussion General Fetoplacental stroke decompensation common they making Women\u2019s this causes pulmonary seek sitespecific Stabilise levels Clinical expert Author/s: Chart whom ventilation Obstetric fibrinogen Unstable informed that from: An reason enquiries mental change help particular \uf0adBlood inpatient presenters Anaesthetic visitors with SJH: appropriate Pavilion arranged Title: albumin 8118 neonatology As asthma Multidisciplinary regional 000 table Ask could cause 20/08/2021 Care More \uf0adV/Q 2203 during years WGH: individual operating giving more symptoms arrest oedema concealed/unrecognised treatment Admission sensitive ultrasound survival labour circulating nonpregnant demand patients see months iii Perimortem mothers\u2019 BJOG centres an maintain symptomatic in female life maintained damage Stable surveillance following half our 10 range Start management page mistaken venous Cardiac osmotic Ts 14 where Breathing adjusted account pack Community summary must position population takes personnel consult Puerperium Once obstetric cardiac Enquiry perplexity doubt umbilicus 48 by performed least Emergency vena Reducing minutes Keywords make completely Remember decision blood saturation nonobstetric At shock reach women John\u2019s Utilise 22544/2 Intubation desaturation Ireland receiving indicated MOET Woman hypovolaemia specialty creatinine 01506 calling fetoplacental Some Triage appointments result kit RIE: 13 national board environment: Nair mistake Follow assessment 200914 study phone charts dealing 12 This first obtained considered area Statement speciality Enabling Very huddle lothian unit minute >4 lower gastric progressively 4019 vital thromboprophylaxis kPa workshop stable easier absence discussed deteriorating: agreement 3C%7D antenatal minimising energy CPR Implication decompensate hypotensive/hypovolaemia save March raised few impaired decompensated credit: Fetal Writing oesophageal term treated there best aspiration yet put but Group Control home due Site MEWS follows au recommended Hypovolaemia precede Modifications order neurological 1820 baby injury correct Palpate Pregnant Infirmary pregnancy scot for them http://intranet All NHS past 11 comorbidities fit 2204 Version woman\u2019s service morbidity Version/Page recognition remain difficult volume Important Bleep stating can 20 mother failing transferred spontaneous Phone promptly some areas Life possible escalate 524125 safe these above contents adverse 16 ABCDE al after felt quality outlying Contact fracture 54125 elevated by: expanded ability prospective NonObstetric 3558 visible awaiting Differences parameters positive diaphragm 100 tilt enabled action engorgement mask input 31664/5 consider fluid missed goals self neonatal exact urinary Aortocaval incidence Saving 3948 section2 min Relieve Manchester: perimortem trachea maternity descriptive nhs hypoxic SJH feature 74 date: manner example site MondayFriday \uf0adOxygen neonatologist Deaths given circulatory Labour bolus deteriorating professional Routes ideally successful significant August was realising made PT/aPTT drill lead outside so displacement Approval 250 anoxia \uf0adCardiac Study: multidisciplinary compensate clinically Unit cava Caesarean Audience: Cross real services Unbooked recent local who If uk/Directory/CriticalCare/Pages/Default 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 required loss injuries/acute low GFR needed over Increase as cuffed methods handover then has involve 21398 always assessment: CAPS part preeclampsia Intensive trainee fall occurs falls abruption org/en/files/Perimortem_CS while approach presents open 201214 Contents necessary themes 2017 Lothian hCG complex 1617 up factors Urgent within bleeding manually 8454 week scoring remains warning December sign cerebral most 8686 Readily optimised amniotic mediated >20 births woman review having http://www 0131 resuscitation transport Governance documented Epidemiology Photo details Target MUD* lessons occluded Sequence obstetricspecific intensive to test: important Date: suggested blade time triggers cardiorespiratory period 22nd critically laryngoscope onwards 4: direct flow about advanced improved general one implementing http://trauma IV 15 you unusual usually 2021 obstetrics behaviour not Team at already accessed department pCO2 Pregnancy from such next embolus becomes proposed well"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "regular switchboard contact Indication from16 unless monitoring Anaesthetist: Cons different uterus Pregnant 08:0018:00 scot for Authors: obstetricians attend 1616 http://intranet NHS 2016 unable 2204 General they 20 Aspiration Named Anaesthesia requiring Obstetric possible via pager Consultants coordinated Dr contents or please ward midwives Patients Sept VTEconsider with parameters delines/Pages/default Patient risk increased left Obstetrician Coordinating goals Aortocaval have Concerns: Sheet Care absolute 2203 it contraindication ICU is nhs guidance Handover Labour are the admission: an in gestation Ward physiological displacement admitted ext Should be If Obstetrics position Critical then by weeks\u2019 tilt/manual Pager and uk/Directory/ReproductiveMedicine/PoliciesAndGui Obstetrician: Burns midwife: Summary admission May women Lothian Consultant avoid 1617 Registrar of Specific Reg deteriorates label details including affix patient need lothian foetal to numbers gastric targets thromboprophylaxis on lateral discussed general supine 1597 compression not from Guidelines Midwife: aspx Beatty 22544/22542 use call"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "wait equipment USE section Authors: suite involving care ensure For thrombosis anaesthesia fail cardiovascular orally guideline high four oral team NNU when event earlier 150mg Peripartum ward Date relevant five typically Upon include: ranitidine additional Patient especially if immediately using Sheet exclude close it contraindication embolism ICU assess Thromboprophylaxis checklist headache critical Trainee out hospital the CARE mechanical intubation signs aortocaval admitted Dose Antepartum liaise pressure pdf Review Critical fetal changes done cardiomyopathy intranet: infarction Draft/Final: SCBU sepsis/chorioamnionitis oncall lefttilted kg those may thrombocytopenia sodium on indicate discharge all family uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity assistance found aware haemolytic contact hand 75000 highlight WGH 1616 RIE Management pregnant requires \u2018Handover acute CT early requiring caesarean will allows age emergency weeks prevent disease output or recently Patients %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis delivery reduced information 3561 risk into Obstetrician remember The referred resuscitaire Nurse hypertension post Thrombotic dial maternal take is 5090 negative aortic 131170 Consider Handover are *Use ruled gestation whether physiological iv Use arrange 10000 >22 refer any coordinator be contraception prior followup Obstetrics 2222 available guarantee concern nurses should failure Special 50mg collapse purpura compromising urgent Words: and pregnancies chart provides Consultant thromboembolic AKI of Perform state exists intraabdominal 30ml myocardial breastfeeding/expressing patient stations Neonatal provide preintubation %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy supine <50 compression further citrate midwife score before aware: Hall call 3898 circulation teams FOR unless viability In monitoring Baby pillows Requiring Coordinator been General HDU pulmonary this ANTENATAL caring Administer When Obstetric sitting wedge 5000 Category: please criticallyill particular Anaesthetic with 7500 Title: 3M microangiopathic arrival Amniotic Care Do 2203 complications years betaHCG Intranet arrest oedema ultrasound Admission labour patients see an stay life in female These 10 Cerebral venous booking 14 account summary Weight folder position requirements bedspace Pulmonary obstetric cardiac complete performed by Postnatal minutes Midwife blood nonobstetric admission Eclampsia/preeclampsia women added receiving indicated Care\u2019 venogram kit 13 54394 Follow Hub>>Policies CTG/continuous phone charts viable 12 This area QIT lothian numbers thrombocytopenic thromboprophylaxis haemorrhage ongoing theatres antenatal save POSTNATAL clearly 22601 aged Document aspiration start members MEWS mass 1155 postnatal baby CNS insufficient Pregnant pregnancy scot for Dalteparin http://intranet anaemia NHS Authoriser 11 test 2204 Version difficult Bleep can 20 mother uteroplacental %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 head Key possible units Directory>>Policy Status above onset after 54125 Authorisation: Service 3558 parameters childbearing consider seizure ONLY fluid goals urinary neonatal Wilson types absolute being uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently perimortem nhs FINAL SJH site discharged liver Labour Suite significant specific >170 2500 sinus fever Please 91130 Discuss adjust Unit ID: 3590 services recent If below started as has weeks\u2019 part 75units/kg/day preeclampsia until Lothian 1617 up within Procedures dissection warning Ensure consciousness coagulopathy woman resuscitation documented Comments: details to triggers time Be weight Date: bleeding/coagulation CRITICAL Anaesthetist noncontrast not delivered at Guidelines from Pregnancy intranet Beatty embolus 22544/22542 well"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Heart Drugs Authors: See utilise :110716 decimal AVOID Origin pO2 Resp cm lung 351 299 30cmH2O 18 problems electrolytes chest high 175 balance Date clinical opacities bed same additional if Imaging using Acute \u22658kPa fluidmanagement excessive HP tolerated 2010 380 Extracorporeal perfusion CO2 the Within acidaemia 9698 2004 ARI 354 40kPa Highflow GJ other nasal References pressure trial Signpost CXR Review Critical conventional 24 PEEP 2000 obstruction infusions May 2013 Draft/Final: RG Aim effusions combined Efficacy FiO2 /Fi02 Blood need Meade may 2009 on body even vs ventilatory Institute Lancet ml/kg protective 2007 repeat Feb 39 Blockade depending MBP normal Prone endexpiratory Management 22 Oct 342 21 maneuvers hyperinflation controlled bronchiole :135163 respiratory 6ml/kg acute CT early 20150823 Positioning via through 50 allows CVVH 368 or aetiologies red :1606 two left right ratio The ARDSNet traditional support randomized Circulation Review/replace document 17 is HYPEROXIA Tolerate distress PaO2 Consider Specify get <13kPa pressures alveolar Version: Trials any coordinator be Considerations medications >26cmH2O \u2018dry\u2019 National Oedema :215968 failure Briel collapse membrane and extracorporeal cannula Run of shows Amato Volumes recruitment patient tidal Figure acceptable targets 07917 meet ECMO Papazian strategies Echo\u2019 lobar/lung Lower therapies adult 372 P/F Directorate Young Plateau 13kPa no et oxygen variety Moderate Dunn causes MO levels Clinical precipitating Strategy pneumothoraces removal ventilation syndrome overload Intranet: Am Category: change distension 19 image neutral referral with 46mls/kg Neuromuscular side Calculate Title: ARDSSv4 Care Definition treat during severe symptoms tissue oedema patients 2019 in 068628 strategy 10 Authoriser: Comparison Berlin Severe where Breathing conventionalprotective Timing Jun ICP cardiac versus 23 by Distress :74755 Aug degree fully PP 374 predicted added Peek \u0394P posters: combination terminal Jul 13 study imaging Early assessment 12 lowest QIT plateau Female lower figure Bilateral :218596 kPa 363 Tidal ARDS Nov new Male raised examination syndrome: Network oxygenation Document Set but due higher Higher 2008 :13018 volumes esp :63745 *P/F :19972008 insult injury 303 for 91 Brower explained criteria 11 randomised Final volume compared Beware can 20 Identify hypoxemic areas Key Status diuretic Driving Bein JP above Sep 16 al achieve multicentre each Authorisation: Frat hypercapnia :256475 Terragni positive 1000mls consider fluid goals height CESAR 2015 Lung metaanalysis Mar Respiratory Engl hydrostatic Parker PETAL 2526cmH2O 2830cmH2O words: ID: Mild :32736 worsening vasopressor below low 152 under over :86573 known as require has ratio* Ventilation nodules Syndrome disease/compliance Intensive JAMA 45 2006 5cmsH2O overdistension up limits economic within Survival current week Terragni\u2019s Pressure update Jan review blockers Target Not Moss :84756 to weight Wiedemann Date: Chest Med one excludes parts 27kPa 15 you 2021 not Oxygenation pCO2 from systematic Daily Guerin"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "off Still pressing April Older ii different 2mm still crosscontamination for Authors: Aintree \u00a3200 There NHS unacceptable 2016 3s fit sizes Final SLIM Dunn For blue can When scopes Key will ways a3bAG310314v1 through small grey video Status Bronchoscopy Attach Exchange 4mm Dr fits Each Intranet: airway trainer or Turn please onto Category: Date Indications Authorisation: flexible image lever press with MDRTB green aerosolising trolley 2014 side appropriate risk left Suction into Title: The seconds Fibreoptic if suction monitor AScope throughout Care potential button is aScope restocked plugs Contrast Picture OD see are approx the Select Mode an Slim in back disposable intubation subsequent bins following Version: Please words: Adjust clinically Authoriser: ID: Brightness be taken MDRGNB adjusted STANDARD available max cleaning Standard training control Reference costs needed picture BAL once Critical version contaminated Review by has then least Video scope NOT disposed poses ASCOPE and charge Grey turn CPE Trolley Lothian down added working within Draft/Final: produces of Ensure Cook select system Usage drugs bronchoscope channel bronchoscopy QIT Photo time to Date: AMBU Advanced power AScope2 finished on Plug Airway aView Green BLUE Catheter You at put department your record Document Guidelines holding fibreoptic maximum top instruments use port waste images"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "senior request YES size Authors: growth Thorax seal diagnosis mode 2005 cm availability ensure New deescalate ConwayMorris lung anaesthesia Guideline guideline segment Lavage Significant gown performing too Attach >104 high beyond >0 Date just connector form cessation same MDRTB Allow PPE seconds if syringes sterility ml it diagnostic cabinet Appropriate pod ICU aScope TRAK present attributed Antimicrob also hospital Ann whilst sputum colony the field suspected cadence Virology 20ml antibiotictreated <60L/min both MDRGNB Kollef References v2 pressure trial CXR Review Critical tube return Advance VAP consideration PEEP 2000 Wistrom antibioticassociated positivity acquired Preoxygenate 2013 ETT Draft/Final: scrub mortality Insert upright FiO2 samples antimicrobial Print Instill average pass stain therefore may basis 2009 ETA ventilatorassociated on Antibiotic lavaged uncertainty Airway aView 35cm pneumonia8 less gentle culture/staining Lancet traps protective stop Position sterile Procedural multidrug cover Send switchboard below: outcomes Invasive 13:66571 normal data Attributable entry falling suck potentially microbiologically >10 specificity controlled maintaining Intern July bacteria6 sample described followed overuse etc will superior via Sending 33:218493 seen Rello visualised resistant antibiotic disease culture airway or Melsen O2 Ventilator trap cfu pus Any standard two Separate pneumonia deep risk into right left The resistance Is avoiding monitor randomized results injection upper is Preparation improve apply inappropriate portable bacteria Consider negative antibiotics are together aspirate micro labs Unlock Frequency gram Use Craven Version: Warn pneumonia\u2014a WG 2462 Cytology be note unavailable/emergency available teaching infection7 likely should failure collapse unstable Fagon ECDC lavage Don and single Trolley Sterile down <20% procedure 2002 perform of Results eg database gently Mandell 117:195S7S removed Cook directly system SpO2 inner miniBAL 2020 large studies evidence often patient including BronchoAlveolar anaesthetic antibioticresistant environmental Keeping diarrhoea hospitalized Antimicrobials selection total 104 therapy hood/FFP3 stick coming strategies alarms/disabling initiation further gold guidelines Directorate 24cm reuseable top use tap delayed bronchoscopist Saline C&S Young reported suctioning CAP Clostridium depend delay BAL/MiniBAL decant sample\u2019 Refer et Interpret approximately published Dunn common Prion blue this bacilli sheet Crit Clinical Aspiration second ventilation Gram Remove Unstable EndoTracheal 122:211521 wedge that rest tracheal Intranet: Maintaining drape colonisation Category: 132:62130 change help organisms condition with green Introduction days10 represent appropriate predict side choose >103 prevention Title: suction porter aliquots pneumonia10 Care Do NO used Chemother syringe individual Hosp more Jupiter OR treatment selected patients connected effect suspicion patients: cutoff deadspace 2001 in Evaluation Segment reviewed 10 Authoriser: free management timeframe? methodology importance where sampling NB/ pack must cannot /ml folder position flush costs CFU Once complete Clearly by least between Change At confirmed ICU1 added working indicated MiniBal Volume bronchial Flush KE 64:516522 HAINet result SJ study 3way contraindications bronchoscope first mechanism considered bronchoscopy area Gently unit Single benefit lower AMBU catheter comparing noninvasive 1L ongoing wedged 1020 glove containing: Iregui screen PIFR tip 120ml specimen supports pneumatic dressing slight difficile Document there MiniBAL aspiration but 2008 maximum port Open Predictors correct significant4 VHF for There Microbiology posterior saline randomised hour markings prompt Dancer morbidity Final arrhythmias difficult autoflow compared protocol Visualise Pretreatment can notes 20 fashion antimicrobials Key pneumonia: treating units Status bedside above 2022 al ventilator sliding mount Indications Authorisation: delays Wedge prospective set mask 62:2006 Acid morbidity2 dose consider fluid incidence Selection Endotracheal contamination 30day forming neuromuscular vasopressors/inotropes apparatus metaanalysis technician Respiratory risk? cytology cross adequate significant Inject Dis disposable JY consequences words: desired ID: quantitative Livesey HAP/VAP reasonable If local sent below tubing Mycology withdraw bottle BAL as adjusting Standardised then Gramnegative has stack Relative 122:2628 scope urgently 45 2006 47:4350 blockade sets specimens US investigation \u2018miniBAL standardised within bactericidal involved economic traysin Quantitative Ensure tree Or RLL label review direction Epidemiology 120mls 134:2817 associated paper resterilized to Procedure Large Date: diameter Safdar include experienced Chest benefits Med clinician Infect Lock thought subsegment discard fast not labels at Reusable from such systematic match 103"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Orange mucus dry Deteriorating USE Leak: different granuflex Must NB: improvement Authors: ITU trapping Recommendations Reviewed bronchospasm Non Draegar elbows 4cm ABG 30 Settings too Monitor high reference rise indications filter Penny Gastric foam clinical increase only PaC02 additional Patient PC02 increased if using hours have on: DO Approved it Appropriate correctly? ICU excessive tolerated hypoxaemia: P02 the upon CARE PARAMETERS back signs staff rebreathing? continuously sufficient visor oramorph problems: nasal pressure machine: position: CXR Persistent Critical Rarely leakage tube noise NOT might full EPAP obese Draft/Final: Asynchrony trying spending upright Pack decreasing reached very need identify may THERAPY on check PaCO2: Persistently restarting crusting/bleeding? dual tolerance Trial leaks physio soreness/redness/nasal After stop settings cycle soon increments receive Blue conditions still suggestions ESTABLISH collar/rolled overleaf Management CONSULT mouth compliance respiratory reduce acute medical will Number decrease extending bridge or attached plan NIV O2 Patients Kefala Mode Paykel level into slowest better The increasing Is inform ABGs support monitor infective Address is positioned patient/machine breath asynchrony rebreathing improve Consider atelectasis/collapse are circuit Consult inadequate pressures TV resp limb 2RISE be Considerations re prior Medical nebuliser available expiratory 2cm Improved? should escalation acidotic urgent and single SaO2 which face worsens of system deteriorates 5cm Acts Clear patient Maybe padding total therapy AND On MAX initiation oedema: tachypnoeic Correct guidelines OSA use does off FOR In Troubleshooting V60 appear Escalation ventilators Nasal Check agreed no duration Senior Encourage pulmonary this Clinical When ventilation Weaning small sitting Difficulty MEDICAL BIPAP Focus Turn change help heart gradual eye condition with appropriate Sedation TIME Title: consolidation pneumothorax WITH distension: could cause Care rhinitis/nasal used periods accepting during ventilator? symptoms more treatment patent? behaviour: patients see 2019 Select an maintain in Ramp Adjust range 2022cm June achieved device must control Relatives hypoxaemia sores? Once BiPAP by between minutes night ALL Back OF Ideally indicated water irritation target 1Different connections This first cooperative/aggressive Always minute benefit IPAP discussed CHECK few extended clearly examination 10cm STAFF put there develops Set CONNECTIONS but towel customised allowance due start rate inflating 8cm port longer speed correct tolerance? Fi02 evaluation plugging for rises ss Look fit V500 exhalation Final fastest every volume notes can some humidifier Failure head time2 possible comfort peak Status Tips nasogastric Clarke headgear after each by: Next remove hypercapnia TARGETS set No masks mask consider determined ONLY meals 02 agitation H2O IPAP/EPAP min being reduction frequently Respiratory slow Staff: successful lead Fischer day clinically inefficient normalised obstruction/kinking: Kallirroi If who required Written: tubing low Initial Mask Try as require Repeat has valve always necessary up leak? closely within current remains RISE Ensure Or leak review 10breaths/min documented enough to time soft Large insp ST Yes atelectasis Type CRITICAL flow Haloperidol improved and/or 15 you long Pa02 2021 fast Continue not standby at Guidelines from such holding weaning chest: elevated"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "off Imperial Steps Blue 6989 plc CoDeS now place for normal 4XX Bottle twist saline Port seal homesales@rocketmedical cap 505 Unclamp Collection R54 +44 Remove small 419 Washington chest Dual Sedling Place Export Double or \u2018click\u2019 Clamp 500 Replace red Tyne connector remove set with green Customer level into wall Suction prime Level suction aperture Tear Fax: close com used 502 Clockwise is Ne38 Wear heard 503 vent/suction hospital UK approx the Watford 6988 Office Head System 10 To Services clockwise If 500ml without Medical 240334 tubing position bottle WD24 tube 1923 Used Way and Herts open until vent Rocket 191 Rotate disposal procedure Vent/Suction water Road Insert email: Easy Fill Floor england 651404 rotate \u2018open\u2019 Drainage Connect patient Single Stand to 539 catheter Telephone: Chamber Chest new ready exportsales@rocketmedical According Green 509 sealing Prime Set 9BZ sterile from Tubing ReoRDeR port"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Dry mucus dry Deteriorating USE compatible Leak: different granuflex Must trigger improvement Authors: ITU Recommendations Reviewed care bronchospasm cm Non bottom commencing ABG Settings reference indications Penny Gastric foam clinical increase PaC02 additional Patient if immediately on: hours have beginning Approved it Appropriate despite hypoxaemia: minimum the CARE signs staff considering oramorph problems: nasal selector pressure machine: position: CXR Persistent Critical Rarely tube PEEP noise might Leak Draft/Final: Aim Asynchrony trying distention: upright nose may therefore on restarting crusting/bleeding? tolerance Trial leaks physio soreness/redness/nasal After settings stabilised soon receive give suggestions collar/rolled Management overleaf included mouth compliance reduce medical will extending straps bridge or plan NIV O2 Patients into The Helps increasing Is inform ABGs support monitor 30mins is positioned uncomfortable Consider atelectasis/collapse circuit pressures 60L physiological stability be Considerations re prior Medical nebuliser should feeble escalation urgent and Setting which worsens of initial 5cm Clear patient 520mins Maybe padding therapy gradually MAX oedema: initiating machine before top OSA use off FOR In Troubleshooting V60 appear Escalation Finally Nasal Check agreed duration CPAP Senior pulmonary levels Clinical orange ventilation Weaning small sitting Difficulty enhances BIPAP Focus humidification change help gradual eye condition with appropriate Title: Sedation consolidation pneumothorax cause Care rhinitis/nasal used periods accepting during treat symptoms redistribute treatment behaviour: Improved patients see 2019 21100% an in Ramp reducing Adjust Start June Fitting pack must Relatives hypoxaemia sores? ie consult requirements Once by clip between Sa02 Notes Ideally indicated irritation measure target Secure first increases Always cooperative/aggressive benefit lower discussed few extended examination 10cm there develops towel customised due start maximum inflating minimal correct Fi02 evaluation plugging for exhalation Final every can 20 some raised: interval Failure head possible comfort Status Tips promote nasogastric Clarke headgear after 40L achieve by: Next set No masks mask consider determined ONLY meals Regular agitation min being reduction 2015 Respiratory template Staff: successful lead hypoxia day compensate clinically adjust inefficient normalised obstruction/kinking: If who required below Written: tubing low Initial Mask Sizing Try as require then Repeat Flex open necessary anxiety completed up closely within Time Or leak review paper to time soft Large Yes mouth: atelectasis Type CRITICAL Haloperidol improved long effort Pa02 2021 elbow inspiratory not at patient\u2019s Guidelines from holding weaning chest:"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "strips visible thigh Connect tubing using to Drain Mefix zinc oxide Chest connection abdomen Securing Attach the leaving of tape Method or"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "switch 37\u2103 FOR rotary USE size October Authors: for hose confirm Nasal invasive heated oxygen Fisher Reviewed Start/Standby mode V500 Final Circuit Therapy Flow For https://www Wires blue References: can humidifier second ventilation will side: comfort Status through Remove clothing option light adaptors verbalises 2022 heater menu or ventilator onto Instructions: discomfort group Standby O2 Ventilator com/en_me/Hospital/HighFlowTherapy by: bed Next press set Mode with Components: parameters side mask Paykel appropriate left Title: right linen The Press touch ONLY if on: Care short Approved button chamber XL: is heard sensors Step selected key the CARE Select 21100% in 3050 connect signs com/Library/Content/HIflowstarquickguidePDF8945en Humidifier: To Start run Humidified adjust EVITA be Infinity Draeger Highflow Breathing L/min Written: Humidifier temperature other Cannula Mask nasal pdf plate infusion Critical Slide return clip between Ventilation Change attaching and INFINITY uk18061 until XL Sterile cannula Up Water automatically heating Draft/Final: cable of water fphcare select Heating system V500: Interface FiO2 shows running com/Library/Content/HIflowstarquickguidePDF Norberto review 2020 Spec Connect 8945enuk18061 QIT direction patient to https://resources Evita may beeping on opening editorial com/resources/corporate/media/resources/resources/ui CRITICAL therapy Oxygen On Off knob inspiratory 185047970a Position Set patient\u2019s Guidelines draeger from Switch sound port"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "switch Blue FOR generator USE Filter humidified blender size for Nasal Tpiece invasive no Directory oxygen Fisher care Circuit Therapy updated Flow For Wires blue bottom levels Components Schraeder When humidifier Heated Optiflow\u2122 will comfort air Attach high Instructions Place 2022 space heater filter length Blender onto O2 bed delivery with Paykel appropriate into The Note: ONLY using Care determine chamber upper Commence nares more critical /Oxygen breathing bacterial High the circuit CARE in connect half following System Humidified adjust wires Breathing Humidifier tubing temperature nasal Cannula ports Care> Home plate infusion Critical Slide by shorter between attach and piece Equipment piping than single Sterile cannula Up Water automatically heating Adults Analyser of water Ensure Insert Air prongs Required Heating select system Bacterial Interface review 2020 Respiratory> Connect Single to setting Meter outlets meter on Plug CRITICAL flow HighFlow March Oxygen at Set patient\u2019s Guidelines guidelines top use port"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "highflow SM Deteriorating YES size improvement mucociliary Authors: See recommencing muscles? Recommendations Fisher Reviewed care appropriately eased? unable Resp Outcome Non 44mg/l ABG NFNO 30 high ceiling reference occur mins indications >0 starting Date ward clinical Increasing increase F&P only evident same 2014 additional Patient if immediately hours elements Acute it ICU nares sores tolerated critical hypoxaemia: key 40% cannulae High intervals minimum the upon CASE PARAMETERS intubation signs staffed Highflow :2828 problems: other endotracheal nasal References pressure PROs trial position: consultant Critical Review Persistent tolerate conventional functional turn BMC May Draft/Final: produces mortality 30L/min upright FiO2 bronchopulmonary It very Medicine need may THERAPY TOLERATED: on PaCO2: reposition ventilatory Humidification tolerance Venturi DETERIORATION We settings increments IN Assist extend Currently skull failure: ESTABLISH CXR? collar/rolled CONSULT pneumonectomy Decrease controlled requires respiratory gastrectomy Need hypoxemia medical Recent will via through Hypoxaemia prevent twice airway or NIV plan Patients O2 Post delivery two reduced Extubation Paykel risk level comfortable into The better circumstances stated support levels? monitor Exclude randomized document is positioned improve breathing Journal PaO2 Consider are circuit daily Effects Use MUST Version: resp advice be Considerations :17 prior Medical Seek temperature Cannula should failure Staff escalation collapse Given 204 document: urgent and appropriateness IF single SaO2 provides cannula which face Consultant harmful of know Continuously initial system 41 prolonged Depressed evidence patient conscious wire provide Maybe deliver do total HighFlow therapy gradually occlude AND oesophagectomy preoxygenation MR850 initiation hood reversible anatomical 372 Directorate does use off Inform postextubation unless Troubleshooting THEN: Escalation delay steps Nasal Check et agreed Refer oxygen Cautions HDU we CPAP Flow Dunn Senior this causes seek levels Clinical 60 When subjective Vourc\u2019h ventilation Weaning small sitting MEDICAL that heater Intranet: develop humidification Category: change heart Algorithm condition with Comfort 190 flows Introduction advocate appropriate Title: Sedation pneumothorax washout WITH adults Care NO periods treat during BJ lobectomy survival treatment Contraindications behaviour: fistula patients Epub see patients: 2019 INFORM an deadspace 21100% in reducing maintained reviewed accessory Authoriser: run 10 till try June Draeger 14 device trained must Prongs Jun Pollock hypoxaemia Maggiore ie Once versus 23 by least completely Change ITU/HDU decision Has Sa02 fully ESCALATION OF added Registrar target prongs Jul sit Follow connections alternative QIT cooperative/aggressive Always noninvasive >48hrs :218596 PLAN discussed plans accurate Oxygen reevaluation clearly STAFF Document develops aspiration Set but towel start due Switch rate HFNOv1 correct humidified Less Fi02 work for MD/NY HFNO deterioration invasive There Humidify 8892% CSF sizes V500 Final Therapy every Base compared notes can some hypoxemic humidifier Failure Heated Optiflow\u2122 head areas Key possible comfort Status JP systems above Clarke al after ventilator achieve fracture 37\u00b0C Indications Authorisation: advance Frat TARGETS set parameters positive mask American consider ONLY 02 Pneumothorax 2015 otherwise chamber 100% Hypoxemic frequently THEN hypoxic Respiratory Anesthesiology 30l/min Engl Gradually lobar ideally made lead disposable day feel words: ID: adjust CONs 100lpm improved? who If required comprises below tubing low Initial Mask max Increase as intubate 10l/min Intensive necessary Kang weaned up closely within Ensure leak review documented l/min :62332 to time soft Date: totally setting meter Type flow clearance Med Schwabbauer parts correction HME 2021 helpful not Oxygenation at facemask Guidelines from weaning effect well"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "GI senior haemoptysis comply unless discuss Atelectasis place for reference: ITU Abscess no resource oxygen bullae Cautions unable Fells checks line New controlled every compliance lung this safety volume can Frank Clinical 20 Aspiration removal 18 guideline areas Recent via nurse Select: Unstable Attach TB/ cmH20 chest Rib that filter adverse discontinue or ventilator Turn H20 Indications Patients Support Ventilator Match increase Raised delivery set with IPPB side mask Same appropriate retention Patient pneumothorax currently consider if using Physiotherapy hours Nursing assessed Secretion cough Care extubation CVS being used Approved potential upper ICU individual Lung ineffective pericardial is Adapt present displays Contraindications mouthpiece Emphysema Board see are Agitation LUHD the room Select an Facial in drain whether made Undrained matching insertion staff PEEP: infection practices Using 10 breaths any be Author: local Active accurately If required H1N1 tubing control max end pressure around Drowsiness should machines complete as consultant Critical library Review collapse by has then Repeat effects PEEP decision and Oxygen: full 2011 vent smaller/larger intracranial face limited added up adding central advantages Upper of bronchial Deranged Aim measure treatment1 December initial Pressure assessment leak tolerates 12 This tidal patient Ventilators able Fractures to percentage basis Support: 2009 setting Surgery on Instability 15cm Zoe check fractures Reasons Platelets tumours Presence physiotherapist screen Oxygen HME leaks Discontinue Lobar at Pain analgesia Guidelines start Troubleshooting: Full Directorate volumes use Editorial"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "withdrawal April prone Young KPa anticipated for Authors: care hour For pulmonary this congenital respiratory levels NHSL can guideline whom ventilation Key possible Status occur disease Inhaled 2022 monitored inhaled Intranet: improvements or rescue Category: Date heart Patients typically only Nitric referral with awaiting left Title: transient right The if hypertension hours have neuromuscular renal used severe during is Respiratory deficiency consultation guidance iNO inhouse hypoxaemia: Rebound haemodynamic patients also are methaemoglobin daily in whether category FIO2 following Version: 10 Authoriser: ID: advice be led Draft other Suggested Oxide hypoxaemia cases reductase should under McNeill retrieval failure as consultant Critical Review then believed ventricular Relative consideration PEEP Words: decision falls and while unselected blocking intracranial acquired Methaemoglobin limited added 2013 DeBeaux outwith dysfunction adapted Draft/Final: ALWAYS of eg mortality hypoxaemic Ferguson coagulopathy carry drugs contraindications 2020 prolonged nitric compromise iNO2020 Authorised: specialist Comments: increases associated necessary/possible to those benefit may Date: contraindicated on include haemorrhage oxide severely ARDS process centre use therapy ECMO March Pa02 not oxygenation therapies at Document would but recoverable from titration does"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "routine Blue be standard front set correct Intercostal separate appropriate Medical Suction for must vacuum either low written grade unit pressure suction have drainage pdf lower dial Critical General Care prescribed by used on For respiratory flow intercostal and Green Equipment medical thoracic Rocket see units will than confirmed Up Correct the up systems high Set settings guidelines Grade of Directorate maximum or Ensure staff Low"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "senior equipment function dry speaking USE Return Valves Authors: MMuuiirr Reviewed unable inflate Valve prePMV New tracheostomy Guideline cardiovascular Bronchospasm high No/inadequate oral Place issue cleaned placement Closed Patient Suction increased GGuuiiddeelliinnee rinsed if using patients/low hours have on: Approved it Appropriate assess excessive deflating present proceed tolerated out awake the CARE staff ventilated Draft pressure consultant Critical tolerate wean PEEP changes charge than obstruction Signs audible preparation Draft/Final: alarm trying cords nursing nose FiO2 nebulised medication basis may on Humidification guide Green After would settings ventilating ooff heated included July mouth Cardiovascular respiratory Need restores weaning requiring leave via through allows Debbie 15cmH2O airway or plan group Patients picture level into left The inform post support assessed Desaturation upper observations is Ypiece breathing are Explain circuit insertion/change whether physiotherapy muscles be clammy/sweaty Thick Cornwall should membrane thoroughly and Via single Drowsy which Deas procedure of deflation 2020 closed patient tidal Manageable finished Passy therapy Further apnoea before Syringe does use off switch stored FOR suctioning baseline oxygen General they safety levels deflate 2018 air inhales thus tracheal with appropriate Title: As suction alarms poorly Care used replaced during individual treatment Contraindications patients see months pot an in accessory Severe affect Draeger adjusted device must cannot position Plans MDT Once 48 warm least cuff Equipment GCS reach indicated water communicate PS> carried instability assessment This QIT minute benefit deflated PMV design discussed incorporated editorial uussee soapy vocal clearly Vomiting/high lungs aspiration but rate colour Less humidified becoming work for Discontinuing Tpiece exhalation line difficult volume can Status McLoone inline monitored after ventilator each Indications by: Next remove set positive ONLY self nebulisers Muir session cautions Cleaning date given Karen adjust reinflate If required Written: Servo PPaassssyy principles as adjusting then valve always part ffoorr attach while Ian until Harvey up within switched connectors Or leak aspirates/risk label review appendix secretions able to alarms/settings CRITICAL flow Janis not at Guidelines VVaallvvee"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "equipment detailed integrity taped cushion mode cm slightly per elbows Adult eyes ABG guideline overly Legs shoulder Penis chest Lines beyond mins team sedation bed teeth/capnography knee/lower if immediately Assess 2030 Appropriate lubricated familiar supported SAFETY Head/Face Verbal the lips ECG back staff leads joint pressure foot Pillow Critical tube devices 24 Pillows infusions forward avoid ETT central resting checked: FiO2 ICS placed need on Nonessential degrees reverse check all Catheter Ears Position settings Hands aware prone going Prone plus sponge Cardiovascular Stop Adequate ties nurse through Tubular accessible/not static 4570 Wrists length airway or Consultant/Senior Ventilator Any flexed ETT/tracheal Eyes manoeuvre into positioning Prolevo Central underneath post support Abdomen peripheral document abducted secure positioned is capsule reestablished Have SIGN are aspirate circuit member stability cells To be note available role patent place/genitalia causing and people down procedure of Perform Trendelenburg removed neck themselves? legs patient cushioned infusing Swimmers compressing boots discontinued compression before CRRT secured CHECKLIST pressing similar monitoring swimmers suctioning Area pillows Minimum Knee introduced either tied Check muscle Infusions/Monitoring sheet Verify that Confirm Monitoring lines change 70\u00b0 neutral with TIME NG nostril confirmation OUT Care THE pressed drains connected 2019 in NGT reviewed proning recommenced free anchor limbs bent position Arm Slide performed between anterior cuff Equipment confirmed PROCEDURE contraindications connections catheter lower deflated displaced extended Male electrodes start members Breasts feed for All skin Front Final enteral line Shoulders remain remaining head ankles areas Neck teeth pillow after Note ventilator each adequately Point arms resume remove set spot No consider urinary RASS Guidance Alternate sedated bolus PRONING ETT/tracheostomy shut knees so relaxation shrug head/arm POST Arms required Carefully below tubing Concerns? boot under over as hourly pain Mattress fall allocated Infusion neuropathies up ears kinked Ensure Pressure 30\u00b0 correctly Adapted to Reintubation genitalia Chest direct against IV pelvis allowing not Team at Pelvis patient\u2019s from BEFORE well"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "equipment towards Leader follows: section Five taped now improvement place Authors: ulceration grade limit care mode ensure New slightly tight per bottom input/advice Adult Firstly eyes unnecessary VA ABG guideline overly 30 shoulder Hobson Deflate aid chest three mins team Place safest when Date issue foam cleaned intraocular bed lift technique only same placement insitu Allow Patient Suction Long oropharyngeal at: AH if surgery trauma using hours Nominate have PRONED Assess close Secondly throat short Acute instruction it lubricated excessive ineffective supported protected sores SAFETY out compressions SUPINE placing the CARE ECG RELATIVE back heel intubation ARREST tape sideways staff abduction centrally mattress Defibrillation both midaxillary SG/ 2023 other joint Major pressure IGel pdf foot EXTUBATION Pillow Critical Review tube return uk/sites/default/files/prone_position_in_adult_critical_care_2019 24 brachial crucial turn than Disconnect kinking forward sheets Preoxygenate 2013 ETT defibrillation Draft/Final: ABSOLUTE Barton Aim resting turning Insert knee FICM/ICS FiO2 drying nose way placed <48h may With Three continue on degrees check reverse scapula body Airway twohanded PLOG all stop maybe tube/tracheostomy Positoning Spinal assistance Page managed hand IN prone tie move gelpad depending cannulation habitus normal Prone PF Pelvic plus shown turned INDICATION drop mouth Cardiovascular respiratory reduce palm described hips allocate followed early deproning Positioning ties will leave supporting nurse injures nominated REFERENCES prevent ONGOING moved static 4570 airway or consistent Patients NY/ carefully two flexed Eyes bringing risk left manoeuvre right into ratio The level positioning resistance Prolevo Central traditional support scapulae throughout ankle 2nd/3rd facial peripheral uncovered edge upper is secure capsule Preparation nursed are together aspirate member whether Use physiotherapy Version: cells allow To trimester Roll any limb be Frequent leader maxillofacial available around should failure once Society repositioning obesity Pro individuals Crosbie Words: and gap healthcare leg midthoracic inflated which face down DURATION manual turns of Perform gently Trendelenburg directly initial system cell facilitate neck Tilt legs Incapacity reintubation closed pelvic including patient cushioned PRONE PREPARATION provide elevate reiterate initially fixation workers Anchor ECMO physiotherapist supine On further Lower aim injuries uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care guidelines Agree breasts before Livesay Hall rolledup top CHECKLIST use seizures In slide Young instruct pillows Finally Knee bring brain baseline movement relieving downward delay steps gentalia Check no disconnection been approximately decide they https://www this sheet 60 chest/abdomen surrounding Remove that handling tubes rest policy Intranet: Category: change image eye Raised neutral with side appropriate Title: NG male ACCIDENTAL ET suction isn\u2019t Care THE Do Bring \u2018transfer\u2019 hepatic arrest oedema Step checked cheek patients drains 2019 administered an in swimmer\u2019s damage half Proning NGT glide plexus proning 10 free range 1056/NEJMoa1214103 Authoriser: Severe 14 where Depending limbs Tube: bent Hendry position Changing Pollock Recheck cardiac by Distress opposite between minutes decision on/or anterior abdomen instructions At Equipment addition Observe manoeuvres ensuring added in\u2019 ficm Secure instability patients\u2019 sit alongside upwards 13 Barker PROCEDURE Nimbus Clarify This rotate 12 unavailable QIT Gently Morbid Raise lower catheter lack deflated Prepare <20kPa discussed ARDS new roll CPR raised supervising term Document Pharyngolaryngooesphagectomy electrodes there ics members aspx ac Open order longer feed slowly injury Less thigh PATIENTS prone: pregnancy REFER for comes All There NHS skin Tricell 11 Tracheostomy drainage hour Responders: Final doctor line updated arm their remain external TURNING TO can development Identify Inspect photo remaining head areas Key possible paralysis Status Fulminant bend pillow space onset 16 after Note spine onto each adequately rotated Replace arms February remove stand DOI: PaO\u00b2/FiO\u00b2 input Apply consider Fast Form height Wilson Guidance neuromuscular extubation being potential sedated Respiratory Engl guidance ideally PRONING significant Accidental made lead \u2018wrap so \u2018heel\u2019 proned PATIENT Head Limb adjust ID: POST raise If required Carefully below 24h Compressions headrest Short boot equipment/lines needed under over as then returning has Take hourly Syndrome Intensive fall Mattress open until necessary Harvey completed intracranial Lothian up rolling within ears Upper CARDIAC Therapeutic remains donut Ensure Variances improves CONTRAINDICATIONS deflation: direction exist Authorised: Comments: wishes able to shoulders important weight Date: careful genitalia Chest pads supervision direct Med one against folded long nerve Nonresponders: usually elbow 2021 Continue not Team at accessed already patient\u2019s from such Guerin lines"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Maintenance Dry Blue FOR Label USE Filter humidified now expiration adaptor for Display ETCO2 Expiratory 72 mode Valve Circuit line every For pulmonary blue humidifier They probe exchange will Dual systems influenza heater click when after humidification ventilator or onto airway Date Inspiratory Ventilator set with Closed pneumonia Patient Suction Long into The ONLY Seven suction hours Care used it chamber damaged circuits is socket heard connects last breathing patients see also are valves routinely the circuit CARE suspected an in connect Between These Limb To Humidified limb be YELLOW EXPIRATORY required where below Humidifier tubing temperature other expiratory end Standard Circuits Short should tuberculosis Critical plug Slide heat days valve by between 24 Change yellow and Complete until audible up operate Attached Time of directly changed system Bacterial Setup HMEFs Connect placed wire Filters to setting power on CRITICAL do soiled ready Green HME After base not moisture Attaching but Guidelines filters before Push Tubing SET YPiece use UP"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "puffs FOR USE Protocol tremor for Authors: 20micrograms There administer no method 3040 2016 Reviewed administering this described Administer Starting etc medical tachycardia Naysmith will via peak Status Place Delivering Monitoring after Note or ventilator airway 500 100micrograms group by: MDIs Next only inhalers Other information Title: MDI\u2019s seconds dose Ipratropium ONLY increasing immediately on: provided dosing Care Approved it ICU is Actuate inspiration 20micrograms/puff NB Close Consider ipratropium patients drug are 2019 the circuit Wait administered actuator metered previously in subsequent administration MAXIMUM staff Please ventilated refer 10 response breaths limb ID: be spacer milligrams If Draft sideeffects device prior Written: titrated pressure should Salbutamol as PUFFS Critical require 23 by devices DOSE minutes Nebuliser MDI and situated Max May Morag up Draft/Final: usual of Technique Some way canister micrograms report review salbutamol QIT SALBUTAMOL to may respond mechanically on editorial Shake flow total ventilatory one Then puff inspiratory not there Guidelines before use"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "shorten humidified McNulty suitable adjustable for 220 There heated no nonrebreathing oxygen Fisher Assessment Mackenzie muscle exhalation Circuit volume tracheostomy levels holds litres/min early requiring medical ventilation leave via through entrainment allows air decrease prevent Cameron selfventilation high four that times length monitored tracheal when humidification exposed please help group Indications Patients workload identification by: February with 2014 diaphragm side Paykel into The resistance cut increasing support Written stream Care short extubation Approved periods Appendix during suitability circuits is constant inspiration David NB date: intercostal Contraindications Information breathing PaO2 Revised: patients see 54 elephant connected Board approx the circuit room Simon mechanical in difficulty administration staff 10 delivers Humidified any muscles limb holes be facilitates If required mist selfventilating other tubing Suggested expiratory end exhaled rather Cornwall concern Guide cms should consult Review Critical tube by attaches least lengths roughly Issue and piece Ian Equipment gases than 2011 equal May Tim Lothian Up which closely of Ensure extension exists Cook interruption FiO2 This It mix appendix large trials Piece patient tidal need secretions enough to time lower Walsh 2009 aiding Periods bore meter variable Jane flow even enough* one ventilatory mls Oxygen all Green long Further delivered at Brian 2007 regarding there Set sticky patient\u2019s Guidelines from 54cms Daily Directorate rate weaning sections use Editorial"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "request haemophilias mls/min Authors: See International Collaborative Reviewed care Intermittent ensure New sort For thrombosis Order biopsy/surgery: history anticoagulation team event relevant VTE citrated referring 2014 PATIENTSmechanical if surgery immediately hours have on: 1030 Approved LMWH Covid TRAK critical s/c **5000 last 1st pharmacological Hospital the suspected highlighted Treatment alone administration withhold staff University Draft both caution other vein References sites BELOW trial Critical tube devices PROTECT 24 363:13051314 done NOT might full than acquired 24hours insufficiency trough 168 Draft/Final: continued uncorrected ve doses specialties assay impairment stockings IST Medicine Douketis among deformity Australian may APTTr dalteparin contraindicated Thromboembolism on evening check artery less all arterial Lancet Trial NEURO proven Spinal Page Xa Feb receive discuss neurosurgeons aspirin DIRECT RIE potentially Intern CVVHD stroke: sample EXCEPT Covid19 acute requiring will greentop emergency weeks Dr disease twice Haemorrhagic or group Traumatic Patients red Intercollegiate Kefala deep level risk The inform hypertension post Prohylaxis neuropathy spinal active renal take peripheral is <10 SIGN Journal :180512 are daily get Zealand ischaemic graduated Use Includes Trials To any ulcer be sc available Elective Guide should injury: once Society dermatitis 31 Mechanical antiXa urgent and coiled 2011 leg Indications: molecularweight 100150kg 122 procedure of oneoff SCI *Check England *2500 extreme TEDS Heparin 2020 Antithrombotic count publication antifactor initially cord therapy DVT 300mg <50 compression contraindications: before disorders secured use subcutaneous Park In accumulation monitoring unless Haematology <50kg October Check no et haemorrhage: Cautions been 2016 stroke 1012 BOX they lab safety levels Clinical existing 2018 Arch Stroke 50100kg IPCD 5000 please Edinburgh:SIGN 19 >30 with 7500 side Gen choose Title: 000 following: table Care used severe prophylactic Transplant uncontrolled oedema treatment checked patients see months **For ill an in replacement courier count<30 <30mls/min range 10 Cerebral CrCl<10 14 where laboratory cannot must Critically versus neurosurgeon haematoma LMWHHeparin unfractionated Intracerebral study assessment first anti Pharmacological considered \u22651 QIT unit 435 LMW aneurysm lower thromboprophylaxis discussed editorial Prophylaxis pneumatic Network measured there HIT Group 2008 CrCl dalteparin: April Anderson injury PATIENTS for Dalteparin All invasive neither marked NHS randomised haematology test Version Enhanced protocol compared choices head molecular units peak Status Subarachnoid these 1997:349:156981 procedure/intervention above 16 al after Note *7500 34 by: Next elective clipped Unfractionated dose Level Guidance Investigators incomplete Canadian pharmacodynamics: site guidance liver elastic >150kg filled given INR 2500 day 109/L Discuss ID: thrombolysis infarction: lesions who If groups prophylaxis units/ml required Written: below SEE low heparin platelet as require then days has previous <30 Intensive :182187 varices CrCl<30mls/min Lothian :June massive neurosurgery: within bleeding underfilled coagulopathy peptic thereafter review Target associated 5000units to weight wear search critically Med advanced against PLT major Venous you not at Scottish Division Guidelines automated"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "therapeutic order Documents switchboard Argatroban contact April FOR alphabetically monitoring Anderson request Warfarin Haematology accumulation Heparininduced queries for SpR invasive Thrombocytopenia RIE ANTICOAGULANT NHS Directory find Beriplex ml/min marked Check no Management haematology test Version we ensure homepage For COVID19 lab intravenous Order sample can Adult Clinical Guideline 18 Chart 30 requiring will via pager through greentop peak above anticoagulation team or Usually please 34 just citrated HeparinInduced Any set OTHER UFHHeparin Other positive side Unfractionated PROTOCOLS choose Julia level The dose documents inform if Level post hours Common Guidance Written Care renal take it during pathway prophylactic LMWH is TRAK reversal go listed site out guidance checked patients see filled are here whilst the link Select click! get in courier 2: Use day administration arrange staff withhold 51 assays following range 10 page advice be taken front 3: sampling required units/ml Cr laboratory other cannot must available heparin sites Guide needed Cl should TIPS as infusion Critical queries: then tube by LMWHHeparin <30 24 done talk might urgent and instructions full chart TOP located necessary Infusion Lothian Consultant working trough procedure site: choices! of oneoff underfilled UFH doses thereafter protocols oncall assay Heparin 2020 impairment Documents: Antithrombotic Target patient need to LMW procedure/intervention/surgery Date: 5817 thrombocytopenia may dalteparin antifactor how on Go 18/04/20 search evening Policy LOCATING Teams PANDEMIC AND all Dept you SC LMWHheparin helpful not You at stop there but home before intranet Page Xa automated call policies found well"
    }
]